6546
{'I-GENE': 0, 'O': 0}
{'I-GENE': 41072.0, 'O': 345128.0}
BACKGROUND O: 0.000081
BACKGROUND O
: I-GENE: 0.000243
: O: 0.002561
: O
Ischemic O: 0.000014
Ischemic O
heart O: 0.000235
heart O
disease O: 0.000632
disease O
is O: 0.006803
is O
the I-GENE: 0.000268
the O: 0.044902
the O
primary O: 0.000281
primary O
cause O: 0.000136
cause O
of I-GENE: 0.002337
of O: 0.042520
of O
morbidity O: 0.000017
morbidity O
and I-GENE: 0.003263
and O: 0.028529
and O
mortality O: 0.000075
mortality O
among O: 0.000304
among O
diabetics I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
especially O: 0.000090
especially O
those O: 0.000461
those O
who O: 0.000348
who O
became O: 0.000043
became O
ill I-GENE
at O: 0.002976
at O
a I-GENE: 0.000317
a O: 0.015893
a O
young O: 0.000072
young O
age O: 0.000406
age O
. I-GENE: 0.004017
. O: 0.044459
. O

More O: 0.000014
More O
importantly I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
this O: 0.001976
this O
fusion I-GENE: 0.000390
fusion O: 0.000255
fusion I-GENE
converted O: 0.000014
converted O
a I-GENE: 0.000317
a O: 0.015893
a O
less O: 0.000724
less O
effective O: 0.000238
effective O
vaccine O: 0.000055
vaccine O
into O: 0.000785
into O
one O: 0.001026
one O
with O: 0.009756
with O
significant O: 0.000687
significant O
potency O: 0.000026
potency O
against O: 0.000255
against O
established O: 0.000127
established O
E7 I-GENE: 0.000341
E7 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
expressing O: 0.000151
expressing O
metastatic O: 0.000064
metastatic O
tumors O: 0.000168
tumors O
. I-GENE: 0.004017
. O: 0.044459
. O

Reverse I-GENE
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
PCR O: 0.000148
PCR O
analysis O: 0.001194
analysis O
of I-GENE: 0.002337
of O: 0.042520
of O
mRNA I-GENE: 0.003530
mRNA O: 0.000475
mRNA I-GENE
from I-GENE: 0.000390
from O: 0.004210
from O
patients O: 0.002538
patients O
shows O: 0.000206
shows O
that O: 0.008362
that O
each O: 0.000475
each O
of I-GENE: 0.002337
of O: 0.042520
of O
these O: 0.001478
these O
five O: 0.000290
five O
mutations I-GENE: 0.000243
mutations O: 0.000435
mutations O
results O: 0.001162
results O
in I-GENE: 0.000536
in O: 0.023304
in O
aberrant O: 0.000041
aberrant O
splicing O: 0.000246
splicing O
. I-GENE: 0.004017
. O: 0.044459
. O

Using O: 0.000200
Using O
the I-GENE: 0.000268
the O: 0.044902
the O
postural I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
force O: 0.000026
force O
data O: 0.000649
data O
as O: 0.003654
as O
input O: 0.000041
input O
to I-GENE: 0.000195
to O: 0.014977
to O
a I-GENE: 0.000317
a O: 0.015893
a O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
D I-GENE: 0.000901
D O: 0.000232
D I-GENE
biomechanical I-GENE
model O: 0.000327
model O
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
lumbosacral I-GENE
spinal O: 0.000090
spinal O
compression O: 0.000017
compression O
was O: 0.006960
was O
calculated O: 0.000099
calculated O
. I-GENE: 0.004017
. O: 0.044459
. O

Sequence O: 0.000113
Sequence O
analysis O: 0.001194
analysis O
revealed O: 0.000643
revealed O
significant O: 0.000687
significant O
differences O: 0.000322
differences O
between O: 0.001394
between O
the I-GENE: 0.000268
the O: 0.044902
the O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
' I-GENE: 0.000950
' O: 0.001701
' O
region I-GENE: 0.001583
region O: 0.001744
region O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
beta I-GENE: 0.007816
beta O: 0.000353
beta I-GENE
subunit I-GENE: 0.001558
subunit O: 0.000278
subunit I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
corresponding O: 0.000252
corresponding O
regions I-GENE: 0.000243
regions O: 0.000501
regions O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
homologous I-GENE: 0.000219
homologous O: 0.000267
homologous O
GlyR I-GENE
alpha I-GENE: 0.009009
alpha O: 0.000313
alpha I-GENE
subunit I-GENE: 0.001558
subunit O: 0.000278
subunit I-GENE
genes I-GENE: 0.004626
genes O: 0.000918
genes I-GENE
; I-GENE: 0.000170
; O: 0.001399
; O
it O: 0.000733
it O
also O: 0.001373
also O
identified O: 0.000823
identified O
a I-GENE: 0.000317
a O: 0.015893
a O
novel O: 0.000385
novel O
exon O: 0.000339
exon O
( I-GENE: 0.006014
( O: 0.014858
( O
exon O: 0.000339
exon O
0 O: 0.002784
0 O
) I-GENE: 0.005210
) O: 0.009341
) O
that O: 0.008362
that O
encodes O: 0.000371
encodes O
most O: 0.000400
most O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
'- I-GENE: 0.000414
'- O: 0.000481
'- O
untranslated O: 0.000145
untranslated O
portion O: 0.000125
portion O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
GlyR I-GENE
beta I-GENE: 0.007816
beta O: 0.000353
beta I-GENE
mRNA I-GENE: 0.003530
mRNA O: 0.000475
mRNA I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Therefore O: 0.000107
Therefore O
, I-GENE: 0.001923
, O: 0.035091
, O
we O: 0.001382
we O
suggested O: 0.000229
suggested O
that O: 0.008362
that O
both O: 0.001631
both O
proteins I-GENE: 0.005673
proteins O: 0.000933
proteins I-GENE
might O: 0.000104
might O
belong O: 0.000023
belong O
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
PLTP I-GENE
family I-GENE: 0.002922
family O: 0.000313
family I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Influence O: 0.000017
Influence O
of I-GENE: 0.002337
of O: 0.042520
of O
compression O: 0.000017
compression O
therapy O: 0.000351
therapy O
on O: 0.003416
on O
symptoms O: 0.000101
symptoms O
following O: 0.000368
following O
soft O: 0.000020
soft O
tissue I-GENE: 0.000536
tissue O: 0.000388
tissue I-GENE
injury O: 0.000107
injury O
from I-GENE: 0.000390
from O: 0.004210
from O
maximal O: 0.000099
maximal O
eccentric I-GENE
exercise O: 0.000148
exercise O
. I-GENE: 0.004017
. O: 0.044459
. O

STAT5A I-GENE
mutations I-GENE: 0.000243
mutations O: 0.000435
mutations O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
Src I-GENE: 0.001339
Src I-GENE
homology I-GENE: 0.000487
homology O: 0.000327
homology I-GENE
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
SH2 I-GENE: 0.001388
SH2 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
SH3 I-GENE: 0.000950
SH3 I-GENE
domains I-GENE: 0.000852
domains O: 0.000400
domains I-GENE
did O: 0.000536
did O
not O: 0.002509
not O
alter O: 0.000055
alter O
the I-GENE: 0.000268
the O: 0.044902
the O
BTK I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
mediated O: 0.000475
mediated O
tyrosine I-GENE: 0.002021
tyrosine O: 0.000261
tyrosine I-GENE
phosphorylation O: 0.000469
phosphorylation O
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
the I-GENE: 0.000268
the O: 0.044902
the O
present O: 0.000551
present O
work O: 0.000099
work O
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
complete O: 0.000197
complete O
genome O: 0.000217
genome O
sequences I-GENE: 0.001290
sequences O: 0.000947
sequences I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
Pyrococcus I-GENE
horikoshii I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
Pyrococcus I-GENE
abyssi I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
two O: 0.001904
two O
species O: 0.000243
species O
in I-GENE: 0.000536
in O: 0.023304
in O
a I-GENE: 0.000317
a O: 0.015893
a O
genus O: 0.000026
genus O
of I-GENE: 0.002337
of O: 0.042520
of O
hyperthermophilic I-GENE
archaeon I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
archaebacterium I-GENE
), O: 0.002269
), O
were O: 0.005244
were O
compared O: 0.000603
compared O
to I-GENE: 0.000195
to O: 0.014977
to O
detect O: 0.000070
detect O
large I-GENE: 0.000146
large O: 0.000278
large O
genome O: 0.000217
genome O
polymorphisms I-GENE
linked O: 0.000235
linked O
with O: 0.009756
with O
restriction O: 0.000072
restriction O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
modification O: 0.000058
modification O
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
homologs I-GENE: 0.000122
homologs O: 0.000026
homologs I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
addition O: 0.000420
addition O
, I-GENE: 0.001923
, O: 0.035091
, O
these O: 0.001478
these O
patients O: 0.002538
patients O
show O: 0.000484
show O
both O: 0.001631
both O
quantitative O: 0.000067
quantitative O
and I-GENE: 0.003263
and O: 0.028529
and O
qualitative O: 0.000026
qualitative O
differences O: 0.000322
differences O
in I-GENE: 0.000536
in O: 0.023304
in O
their O: 0.000736
their O
infectious O: 0.000035
infectious O
microbiological I-GENE
spectrum O: 0.000043
spectrum O
, I-GENE: 0.001923
, O: 0.035091
, O
mainly O: 0.000084
mainly O
in I-GENE: 0.000536
in O: 0.023304
in O
clean I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
contaminated O: 0.000020
contaminated O
, I-GENE: 0.001923
, O: 0.035091
, O
contaminated O: 0.000020
contaminated O
and I-GENE: 0.003263
and O: 0.028529
and O
dirty I-GENE
surgical O: 0.000075
surgical O
procedures O: 0.000052
procedures O
. I-GENE: 0.004017
. O: 0.044459
. O

Here O: 0.000214
Here O
we O: 0.001382
we O
show O: 0.000484
show O
that O: 0.008362
that O
PKC I-GENE: 0.001510
PKC I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
p44 I-GENE: 0.000122
p44 I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
p42MAPK I-GENE
signalings I-GENE
are O: 0.002918
are O
required O: 0.000591
required O
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
HBx I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
induced O: 0.001176
induced O
Sp1 I-GENE: 0.002045
Sp1 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
mediated O: 0.000475
mediated O
IGF I-GENE: 0.000560
IGF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
II I-GENE: 0.003263
II O: 0.000362
II I-GENE
P4 I-GENE
transcriptional I-GENE: 0.000268
transcriptional O: 0.000672
transcriptional O
activity O: 0.002295
activity O
since O: 0.000104
since O
( I-GENE: 0.006014
( O: 0.014858
( O
i I-GENE: 0.000170
i O: 0.000368
i O
) I-GENE: 0.005210
) O: 0.009341
) O
PKC I-GENE: 0.001510
PKC I-GENE
activation I-GENE: 0.000365
activation O: 0.001153
activation O
by O: 0.006887
by O
PMA O: 0.000041
PMA O
or I-GENE: 0.000219
or O: 0.003321
or O
PKC I-GENE: 0.001510
PKC I-GENE
expression O: 0.002231
expression O
vector O: 0.000145
vector O
increases O: 0.000156
increases O
Sp1 I-GENE: 0.002045
Sp1 I-GENE
phosphorylation O: 0.000469
phosphorylation O
and I-GENE: 0.003263
and O: 0.028529
and O
P4 I-GENE
activity O: 0.002295
activity O
in I-GENE: 0.000536
in O: 0.023304
in O
HBx I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
transfected O: 0.000185
transfected O
HepG2 O: 0.000038
HepG2 O
cells O: 0.002663
cells O
; I-GENE: 0.000170
; O: 0.001399
; O
( I-GENE: 0.006014
( O: 0.014858
( O
ii O: 0.000067
ii O
) I-GENE: 0.005210
) O: 0.009341
) O
PKC I-GENE: 0.001510
PKC I-GENE
inhibition O: 0.000284
inhibition O
by O: 0.006887
by O
PKC I-GENE: 0.001510
PKC I-GENE
inhibitor I-GENE: 0.000438
inhibitor O: 0.000238
inhibitor I-GENE
Go6976 I-GENE
reduces O: 0.000052
reduces O
Sp1 I-GENE: 0.002045
Sp1 I-GENE
phosphorylation O: 0.000469
phosphorylation O
, I-GENE: 0.001923
, O: 0.035091
, O
P4 I-GENE
activity O: 0.002295
activity O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
IGF I-GENE: 0.000560
IGF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
II I-GENE: 0.003263
II O: 0.000362
II I-GENE
mRNA I-GENE: 0.003530
mRNA O: 0.000475
mRNA I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
HBx I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
transfected O: 0.000185
transfected O
HepG2 O: 0.000038
HepG2 O
cells O: 0.002663
cells O
; I-GENE: 0.000170
; O: 0.001399
; O
and I-GENE: 0.003263
and O: 0.028529
and O
( I-GENE: 0.006014
( O: 0.014858
( O
iii O: 0.000046
iii O
) I-GENE: 0.005210
) O: 0.009341
) O
the I-GENE: 0.000268
the O: 0.044902
the O
inhibition O: 0.000284
inhibition O
of I-GENE: 0.002337
of O: 0.042520
of O
MEK I-GENE: 0.000584
MEK I-GENE
activation I-GENE: 0.000365
activation O: 0.001153
activation O
by O: 0.006887
by O
U0126 I-GENE
reduces O: 0.000052
reduces O
Sp1 I-GENE: 0.002045
Sp1 I-GENE
phosphorylation O: 0.000469
phosphorylation O
, I-GENE: 0.001923
, O: 0.035091
, O
P4 I-GENE
activity O: 0.002295
activity O
and I-GENE: 0.003263
and O: 0.028529
and O
IGF I-GENE: 0.000560
IGF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
II I-GENE: 0.003263
II O: 0.000362
II I-GENE
mRNA I-GENE: 0.003530
mRNA O: 0.000475
mRNA I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
HBx I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
transfected O: 0.000185
transfected O
HepG2 O: 0.000038
HepG2 O
cells O: 0.002663
cells O
. I-GENE: 0.004017
. O: 0.044459
. O

We O: 0.001417
We O
show O: 0.000484
show O
that O: 0.008362
that O
p73 I-GENE
can O: 0.000924
can O
transcriptionally O: 0.000081
transcriptionally O
inhibit O: 0.000142
inhibit O
a I-GENE: 0.000317
a O: 0.015893
a O
number O: 0.000362
number O
of I-GENE: 0.002337
of O: 0.042520
of O
cellular I-GENE: 0.000243
cellular O: 0.000304
cellular O
and I-GENE: 0.003263
and O: 0.028529
and O
viral I-GENE: 0.000487
viral O: 0.000185
viral I-GENE
promoters I-GENE: 0.000609
promoters O: 0.000194
promoters I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Similarly O: 0.000046
Similarly O
, I-GENE: 0.001923
, O: 0.035091
, O
curcumin I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
diferuloylmethane I-GENE
), O: 0.002269
), O
an O: 0.003112
an O
anti I-GENE: 0.001704
anti O: 0.000087
anti I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
inflammatory O: 0.000101
inflammatory O
agent O: 0.000113
agent O
, I-GENE: 0.001923
, O: 0.035091
, O
suppressed O: 0.000101
suppressed O
OSM I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
stimulated O: 0.000275
stimulated O
STAT1 I-GENE: 0.000243
STAT1 I-GENE
phosphorylation O: 0.000469
phosphorylation O
, I-GENE: 0.001923
, O: 0.035091
, O
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
activity O: 0.002295
activity O
of I-GENE: 0.002337
of O: 0.042520
of O
STAT1 I-GENE: 0.000243
STAT1 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
c I-GENE: 0.006111
c O: 0.000101
c I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
Jun I-GENE: 0.001217
Jun I-GENE
N I-GENE: 0.001217
N O: 0.000614
N I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
terminal I-GENE: 0.001169
terminal O: 0.000884
terminal I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
activation I-GENE: 0.000365
activation O: 0.001153
activation O
without O: 0.000322
without O
affecting O: 0.000058
affecting O
JAK1 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
JAK2 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
JAK3 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
ERK1 I-GENE: 0.000122
ERK1 I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
p38 I-GENE: 0.000682
p38 I-GENE
phosphorylation O: 0.000469
phosphorylation O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
effects O: 0.000652
effects O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
transfected O: 0.000185
transfected O
receptors I-GENE: 0.001753
receptors O: 0.000148
receptors I-GENE
were O: 0.005244
were O
associated I-GENE: 0.000755
associated O: 0.000716
associated I-GENE
with O: 0.009756
with O
antagonism I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
activator I-GENE: 0.001120
activator O: 0.000093
activator I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
AP I-GENE: 0.002630
AP O: 0.000017
AP I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
activity O: 0.002295
activity O
. I-GENE: 0.004017
. O: 0.044459
. O

Furthermore O: 0.000238
Furthermore O
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
soluble O: 0.000072
soluble O
forms O: 0.000203
forms O
of I-GENE: 0.002337
of O: 0.042520
of O
ATF6 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
G13 I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
product I-GENE: 0.001217
product O: 0.000151
product I-GENE
are O: 0.002918
are O
unable O: 0.000061
unable O
to I-GENE: 0.000195
to O: 0.014977
to O
bind O: 0.000296
bind O
to I-GENE: 0.000195
to O: 0.014977
to O
several O: 0.000443
several O
point O: 0.000148
point O
mutants I-GENE: 0.001315
mutants O: 0.000258
mutants I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
cis I-GENE: 0.000146
cis O: 0.000200
cis O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
acting O: 0.000203
acting O
ER I-GENE: 0.000414
ER O: 0.000032
ER I-GENE
stress I-GENE: 0.000219
stress O: 0.000232
stress O
response I-GENE: 0.000779
response O: 0.000794
response O
element I-GENE: 0.001680
element O: 0.000577
element I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
vitro O: 0.000640
vitro O
that O: 0.008362
that O
hardly I-GENE
respond O: 0.000058
respond O
to I-GENE: 0.000195
to O: 0.014977
to O
ER I-GENE: 0.000414
ER O: 0.000032
ER I-GENE
stress I-GENE: 0.000219
stress O: 0.000232
stress O
in I-GENE: 0.000536
in O: 0.023304
in O
vivo O: 0.000464
vivo O
. I-GENE: 0.004017
. O: 0.044459
. O

PURPOSE O: 0.000035
PURPOSE O
: I-GENE: 0.000243
: O: 0.002561
: O
The O: 0.007383
The O
objective O: 0.000035
objective O
of I-GENE: 0.002337
of O: 0.042520
of O
this O: 0.001976
this O
study O: 0.001101
study O
was O: 0.006960
was O
to I-GENE: 0.000195
to O: 0.014977
to O
assess O: 0.000087
assess O
first O: 0.000591
first O
embryo O: 0.000072
embryo O
cleavage O: 0.000139
cleavage O
( I-GENE: 0.006014
( O: 0.014858
( O
FEC I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
25 O: 0.000252
25 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
27 O: 0.000125
27 O
h O: 0.000368
h O
after O: 0.001385
after O
intracytoplasmic I-GENE
sperm O: 0.000052
sperm O
injection O: 0.000165
injection O
( I-GENE: 0.006014
( O: 0.014858
( O
ICSI I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
as O: 0.003654
as O
a I-GENE: 0.000317
a O: 0.015893
a O
parameter O: 0.000032
parameter O
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
embryo O: 0.000072
embryo O
selection O: 0.000090
selection O
process O: 0.000119
process O
. I-GENE: 0.004017
. O: 0.044459
. O

RESULTS O: 0.000180
RESULTS O
: I-GENE: 0.000243
: O: 0.002561
: O
A I-GENE: 0.003530
A O: 0.002246
A I-GENE
significant O: 0.000687
significant O
correlation O: 0.000177
correlation O
( I-GENE: 0.006014
( O: 0.014858
( O
p I-GENE: 0.000122
p O: 0.000681
p O
< O: 0.000455
< O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
001 O: 0.000197
001 O
) I-GENE: 0.005210
) O: 0.009341
) O
was O: 0.006960
was O
observed O: 0.000635
observed O
for O: 0.006951
for O
mean O: 0.000423
mean O
wall O: 0.000107
wall O
thickness O: 0.000038
thickness O
and I-GENE: 0.003263
and O: 0.028529
and O
vessel O: 0.000023
vessel O
wall O: 0.000107
wall O
area O: 0.000180
area O
between O: 0.001394
between O
MRI O: 0.000029
MRI O
and I-GENE: 0.003263
and O: 0.028529
and O
histopathology I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
r O: 0.000156
r O
= O: 0.000855
= O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
87 O: 0.000052
87 O
and I-GENE: 0.003263
and O: 0.028529
and O
r O: 0.000156
r O
= O: 0.000855
= O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
85 O: 0.000084
85 O
, I-GENE: 0.001923
, O: 0.035091
, O
respectively O: 0.000658
respectively O
). O: 0.002228
). O

Molecular O: 0.000101
Molecular O
cloning O: 0.000203
cloning O
, I-GENE: 0.001923
, O: 0.035091
, O
genomic I-GENE: 0.000122
genomic O: 0.000333
genomic O
mapping O: 0.000154
mapping O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
expression O: 0.002231
expression O
of I-GENE: 0.002337
of O: 0.042520
of O
two O: 0.001904
two O
secretor I-GENE
blood O: 0.000884
blood O
group I-GENE: 0.000414
group O: 0.000869
group O
alpha I-GENE: 0.009009
alpha O: 0.000313
alpha I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
fucosyltransferase I-GENE
genes I-GENE: 0.004626
genes O: 0.000918
genes I-GENE
differentially O: 0.000046
differentially O
regulated I-GENE: 0.000268
regulated O: 0.000368
regulated O
in I-GENE: 0.000536
in O: 0.023304
in O
mouse I-GENE: 0.001680
mouse O: 0.000403
mouse I-GENE
uterine O: 0.000058
uterine O
epithelium O: 0.000035
epithelium O
and I-GENE: 0.003263
and O: 0.028529
and O
gastrointestinal O: 0.000041
gastrointestinal O
tract O: 0.000084
tract O
. I-GENE: 0.004017
. O: 0.044459
. O

We O: 0.001417
We O
show O: 0.000484
show O
that O: 0.008362
that O
several O: 0.000443
several O
heme O: 0.000023
heme O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
responsive I-GENE: 0.000414
responsive O: 0.000185
responsive I-GENE
mechanisms O: 0.000212
mechanisms O
combine I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
regulate O: 0.000119
regulate O
DAN I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
TIR I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
expression O: 0.002231
expression O
. I-GENE: 0.004017
. O: 0.044459
. O

No O: 0.000174
No O
' I-GENE: 0.000950
' O: 0.001701
' O
TATA I-GENE: 0.000390
TATA O: 0.000243
TATA I-GENE
' I-GENE: 0.000950
' O: 0.001701
' O
motif I-GENE: 0.000706
motif O: 0.000316
motif I-GENE
was O: 0.006960
was O
identified O: 0.000823
identified O
near O: 0.000165
near O
either O: 0.000452
either O
the I-GENE: 0.000268
the O: 0.044902
the O
GABPalpha I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
ATPsynCF6 I-GENE
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
start O: 0.000203
start O
sites I-GENE: 0.001875
sites O: 0.000690
sites I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

These O: 0.000979
These O
results O: 0.001162
results O
indicate O: 0.000438
indicate O
the I-GENE: 0.000268
the O: 0.044902
the O
presence O: 0.000466
presence O
of I-GENE: 0.002337
of O: 0.042520
of O
TATA I-GENE: 0.000390
TATA O: 0.000243
TATA I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
unified I-GENE
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
systems O: 0.000093
systems O
in I-GENE: 0.000536
in O: 0.023304
in O
contemporary I-GENE
eukaryotes O: 0.000020
eukaryotes O
and I-GENE: 0.003263
and O: 0.028529
and O
provide O: 0.000159
provide O
insight O: 0.000023
insight O
into O: 0.000785
into O
the I-GENE: 0.000268
the O: 0.044902
the O
residual O: 0.000046
residual O
need O: 0.000061
need O
for O: 0.006951
for O
TBP I-GENE: 0.000487
TBP I-GENE
by O: 0.006887
by O
all O: 0.000762
all O
three O: 0.000785
three O
Pols I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
other O: 0.000994
other O
eukaryotes O: 0.000020
eukaryotes O
despite O: 0.000084
despite O
a I-GENE: 0.000317
a O: 0.015893
a O
lack O: 0.000093
lack O
of I-GENE: 0.002337
of O: 0.042520
of O
TATA I-GENE: 0.000390
TATA O: 0.000243
TATA I-GENE
elements I-GENE: 0.000414
elements O: 0.000493
elements O
in I-GENE: 0.000536
in O: 0.023304
in O
their O: 0.000736
their O
promoters I-GENE: 0.000609
promoters O: 0.000194
promoters I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Different I-GENE
thermoluminescent I-GENE
detectors I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
TLD I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
have O: 0.001788
have O
been O: 0.001229
been O
used O: 0.000808
used O
to I-GENE: 0.000195
to O: 0.014977
to O
measure O: 0.000084
measure O
the I-GENE: 0.000268
the O: 0.044902
the O
contribution O: 0.000032
contribution O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
low I-GENE: 0.000146
low O: 0.000440
low O
linear O: 0.000052
linear O
energy O: 0.000145
energy O
transfer I-GENE: 0.000170
transfer O: 0.000099
transfer I-GENE
component O: 0.000180
component O
( I-GENE: 0.006014
( O: 0.014858
( O
LET I-GENE
< O: 0.000455
< O
10 I-GENE: 0.000292
10 O: 0.000936
10 O
keV I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
micrometer I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
plastic I-GENE
nuclear I-GENE: 0.001826
nuclear O: 0.000614
nuclear I-GENE
track I-GENE
detectors I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
PNTD I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
high I-GENE: 0.000341
high O: 0.000924
high O
linear O: 0.000052
linear O
energy O: 0.000145
energy O
tranfer I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
LET I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
component O: 0.000180
component O
. I-GENE: 0.004017
. O: 0.044459
. O

However O: 0.000417
However O
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
beta5L I-GENE
splice O: 0.000125
splice O
variant I-GENE: 0.000268
variant O: 0.000075
variant I-GENE
was O: 0.006960
was O
found O: 0.001026
found O
only O: 0.000794
only O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
retina O: 0.000014
retina O
. I-GENE: 0.004017
. O: 0.044459
. O

This O: 0.000927
This O
analysis O: 0.001194
analysis O
supports O: 0.000032
supports O
the I-GENE: 0.000268
the O: 0.044902
the O
use O: 0.000380
use O
of I-GENE: 0.002337
of O: 0.042520
of O
fluticasone I-GENE
propionate I-GENE
88 O: 0.000052
88 O
microg O: 0.000032
microg O
twice O: 0.000049
twice O
daily O: 0.000154
daily O
as O: 0.003654
as O
first O: 0.000591
first O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
line O: 0.000319
line O
treatment O: 0.000921
treatment O
in I-GENE: 0.000536
in O: 0.023304
in O
patients O: 0.002538
patients O
with O: 0.009756
with O
persistent O: 0.000035
persistent O
asthma O: 0.000070
asthma O
previously O: 0.000481
previously O
treated O: 0.000365
treated O
with O: 0.009756
with O
short O: 0.000214
short O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
acting O: 0.000203
acting O
beta2 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
agonist O: 0.000101
agonist O
alone O: 0.000185
alone O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
mice O: 0.000353
mice O
are O: 0.002918
are O
phenotypically I-GENE
normal O: 0.000759
normal O
and I-GENE: 0.003263
and O: 0.028529
and O
do O: 0.000165
do O
not O: 0.002509
not O
develop O: 0.000058
develop O
spontaneous O: 0.000075
spontaneous O
tumors O: 0.000168
tumors O
at O: 0.002976
at O
an O: 0.003112
an O
early I-GENE: 0.000706
early O: 0.000374
early I-GENE
age O: 0.000406
age O
, I-GENE: 0.001923
, O: 0.035091
, O
in I-GENE: 0.000536
in O: 0.023304
in O
contrast O: 0.000336
contrast O
to I-GENE: 0.000195
to O: 0.014977
to O
knock I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
out O: 0.000232
out O
( I-GENE: 0.006014
( O: 0.014858
( O
p53 I-GENE: 0.001802
p53 I-GENE
(-/-)) I-GENE
strains O: 0.000243
strains O
with O: 0.009756
with O
a I-GENE: 0.000317
a O: 0.015893
a O
defective O: 0.000078
defective O
p53 I-GENE: 0.001802
p53 I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Furthermore O: 0.000238
Furthermore O
, I-GENE: 0.001923
, O: 0.035091
, O
stable O: 0.000133
stable O
expression O: 0.002231
expression O
of I-GENE: 0.002337
of O: 0.042520
of O
a I-GENE: 0.000317
a O: 0.015893
a O
constitutively O: 0.000125
constitutively O
active O: 0.000293
active O
form O: 0.000333
form O
of I-GENE: 0.002337
of O: 0.042520
of O
chicken I-GENE: 0.000463
chicken O: 0.000049
chicken I-GENE
Notch1 I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
Notch2 I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
a I-GENE: 0.000317
a O: 0.015893
a O
B I-GENE: 0.004066
B O: 0.000640
B I-GENE
cell I-GENE: 0.001144
cell O: 0.001927
cell O
line O: 0.000319
line O
results O: 0.001162
results O
in I-GENE: 0.000536
in O: 0.023304
in O
a I-GENE: 0.000317
a O: 0.015893
a O
down O: 0.000084
down O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
regulation O: 0.000553
regulation O
of I-GENE: 0.002337
of O: 0.042520
of O
surface I-GENE: 0.000195
surface O: 0.000209
surface O
IgM I-GENE: 0.000487
IgM I-GENE
expression O: 0.002231
expression O
, I-GENE: 0.001923
, O: 0.035091
, O
which O: 0.002472
which O
is O: 0.006803
is O
accompanied O: 0.000049
accompanied O
by O: 0.006887
by O
the I-GENE: 0.000268
the O: 0.044902
the O
reduction O: 0.000206
reduction O
of I-GENE: 0.002337
of O: 0.042520
of O
IgH I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
transcripts I-GENE: 0.000852
transcripts O: 0.000188
transcripts I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

On O: 0.000142
On O
Cox O: 0.000017
Cox O
proportional I-GENE
hazards I-GENE
regression O: 0.000058
regression O
adenocarcinoma O: 0.000032
adenocarcinoma O
( I-GENE: 0.006014
( O: 0.014858
( O
P I-GENE: 0.001023
P O: 0.000614
P I-GENE
= O: 0.000855
= O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
006 I-GENE
), O: 0.002269
), O
the I-GENE: 0.000268
the O: 0.044902
the O
development O: 0.000388
development O
of I-GENE: 0.002337
of O: 0.042520
of O
BPF I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
P I-GENE: 0.001023
P O: 0.000614
P I-GENE
= O: 0.000855
= O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
003 I-GENE
), O: 0.002269
), O
older O: 0.000041
older O
age O: 0.000406
age O
( I-GENE: 0.006014
( O: 0.014858
( O
P I-GENE: 0.001023
P O: 0.000614
P I-GENE
= O: 0.000855
= O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
03 O: 0.000052
03 O
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
higher O: 0.000469
higher O
pathological O: 0.000041
pathological O
stage O: 0.000183
stage O
( I-GENE: 0.006014
( O: 0.014858
( O
P I-GENE: 0.001023
P O: 0.000614
P I-GENE
= O: 0.000855
= O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
02 O: 0.000049
02 O
) I-GENE: 0.005210
) O: 0.009341
) O
were O: 0.005244
were O
independent O: 0.000269
independent O
adverse O: 0.000070
adverse O
predictors O: 0.000038
predictors O
of I-GENE: 0.002337
of O: 0.042520
of O
survival O: 0.000197
survival O
. I-GENE: 0.004017
. O: 0.044459
. O

We O: 0.001417
We O
found O: 0.001026
found O
that O: 0.008362
that O
RhoA I-GENE: 0.000219
RhoA I-GENE
can O: 0.000924
can O
initiate O: 0.000017
initiate O
a I-GENE: 0.000317
a O: 0.015893
a O
linear O: 0.000052
linear O
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
cascade O: 0.000043
cascade O
leading O: 0.000058
leading O
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
activation I-GENE: 0.000365
activation O: 0.001153
activation O
of I-GENE: 0.002337
of O: 0.042520
of O
ERK6 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
p38 I-GENE: 0.000682
p38 I-GENE
gamma I-GENE: 0.002240
gamma O: 0.000081
gamma I-GENE
), O: 0.002269
), O
a I-GENE: 0.000317
a O: 0.015893
a O
recently O: 0.000139
recently O
identified O: 0.000823
identified O
member O: 0.000162
member O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
p38 I-GENE: 0.000682
p38 I-GENE
family I-GENE: 0.002922
family O: 0.000313
family I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
MAPKs I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Twenty O: 0.000049
Twenty O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
six O: 0.000212
six O
( I-GENE: 0.006014
( O: 0.014858
( O
55 O: 0.000096
55 O
%) O: 0.000385
%) O
( I-GENE: 0.006014
( O: 0.014858
( O
95 O: 0.000174
95 O
% O: 0.001741
% O
CI O: 0.000078
CI O
, I-GENE: 0.001923
, O: 0.035091
, O
41 O: 0.000119
41 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
69 O: 0.000052
69 O
%) O: 0.000385
%) O
patients O: 0.002538
patients O
experienced O: 0.000020
experienced O
> O: 0.000119
> O
or I-GENE: 0.000219
or O: 0.003321
or O
= O: 0.000855
= O
grade O: 0.000058
grade O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
acute O: 0.000359
acute O
toxicity O: 0.000087
toxicity O
( I-GENE: 0.006014
( O: 0.014858
( O
RTOG I-GENE
). O: 0.002228
). O

We O: 0.001417
We O
hypothesize I-GENE
that O: 0.008362
that O
proprioception I-GENE
may O: 0.001078
may O
be O: 0.002370
be O
used O: 0.000808
used O
to I-GENE: 0.000195
to O: 0.014977
to O
calibrate I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
efference I-GENE
copy O: 0.000104
copy O
during O: 0.001095
during O
development O: 0.000388
development O
and I-GENE: 0.003263
and O: 0.028529
and O
in I-GENE: 0.000536
in O: 0.023304
in O
response I-GENE: 0.000779
response O: 0.000794
response O
to I-GENE: 0.000195
to O: 0.014977
to O
perturbations I-GENE
by O: 0.006887
by O
signaling O: 0.000293
signaling O
potential O: 0.000336
potential O
mismatches I-GENE
between O: 0.001394
between O
eye O: 0.000061
eye O
movement O: 0.000046
movement O
information O: 0.000081
information O
derived I-GENE: 0.000268
derived O: 0.000290
derived O
from I-GENE: 0.000390
from O: 0.004210
from O
the I-GENE: 0.000268
the O: 0.044902
the O
efferent I-GENE
command I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
actual O: 0.000014
actual O
motion O: 0.000035
motion O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
eye O: 0.000061
eye O
transduced I-GENE
by O: 0.006887
by O
the I-GENE: 0.000268
the O: 0.044902
the O
proprioceptive I-GENE
organs O: 0.000046
organs O
. I-GENE: 0.004017
. O: 0.044459
. O

Thus O: 0.000284
Thus O
, I-GENE: 0.001923
, O: 0.035091
, O
BALB O: 0.000029
BALB O
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
c I-GENE: 0.006111
c O: 0.000101
c I-GENE
mice O: 0.000353
mice O
appear O: 0.000084
appear O
to I-GENE: 0.000195
to O: 0.014977
to O
be O: 0.002370
be O
the I-GENE: 0.000268
the O: 0.044902
the O
most O: 0.000400
most O
appropriate O: 0.000058
appropriate O
strain O: 0.000162
strain O
of I-GENE: 0.002337
of O: 0.042520
of O
mice O: 0.000353
mice O
to I-GENE: 0.000195
to O: 0.014977
to O
perform O: 0.000017
perform O
studies O: 0.000678
studies O
on O: 0.003416
on O
the I-GENE: 0.000268
the O: 0.044902
the O
possible O: 0.000267
possible O
connection I-GENE
between O: 0.001394
between O
infection O: 0.000319
infection O
with O: 0.009756
with O
T I-GENE: 0.001558
T O: 0.000548
T I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
canis I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
allergic O: 0.000014
allergic O
asthma O: 0.000070
asthma O
. I-GENE: 0.004017
. O: 0.044459
. O

They O: 0.000067
They O
correspond O: 0.000023
correspond O
to I-GENE: 0.000195
to O: 0.014977
to O
nucleotides O: 0.000203
nucleotides O
equivalent O: 0.000043
equivalent O
to I-GENE: 0.000195
to O: 0.014977
to O
base O: 0.000313
base O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
pair O: 0.000154
pair O
C1 I-GENE: 0.000243
C1 O: 0.000029
C1 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
G72 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
discriminator I-GENE
base O: 0.000313
base O
A73 I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
amino I-GENE: 0.000560
amino O: 0.001116
amino O
acid I-GENE: 0.001315
acid O: 0.000997
acid I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
acceptor O: 0.000026
acceptor O
branch O: 0.000029
branch O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
molecule I-GENE: 0.000170
molecule O: 0.000075
molecule I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Our O: 0.000235
Our O
results O: 0.001162
results O
suggest O: 0.000585
suggest O
that O: 0.008362
that O
the I-GENE: 0.000268
the O: 0.044902
the O
central O: 0.000171
central O
role O: 0.000681
role O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
Notch I-GENE: 0.000195
Notch I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
CBF1 I-GENE: 0.000195
CBF1 I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
RBP I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
Jkappa I-GENE
signaling O: 0.000293
signaling O
pathway O: 0.000385
pathway O
in I-GENE: 0.000536
in O: 0.023304
in O
cell I-GENE: 0.001144
cell O: 0.001927
cell O
fate O: 0.000029
fate O
decisions I-GENE
renders I-GENE
it O: 0.000733
it O
susceptible O: 0.000029
susceptible O
to I-GENE: 0.000195
to O: 0.014977
to O
pathways O: 0.000171
pathways O
of I-GENE: 0.002337
of O: 0.042520
of O
viral I-GENE: 0.000487
viral O: 0.000185
viral I-GENE
replication I-GENE: 0.000146
replication O: 0.000243
replication O
and I-GENE: 0.003263
and O: 0.028529
and O
oncogenic O: 0.000035
oncogenic O
conversion O: 0.000061
conversion O
. I-GENE: 0.004017
. O: 0.044459
. O

High O: 0.000064
High O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
affinity O: 0.000229
affinity O
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
NF I-GENE: 0.002922
NF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
PSE I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
B I-GENE: 0.004066
B O: 0.000640
B I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
but O: 0.001675
but O
not O: 0.002509
not O
to I-GENE: 0.000195
to O: 0.014977
to O
PSE I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
A I-GENE: 0.003530
A O: 0.002246
A I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
was O: 0.006960
was O
confirmed O: 0.000139
confirmed O
by O: 0.006887
by O
competition O: 0.000041
competition O
of I-GENE: 0.002337
of O: 0.042520
of O
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
interactions O: 0.000226
interactions O
by O: 0.006887
by O
using O: 0.000979
using O
NF I-GENE: 0.002922
NF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
elements I-GENE: 0.000414
elements O: 0.000493
elements O
and I-GENE: 0.003263
and O: 0.028529
and O
antibodies I-GENE: 0.001144
antibodies O: 0.000159
antibodies I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
first O: 0.000591
first O
case O: 0.000220
case O
of I-GENE: 0.002337
of O: 0.042520
of O
HCV I-GENE: 0.000146
HCV O: 0.000035
HCV I-GENE
seroconversion I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
Portugal I-GENE
after O: 0.001385
after O
the I-GENE: 0.000268
the O: 0.044902
the O
introduction O: 0.000038
introduction O
of I-GENE: 0.002337
of O: 0.042520
of O
HCV I-GENE: 0.000146
HCV O: 0.000035
HCV I-GENE
NAT I-GENE
screening O: 0.000130
screening O
. I-GENE: 0.004017
. O: 0.044459
. O

Substitutions I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
YFV I-GENE
Ag I-GENE: 0.000341
Ag I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
region I-GENE: 0.001583
region O: 0.001744
region O
( I-GENE: 0.006014
( O: 0.014858
( O
ABR I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
occur O: 0.000087
occur O
at O: 0.002976
at O
four O: 0.000406
four O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
eight O: 0.000148
eight O
highly O: 0.000391
highly O
conserved O: 0.000507
conserved O
residues I-GENE: 0.000146
residues O: 0.000426
residues O
that O: 0.008362
that O
are O: 0.002918
are O
essential O: 0.000351
essential O
for O: 0.006951
for O
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
peptide I-GENE: 0.000584
peptide O: 0.000212
peptide I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
Ag I-GENE: 0.000341
Ag I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
class I-GENE: 0.000706
class O: 0.000148
class I-GENE
Ia I-GENE
molecules I-GENE: 0.000268
molecules O: 0.000125
molecules I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
Novacor I-GENE
Left I-GENE
Ventricular I-GENE
Assist I-GENE
System I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
LVAS I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
( I-GENE: 0.006014
( O: 0.014858
( O
Novacor I-GENE
Corp I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
Oakland I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
CA I-GENE: 0.000317
CA O: 0.000026
CA I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
was O: 0.006960
was O
initially O: 0.000058
initially O
console I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
based O: 0.000287
based O
and I-GENE: 0.003263
and O: 0.028529
and O
has O: 0.001356
has O
been O: 0.001229
been O
available O: 0.000087
available O
since O: 0.000104
since O
1993 O: 0.000032
1993 O
in I-GENE: 0.000536
in O: 0.023304
in O
a I-GENE: 0.000317
a O: 0.015893
a O
wearable I-GENE
configuration O: 0.000017
configuration O
. I-GENE: 0.004017
. O: 0.044459
. O

Ileal I-GENE
digestibilities I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
DM O: 0.000017
DM O
, I-GENE: 0.001923
, O: 0.035091
, O
OM I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
CP I-GENE: 0.000146
CP O: 0.000029
CP I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
total O: 0.000443
total O
dietary O: 0.000072
dietary O
fiber O: 0.000043
fiber O
( I-GENE: 0.006014
( O: 0.014858
( O
TDF I-GENE
), O: 0.002269
), O
fat O: 0.000096
fat O
and I-GENE: 0.003263
and O: 0.028529
and O
gross O: 0.000043
gross O
energy O: 0.000145
energy O
( I-GENE: 0.006014
( O: 0.014858
( O
GE I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
were O: 0.005244
were O
lower O: 0.000298
lower O
( I-GENE: 0.006014
( O: 0.014858
( O
P I-GENE: 0.001023
P O: 0.000614
P I-GENE
< O: 0.000455
< O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
05 O: 0.000287
05 O
) I-GENE: 0.005210
) O: 0.009341
) O
for O: 0.006951
for O
dogs O: 0.000130
dogs O
fed O: 0.000081
fed O
diets O: 0.000014
diets O
containing I-GENE: 0.000414
containing O: 0.000837
containing O
supplemental I-GENE
fiber O: 0.000043
fiber O
compared O: 0.000603
compared O
with O: 0.009756
with O
dogs O: 0.000130
dogs O
fed O: 0.000081
fed O
the I-GENE: 0.000268
the O: 0.044902
the O
control I-GENE: 0.000170
control O: 0.000834
control O
diet O: 0.000093
diet O
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
addition O: 0.000420
addition O
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
consensus I-GENE: 0.000317
consensus O: 0.000246
consensus I-GENE
amino I-GENE: 0.000560
amino O: 0.001116
amino O
acid I-GENE: 0.001315
acid O: 0.000997
acid I-GENE
motif I-GENE: 0.000706
motif O: 0.000316
motif I-GENE
for O: 0.006951
for O
serine I-GENE: 0.000584
serine O: 0.000101
serine I-GENE
threonine I-GENE: 0.000341
threonine O: 0.000049
threonine I-GENE
receptor I-GENE: 0.006817
receptor O: 0.000258
receptor I-GENE
kinases I-GENE: 0.001777
kinases O: 0.000058
kinases I-GENE
was O: 0.006960
was O
also O: 0.001373
also O
present O: 0.000551
present O
. I-GENE: 0.004017
. O: 0.044459
. O

Here O: 0.000214
Here O
, I-GENE: 0.001923
, O: 0.035091
, O
we O: 0.001382
we O
show O: 0.000484
show O
that O: 0.008362
that O
the I-GENE: 0.000268
the O: 0.044902
the O
phorbol O: 0.000104
phorbol O
ester O: 0.000049
ester O
PMA O: 0.000041
PMA O
decreases O: 0.000061
decreases O
both O: 0.001631
both O
basal I-GENE: 0.000122
basal O: 0.000223
basal O
and I-GENE: 0.003263
and O: 0.028529
and O
dexamethasone O: 0.000026
dexamethasone O
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
cAMP I-GENE: 0.000560
cAMP O: 0.000206
cAMP I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
induced O: 0.001176
induced O
expression O: 0.002231
expression O
of I-GENE: 0.002337
of O: 0.042520
of O
a I-GENE: 0.000317
a O: 0.015893
a O
luciferase I-GENE: 0.000682
luciferase I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
under O: 0.000351
under O
the I-GENE: 0.000268
the O: 0.044902
the O
control I-GENE: 0.000170
control O: 0.000834
control O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
G6Pase I-GENE
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
transiently O: 0.000067
transiently O
transfected O: 0.000185
transfected O
H4IIE I-GENE
hepatoma O: 0.000029
hepatoma O
cells O: 0.002663
cells O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
difference O: 0.000156
difference O
between O: 0.001394
between O
the I-GENE: 0.000268
the O: 0.044902
the O
patients O: 0.002538
patients O
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
controls O: 0.000238
controls O
was O: 0.006960
was O
statistically O: 0.000049
statistically O
significant O: 0.000687
significant O
( I-GENE: 0.006014
( O: 0.014858
( O
p I-GENE: 0.000122
p O: 0.000681
p O
= O: 0.000855
= O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
03 O: 0.000052
03 O
). O: 0.002228
). O

Altogether O: 0.000020
Altogether O
, I-GENE: 0.001923
, O: 0.035091
, O
we O: 0.001382
we O
confirm O: 0.000046
confirm O
that O: 0.008362
that O
all O: 0.000762
all O
genes I-GENE: 0.004626
genes O: 0.000918
genes I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
Rad52 I-GENE
recombinational I-GENE
repair I-GENE: 0.000146
repair O: 0.000110
repair I-GENE
pathway O: 0.000385
pathway O
are O: 0.002918
are O
required O: 0.000591
required O
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
survival O: 0.000197
survival O
of I-GENE: 0.002337
of O: 0.042520
of O
rad27 I-GENE
Delta O: 0.000023
Delta O
strains O: 0.000243
strains O
at O: 0.002976
at O
both O: 0.001631
both O
permissive O: 0.000017
permissive O
( I-GENE: 0.006014
( O: 0.014858
( O
23 O: 0.000139
23 O
degrees O: 0.000180
degrees O
C I-GENE: 0.005113
C O: 0.001005
C I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
semipermissive I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
30 O: 0.000423
30 O
degrees O: 0.000180
degrees O
C I-GENE: 0.005113
C O: 0.001005
C I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
temperatures O: 0.000020
temperatures O
for O: 0.006951
for O
growth I-GENE: 0.002337
growth O: 0.000510
growth I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Neuron I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
Bcl I-GENE: 0.000390
Bcl I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
homology I-GENE: 0.000487
homology O: 0.000327
homology I-GENE
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
only O: 0.000794
only O
splice O: 0.000125
splice O
variant I-GENE: 0.000268
variant O: 0.000075
variant I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
Bak I-GENE
is O: 0.006803
is O
anti I-GENE: 0.001704
anti O: 0.000087
anti I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
apoptotic O: 0.000029
apoptotic O
in I-GENE: 0.000536
in O: 0.023304
in O
neurons O: 0.000101
neurons O
, I-GENE: 0.001923
, O: 0.035091
, O
but O: 0.001675
but O
pro I-GENE: 0.000146
pro O: 0.000032
pro I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
apoptotic O: 0.000029
apoptotic O
in I-GENE: 0.000536
in O: 0.023304
in O
non I-GENE: 0.000292
non O: 0.000449
non O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
neuronal O: 0.000072
neuronal O
cells O: 0.002663
cells O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
mechanism O: 0.000304
mechanism O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
induction O: 0.000284
induction O
of I-GENE: 0.002337
of O: 0.042520
of O
3beta I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
HSD I-GENE
type I-GENE: 0.003384
type O: 0.000884
type I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
expression O: 0.002231
expression O
was O: 0.006960
was O
further O: 0.000261
further O
characterized O: 0.000316
characterized O
in I-GENE: 0.000536
in O: 0.023304
in O
ZR I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
75 O: 0.000127
75 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
breast O: 0.000125
breast O
cancer O: 0.000284
cancer O
cells O: 0.002663
cells O
. I-GENE: 0.004017
. O: 0.044459
. O

Contagious I-GENE
bovine I-GENE: 0.000584
bovine O: 0.000099
bovine I-GENE
pleuropneumonia I-GENE
is O: 0.006803
is O
a I-GENE: 0.000317
a O: 0.015893
a O
major I-GENE: 0.000341
major O: 0.000333
major I-GENE
threat I-GENE
for O: 0.006951
for O
cattle O: 0.000035
cattle O
in I-GENE: 0.000536
in O: 0.023304
in O
Africa I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Treatment O: 0.000075
Treatment O
includes O: 0.000087
includes O
both O: 0.001631
both O
medical O: 0.000046
medical O
and I-GENE: 0.003263
and O: 0.028529
and O
surgical O: 0.000075
surgical O
options I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
with O: 0.009756
with O
medical O: 0.000046
medical O
therapy O: 0.000351
therapy O
further O: 0.000261
further O
subclassified I-GENE
into O: 0.000785
into O
pharmacologic I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
pneumatic I-GENE
dilation I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Since O: 0.000099
Since O
the I-GENE: 0.000268
the O: 0.044902
the O
latter O: 0.000072
latter O
is O: 0.006803
is O
very O: 0.000223
very O
small I-GENE: 0.000682
small O: 0.000290
small I-GENE
for O: 0.006951
for O
physiological O: 0.000084
physiological O
flows I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
result O: 0.000232
result O
is O: 0.006803
is O
that O: 0.008362
that O
alpha I-GENE: 0.009009
alpha O: 0.000313
alpha I-GENE
< O: 0.000455
< O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
even O: 0.000154
even O
at O: 0.002976
at O
relatively O: 0.000099
relatively O
high I-GENE: 0.000341
high O: 0.000924
high O
values O: 0.000339
values O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
Reynolds I-GENE
number O: 0.000362
number O
( I-GENE: 0.006014
( O: 0.014858
( O
i I-GENE: 0.000170
i O: 0.000368
i O
. I-GENE: 0.004017
. O: 0.044459
. O
e O: 0.000209
e O
., O: 0.000446
., O
for O: 0.006951
for O
non I-GENE: 0.000292
non O: 0.000449
non O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
negligible I-GENE
inertia I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
we O: 0.001382
we O
validate I-GENE
our O: 0.000252
our O
perturbation I-GENE
theory O: 0.000032
theory O
results O: 0.001162
results O
by O: 0.006887
by O
comparison O: 0.000214
comparison O
with O: 0.009756
with O
a I-GENE: 0.000317
a O: 0.015893
a O
numerical I-GENE
integration O: 0.000043
integration O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
full I-GENE: 0.000414
full O: 0.000180
full I-GENE
model O: 0.000327
model O
. I-GENE: 0.004017
. O: 0.044459
. O

This O: 0.000927
This O
plus O: 0.000127
plus O
the I-GENE: 0.000268
the O: 0.044902
the O
reduced O: 0.000452
reduced O
phosphorylation O: 0.000469
phosphorylation O
of I-GENE: 0.002337
of O: 0.042520
of O
p27 I-GENE: 0.000146
p27 I-GENE
by O: 0.006887
by O
MAPK I-GENE: 0.000706
MAPK I-GENE
enhanced O: 0.000162
enhanced O
the I-GENE: 0.000268
the O: 0.044902
the O
stability O: 0.000070
stability O
of I-GENE: 0.002337
of O: 0.042520
of O
p27 I-GENE: 0.000146
p27 I-GENE
that O: 0.008362
that O
associated I-GENE: 0.000755
associated O: 0.000716
associated I-GENE
with O: 0.009756
with O
nuclear I-GENE: 0.001826
nuclear O: 0.000614
nuclear I-GENE
Cdk2 I-GENE: 0.000365
Cdk2 I-GENE
at O: 0.002976
at O
high I-GENE: 0.000341
high O: 0.000924
high O
stoichiometry I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
inhibited O: 0.000220
inhibited O
its O: 0.001020
its O
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
activity O: 0.002295
activity O
. I-GENE: 0.004017
. O: 0.044459
. O

Similar O: 0.000038
Similar O
data O: 0.000649
data O
were O: 0.005244
were O
also O: 0.001373
also O
obtained O: 0.000417
obtained O
when O: 0.000690
when O
either O: 0.000452
either O
dominant I-GENE: 0.000243
dominant O: 0.000110
dominant I-GENE
negative I-GENE: 0.000219
negative O: 0.000403
negative O
EGFR I-GENE: 0.000170
EGFR I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
CD533 I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
dominant I-GENE: 0.000243
dominant O: 0.000110
dominant I-GENE
negative I-GENE: 0.000219
negative O: 0.000403
negative O
Ras I-GENE: 0.001923
Ras I-GENE
N17 I-GENE
were O: 0.005244
were O
used O: 0.000808
used O
to I-GENE: 0.000195
to O: 0.014977
to O
block O: 0.000081
block O
MAPK I-GENE: 0.000706
MAPK I-GENE
activation I-GENE: 0.000365
activation O: 0.001153
activation O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
assay O: 0.000235
assay O
herein I-GENE
described O: 0.000232
described O
allows O: 0.000046
allows O
the I-GENE: 0.000268
the O: 0.044902
the O
comparison O: 0.000214
comparison O
of I-GENE: 0.002337
of O: 0.042520
of O
relative O: 0.000223
relative O
FGFR I-GENE: 0.000195
FGFR I-GENE
expression O: 0.002231
expression O
levels O: 0.001304
levels O
, I-GENE: 0.001923
, O: 0.035091
, O
both O: 0.001631
both O
within O: 0.000823
within O
a I-GENE: 0.000317
a O: 0.015893
a O
single I-GENE: 0.000195
single O: 0.000582
single O
RNA I-GENE: 0.003555
RNA O: 0.000591
RNA I-GENE
pool O: 0.000020
pool O
and I-GENE: 0.003263
and O: 0.028529
and O
among O: 0.000304
among O
multiple O: 0.000409
multiple O
RNA I-GENE: 0.003555
RNA O: 0.000591
RNA I-GENE
pool O: 0.000020
pool O
samples O: 0.000142
samples O
. I-GENE: 0.004017
. O: 0.044459
. O

This O: 0.000927
This O
was O: 0.006960
was O
most O: 0.000400
most O
pronounced O: 0.000041
pronounced O
during O: 0.001095
during O
the I-GENE: 0.000268
the O: 0.044902
the O
initial O: 0.000154
initial O
phase O: 0.000417
phase O
of I-GENE: 0.002337
of O: 0.042520
of O
Erk I-GENE
activation I-GENE: 0.000365
activation O: 0.001153
activation O
. I-GENE: 0.004017
. O: 0.044459
. O

DESIGN O: 0.000029
DESIGN O
: I-GENE: 0.000243
: O: 0.002561
: O
Prospective I-GENE
cohort O: 0.000032
cohort O
study O: 0.001101
study O
with O: 0.009756
with O
a I-GENE: 0.000317
a O: 0.015893
a O
20 I-GENE: 0.000146
20 O: 0.000484
20 O
y I-GENE
follow O: 0.000090
follow O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
up O: 0.000336
up O
period O: 0.000229
period O
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
First O: 0.000014
First O
National O: 0.000029
National O
Health O: 0.000035
Health O
and I-GENE: 0.003263
and O: 0.028529
and O
Examination O: 0.000029
Examination O
Survey I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
NHANES I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
Epidemiologic I-GENE
Follow I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
up O: 0.000336
up O
Study O: 0.000070
Study O
( I-GENE: 0.006014
( O: 0.014858
( O
NHEFS I-GENE
). O: 0.002228
). O

To O: 0.000522
To O
assess O: 0.000087
assess O
the I-GENE: 0.000268
the O: 0.044902
the O
maximum O: 0.000099
maximum O
oxygen O: 0.000139
oxygen O
uptake O: 0.000122
uptake O
( I-GENE: 0.006014
( O: 0.014858
( O
V I-GENE: 0.000463
V O: 0.000151
V I-GENE
' I-GENE: 0.000950
' O: 0.001701
' O
O2 O: 0.000223
O2 O
max O: 0.000026
max O
) I-GENE: 0.005210
) O: 0.009341
) O
of I-GENE: 0.002337
of O: 0.042520
of O
Hong I-GENE
Kong I-GENE
Chinese O: 0.000035
Chinese O
children O: 0.000307
children O
and I-GENE: 0.003263
and O: 0.028529
and O
to I-GENE: 0.000195
to O: 0.014977
to O
explore O: 0.000026
explore O
its O: 0.001020
its O
association O: 0.000206
association O
with O: 0.009756
with O
respiratory O: 0.000116
respiratory O
illnesses I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
we O: 0.001382
we O
conducted O: 0.000067
conducted O
the I-GENE: 0.000268
the O: 0.044902
the O
Multistage I-GENE
Fitness I-GENE
Test O: 0.000026
Test O
( I-GENE: 0.006014
( O: 0.014858
( O
MFT I-GENE
), O: 0.002269
), O
a I-GENE: 0.000317
a O: 0.015893
a O
20 I-GENE: 0.000146
20 O: 0.000484
20 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
m I-GENE: 0.000170
m O: 0.000107
m I-GENE
shuttle I-GENE
run O: 0.000020
run O
test O: 0.000391
test O
, I-GENE: 0.001923
, O: 0.035091
, O
in I-GENE: 0.000536
in O: 0.023304
in O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
427 I-GENE
schoolchildren I-GENE
aged O: 0.000049
aged O
between O: 0.001394
between O
8 I-GENE: 0.000803
8 O: 0.000939
8 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
12 I-GENE: 0.000292
12 O: 0.000539
12 O
years O: 0.000409
years O
. I-GENE: 0.004017
. O: 0.044459
. O

After O: 0.000168
After O
all O: 0.000762
all O
doses O: 0.000183
doses O
of I-GENE: 0.002337
of O: 0.042520
of O
d I-GENE: 0.000122
d O: 0.000180
d O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
amphetamine O: 0.000017
amphetamine O
, I-GENE: 0.001923
, O: 0.035091
, O
responding O: 0.000041
responding O
occurred O: 0.000154
occurred O
largely O: 0.000043
largely O
on O: 0.003416
on O
the I-GENE: 0.000268
the O: 0.044902
the O
saline O: 0.000072
saline O
key O: 0.000090
key O
under O: 0.000351
under O
both O: 0.001631
both O
schedules I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
novel O: 0.000385
novel O
myeloid O: 0.000058
myeloid O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
restricted O: 0.000099
restricted O
zebrafish I-GENE
CCAAT I-GENE: 0.000317
CCAAT O: 0.000052
CCAAT I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
enhancer I-GENE: 0.001461
enhancer O: 0.000226
enhancer I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
with O: 0.009756
with O
a I-GENE: 0.000317
a O: 0.015893
a O
potent O: 0.000101
potent O
transcriptional I-GENE: 0.000268
transcriptional O: 0.000672
transcriptional O
activation I-GENE: 0.000365
activation O: 0.001153
activation O
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

METHODS O: 0.000139
METHODS O
: I-GENE: 0.000243
: O: 0.002561
: O
Humphrey I-GENE
Field I-GENE
Analyzer I-GENE
model O: 0.000327
model O
630 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
HFA I-GENE
I I-GENE: 0.004602
I O: 0.000487
I I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
program O: 0.000061
program O
30 O: 0.000423
30 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
with O: 0.009756
with O
a I-GENE: 0.000317
a O: 0.015893
a O
rectangular I-GENE
6 I-GENE: 0.002118
6 O: 0.001153
6 I-GENE
degrees O: 0.000180
degrees O
x O: 0.000200
x O
6 I-GENE: 0.002118
6 O: 0.001153
6 I-GENE
degrees O: 0.000180
degrees O
grid I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
was O: 0.006960
was O
used O: 0.000808
used O
as O: 0.003654
as O
the I-GENE: 0.000268
the O: 0.044902
the O
conventional O: 0.000049
conventional O
perimetric I-GENE
method O: 0.000385
method O
. I-GENE: 0.004017
. O: 0.044459
. O

These O: 0.000979
These O
data O: 0.000649
data O
reveal O: 0.000052
reveal O
a I-GENE: 0.000317
a O: 0.015893
a O
complex I-GENE: 0.001315
complex O: 0.000588
complex I-GENE
network O: 0.000017
network O
of I-GENE: 0.002337
of O: 0.042520
of O
interactions O: 0.000226
interactions O
between O: 0.001394
between O
GTPases I-GENE: 0.000122
GTPases I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
ARF I-GENE: 0.000292
ARF I-GENE
family I-GENE: 0.002922
family O: 0.000313
family I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
their O: 0.000736
their O
effectors O: 0.000014
effectors O
and I-GENE: 0.003263
and O: 0.028529
and O
reveal O: 0.000052
reveal O
a I-GENE: 0.000317
a O: 0.015893
a O
potential O: 0.000336
potential O
for O: 0.006951
for O
cross O: 0.000145
cross O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
talk I-GENE
not O: 0.002509
not O
demonstrated O: 0.000409
demonstrated O
previously O: 0.000481
previously O
. I-GENE: 0.004017
. O: 0.044459
. O

Net I-GENE
lift I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
combined O: 0.000122
combined O
drag I-GENE
from I-GENE: 0.000390
from O: 0.004210
from O
all O: 0.000762
all O
8 I-GENE: 0.000803
8 O: 0.000939
8 O
bearings I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
4 I-GENE: 0.002362
4 O: 0.001307
4 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
bladed I-GENE
impeller I-GENE
are O: 0.002918
are O
compared O: 0.000603
compared O
with O: 0.009756
with O
predictions O: 0.000014
predictions O
based O: 0.000287
based O
on O: 0.003416
on O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
D I-GENE: 0.000901
D O: 0.000232
D I-GENE
theory O: 0.000032
theory O
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
the I-GENE: 0.000268
the O: 0.044902
the O
course O: 0.000122
course O
of I-GENE: 0.002337
of O: 0.042520
of O
screening O: 0.000130
screening O
for O: 0.006951
for O
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
factors I-GENE: 0.001388
factors O: 0.000626
factors I-GENE
which O: 0.002472
which O
interact O: 0.000127
interact O
with O: 0.009756
with O
the I-GENE: 0.000268
the O: 0.044902
the O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
myeloperoxidase I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
MPO I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
we O: 0.001382
we O
, I-GENE: 0.001923
, O: 0.035091
, O
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
first O: 0.000591
first O
time O: 0.000542
time O
, I-GENE: 0.001923
, O: 0.035091
, O
identified O: 0.000823
identified O
and I-GENE: 0.003263
and O: 0.028529
and O
cloned O: 0.000319
cloned O
the I-GENE: 0.000268
the O: 0.044902
the O
cDNA I-GENE: 0.001802
cDNA O: 0.000640
cDNA I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
genomic I-GENE: 0.000122
genomic O: 0.000333
genomic O
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
for O: 0.006951
for O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
HBP1 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
HMG I-GENE: 0.000560
HMG I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
Box I-GENE
containing I-GENE: 0.000414
containing O: 0.000837
containing O
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
), O: 0.002269
), O
a I-GENE: 0.000317
a O: 0.015893
a O
member O: 0.000162
member O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
high I-GENE: 0.000341
high O: 0.000924
high O
mobility I-GENE: 0.000243
mobility O: 0.000148
mobility I-GENE
group I-GENE: 0.000414
group O: 0.000869
group O
of I-GENE: 0.002337
of O: 0.042520
of O
non I-GENE: 0.000292
non O: 0.000449
non O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
histone I-GENE: 0.000536
histone I-GENE
chromosomal I-GENE: 0.000195
chromosomal O: 0.000136
chromosomal I-GENE
proteins I-GENE: 0.005673
proteins O: 0.000933
proteins I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Therefore O: 0.000107
Therefore O
, I-GENE: 0.001923
, O: 0.035091
, O
vitamin I-GENE: 0.000122
vitamin O: 0.000133
vitamin O
D3 O: 0.000049
D3 O
analogues O: 0.000014
analogues O
have O: 0.001788
have O
a I-GENE: 0.000317
a O: 0.015893
a O
substantial O: 0.000035
substantial O
antipsoriatic I-GENE
effect O: 0.000866
effect O
. I-GENE: 0.004017
. O: 0.044459
. O

Methylation I-GENE
at O: 0.002976
at O
both O: 0.001631
both O
cytosine O: 0.000017
cytosine O
residues I-GENE: 0.000146
residues O: 0.000426
residues O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
E2F I-GENE: 0.001144
E2F I-GENE
element I-GENE: 0.001680
element O: 0.000577
element I-GENE
(( I-GENE
m I-GENE: 0.000170
m O: 0.000107
m I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
CG I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
m I-GENE: 0.000170
m O: 0.000107
m I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
CG I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
generated O: 0.000139
generated O
a I-GENE: 0.000317
a O: 0.015893
a O
new O: 0.000464
new O
methylcytosine I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
complex I-GENE: 0.001315
complex O: 0.000588
complex I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Hepatitis O: 0.000023
Hepatitis O
A I-GENE: 0.003530
A O: 0.002246
A I-GENE
infected O: 0.000223
infected O
food O: 0.000075
food O
handler I-GENE
at O: 0.002976
at O
an O: 0.003112
an O
Edmonton I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
Alberta I-GENE
retail I-GENE
food O: 0.000075
food O
facility I-GENE
: I-GENE: 0.000243
: O: 0.002561
: O
public I-GENE
health O: 0.000070
health O
protection O: 0.000096
protection O
strategies O: 0.000020
strategies O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
co O: 0.000156
co O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
existence O: 0.000064
existence O
of I-GENE: 0.002337
of O: 0.042520
of O
TE I-GENE
domains I-GENE: 0.000852
domains O: 0.000400
domains I-GENE
within O: 0.000823
within O
modular I-GENE
PKSs I-GENE
along O: 0.000090
along O
with O: 0.009756
with O
physically O: 0.000032
physically O
separated O: 0.000078
separated O
, I-GENE: 0.001923
, O: 0.035091
, O
monofunctional I-GENE
TEs I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
TE I-GENE
IIs I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
has O: 0.001356
has O
been O: 0.001229
been O
reported O: 0.000278
reported O
for O: 0.006951
for O
a I-GENE: 0.000317
a O: 0.015893
a O
number O: 0.000362
number O
of I-GENE: 0.002337
of O: 0.042520
of O
modular I-GENE
polyketide I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
non I-GENE: 0.000292
non O: 0.000449
non O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
ribosomal I-GENE: 0.000609
ribosomal O: 0.000038
ribosomal I-GENE
peptide I-GENE: 0.000584
peptide O: 0.000212
peptide I-GENE
synthases I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
NRPS I-GENE
). O: 0.002228
). O

Two O: 0.000246
Two O
independent O: 0.000269
independent O
transgenic O: 0.000067
transgenic O
lines O: 0.000287
lines O
were O: 0.005244
were O
produced O: 0.000319
produced O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
both O: 0.001631
both O
showed O: 0.000863
showed O
expression O: 0.002231
expression O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
Gus I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
specifically O: 0.000206
specifically O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
endosperm I-GENE
during O: 0.001095
during O
mid O: 0.000035
mid O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
development O: 0.000388
development O
( I-GENE: 0.006014
( O: 0.014858
( O
first O: 0.000591
first O
detected O: 0.000368
detected O
10 I-GENE: 0.000292
10 O: 0.000936
10 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
12 I-GENE: 0.000292
12 O: 0.000539
12 O
d I-GENE: 0.000122
d O: 0.000180
d O
after O: 0.001385
after O
anthesis I-GENE
). O: 0.002228
). O

Treadmill I-GENE
training O: 0.000070
training O
at O: 0.002976
at O
least O: 0.000255
least O
for O: 0.006951
for O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
weeks O: 0.000240
weeks O
can O: 0.000924
can O
reduce O: 0.000058
reduce O
the I-GENE: 0.000268
the O: 0.044902
the O
infarction O: 0.000099
infarction O
size O: 0.000197
size O
and I-GENE: 0.003263
and O: 0.028529
and O
edema O: 0.000020
edema O
caused O: 0.000220
caused O
by O: 0.006887
by O
MCA I-GENE
occlusion O: 0.000055
occlusion O
( I-GENE: 0.006014
( O: 0.014858
( O
P I-GENE: 0.001023
P O: 0.000614
P I-GENE
< O: 0.000455
< O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
01 O: 0.000238
01 O
). O: 0.002228
). O

Mechanism O: 0.000014
Mechanism O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
sequential O: 0.000026
sequential O
control I-GENE: 0.000170
control O: 0.000834
control O
of I-GENE: 0.002337
of O: 0.042520
of O
cell I-GENE: 0.001144
cell O: 0.001927
cell O
morphology O: 0.000052
morphology O
and I-GENE: 0.003263
and O: 0.028529
and O
S I-GENE: 0.001631
S O: 0.000449
S I-GENE
phase O: 0.000417
phase O
entry O: 0.000049
entry O
by O: 0.006887
by O
epidermal I-GENE: 0.000463
epidermal I-GENE
growth I-GENE: 0.002337
growth O: 0.000510
growth I-GENE
factor I-GENE: 0.008984
factor O: 0.000510
factor I-GENE
involves O: 0.000084
involves O
distinct O: 0.000252
distinct O
MEK I-GENE: 0.000584
MEK I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
ERK I-GENE: 0.000633
ERK I-GENE
activations I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

We O: 0.001417
We O
randomly O: 0.000043
randomly O
assigned O: 0.000029
assigned O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
219 I-GENE
subjects O: 0.000394
subjects O
to I-GENE: 0.000195
to O: 0.014977
to O
receive O: 0.000029
receive O
either O: 0.000452
either O
the I-GENE: 0.000268
the O: 0.044902
the O
standard O: 0.000133
standard O
three O: 0.000785
three O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
times O: 0.000203
times O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
weekly O: 0.000035
weekly O
( I-GENE: 0.006014
( O: 0.014858
( O
TIW I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
interferon I-GENE: 0.001071
interferon I-GENE
alfa I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
2b I-GENE: 0.000268
2b I-GENE
dose O: 0.000469
dose O
( I-GENE: 0.006014
( O: 0.014858
( O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
MIU I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
or I-GENE: 0.000219
or O: 0.003321
or O
the I-GENE: 0.000268
the O: 0.044902
the O
once O: 0.000049
once O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
weekly O: 0.000035
weekly O
( I-GENE: 0.006014
( O: 0.014858
( O
QW I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
peginterferon I-GENE
alfa I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
2b I-GENE: 0.000268
2b I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
0 O: 0.002784
0 O
, I-GENE: 0.001923
, O: 0.035091
, O
or I-GENE: 0.000219
or O: 0.003321
or O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
microg O: 0.000032
microg O
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
kg O: 0.000585
kg O
). O: 0.002228
). O

These O: 0.000979
These O
data O: 0.000649
data O
suggest O: 0.000585
suggest O
that O: 0.008362
that O
proper O: 0.000043
proper O
direct O: 0.000264
direct O
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
Nhp2p I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
H I-GENE: 0.001290
H O: 0.000240
H I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
ACA I-GENE
snoRNAs I-GENE
is O: 0.006803
is O
required O: 0.000591
required O
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
assembly O: 0.000110
assembly O
of I-GENE: 0.002337
of O: 0.042520
of O
H I-GENE: 0.001290
H O: 0.000240
H I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
ACA I-GENE
snoRNPs I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
hence O: 0.000026
hence O
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
stability O: 0.000070
stability O
of I-GENE: 0.002337
of O: 0.042520
of O
some O: 0.000307
some O
of I-GENE: 0.002337
of O: 0.042520
of O
their O: 0.000736
their O
components O: 0.000177
components O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
decrements I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
cerebrovascular I-GENE
resistance I-GENE: 0.000146
resistance O: 0.000183
resistance O
induced O: 0.001176
induced O
by O: 0.006887
by O
hexamethonium I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
in I-GENE: 0.000536
in O: 0.023304
in O
mm O: 0.000127
mm O
Hg O: 0.000070
Hg O
ml O: 0.000438
ml O
(- O: 0.000223
(- O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
). O: 0.002228
). O
min O: 0.000481
min O
(- O: 0.000223
(- O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
), O: 0.002269
), O
were O: 0.005244
were O
: I-GENE: 0.000243
: O: 0.002561
: O
under O: 0.000351
under O
control I-GENE: 0.000170
control O: 0.000834
control O
. I-GENE: 0.004017
. O: 0.044459
. O

Here O: 0.000214
Here O
we O: 0.001382
we O
provide O: 0.000159
provide O
the I-GENE: 0.000268
the O: 0.044902
the O
first O: 0.000591
first O
evidence O: 0.000342
evidence O
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
involvement O: 0.000110
involvement O
of I-GENE: 0.002337
of O: 0.042520
of O
GCN1 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
GCN2 I-GENE: 0.000146
GCN2 I-GENE
interaction I-GENE: 0.000122
interaction O: 0.000478
interaction O
in I-GENE: 0.000536
in O: 0.023304
in O
activation I-GENE: 0.000365
activation O: 0.001153
activation O
of I-GENE: 0.002337
of O: 0.042520
of O
GCN2 I-GENE: 0.000146
GCN2 I-GENE
per O: 0.000293
per O
se I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

As O: 0.000162
As O
a I-GENE: 0.000317
a O: 0.015893
a O
reflection I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
uncertainties I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
estimates O: 0.000038
estimates O
for O: 0.006951
for O
individual O: 0.000107
individual O
sources O: 0.000029
sources O
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
90th I-GENE
percentiles I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
PCDD I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
F I-GENE: 0.000487
F O: 0.000142
F I-GENE
releases I-GENE
for O: 0.006951
for O
1999 I-GENE
ranged O: 0.000046
ranged O
up O: 0.000336
up O
to I-GENE: 0.000195
to O: 0.014977
to O
4 I-GENE: 0.002362
4 O: 0.001307
4 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
g O: 0.000307
g O
I I-GENE: 0.004602
I O: 0.000487
I I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
TEQ I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
y I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

To O: 0.000522
To O
test O: 0.000391
test O
the I-GENE: 0.000268
the O: 0.044902
the O
hypothesis O: 0.000067
hypothesis O
that O: 0.008362
that O
these O: 0.001478
these O
elements I-GENE: 0.000414
elements O: 0.000493
elements O
are O: 0.002918
are O
required O: 0.000591
required O
for O: 0.006951
for O
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
activity O: 0.002295
activity O
, I-GENE: 0.001923
, O: 0.035091
, O
we O: 0.001382
we O
compared O: 0.000603
compared O
the I-GENE: 0.000268
the O: 0.044902
the O
reporter I-GENE: 0.000828
reporter O: 0.000246
reporter I-GENE
expression O: 0.002231
expression O
activity O: 0.002295
activity O
of I-GENE: 0.002337
of O: 0.042520
of O
segments O: 0.000072
segments O
containing I-GENE: 0.000414
containing O: 0.000837
containing O
mutations I-GENE: 0.000243
mutations O: 0.000435
mutations O
of I-GENE: 0.002337
of O: 0.042520
of O
these O: 0.001478
these O
elements I-GENE: 0.000414
elements O: 0.000493
elements O
with O: 0.009756
with O
activity O: 0.002295
activity O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
parent I-GENE
Hlx I-GENE
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
sequence I-GENE: 0.002021
sequence O: 0.001866
sequence I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Using O: 0.000200
Using O
RACE O: 0.000020
RACE O
techniques O: 0.000061
techniques O
we O: 0.001382
we O
have O: 0.001788
have O
cloned O: 0.000319
cloned O
and I-GENE: 0.003263
and O: 0.028529
and O
sequenced O: 0.000125
sequenced O
one O: 0.001026
one O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
hamster I-GENE: 0.000122
hamster O: 0.000041
hamster I-GENE
liver I-GENE: 0.000243
liver O: 0.000382
liver O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
hydroxy I-GENE: 0.000122
hydroxy O: 0.000020
hydroxy I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
hexobarbital I-GENE
dehydrogenases I-GENE
which O: 0.002472
which O
catalyze I-GENE
not O: 0.002509
not O
only O: 0.000794
only O
cyclic I-GENE: 0.000195
cyclic O: 0.000052
cyclic I-GENE
alcohols I-GENE
but O: 0.001675
but O
also O: 0.001373
also O
17beta I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
hydroxy I-GENE: 0.000122
hydroxy O: 0.000020
hydroxy I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
steroids O: 0.000041
steroids O
and I-GENE: 0.003263
and O: 0.028529
and O
3alpha I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
hydroxysteroids I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Concerted I-GENE
transcriptional I-GENE: 0.000268
transcriptional O: 0.000672
transcriptional O
activation I-GENE: 0.000365
activation O: 0.001153
activation O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
low I-GENE: 0.000146
low O: 0.000440
low O
density I-GENE: 0.000219
density O: 0.000119
density I-GENE
lipoprotein I-GENE: 0.000292
lipoprotein O: 0.000020
lipoprotein I-GENE
receptor I-GENE: 0.006817
receptor O: 0.000258
receptor I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
by O: 0.006887
by O
insulin I-GENE: 0.002240
insulin I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
luteinizing I-GENE
hormone I-GENE: 0.001363
hormone O: 0.000107
hormone I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
cultured O: 0.000041
cultured O
porcine O: 0.000020
porcine O
granulosa I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
luteal O: 0.000029
luteal O
cells O: 0.002663
cells O
: I-GENE: 0.000243
: O: 0.002561
: O
possible O: 0.000267
possible O
convergence I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
a I-GENE: 0.000317
a O: 0.015893
a O
, I-GENE: 0.001923
, O: 0.035091
, O
phosphatidylinositol I-GENE: 0.000463
phosphatidylinositol I-GENE
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
mitogen I-GENE: 0.000755
mitogen O: 0.000017
mitogen I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
activated I-GENE: 0.001412
activated O: 0.000356
activated I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
signaling O: 0.000293
signaling O
pathways O: 0.000171
pathways O
. I-GENE: 0.004017
. O: 0.044459
. O

Human I-GENE: 0.000511
Human O: 0.000046
Human I-GENE
T I-GENE: 0.001558
T O: 0.000548
T I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
cell I-GENE: 0.001144
cell O: 0.001927
cell O
leukemia I-GENE: 0.000146
leukemia O: 0.000139
leukemia I-GENE
virus I-GENE: 0.001437
virus O: 0.000669
virus I-GENE
type I-GENE: 0.003384
type O: 0.000884
type I-GENE
I I-GENE: 0.004602
I O: 0.000487
I I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
HTLV O: 0.000041
HTLV O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
I I-GENE: 0.004602
I O: 0.000487
I I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
Tax I-GENE: 0.000511
Tax I-GENE
is O: 0.006803
is O
a I-GENE: 0.000317
a O: 0.015893
a O
potent O: 0.000101
potent O
transcriptional I-GENE: 0.000268
transcriptional O: 0.000672
transcriptional O
regulator I-GENE: 0.000195
regulator O: 0.000104
regulator I-GENE
that O: 0.008362
that O
can O: 0.000924
can O
activate O: 0.000165
activate O
or I-GENE: 0.000219
or O: 0.003321
or O
repress O: 0.000038
repress O
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
cellular I-GENE: 0.000243
cellular O: 0.000304
cellular O
genes I-GENE: 0.004626
genes O: 0.000918
genes I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
that O: 0.008362
that O
has O: 0.001356
has O
been O: 0.001229
been O
proposed O: 0.000081
proposed O
to I-GENE: 0.000195
to O: 0.014977
to O
contribute O: 0.000087
contribute O
to I-GENE: 0.000195
to O: 0.014977
to O
leukemogenesis I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
adult O: 0.000162
adult O
T I-GENE: 0.001558
T O: 0.000548
T I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
cell I-GENE: 0.001144
cell O: 0.001927
cell O
leukemia I-GENE: 0.000146
leukemia O: 0.000139
leukemia I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Also O: 0.000038
Also O
, I-GENE: 0.001923
, O: 0.035091
, O
small I-GENE: 0.000682
small O: 0.000290
small I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
sense O: 0.000046
sense O
and I-GENE: 0.003263
and O: 0.028529
and O
antisense O: 0.000041
antisense O
approximately O: 0.000307
approximately O
22 O: 0.000162
22 O
nt O: 0.000136
nt O
RNAs I-GENE: 0.000122
RNAs O: 0.000072
RNAs I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
derived I-GENE: 0.000268
derived O: 0.000290
derived O
from I-GENE: 0.000390
from O: 0.004210
from O
the I-GENE: 0.000268
the O: 0.044902
the O
satRNA I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
were O: 0.005244
were O
associated I-GENE: 0.000755
associated O: 0.000716
associated I-GENE
with O: 0.009756
with O
the I-GENE: 0.000268
the O: 0.044902
the O
replicating O: 0.000020
replicating O
satellite O: 0.000017
satellite O
. I-GENE: 0.004017
. O: 0.044459
. O

Deletional I-GENE
analyses O: 0.000194
analyses O
of I-GENE: 0.002337
of O: 0.042520
of O
VDR I-GENE: 0.000292
VDR I-GENE
indicated O: 0.000229
indicated O
that O: 0.008362
that O
GRIP1 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
RAC3 I-GENE
required O: 0.000591
required O
an O: 0.003112
an O
intact O: 0.000130
intact O
VDR I-GENE: 0.000292
VDR I-GENE
activation I-GENE: 0.000365
activation O: 0.001153
activation O
function O: 0.000855
function O
( I-GENE: 0.006014
( O: 0.014858
( O
AF O: 0.000032
AF O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
for O: 0.006951
for O
efficient O: 0.000072
efficient O
interaction I-GENE: 0.000122
interaction O: 0.000478
interaction O
as O: 0.003654
as O
well O: 0.000626
well O
as O: 0.003654
as O
additional O: 0.000156
additional O
but O: 0.001675
but O
distinct O: 0.000252
distinct O
regions I-GENE: 0.000243
regions O: 0.000501
regions O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
VDR I-GENE: 0.000292
VDR I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

RESULTS O: 0.000180
RESULTS O
: I-GENE: 0.000243
: O: 0.002561
: O
During O: 0.000154
During O
the I-GENE: 0.000268
the O: 0.044902
the O
stabilization O: 0.000026
stabilization O
period O: 0.000229
period O
, I-GENE: 0.001923
, O: 0.035091
, O
PaCO2 O: 0.000029
PaCO2 O
( I-GENE: 0.006014
( O: 0.014858
( O
mean O: 0.000423
mean O
+/- O: 0.001124
+/- O
SD O: 0.000130
SD O
) I-GENE: 0.005210
) O: 0.009341
) O
was O: 0.006960
was O
33 O: 0.000116
33 O
+/- O: 0.001124
+/- O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
mm O: 0.000127
mm O
Hg O: 0.000070
Hg O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
arrhythmias O: 0.000035
arrhythmias O
were O: 0.005244
were O
not O: 0.002509
not O
detected O: 0.000368
detected O
. I-GENE: 0.004017
. O: 0.044459
. O

TT I-GENE
cells O: 0.002663
cells O
, I-GENE: 0.001923
, O: 0.035091
, O
a I-GENE: 0.000317
a O: 0.015893
a O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
MTC I-GENE
cell I-GENE: 0.001144
cell O: 0.001927
cell O
line O: 0.000319
line O
expressing O: 0.000151
expressing O
MEN I-GENE
2A I-GENE: 0.000219
2A I-GENE
type I-GENE: 0.003384
type O: 0.000884
type I-GENE
RET I-GENE: 0.000146
RET I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
display O: 0.000058
display O
transcriptionally O: 0.000081
transcriptionally O
active O: 0.000293
active O
RelA I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
p65 I-GENE: 0.000341
p65 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
nucleus O: 0.000154
nucleus O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
sequence I-GENE: 0.002021
sequence O: 0.001866
sequence I-GENE
exhibits O: 0.000035
exhibits O
a I-GENE: 0.000317
a O: 0.015893
a O
putative O: 0.000348
putative O
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
similar O: 0.000574
similar O
to I-GENE: 0.000195
to O: 0.014977
to O
that O: 0.008362
that O
seen O: 0.000162
seen O
in I-GENE: 0.000536
in O: 0.023304
in O
rat I-GENE: 0.001607
rat O: 0.000409
rat I-GENE
HBP1 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
shows O: 0.000206
shows O
homology I-GENE: 0.000487
homology O: 0.000327
homology I-GENE
with O: 0.009756
with O
the I-GENE: 0.000268
the O: 0.044902
the O
activation I-GENE: 0.000365
activation O: 0.001153
activation O
and I-GENE: 0.003263
and O: 0.028529
and O
repressor I-GENE: 0.000414
repressor O: 0.000099
repressor I-GENE
domains I-GENE: 0.000852
domains O: 0.000400
domains I-GENE
previously O: 0.000481
previously O
demonstrated O: 0.000409
demonstrated O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
rat I-GENE: 0.001607
rat O: 0.000409
rat I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
contrast O: 0.000336
contrast O
the I-GENE: 0.000268
the O: 0.044902
the O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
mouse I-GENE: 0.001680
mouse O: 0.000403
mouse I-GENE
BCNT I-GENE
proteins I-GENE: 0.005673
proteins O: 0.000933
proteins I-GENE
contain O: 0.000246
contain O
one O: 0.001026
one O
repeat I-GENE: 0.000317
repeat O: 0.000209
repeat I-GENE
unit I-GENE: 0.000122
unit O: 0.000116
unit I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
lack O: 0.000093
lack O
the I-GENE: 0.000268
the O: 0.044902
the O
RTE I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
derived I-GENE: 0.000268
derived O: 0.000290
derived O
portion O: 0.000125
portion O
. I-GENE: 0.004017
. O: 0.044459
. O

Direct I-GENE
superoxide I-GENE: 0.000243
superoxide I-GENE
scavenging I-GENE
activity O: 0.002295
activity O
of I-GENE: 0.002337
of O: 0.042520
of O
nonsteroidal I-GENE
anti I-GENE: 0.001704
anti O: 0.000087
anti I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
inflammatory O: 0.000101
inflammatory O
drugs O: 0.000159
drugs O
: I-GENE: 0.000243
: O: 0.002561
: O
determination O: 0.000154
determination O
by O: 0.006887
by O
electron O: 0.000087
electron O
spin O: 0.000026
spin O
resonance O: 0.000055
resonance O
using O: 0.000979
using O
the I-GENE: 0.000268
the O: 0.044902
the O
spin O: 0.000026
spin O
trap I-GENE
method O: 0.000385
method O
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
single I-GENE: 0.000195
single O: 0.000582
single O
nucleotide I-GENE: 0.000317
nucleotide O: 0.000310
nucleotide I-GENE
polymorphism O: 0.000026
polymorphism O
( I-GENE: 0.006014
( O: 0.014858
( O
SNP I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
in I-GENE: 0.000536
in O: 0.023304
in O
exon O: 0.000339
exon O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
which O: 0.002472
which O
is O: 0.006803
is O
tightly O: 0.000026
tightly O
liked I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
another O: 0.000113
another O
SNP I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
GTG83 I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
ATG83 I-GENE
), O: 0.002269
), O
creates I-GENE
an O: 0.003112
an O
additional O: 0.000156
additional O
alternative O: 0.000188
alternative O
in I-GENE: 0.000536
in O: 0.023304
in O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
frame I-GENE: 0.000122
frame O: 0.000220
frame O
AUG O: 0.000020
AUG O
in I-GENE: 0.000536
in O: 0.023304
in O
B I-GENE: 0.004066
B O: 0.000640
B I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
type I-GENE: 0.003384
type O: 0.000884
type I-GENE
MTH1 I-GENE
mRNAs I-GENE: 0.000487
mRNAs O: 0.000116
mRNAs I-GENE
yielding I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
fourth O: 0.000035
fourth O
MTH1 I-GENE
polypeptide I-GENE: 0.000341
polypeptide O: 0.000136
polypeptide I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
p26 I-GENE
that O: 0.008362
that O
possesses O: 0.000041
possesses O
an O: 0.003112
an O
additional O: 0.000156
additional O
mitochondrial I-GENE: 0.000268
mitochondrial O: 0.000107
mitochondrial I-GENE
targeting O: 0.000075
targeting O
signal I-GENE: 0.000536
signal O: 0.000362
signal I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Six O: 0.000032
Six O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
gstC I-GENE
' I-GENE: 0.000950
' O: 0.001701
' O
mutants I-GENE: 0.001315
mutants O: 0.000258
mutants I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
primarily O: 0.000093
primarily O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
C I-GENE: 0.005113
C O: 0.001005
C I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
terminal I-GENE: 0.001169
terminal O: 0.000884
terminal I-GENE
half O: 0.000145
half O
of I-GENE: 0.002337
of O: 0.042520
of O
C I-GENE: 0.005113
C O: 0.001005
C I-GENE
', O: 0.000035
', O
exhibited O: 0.000087
exhibited O
a I-GENE: 0.000317
a O: 0.015893
a O
defect O: 0.000075
defect O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
ability O: 0.000290
ability O
to I-GENE: 0.000195
to O: 0.014977
to O
bind O: 0.000296
bind O
L I-GENE: 0.000779
L O: 0.000316
L I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

We O: 0.001417
We O
developed O: 0.000226
developed O
a I-GENE: 0.000317
a O: 0.015893
a O
system O: 0.000524
system O
for O: 0.006951
for O
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
shuffling I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
establish O: 0.000041
establish O
the I-GENE: 0.000268
the O: 0.044902
the O
function O: 0.000855
function O
of I-GENE: 0.002337
of O: 0.042520
of O
C1 I-GENE: 0.000243
C1 O: 0.000029
C1 I-GENE
domains I-GENE: 0.000852
domains O: 0.000400
domains I-GENE
from I-GENE: 0.000390
from O: 0.004210
from O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
Raf I-GENE: 0.000755
Raf I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
rat I-GENE: 0.001607
rat O: 0.000409
rat I-GENE
PKC I-GENE: 0.001510
PKC I-GENE
eta I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
yeast I-GENE: 0.001242
yeast O: 0.000498
yeast I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Expression O: 0.000133
Expression O
of I-GENE: 0.002337
of O: 0.042520
of O
herpes I-GENE: 0.000146
herpes O: 0.000043
herpes I-GENE
simplex I-GENE: 0.000122
simplex O: 0.000026
simplex I-GENE
virus I-GENE: 0.001437
virus O: 0.000669
virus I-GENE
type I-GENE: 0.003384
type O: 0.000884
type I-GENE
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
US3 I-GENE
affects O: 0.000041
affects O
the I-GENE: 0.000268
the O: 0.044902
the O
Cdc42 I-GENE: 0.000268
Cdc42 I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
Rac I-GENE: 0.000219
Rac I-GENE
pathway O: 0.000385
pathway O
and I-GENE: 0.003263
and O: 0.028529
and O
attenuates O: 0.000014
attenuates O
c I-GENE: 0.006111
c O: 0.000101
c I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
Jun I-GENE: 0.001217
Jun I-GENE
N I-GENE: 0.001217
N O: 0.000614
N I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
terminal I-GENE: 0.001169
terminal O: 0.000884
terminal I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
activation I-GENE: 0.000365
activation O: 0.001153
activation O
. I-GENE: 0.004017
. O: 0.044459
. O

Inhibition O: 0.000029
Inhibition O
of I-GENE: 0.002337
of O: 0.042520
of O
constitutive O: 0.000107
constitutive O
NF I-GENE: 0.002922
NF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
kappaB I-GENE: 0.001363
kappaB I-GENE
activity O: 0.002295
activity O
results O: 0.001162
results O
in I-GENE: 0.000536
in O: 0.023304
in O
cell I-GENE: 0.001144
cell O: 0.001927
cell O
death O: 0.000136
death O
of I-GENE: 0.002337
of O: 0.042520
of O
TT I-GENE
cells O: 0.002663
cells O
and I-GENE: 0.003263
and O: 0.028529
and O
blocks O: 0.000081
blocks O
focus O: 0.000032
focus O
formation O: 0.000330
formation O
induced O: 0.001176
induced O
by O: 0.006887
by O
oncogenic O: 0.000035
oncogenic O
forms O: 0.000203
forms O
of I-GENE: 0.002337
of O: 0.042520
of O
RET I-GENE: 0.000146
RET I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
NIH O: 0.000052
NIH O
3T3 O: 0.000087
3T3 O
cells O: 0.002663
cells O
. I-GENE: 0.004017
. O: 0.044459
. O

Corneal I-GENE
scrapping I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
deep O: 0.000043
deep O
stromal I-GENE
biopsy O: 0.000052
biopsy O
were O: 0.005244
were O
obtained O: 0.000417
obtained O
and I-GENE: 0.003263
and O: 0.028529
and O
stained O: 0.000023
stained O
for O: 0.006951
for O
microscopic O: 0.000032
microscopic O
evaluation O: 0.000151
evaluation O
with O: 0.009756
with O
periodic O: 0.000017
periodic O
acid I-GENE: 0.001315
acid O: 0.000997
acid I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
Schiff I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
Giemsa I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
Gomori I-GENE
' I-GENE: 0.000950
' O: 0.001701
' O
s I-GENE: 0.000243
s O: 0.000724
s O
methenamine I-GENE
silver O: 0.000020
silver O
stains I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

ICAM I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
has O: 0.001356
has O
been O: 0.001229
been O
suggested O: 0.000229
suggested O
a I-GENE: 0.000317
a O: 0.015893
a O
predictor O: 0.000020
predictor O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
onset O: 0.000101
onset O
of I-GENE: 0.002337
of O: 0.042520
of O
GO I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Once O: 0.000014
Once O
ICP I-GENE
reaches I-GENE
critical O: 0.000183
critical O
values O: 0.000339
values O
(> O: 0.000017
(> O
30 O: 0.000423
30 O
mm O: 0.000127
mm O
Hg O: 0.000070
Hg O
) I-GENE: 0.005210
) O: 0.009341
) O
herniation I-GENE
occurs O: 0.000119
occurs O
, I-GENE: 0.001923
, O: 0.035091
, O
usually O: 0.000052
usually O
within O: 0.000823
within O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
days O: 0.000356
days O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
present O: 0.000551
present O
data O: 0.000649
data O
also O: 0.001373
also O
demonstrate O: 0.000290
demonstrate O
that O: 0.008362
that O
ectopic O: 0.000032
ectopic O
expression O: 0.002231
expression O
of I-GENE: 0.002337
of O: 0.042520
of O
blr1 I-GENE
increased O: 0.000817
increased O
JNK I-GENE: 0.000803
JNK I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
SAPK I-GENE: 0.000243
SAPK I-GENE
activity O: 0.002295
activity O
, I-GENE: 0.001923
, O: 0.035091
, O
but O: 0.001675
but O
JNK I-GENE: 0.000803
JNK I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
SAPK I-GENE: 0.000243
SAPK I-GENE
activation I-GENE: 0.000365
activation O: 0.001153
activation O
was O: 0.006960
was O
not O: 0.002509
not O
needed O: 0.000055
needed O
for O: 0.006951
for O
accelerated O: 0.000023
accelerated O
RA O: 0.000072
RA O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
induced O: 0.001176
induced O
differentiation O: 0.000217
differentiation O
and I-GENE: 0.003263
and O: 0.028529
and O
growth I-GENE: 0.002337
growth O: 0.000510
growth I-GENE
arrest O: 0.000084
arrest O
. I-GENE: 0.004017
. O: 0.044459
. O

Here O: 0.000214
Here O
, I-GENE: 0.001923
, O: 0.035091
, O
we O: 0.001382
we O
identify O: 0.000177
identify O
Rsc3 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
Rsc30 I-GENE
as O: 0.003654
as O
novel O: 0.000385
novel O
components O: 0.000177
components O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
essential O: 0.000351
essential O
yeast I-GENE: 0.001242
yeast O: 0.000498
yeast I-GENE
remodeler I-GENE
RSC I-GENE
complex I-GENE: 0.001315
complex O: 0.000588
complex I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
pharmacokinetic O: 0.000032
pharmacokinetic O
profiles O: 0.000049
profiles O
of I-GENE: 0.002337
of O: 0.042520
of O
digoxin I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
warfarin I-GENE
were O: 0.005244
were O
not O: 0.002509
not O
altered O: 0.000113
altered O
by O: 0.006887
by O
the I-GENE: 0.000268
the O: 0.044902
the O
simultaneous O: 0.000055
simultaneous O
and I-GENE: 0.003263
and O: 0.028529
and O
continued O: 0.000032
continued O
administration O: 0.000301
administration O
of I-GENE: 0.002337
of O: 0.042520
of O
sevelamer I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Forskolin I-GENE
treatment O: 0.000921
treatment O
( I-GENE: 0.006014
( O: 0.014858
( O
10 I-GENE: 0.000292
10 O: 0.000936
10 O
microM O: 0.000020
microM O
) I-GENE: 0.005210
) O: 0.009341
) O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
transfected O: 0.000185
transfected O
cells O: 0.002663
cells O
for O: 0.006951
for O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
-- O: 0.000301
-- O
6 I-GENE: 0.002118
6 O: 0.001153
6 I-GENE
h O: 0.000368
h O
maximally I-GENE
induced O: 0.001176
induced O
luciferase I-GENE: 0.000682
luciferase I-GENE
threefold O: 0.000020
threefold O
. I-GENE: 0.004017
. O: 0.044459
. O

E2F1 I-GENE: 0.000146
E2F1 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
mediated O: 0.000475
mediated O
transcriptional I-GENE: 0.000268
transcriptional O: 0.000672
transcriptional O
inhibition O: 0.000284
inhibition O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
plasminogen I-GENE: 0.000706
plasminogen I-GENE
activator I-GENE: 0.001120
activator O: 0.000093
activator I-GENE
inhibitor I-GENE: 0.000438
inhibitor O: 0.000238
inhibitor I-GENE
type I-GENE: 0.003384
type O: 0.000884
type I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
this O: 0.001976
this O
report O: 0.000304
report O
this O: 0.001976
this O
technique O: 0.000183
technique O
was O: 0.006960
was O
applied O: 0.000061
applied O
to I-GENE: 0.000195
to O: 0.014977
to O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
breast O: 0.000125
breast O
carcinoma O: 0.000217
carcinoma O
MDA I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
MB231 I-GENE
cells O: 0.002663
cells O
overexpressing O: 0.000023
overexpressing O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
MPG I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
order O: 0.000206
order O
to I-GENE: 0.000195
to O: 0.014977
to O
assess O: 0.000087
assess O
whether O: 0.000220
whether O
up O: 0.000336
up O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
regulation O: 0.000553
regulation O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
initial O: 0.000154
initial O
step O: 0.000081
step O
in I-GENE: 0.000536
in O: 0.023304
in O
BER I-GENE
alters O: 0.000014
alters O
the I-GENE: 0.000268
the O: 0.044902
the O
activity O: 0.002295
activity O
of I-GENE: 0.002337
of O: 0.042520
of O
selected O: 0.000139
selected O
other O: 0.000994
other O
BER I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
hOGG1 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
APE I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
ref I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
or I-GENE: 0.000219
or O: 0.003321
or O
direct O: 0.000264
direct O
reversal O: 0.000032
reversal O
( I-GENE: 0.006014
( O: 0.014858
( O
MGMT I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
repair I-GENE: 0.000146
repair O: 0.000110
repair I-GENE
activities O: 0.000261
activities O
. I-GENE: 0.004017
. O: 0.044459
. O

Chlamydia O: 0.000014
Chlamydia O
and I-GENE: 0.003263
and O: 0.028529
and O
cervical O: 0.000081
cervical O
cancer O: 0.000284
cancer O
: I-GENE: 0.000243
: O: 0.002561
: O
a I-GENE: 0.000317
a O: 0.015893
a O
real O: 0.000023
real O
association O: 0.000206
association O
? O: 0.000081
? O

In O: 0.002266
In O
children O: 0.000307
children O
unable O: 0.000061
unable O
to I-GENE: 0.000195
to O: 0.014977
to O
perform O: 0.000017
perform O
forced I-GENE
expiratory O: 0.000020
expiratory O
maneuvers I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
n O: 0.000264
n O
= O: 0.000855
= O
25 O: 0.000252
25 O
), O: 0.002269
), O
FOT I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
contrary I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
interrupter I-GENE
technique O: 0.000183
technique O
, I-GENE: 0.001923
, O: 0.035091
, O
clearly O: 0.000041
clearly O
identified O: 0.000823
identified O
a I-GENE: 0.000317
a O: 0.015893
a O
subgroup O: 0.000058
subgroup O
of I-GENE: 0.002337
of O: 0.042520
of O
young O: 0.000072
young O
children O: 0.000307
children O
with O: 0.009756
with O
high I-GENE: 0.000341
high O: 0.000924
high O
resistance I-GENE: 0.000146
resistance O: 0.000183
resistance O
values O: 0.000339
values O
at O: 0.002976
at O
baseline O: 0.000099
baseline O
, I-GENE: 0.001923
, O: 0.035091
, O
which O: 0.002472
which O
returned O: 0.000026
returned O
to I-GENE: 0.000195
to O: 0.014977
to O
normal O: 0.000759
normal O
after O: 0.001385
after O
bronchodilation I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Together O: 0.000026
Together O
, I-GENE: 0.001923
, O: 0.035091
, O
these O: 0.001478
these O
results O: 0.001162
results O
identify O: 0.000177
identify O
HPK1 I-GENE
as O: 0.003654
as O
a I-GENE: 0.000317
a O: 0.015893
a O
new O: 0.000464
new O
component O: 0.000180
component O
of I-GENE: 0.002337
of O: 0.042520
of O
TCR I-GENE: 0.000730
TCR I-GENE
signaling O: 0.000293
signaling O
. I-GENE: 0.004017
. O: 0.044459
. O

Pro O: 0.000023
Pro O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
inflammatory O: 0.000101
inflammatory O
cytokine O: 0.000081
cytokine O
, I-GENE: 0.001923
, O: 0.035091
, O
tumor I-GENE: 0.000487
tumor O: 0.000310
tumor I-GENE
necrosis I-GENE: 0.000438
necrosis O: 0.000041
necrosis I-GENE
factor I-GENE: 0.008984
factor O: 0.000510
factor I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
alpha I-GENE: 0.009009
alpha O: 0.000313
alpha I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
TNF I-GENE: 0.001023
TNF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
alpha I-GENE: 0.009009
alpha O: 0.000313
alpha I-GENE
), O: 0.002269
), O
produced O: 0.000319
produced O
from I-GENE: 0.000390
from O: 0.004210
from O
adipose O: 0.000014
adipose O
tissues O: 0.000235
tissues O
in I-GENE: 0.000536
in O: 0.023304
in O
obese O: 0.000029
obese O
subjects O: 0.000394
subjects O
, I-GENE: 0.001923
, O: 0.035091
, O
is O: 0.006803
is O
known O: 0.000359
known O
to I-GENE: 0.000195
to O: 0.014977
to O
play O: 0.000162
play O
a I-GENE: 0.000317
a O: 0.015893
a O
predominant O: 0.000032
predominant O
role O: 0.000681
role O
in I-GENE: 0.000536
in O: 0.023304
in O
inducing O: 0.000026
inducing O
insulin I-GENE: 0.002240
insulin I-GENE
resistance I-GENE: 0.000146
resistance O: 0.000183
resistance O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
Schistosoma I-GENE
mansoni I-GENE
homologue I-GENE: 0.000317
homologue O: 0.000035
homologue I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
SmSmad2 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
was O: 0.006960
was O
overexpressed O: 0.000061
overexpressed O
in I-GENE: 0.000536
in O: 0.023304
in O
bacteria O: 0.000087
bacteria O
as O: 0.003654
as O
a I-GENE: 0.000317
a O: 0.015893
a O
Sj26 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
GST I-GENE: 0.000487
GST I-GENE
fusion I-GENE: 0.000390
fusion O: 0.000255
fusion I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
used O: 0.000808
used O
to I-GENE: 0.000195
to O: 0.014977
to O
raise I-GENE
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
antibodies I-GENE: 0.001144
antibodies O: 0.000159
antibodies I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

To O: 0.000522
To O
study O: 0.001101
study O
the I-GENE: 0.000268
the O: 0.044902
the O
in I-GENE: 0.000536
in O: 0.023304
in O
vivo O: 0.000464
vivo O
role O: 0.000681
role O
of I-GENE: 0.002337
of O: 0.042520
of O
p16 I-GENE: 0.000122
p16 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
7 I-GENE: 0.000390
7 O: 0.000942
7 O
, I-GENE: 0.001923
, O: 0.035091
, O
a I-GENE: 0.000317
a O: 0.015893
a O
phi29 I-GENE
mutant I-GENE: 0.002386
mutant O: 0.000385
mutant I-GENE
containing I-GENE: 0.000414
containing O: 0.000837
containing O
a I-GENE: 0.000317
a O: 0.015893
a O
suppressible I-GENE
mutation I-GENE: 0.000560
mutation O: 0.000296
mutation I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
16 I-GENE: 0.000243
16 O: 0.000348
16 O
. I-GENE: 0.004017
. O: 0.044459
. O
7 I-GENE: 0.000390
7 O: 0.000942
7 O
was O: 0.006960
was O
constructed O: 0.000110
constructed O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
differences O: 0.000322
differences O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
CPIgG I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
CRP I-GENE: 0.000341
CRP I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
fibrinogen I-GENE: 0.000560
fibrinogen I-GENE
levels O: 0.001304
levels O
in I-GENE: 0.000536
in O: 0.023304
in O
patients O: 0.002538
patients O
who O: 0.000348
who O
were O: 0.005244
were O
diagnosed O: 0.000067
diagnosed O
with O: 0.009756
with O
ACS I-GENE
versus O: 0.000122
versus O
those O: 0.000461
those O
who O: 0.000348
who O
were O: 0.005244
were O
not O: 0.002509
not O
( I-GENE: 0.006014
( O: 0.014858
( O
non I-GENE: 0.000292
non O: 0.000449
non O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
ACS I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
were O: 0.005244
were O
evaluated O: 0.000203
evaluated O
. I-GENE: 0.004017
. O: 0.044459
. O

There O: 0.000185
There O
are O: 0.002918
are O
many O: 0.000180
many O
different O: 0.000669
different O
proposals I-GENE
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
statistical O: 0.000038
statistical O
analysis O: 0.001194
analysis O
of I-GENE: 0.002337
of O: 0.042520
of O
data O: 0.000649
data O
to I-GENE: 0.000195
to O: 0.014977
to O
determine O: 0.000255
determine O
early I-GENE: 0.000706
early O: 0.000374
early I-GENE
onset O: 0.000101
onset O
of I-GENE: 0.002337
of O: 0.042520
of O
action O: 0.000177
action O
. I-GENE: 0.004017
. O: 0.044459
. O

Coexpression I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
p120 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
ctn I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
with O: 0.009756
with O
an O: 0.003112
an O
N I-GENE: 0.001217
N O: 0.000614
N I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
terminal I-GENE: 0.001169
terminal O: 0.000884
terminal I-GENE
deletion I-GENE: 0.000195
deletion O: 0.000238
deletion O
, I-GENE: 0.001923
, O: 0.035091
, O
which O: 0.002472
which O
eliminates I-GENE
some O: 0.000307
some O
potential O: 0.000336
potential O
tyrosine I-GENE: 0.002021
tyrosine O: 0.000261
tyrosine I-GENE
phosphorylation O: 0.000469
phosphorylation O
sites I-GENE: 0.001875
sites O: 0.000690
sites I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
or I-GENE: 0.000219
or O: 0.003321
or O
the I-GENE: 0.000268
the O: 0.044902
the O
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
with O: 0.009756
with O
a I-GENE: 0.000317
a O: 0.015893
a O
single I-GENE: 0.000195
single O: 0.000582
single O
amino I-GENE: 0.000560
amino O: 0.001116
amino O
acid I-GENE: 0.001315
acid O: 0.000997
acid I-GENE
substitution O: 0.000075
substitution O
( I-GENE: 0.006014
( O: 0.014858
( O
tyrosine I-GENE: 0.002021
tyrosine O: 0.000261
tyrosine I-GENE
at O: 0.002976
at O
217 I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
phenylalanine I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
resulted O: 0.000287
resulted O
in I-GENE: 0.000536
in O: 0.023304
in O
an O: 0.003112
an O
increase O: 0.000513
increase O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
aggregation O: 0.000029
aggregation O
of I-GENE: 0.002337
of O: 0.042520
of O
v I-GENE: 0.001169
v O: 0.000177
v I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
Src I-GENE: 0.001339
Src I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
transformed O: 0.000174
transformed O
EL I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
EalphaCL I-GENE
cells O: 0.002663
cells O
. I-GENE: 0.004017
. O: 0.044459
. O

We O: 0.001417
We O
find O: 0.000049
find O
that O: 0.008362
that O
our O: 0.000252
our O
response I-GENE: 0.000779
response O: 0.000794
response O
function O: 0.000855
function O
is O: 0.006803
is O
well O: 0.000626
well O
approximated I-GENE
by O: 0.006887
by O
the I-GENE: 0.000268
the O: 0.044902
the O
GSER I-GENE
only O: 0.000794
only O
within O: 0.000823
within O
a I-GENE: 0.000317
a O: 0.015893
a O
particular O: 0.000081
particular O
frequency O: 0.000171
frequency O
range O: 0.000229
range O
determined O: 0.000458
determined O
by O: 0.006887
by O
the I-GENE: 0.000268
the O: 0.044902
the O
material O: 0.000052
material O
parameters O: 0.000145
parameters O
of I-GENE: 0.002337
of O: 0.042520
of O
both O: 0.001631
both O
the I-GENE: 0.000268
the O: 0.044902
the O
bead I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
network O: 0.000017
network O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
novel O: 0.000385
novel O
approach O: 0.000104
approach O
to I-GENE: 0.000195
to O: 0.014977
to O
insulin I-GENE: 0.002240
insulin I-GENE
administration O: 0.000301
administration O
known O: 0.000359
known O
as O: 0.003654
as O
chronic O: 0.000304
chronic O
intermittent O: 0.000014
intermittent O
intravenous O: 0.000119
intravenous O
insulin I-GENE: 0.002240
insulin I-GENE
therapy O: 0.000351
therapy O
( I-GENE: 0.006014
( O: 0.014858
( O
CIIIT I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
delivers I-GENE
insulin I-GENE: 0.002240
insulin I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
a I-GENE: 0.000317
a O: 0.015893
a O
pulsatile I-GENE
fashion O: 0.000046
fashion O
and I-GENE: 0.003263
and O: 0.028529
and O
achieves I-GENE
physiological O: 0.000084
physiological O
insulin I-GENE: 0.002240
insulin I-GENE
concentration O: 0.000330
concentration O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
portal O: 0.000035
portal O
vein O: 0.000081
vein O
. I-GENE: 0.004017
. O: 0.044459
. O

This O: 0.000927
This O
article O: 0.000029
article O
comparatively I-GENE
evaluates I-GENE
five O: 0.000290
five O
Generic I-GENE
Systems I-GENE
that O: 0.008362
that O
describe O: 0.000093
describe O
the I-GENE: 0.000268
the O: 0.044902
the O
basic I-GENE: 0.000341
basic O: 0.000099
basic I-GENE
alternatives I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
composting I-GENE
facility I-GENE
design O: 0.000026
design O
and I-GENE: 0.003263
and O: 0.028529
and O
control I-GENE: 0.000170
control O: 0.000834
control O
. I-GENE: 0.004017
. O: 0.044459
. O

With O: 0.000093
With O
a I-GENE: 0.000317
a O: 0.015893
a O
GC O: 0.000078
GC O
content O: 0.000154
content O
of I-GENE: 0.002337
of O: 0.042520
of O
45 O: 0.000136
45 O
% O: 0.001741
% O
the I-GENE: 0.000268
the O: 0.044902
the O
one O: 0.001026
one O
segment I-GENE: 0.000122
segment O: 0.000162
segment O
would O: 0.000107
would O
correspond O: 0.000023
correspond O
to I-GENE: 0.000195
to O: 0.014977
to O
" I-GENE: 0.000170
" O: 0.000449
" O
isochore I-GENE
H1 I-GENE: 0.000341
H1 I-GENE
" I-GENE: 0.000170
" O: 0.000449
" O
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
other O: 0.000994
other O
segment I-GENE: 0.000122
segment O: 0.000162
segment O
( I-GENE: 0.006014
( O: 0.014858
( O
39 O: 0.000087
39 O
% O: 0.001741
% O
GC O: 0.000078
GC O
in I-GENE: 0.000536
in O: 0.023304
in O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
40 I-GENE: 0.000292
40 O: 0.000258
40 I-GENE
% O: 0.001741
% O
GC O: 0.000078
GC O
in I-GENE: 0.000536
in O: 0.023304
in O
mouse I-GENE: 0.001680
mouse O: 0.000403
mouse I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
to I-GENE: 0.000195
to O: 0.014977
to O
" I-GENE: 0.000170
" O: 0.000449
" O
isochore I-GENE
L1 I-GENE: 0.000243
L1 O: 0.000038
L1 I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
L2 O: 0.000029
L2 O
". O: 0.000020
". O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
review O: 0.000070
review O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
literature O: 0.000046
literature O
identified O: 0.000823
identified O
8 I-GENE: 0.000803
8 O: 0.000939
8 O
comprehensive I-GENE
clinical O: 0.000417
clinical O
studies O: 0.000678
studies O
, I-GENE: 0.001923
, O: 0.035091
, O
all O: 0.000762
all O
of I-GENE: 0.002337
of O: 0.042520
of O
which O: 0.002472
which O
failed O: 0.000093
failed O
to I-GENE: 0.000195
to O: 0.014977
to O
document I-GENE
any O: 0.000264
any O
relationship O: 0.000145
relationship O
between O: 0.001394
between O
NF1 I-GENE: 0.000292
NF1 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
intracranial I-GENE
aneurysms I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Serial I-GENE
US O: 0.000023
US O
images O: 0.000041
images O
were O: 0.005244
were O
obtained O: 0.000417
obtained O
before O: 0.000296
before O
and I-GENE: 0.003263
and O: 0.028529
and O
20 I-GENE: 0.000146
20 O: 0.000484
20 O
, I-GENE: 0.001923
, O: 0.035091
, O
30 O: 0.000423
30 O
, I-GENE: 0.001923
, O: 0.035091
, O
40 I-GENE: 0.000292
40 O: 0.000258
40 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
50 O: 0.000322
50 O
, I-GENE: 0.001923
, O: 0.035091
, O
60 O: 0.000238
60 O
, I-GENE: 0.001923
, O: 0.035091
, O
90 O: 0.000180
90 O
, I-GENE: 0.001923
, O: 0.035091
, O
120 O: 0.000075
120 O
, I-GENE: 0.001923
, O: 0.035091
, O
150 O: 0.000122
150 O
, I-GENE: 0.001923
, O: 0.035091
, O
180 O: 0.000029
180 O
, I-GENE: 0.001923
, O: 0.035091
, O
240 O: 0.000014
240 O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
300 O: 0.000058
300 O
s I-GENE: 0.000243
s O: 0.000724
s O
after O: 0.001385
after O
intravenous O: 0.000119
intravenous O
injection O: 0.000165
injection O
of I-GENE: 0.002337
of O: 0.042520
of O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
g O: 0.000307
g O
of I-GENE: 0.002337
of O: 0.042520
of O
contrast O: 0.000336
contrast O
agent O: 0.000113
agent O
using O: 0.000979
using O
conventional O: 0.000049
conventional O
and I-GENE: 0.003263
and O: 0.028529
and O
harmonic I-GENE
PD I-GENE
US O: 0.000023
US O
. I-GENE: 0.004017
. O: 0.044459
. O

Eight O: 0.000035
Eight O
CAD I-GENE: 0.000122
CAD I-GENE
patients O: 0.002538
patients O
who O: 0.000348
who O
were O: 0.005244
were O
matched O: 0.000049
matched O
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
treated O: 0.000365
treated O
patients O: 0.002538
patients O
for O: 0.006951
for O
age O: 0.000406
age O
(+/- O: 0.000035
(+/- O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
years O: 0.000409
years O
), O: 0.002269
), O
baseline O: 0.000099
baseline O
low I-GENE: 0.000146
low O: 0.000440
low O
density I-GENE: 0.000219
density O: 0.000119
density I-GENE
lipoprotein I-GENE: 0.000292
lipoprotein O: 0.000020
lipoprotein I-GENE
(+/- O: 0.000035
(+/- O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
mg O: 0.000892
mg O
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
dL O: 0.000014
dL O
), O: 0.002269
), O
and I-GENE: 0.003263
and O: 0.028529
and O
triglycerides O: 0.000023
triglycerides O
(+/- O: 0.000035
(+/- O
50 O: 0.000322
50 O
mg O: 0.000892
mg O
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
dL O: 0.000014
dL O
) I-GENE: 0.005210
) O: 0.009341
) O
but O: 0.001675
but O
who O: 0.000348
who O
had O: 0.000890
had O
never O: 0.000014
never O
been O: 0.001229
been O
treated O: 0.000365
treated O
with O: 0.009756
with O
lipid O: 0.000087
lipid O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
lowering O: 0.000023
lowering O
drugs O: 0.000159
drugs O
were O: 0.005244
were O
selected O: 0.000139
selected O
as O: 0.003654
as O
controls O: 0.000238
controls O
. I-GENE: 0.004017
. O: 0.044459
. O

Here O: 0.000214
Here O
we O: 0.001382
we O
present O: 0.000551
present O
evidence O: 0.000342
evidence O
that O: 0.008362
that O
the I-GENE: 0.000268
the O: 0.044902
the O
distal O: 0.000110
distal O
half O: 0.000145
half O
( I-GENE: 0.006014
( O: 0.014858
( O
Stem I-GENE
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
conserved O: 0.000507
conserved O
base O: 0.000313
base O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
paired I-GENE: 0.000146
paired O: 0.000020
paired I-GENE
stem O: 0.000093
stem O
structure O: 0.000513
structure O
found O: 0.001026
found O
in I-GENE: 0.000536
in O: 0.023304
in O
all O: 0.000762
all O
hY I-GENE
RNAs I-GENE: 0.000122
RNAs O: 0.000072
RNAs I-GENE
also O: 0.001373
also O
plays O: 0.000101
plays O
a I-GENE: 0.000317
a O: 0.015893
a O
critical O: 0.000183
critical O
role O: 0.000681
role O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
export O: 0.000067
export O
process O: 0.000119
process O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
contrasting I-GENE
effects O: 0.000652
effects O
of I-GENE: 0.002337
of O: 0.042520
of O
dopaminergic O: 0.000020
dopaminergic O
stimulation O: 0.000293
stimulation O
on O: 0.003416
on O
the I-GENE: 0.000268
the O: 0.044902
the O
motor O: 0.000087
motor O
performance O: 0.000159
performance O
and I-GENE: 0.003263
and O: 0.028529
and O
on O: 0.003416
on O
some O: 0.000307
some O
aspects O: 0.000046
aspects O
of I-GENE: 0.002337
of O: 0.042520
of O
cognitive O: 0.000029
cognitive O
processing O: 0.000171
processing O
suggest O: 0.000585
suggest O
the I-GENE: 0.000268
the O: 0.044902
the O
existence O: 0.000064
existence O
of I-GENE: 0.002337
of O: 0.042520
of O
complex I-GENE: 0.001315
complex O: 0.000588
complex I-GENE
interactions O: 0.000226
interactions O
within O: 0.000823
within O
pre I-GENE: 0.000219
pre O: 0.000180
pre I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
postsynaptic I-GENE
brain I-GENE: 0.000170
brain O: 0.000304
brain O
dopamine I-GENE: 0.000243
dopamine O: 0.000061
dopamine I-GENE
receptors I-GENE: 0.001753
receptors O: 0.000148
receptors I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
an O: 0.003112
an O
intervention O: 0.000026
intervention O
of I-GENE: 0.002337
of O: 0.042520
of O
segregated I-GENE
basal I-GENE: 0.000122
basal O: 0.000223
basal O
ganglia I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
prefrontal I-GENE
cortex O: 0.000130
cortex O
loops O: 0.000014
loops O
in I-GENE: 0.000536
in O: 0.023304
in O
motor O: 0.000087
motor O
and I-GENE: 0.003263
and O: 0.028529
and O
cognitive O: 0.000029
cognitive O
behaviour O: 0.000043
behaviour O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
size O: 0.000197
size O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
infarct O: 0.000038
infarct O
was O: 0.006960
was O
determined O: 0.000458
determined O
using O: 0.000979
using O
the I-GENE: 0.000268
the O: 0.044902
the O
creatine I-GENE: 0.000341
creatine I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
integral O: 0.000020
integral O
method O: 0.000385
method O
. I-GENE: 0.004017
. O: 0.044459
. O

These O: 0.000979
These O
corrections I-GENE
do O: 0.000165
do O
not O: 0.002509
not O
involve O: 0.000038
involve O
sequences I-GENE: 0.001290
sequences O: 0.000947
sequences I-GENE
predicted O: 0.000238
predicted O
to I-GENE: 0.000195
to O: 0.014977
to O
function O: 0.000855
function O
as O: 0.003654
as O
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
factor I-GENE: 0.008984
factor O: 0.000510
factor I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
sites I-GENE: 0.001875
sites O: 0.000690
sites I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
comprehensive I-GENE
neuropsychological I-GENE
battery O: 0.000014
battery O
was O: 0.006960
was O
administered O: 0.000185
administered O
to I-GENE: 0.000195
to O: 0.014977
to O
48 O: 0.000081
48 O
veterans I-GENE
with O: 0.009756
with O
Gulf I-GENE
War I-GENE
Illness I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
GWI I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
characterized O: 0.000316
characterized O
by O: 0.006887
by O
severe O: 0.000183
severe O
fatigue I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
GV I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
F I-GENE: 0.000487
F O: 0.000142
F I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
39 O: 0.000087
39 O
healthy O: 0.000171
healthy O
veterans I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
GV I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
H I-GENE: 0.001290
H O: 0.000240
H I-GENE
). O: 0.002228
). O

Quantitative O: 0.000023
Quantitative O
PCR O: 0.000148
PCR O
studies O: 0.000678
studies O
indicated O: 0.000229
indicated O
that O: 0.008362
that O
synthesis O: 0.000275
synthesis O
and I-GENE: 0.003263
and O: 0.028529
and O
transport O: 0.000127
transport O
of I-GENE: 0.002337
of O: 0.042520
of O
vector O: 0.000145
vector O
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
into O: 0.000785
into O
the I-GENE: 0.000268
the O: 0.044902
the O
nucleus O: 0.000154
nucleus O
were O: 0.005244
were O
similar O: 0.000574
similar O
for O: 0.006951
for O
macrophages O: 0.000041
macrophages O
infected O: 0.000223
infected O
with O: 0.009756
with O
the I-GENE: 0.000268
the O: 0.044902
the O
clone I-GENE: 0.000122
clone O: 0.000240
clone O
239 O: 0.000023
239 O
and I-GENE: 0.003263
and O: 0.028529
and O
316 I-GENE
pseudotypes I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
suggesting O: 0.000400
suggesting O
that O: 0.008362
that O
the I-GENE: 0.000268
the O: 0.044902
the O
restriction O: 0.000072
restriction O
for O: 0.006951
for O
SIVmac239 I-GENE
infection O: 0.000319
infection O
is O: 0.006803
is O
after O: 0.001385
after O
reverse I-GENE: 0.000219
reverse O: 0.000067
reverse I-GENE
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
nuclear I-GENE: 0.001826
nuclear O: 0.000614
nuclear I-GENE
import O: 0.000041
import O
of I-GENE: 0.002337
of O: 0.042520
of O
viral I-GENE: 0.000487
viral O: 0.000185
viral I-GENE
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

EXAFS I-GENE
measurements O: 0.000156
measurements O
around O: 0.000072
around O
the I-GENE: 0.000268
the O: 0.044902
the O
Ge I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
K I-GENE: 0.000511
K O: 0.000136
K I-GENE
edge I-GENE
have O: 0.001788
have O
been O: 0.001229
been O
carried O: 0.000127
carried O
out O: 0.000232
out O
for O: 0.006951
for O
liquid O: 0.000084
liquid O
Ge I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
Si I-GENE
alloys I-GENE
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
first O: 0.000591
first O
time O: 0.000542
time O
to I-GENE: 0.000195
to O: 0.014977
to O
investigate O: 0.000104
investigate O
the I-GENE: 0.000268
the O: 0.044902
the O
local O: 0.000101
local O
structure O: 0.000513
structure O
around O: 0.000072
around O
a I-GENE: 0.000317
a O: 0.015893
a O
Ge I-GENE
atom I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Hp I-GENE
positive O: 0.000411
positive O
relatives I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
gastric O: 0.000119
gastric O
cancer O: 0.000284
cancer O
had O: 0.000890
had O
a I-GENE: 0.000317
a O: 0.015893
a O
markedly O: 0.000101
markedly O
higher O: 0.000469
higher O
prevalence O: 0.000110
prevalence O
of I-GENE: 0.002337
of O: 0.042520
of O
atrophy O: 0.000020
atrophy O
than O: 0.001657
than O
those O: 0.000461
those O
with O: 0.009756
with O
Hp I-GENE
negativity I-GENE
without O: 0.000322
without O
cancer O: 0.000284
cancer O
relatives I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
29 O: 0.000122
29 O
vs O: 0.000159
vs O
. I-GENE: 0.004017
. O: 0.044459
. O

Thus O: 0.000284
Thus O
, I-GENE: 0.001923
, O: 0.035091
, O
replication I-GENE: 0.000146
replication O: 0.000243
replication O
fork I-GENE: 0.000146
fork I-GENE
movement O: 0.000046
movement O
near O: 0.000165
near O
HML I-GENE
pauses I-GENE
at O: 0.002976
at O
a I-GENE: 0.000317
a O: 0.015893
a O
silent O: 0.000014
silent O
origin O: 0.000119
origin O
which O: 0.002472
which O
is O: 0.006803
is O
competent O: 0.000029
competent O
for O: 0.006951
for O
replication I-GENE: 0.000146
replication O: 0.000243
replication O
initiation I-GENE: 0.000292
initiation O: 0.000267
initiation I-GENE
but O: 0.001675
but O
kept O: 0.000017
kept O
silent O: 0.000014
silent O
through O: 0.000403
through O
Orc2p I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
a I-GENE: 0.000317
a O: 0.015893
a O
component O: 0.000180
component O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
replication I-GENE: 0.000146
replication O: 0.000243
replication O
initiator O: 0.000026
initiator O
. I-GENE: 0.004017
. O: 0.044459
. O

Cardiac O: 0.000014
Cardiac O
markers O: 0.000096
markers O
troponin I-GENE
T I-GENE: 0.001558
T O: 0.000548
T I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
CK I-GENE: 0.000341
CK I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
MB I-GENE: 0.000243
MB O: 0.000017
MB I-GENE
mass O: 0.000197
mass O
and I-GENE: 0.003263
and O: 0.028529
and O
myoglobin I-GENE: 0.000146
myoglobin I-GENE
were O: 0.005244
were O
helpful O: 0.000014
helpful O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
differential O: 0.000084
differential O
diagnosis O: 0.000275
diagnosis O
of I-GENE: 0.002337
of O: 0.042520
of O
chest O: 0.000035
chest O
pain O: 0.000110
pain O
, I-GENE: 0.001923
, O: 0.035091
, O
even O: 0.000154
even O
when O: 0.000690
when O
the I-GENE: 0.000268
the O: 0.044902
the O
ECG O: 0.000049
ECG O
was O: 0.006960
was O
unremarkable I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
nonspecific O: 0.000020
nonspecific O
. I-GENE: 0.004017
. O: 0.044459
. O

RESULTS O: 0.000180
RESULTS O
: I-GENE: 0.000243
: O: 0.002561
: O
A I-GENE: 0.003530
A O: 0.002246
A I-GENE
novel O: 0.000385
novel O
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
was O: 0.006960
was O
cloned O: 0.000319
cloned O
. I-GENE: 0.004017
. O: 0.044459
. O

Both O: 0.000168
Both O
pancreatic O: 0.000075
pancreatic O
and I-GENE: 0.003263
and O: 0.028529
and O
intestinal O: 0.000052
intestinal O
cell I-GENE: 0.001144
cell O: 0.001927
cell O
lines O: 0.000287
lines O
were O: 0.005244
were O
found O: 0.001026
found O
to I-GENE: 0.000195
to O: 0.014977
to O
express O: 0.000093
express O
a I-GENE: 0.000317
a O: 0.015893
a O
number O: 0.000362
number O
of I-GENE: 0.002337
of O: 0.042520
of O
POU I-GENE: 0.000536
POU I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
OCT I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
homeodomain I-GENE: 0.000511
homeodomain I-GENE
proteins I-GENE: 0.005673
proteins O: 0.000933
proteins I-GENE
examined O: 0.000275
examined O
by O: 0.006887
by O
electrophoretic O: 0.000052
electrophoretic O
mobility I-GENE: 0.000243
mobility O: 0.000148
mobility I-GENE
shift O: 0.000246
shift O
assay O: 0.000235
assay O
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
conclusion O: 0.000055
conclusion O
, I-GENE: 0.001923
, O: 0.035091
, O
USPIO I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
enhanced O: 0.000162
enhanced O
MRI O: 0.000029
MRI O
data O: 0.000649
data O
were O: 0.005244
were O
capable O: 0.000099
capable O
to I-GENE: 0.000195
to O: 0.014977
to O
characterize O: 0.000064
characterize O
tumor I-GENE: 0.000487
tumor O: 0.000310
tumor I-GENE
microvessel I-GENE
properties O: 0.000197
properties O
in I-GENE: 0.000536
in O: 0.023304
in O
this O: 0.001976
this O
breast O: 0.000125
breast O
cancer O: 0.000284
cancer O
model O: 0.000327
model O
: I-GENE: 0.000243
: O: 0.002561
: O
microvascular O: 0.000017
microvascular O
permeability O: 0.000014
permeability O
( I-GENE: 0.006014
( O: 0.014858
( O
determined O: 0.000458
determined O
using O: 0.000979
using O
USPIO I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
correlated O: 0.000156
correlated O
significantly O: 0.000733
significantly O
with O: 0.009756
with O
tumor I-GENE: 0.000487
tumor O: 0.000310
tumor I-GENE
grade O: 0.000058
grade O
. I-GENE: 0.004017
. O: 0.044459
. O

Radiolabeled I-GENE
biantennary I-GENE
N I-GENE: 0.001217
N O: 0.000614
N I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
glycans I-GENE
synthesized O: 0.000064
synthesized O
by O: 0.006887
by O
Pro O: 0.000023
Pro O
(-) I-GENE
5Lec20 I-GENE
were O: 0.005244
were O
proportionately I-GENE
less O: 0.000724
less O
ricin I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
bound O: 0.000301
bound O
than O: 0.001657
than O
similar O: 0.000574
similar O
species O: 0.000243
species O
from I-GENE: 0.000390
from O: 0.004210
from O
parental O: 0.000049
parental O
CHO O: 0.000026
CHO O
cells O: 0.002663
cells O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
Lec20 I-GENE
cell I-GENE: 0.001144
cell O: 0.001927
cell O
extracts O: 0.000229
extracts O
had O: 0.000890
had O
a I-GENE: 0.000317
a O: 0.015893
a O
markedly O: 0.000101
markedly O
reduced O: 0.000452
reduced O
ability O: 0.000290
ability O
to I-GENE: 0.000195
to O: 0.014977
to O
transfer I-GENE: 0.000170
transfer O: 0.000099
transfer I-GENE
Gal I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
GlcNAc I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
terminating I-GENE
acceptors I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

CONCLUSION O: 0.000113
CONCLUSION O
: I-GENE: 0.000243
: O: 0.002561
: O
The O: 0.007383
The O
training O: 0.000070
training O
of I-GENE: 0.002337
of O: 0.042520
of O
novices I-GENE
using O: 0.000979
using O
MIST I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
VR I-GENE
yields O: 0.000023
yields O
quantifiable I-GENE
changes O: 0.000466
changes O
in I-GENE: 0.000536
in O: 0.023304
in O
skill I-GENE
that O: 0.008362
that O
are O: 0.002918
are O
transferable I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
a I-GENE: 0.000317
a O: 0.015893
a O
simple O: 0.000099
simple O
real O: 0.000023
real O
task O: 0.000090
task O
and I-GENE: 0.003263
and O: 0.028529
and O
are O: 0.002918
are O
similar O: 0.000574
similar O
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
results O: 0.001162
results O
achieved O: 0.000055
achieved O
with O: 0.009756
with O
conventional O: 0.000049
conventional O
training O: 0.000070
training O
. I-GENE: 0.004017
. O: 0.044459
. O

To O: 0.000522
To O
investigate O: 0.000104
investigate O
the I-GENE: 0.000268
the O: 0.044902
the O
convergent I-GENE
role O: 0.000681
role O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
insulin I-GENE: 0.002240
insulin I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
IGF I-GENE: 0.000560
IGF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
I I-GENE: 0.004602
I O: 0.000487
I I-GENE
effector O: 0.000014
effector O
pathway O: 0.000385
pathway O
mediating O: 0.000061
mediating O
bihormonal I-GENE
stimulation O: 0.000293
stimulation O
of I-GENE: 0.002337
of O: 0.042520
of O
LDL I-GENE: 0.000365
LDL I-GENE
receptor I-GENE: 0.006817
receptor O: 0.000258
receptor I-GENE
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
expression O: 0.002231
expression O
, I-GENE: 0.001923
, O: 0.035091
, O
transfected O: 0.000185
transfected O
granulosa I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
luteal O: 0.000029
luteal O
cells O: 0.002663
cells O
were O: 0.005244
were O
pretreated O: 0.000020
pretreated O
for O: 0.006951
for O
30 O: 0.000423
30 O
min O: 0.000481
min O
with O: 0.009756
with O
two O: 0.001904
two O
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
inhibitors O: 0.000162
inhibitors O
of I-GENE: 0.002337
of O: 0.042520
of O
phophatidylinositol I-GENE
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
wortmannin O: 0.000020
wortmannin O
( I-GENE: 0.006014
( O: 0.014858
( O
100 O: 0.000400
100 O
nM O: 0.000032
nM O
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
LY I-GENE
294002 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
10 I-GENE: 0.000292
10 O: 0.000936
10 O
microM O: 0.000020
microM O
), O: 0.002269
), O
or I-GENE: 0.000219
or O: 0.003321
or O
of I-GENE: 0.002337
of O: 0.042520
of O
mitogen I-GENE: 0.000755
mitogen O: 0.000017
mitogen I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
activated I-GENE: 0.001412
activated O: 0.000356
activated I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
PD I-GENE
98059 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
50 O: 0.000322
50 O
microM O: 0.000020
microM O
), O: 0.002269
), O
U0126 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
10 I-GENE: 0.000292
10 O: 0.000936
10 O
microM O: 0.000020
microM O
), O: 0.002269
), O
or I-GENE: 0.000219
or O: 0.003321
or O
the I-GENE: 0.000268
the O: 0.044902
the O
latter O: 0.000072
latter O
' I-GENE: 0.000950
' O: 0.001701
' O
s I-GENE: 0.000243
s O: 0.000724
s O
inactive O: 0.000078
inactive O
derivative O: 0.000043
derivative O
, I-GENE: 0.001923
, O: 0.035091
, O
U0124 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
10 I-GENE: 0.000292
10 O: 0.000936
10 O
microM O: 0.000020
microM O
). O: 0.002228
). O

Instead O: 0.000014
Instead O
, I-GENE: 0.001923
, O: 0.035091
, O
affective O: 0.000020
affective O
flattening I-GENE
was O: 0.006960
was O
associated I-GENE: 0.000755
associated O: 0.000716
associated I-GENE
with O: 0.009756
with O
both O: 0.001631
both O
dopamine I-GENE: 0.000243
dopamine O: 0.000061
dopamine I-GENE
receptor I-GENE: 0.006817
receptor O: 0.000258
receptor I-GENE
sensitivity O: 0.000212
sensitivity O
and I-GENE: 0.003263
and O: 0.028529
and O
psychomotor I-GENE
slowing I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Other O: 0.000020
Other O
therapies I-GENE
are O: 0.002918
are O
also O: 0.001373
also O
available O: 0.000087
available O
, I-GENE: 0.001923
, O: 0.035091
, O
including O: 0.000446
including O
hypertonic I-GENE
saline O: 0.000072
saline O
solution O: 0.000113
solution O
, I-GENE: 0.001923
, O: 0.035091
, O
THAM I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
Tris I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
hydroxy I-GENE: 0.000122
hydroxy O: 0.000020
hydroxy I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
methyl O: 0.000058
methyl O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
aminomethane I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
buffer I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
high I-GENE: 0.000341
high O: 0.000924
high O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
dose O: 0.000469
dose O
barbiturates I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

CONCLUSION O: 0.000113
CONCLUSION O
: I-GENE: 0.000243
: O: 0.002561
: O
There O: 0.000185
There O
are O: 0.002918
are O
no O: 0.000687
no O
differences O: 0.000322
differences O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
measurement O: 0.000093
measurement O
data O: 0.000649
data O
derived I-GENE: 0.000268
derived O: 0.000290
derived O
from I-GENE: 0.000390
from O: 0.004210
from O
this O: 0.001976
this O
method O: 0.000385
method O
and I-GENE: 0.003263
and O: 0.028529
and O
actual O: 0.000014
actual O
measurement O: 0.000093
measurement O
data O: 0.000649
data O
from I-GENE: 0.000390
from O: 0.004210
from O
an O: 0.003112
an O
object I-GENE
created O: 0.000014
created O
by O: 0.006887
by O
the I-GENE: 0.000268
the O: 0.044902
the O
computer O: 0.000032
computer O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
aided I-GENE
dental O: 0.000035
dental O
design O: 0.000026
design O
program O: 0.000061
program O
. I-GENE: 0.004017
. O: 0.044459
. O

NF I-GENE: 0.002922
NF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
kappaB I-GENE: 0.001363
kappaB I-GENE
pathway O: 0.000385
pathway O
activation I-GENE: 0.000365
activation O: 0.001153
activation O
occurs O: 0.000119
occurs O
during O: 0.001095
during O
transformation O: 0.000125
transformation O
induced O: 0.001176
induced O
by O: 0.006887
by O
a I-GENE: 0.000317
a O: 0.015893
a O
number O: 0.000362
number O
of I-GENE: 0.002337
of O: 0.042520
of O
classical O: 0.000032
classical O
oncogenes O: 0.000020
oncogenes O
, I-GENE: 0.001923
, O: 0.035091
, O
including O: 0.000446
including O
Bcr I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
Abl I-GENE: 0.000146
Abl I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
Ras I-GENE: 0.001923
Ras I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
Rac I-GENE: 0.000219
Rac I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
is O: 0.006803
is O
necessary O: 0.000183
necessary O
for O: 0.006951
for O
full I-GENE: 0.000414
full O: 0.000180
full I-GENE
transforming I-GENE: 0.000122
transforming O: 0.000061
transforming I-GENE
potential O: 0.000336
potential O
. I-GENE: 0.004017
. O: 0.044459
. O

Our O: 0.000235
Our O
results O: 0.001162
results O
indicate O: 0.000438
indicate O
that O: 0.008362
that O
Gab1 I-GENE
is O: 0.006803
is O
involved O: 0.000539
involved O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
control I-GENE: 0.000170
control O: 0.000834
control O
of I-GENE: 0.002337
of O: 0.042520
of O
egr I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
expression O: 0.002231
expression O
regulated I-GENE: 0.000268
regulated O: 0.000368
regulated O
by O: 0.006887
by O
insulin I-GENE: 0.002240
insulin I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
cytomegalovirus O: 0.000023
cytomegalovirus O
( I-GENE: 0.006014
( O: 0.014858
( O
HCMV O: 0.000014
HCMV O
) I-GENE: 0.005210
) O: 0.009341
) O
major I-GENE: 0.000341
major O: 0.000333
major I-GENE
immediate I-GENE: 0.000317
immediate O: 0.000043
immediate I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
early I-GENE: 0.000706
early O: 0.000374
early I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
IE2 I-GENE: 0.000243
IE2 I-GENE
is O: 0.006803
is O
a I-GENE: 0.000317
a O: 0.015893
a O
nuclear I-GENE: 0.001826
nuclear O: 0.000614
nuclear I-GENE
phosphoprotein O: 0.000023
phosphoprotein O
that O: 0.008362
that O
is O: 0.006803
is O
believed O: 0.000041
believed O
to I-GENE: 0.000195
to O: 0.014977
to O
be O: 0.002370
be O
a I-GENE: 0.000317
a O: 0.015893
a O
key O: 0.000090
key O
regulator I-GENE: 0.000195
regulator O: 0.000104
regulator I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
both O: 0.001631
both O
lytic O: 0.000017
lytic O
and I-GENE: 0.003263
and O: 0.028529
and O
latent I-GENE: 0.000170
latent O: 0.000035
latent I-GENE
infections O: 0.000096
infections O
. I-GENE: 0.004017
. O: 0.044459
. O

Unexpectedly I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
Arg1 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
expressing O: 0.000151
expressing O
COS1 I-GENE
cells O: 0.002663
cells O
showed O: 0.000863
showed O
no O: 0.000687
no O
significant O: 0.000687
significant O
proteinase I-GENE: 0.000195
proteinase I-GENE
activity O: 0.002295
activity O
to I-GENE: 0.000195
to O: 0.014977
to O
various O: 0.000240
various O
synthesized O: 0.000064
synthesized O
substrates O: 0.000075
substrates O
under O: 0.000351
under O
neutral O: 0.000017
neutral O
or I-GENE: 0.000219
or O: 0.003321
or O
acidic O: 0.000043
acidic O
conditions O: 0.000261
conditions O
in I-GENE: 0.000536
in O: 0.023304
in O
this O: 0.001976
this O
study O: 0.001101
study O
. I-GENE: 0.004017
. O: 0.044459
. O

METHODS O: 0.000139
METHODS O
: I-GENE: 0.000243
: O: 0.002561
: O
126 O: 0.000017
126 O
patients O: 0.002538
patients O
with O: 0.009756
with O
histologically O: 0.000017
histologically O
confirmed O: 0.000139
confirmed O
MFH I-GENE
were O: 0.005244
were O
analyzed O: 0.000151
analyzed O
. I-GENE: 0.004017
. O: 0.044459
. O

Regression I-GENE
analyses O: 0.000194
analyses O
showed O: 0.000863
showed O
that O: 0.008362
that O
SOREMP I-GENE
dream I-GENE
occurrences I-GENE
were O: 0.005244
were O
significantly O: 0.000733
significantly O
related I-GENE: 0.001266
related O: 0.000597
related I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
amount O: 0.000078
amount O
of I-GENE: 0.002337
of O: 0.042520
of O
REM O: 0.000014
REM O
sleep O: 0.000061
sleep O
, I-GENE: 0.001923
, O: 0.035091
, O
while O: 0.000403
while O
NREMP I-GENE
dream I-GENE
occurrences I-GENE
were O: 0.005244
were O
related I-GENE: 0.001266
related O: 0.000597
related I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
arousals I-GENE
from I-GENE: 0.000390
from O: 0.004210
from O
NREM I-GENE
sleep O: 0.000061
sleep O
. I-GENE: 0.004017
. O: 0.044459
. O

[ O: 0.000382
[ O
Diabetologia I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
2001 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
44 O: 0.000093
44 O
[ O: 0.000382
[ O
Suppl I-GENE
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
]: I-GENE
B37 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
B44 I-GENE
] I-GENE: 0.000122
] O: 0.000240
] O

RESULTS O: 0.000180
RESULTS O
: I-GENE: 0.000243
: O: 0.002561
: O
In O: 0.002266
In O
vivo O: 0.000464
vivo O
, I-GENE: 0.001923
, O: 0.035091
, O
there O: 0.000275
there O
was O: 0.006960
was O
a I-GENE: 0.000317
a O: 0.015893
a O
wide O: 0.000064
wide O
distribution O: 0.000194
distribution O
with O: 0.009756
with O
the I-GENE: 0.000268
the O: 0.044902
the O
coefficient O: 0.000032
coefficient O
of I-GENE: 0.002337
of O: 0.042520
of O
variation O: 0.000049
variation O
( I-GENE: 0.006014
( O: 0.014858
( O
SD O: 0.000130
SD O
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
mean O: 0.000423
mean O
x O: 0.000200
x O
100 O: 0.000400
100 O
%) O: 0.000385
%) O
for O: 0.006951
for O
different O: 0.000669
different O
valve O: 0.000026
valve O
sizes O: 0.000032
sizes O
ranging O: 0.000032
ranging O
from I-GENE: 0.000390
from O: 0.004210
from O
21 O: 0.000235
21 O
% O: 0.001741
% O
to I-GENE: 0.000195
to O: 0.014977
to O
39 O: 0.000087
39 O
% O: 0.001741
% O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
St I-GENE
Jude I-GENE
Medical I-GENE
valve O: 0.000026
valve O
and I-GENE: 0.003263
and O: 0.028529
and O
from I-GENE: 0.000390
from O: 0.004210
from O
25 O: 0.000252
25 O
% O: 0.001741
% O
to I-GENE: 0.000195
to O: 0.014977
to O
33 O: 0.000116
33 O
% O: 0.001741
% O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
Omnicarbon I-GENE
valve O: 0.000026
valve O
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
microsporidian I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
Nosema I-GENE
algerae I-GENE
Vavra I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
undeen I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
was O: 0.006960
was O
found O: 0.001026
found O
parasitizing I-GENE
larvae O: 0.000029
larvae O
and I-GENE: 0.003263
and O: 0.028529
and O
adults O: 0.000070
adults O
of I-GENE: 0.002337
of O: 0.042520
of O
a I-GENE: 0.000317
a O: 0.015893
a O
laboratory O: 0.000122
laboratory O
colony I-GENE: 0.000438
colony O: 0.000014
colony I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
Culex I-GENE
pipiens I-GENE
L I-GENE: 0.000779
L O: 0.000316
L I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
originated I-GENE
from I-GENE: 0.000390
from O: 0.004210
from O
Gharbia I-GENE
Governorate I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Nearly I-GENE
all O: 0.000762
all O
isolates O: 0.000064
isolates O
of I-GENE: 0.002337
of O: 0.042520
of O
S I-GENE: 0.001631
S O: 0.000449
S I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
intermedius I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
most O: 0.000400
most O
isolates O: 0.000064
isolates O
of I-GENE: 0.002337
of O: 0.042520
of O
S I-GENE: 0.001631
S O: 0.000449
S I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
constellatus I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
but O: 0.001675
but O
only O: 0.000794
only O
19 I-GENE: 0.000146
19 O: 0.000226
19 O
% O: 0.001741
% O
of I-GENE: 0.002337
of O: 0.042520
of O
those O: 0.000461
those O
of I-GENE: 0.002337
of O: 0.042520
of O
S I-GENE: 0.001631
S O: 0.000449
S I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
anginosus I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
were O: 0.005244
were O
associated I-GENE: 0.000755
associated O: 0.000716
associated I-GENE
with O: 0.009756
with O
abscess O: 0.000020
abscess O
. I-GENE: 0.004017
. O: 0.044459
. O

One O: 0.000165
One O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
conserved O: 0.000507
conserved O
RNA I-GENE: 0.003555
RNA O: 0.000591
RNA I-GENE
subdomains O: 0.000017
subdomains O
, I-GENE: 0.001923
, O: 0.035091
, O
designated O: 0.000130
designated O
P3 O: 0.000023
P3 O
, I-GENE: 0.001923
, O: 0.035091
, O
has O: 0.001356
has O
previously O: 0.000481
previously O
been O: 0.001229
been O
shown O: 0.000504
shown O
to I-GENE: 0.000195
to O: 0.014977
to O
be O: 0.002370
be O
required O: 0.000591
required O
for O: 0.006951
for O
nucleolar O: 0.000014
nucleolar O
localization O: 0.000174
localization O
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
total O: 0.000443
total O
of I-GENE: 0.002337
of O: 0.042520
of O
25 O: 0.000252
25 O
patients O: 0.002538
patients O
with O: 0.009756
with O
malignant O: 0.000104
malignant O
brain I-GENE: 0.000170
brain O: 0.000304
brain O
tumours O: 0.000023
tumours O
were O: 0.005244
were O
investigated O: 0.000217
investigated O
. I-GENE: 0.004017
. O: 0.044459
. O

Interventions I-GENE
aimed O: 0.000014
aimed O
at O: 0.002976
at O
these O: 0.001478
these O
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
mediators I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
processes O: 0.000090
processes O
may O: 0.001078
may O
be O: 0.002370
be O
successful O: 0.000049
successful O
in I-GENE: 0.000536
in O: 0.023304
in O
reducing O: 0.000046
reducing O
the I-GENE: 0.000268
the O: 0.044902
the O
very O: 0.000223
very O
significant O: 0.000687
significant O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
economic I-GENE
costs O: 0.000029
costs O
of I-GENE: 0.002337
of O: 0.042520
of O
vascular I-GENE: 0.000146
vascular O: 0.000084
vascular I-GENE
access O: 0.000020
access O
dysfunction O: 0.000041
dysfunction O
. I-GENE: 0.004017
. O: 0.044459
. O

We O: 0.001417
We O
used O: 0.000808
used O
stored O: 0.000017
stored O
plasma I-GENE: 0.000609
plasma O: 0.000484
plasma I-GENE
samples O: 0.000142
samples O
from I-GENE: 0.000390
from O: 0.004210
from O
409 I-GENE
patients O: 0.002538
patients O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
National O: 0.000029
National O
Institute O: 0.000023
Institute O
of I-GENE: 0.002337
of O: 0.042520
of O
Neurological I-GENE
Diseases I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
Stroke I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
NINDS I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
tissue I-GENE: 0.000536
tissue O: 0.000388
tissue I-GENE
plasminogen I-GENE: 0.000706
plasminogen I-GENE
activator I-GENE: 0.001120
activator O: 0.000093
activator I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
t I-GENE: 0.000146
t O: 0.000075
t I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
PA I-GENE: 0.000122
PA O: 0.000017
PA I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
Stroke I-GENE
Trial I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
examine O: 0.000099
examine O
the I-GENE: 0.000268
the O: 0.044902
the O
relationship O: 0.000145
relationship O
between O: 0.001394
between O
an O: 0.003112
an O
apolipoprotein I-GENE: 0.000146
apolipoprotein I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
Apo I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
E2 I-GENE: 0.000852
E2 O: 0.000072
E2 I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
an O: 0.003112
an O
Apo I-GENE
E4 I-GENE
phenotype O: 0.000159
phenotype O
and I-GENE: 0.003263
and O: 0.028529
and O
a I-GENE: 0.000317
a O: 0.015893
a O
favorable I-GENE
outcome O: 0.000061
outcome O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
months O: 0.000246
months O
after O: 0.001385
after O
stroke O: 0.000041
stroke O
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
risk O: 0.000313
risk O
of I-GENE: 0.002337
of O: 0.042520
of O
intracerebral I-GENE
hemorrhage O: 0.000049
hemorrhage O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
response I-GENE: 0.000779
response O: 0.000794
response O
to I-GENE: 0.000195
to O: 0.014977
to O
intravenous O: 0.000119
intravenous O
t I-GENE: 0.000146
t O: 0.000075
t I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
PA I-GENE: 0.000122
PA O: 0.000017
PA I-GENE
therapy O: 0.000351
therapy O
. I-GENE: 0.004017
. O: 0.044459
. O

These O: 0.000979
These O
results O: 0.001162
results O
were O: 0.005244
were O
robust I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
changes O: 0.000466
changes O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
baseline O: 0.000099
baseline O
assumptions I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
model O: 0.000327
model O
. I-GENE: 0.004017
. O: 0.044459
. O

Cis I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
acting O: 0.000203
acting O
CCAAT I-GENE: 0.000317
CCAAT O: 0.000052
CCAAT I-GENE
elements I-GENE: 0.000414
elements O: 0.000493
elements O
are O: 0.002918
are O
frequently O: 0.000075
frequently O
found O: 0.001026
found O
in I-GENE: 0.000536
in O: 0.023304
in O
eukaryotic I-GENE: 0.000195
eukaryotic O: 0.000078
eukaryotic I-GENE
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
regions I-GENE: 0.000243
regions O: 0.000501
regions O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
binary I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
tertiary O: 0.000017
tertiary O
combinations O: 0.000014
combinations O
of I-GENE: 0.002337
of O: 0.042520
of O
plant O: 0.000084
plant O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
derived I-GENE: 0.000268
derived O: 0.000290
derived O
molluscicides I-GENE
Azadirachta I-GENE
indica I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
Cedrus I-GENE
deodara I-GENE
oil O: 0.000038
oil O
with O: 0.009756
with O
synergists I-GENE
MGK I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
264 O: 0.000014
264 O
, I-GENE: 0.001923
, O: 0.035091
, O
piperonyl I-GENE
butoxide I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
PB I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
fruit I-GENE
powder I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
Embelia I-GENE
ribes I-GENE
were O: 0.005244
were O
used O: 0.000808
used O
against O: 0.000255
against O
the I-GENE: 0.000268
the O: 0.044902
the O
Lymnaea I-GENE
acuminata I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

This O: 0.000927
This O
article O: 0.000029
article O
reports O: 0.000041
reports O
the I-GENE: 0.000268
the O: 0.044902
the O
design O: 0.000026
design O
and I-GENE: 0.003263
and O: 0.028529
and O
development O: 0.000388
development O
of I-GENE: 0.002337
of O: 0.042520
of O
an O: 0.003112
an O
ECG O: 0.000049
ECG O
simulator I-GENE
intended I-GENE
for O: 0.006951
for O
use O: 0.000380
use O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
testing O: 0.000090
testing O
, I-GENE: 0.001923
, O: 0.035091
, O
calibration I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
maintenance O: 0.000067
maintenance O
of I-GENE: 0.002337
of O: 0.042520
of O
electrocardiographic I-GENE
equipment I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Exchanging I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
propeptide I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
this O: 0.001976
this O
chimera I-GENE
with O: 0.009756
with O
either O: 0.000452
either O
the I-GENE: 0.000268
the O: 0.044902
the O
murine I-GENE: 0.000779
murine O: 0.000148
murine I-GENE
MIC I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
TGF I-GENE: 0.000998
TGF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
beta1 I-GENE: 0.000414
beta1 I-GENE
propeptide I-GENE
resulted O: 0.000287
resulted O
in I-GENE: 0.000536
in O: 0.023304
in O
secretion O: 0.000165
secretion O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
unprocessed I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
monomeric O: 0.000020
monomeric O
chimera I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
suggesting O: 0.000400
suggesting O
a I-GENE: 0.000317
a O: 0.015893
a O
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
interaction I-GENE: 0.000122
interaction O: 0.000478
interaction O
between O: 0.001394
between O
the I-GENE: 0.000268
the O: 0.044902
the O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
MIC I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
propeptide I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
mature O: 0.000104
mature O
peptide I-GENE: 0.000584
peptide O: 0.000212
peptide I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

RESULTS O: 0.000180
RESULTS O
: I-GENE: 0.000243
: O: 0.002561
: O
The O: 0.007383
The O
analyzed O: 0.000151
analyzed O
fragment I-GENE: 0.000487
fragment O: 0.000258
fragment I-GENE
has O: 0.001356
has O
significant O: 0.000687
significant O
activity O: 0.002295
activity O
in I-GENE: 0.000536
in O: 0.023304
in O
EpCAM I-GENE
positive O: 0.000411
positive O
cells O: 0.002663
cells O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
it O: 0.000733
it O
is O: 0.006803
is O
regulated I-GENE: 0.000268
regulated O: 0.000368
regulated O
negatively O: 0.000107
negatively O
by O: 0.006887
by O
tumor I-GENE: 0.000487
tumor O: 0.000310
tumor I-GENE
necrosis I-GENE: 0.000438
necrosis O: 0.000041
necrosis I-GENE
factor I-GENE: 0.008984
factor O: 0.000510
factor I-GENE
alpha I-GENE: 0.009009
alpha O: 0.000313
alpha I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
TNFalpha I-GENE
). O: 0.002228
). O

The O: 0.007383
The O
mutant I-GENE: 0.002386
mutant O: 0.000385
mutant I-GENE
receptors I-GENE: 0.001753
receptors O: 0.000148
receptors I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
as O: 0.003654
as O
well O: 0.000626
well O
as O: 0.003654
as O
sBMPR I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
IA O: 0.000026
IA O
, I-GENE: 0.001923
, O: 0.035091
, O
were O: 0.005244
were O
expressed O: 0.000840
expressed O
as O: 0.003654
as O
fusion I-GENE: 0.000390
fusion O: 0.000255
fusion I-GENE
proteins I-GENE: 0.005673
proteins O: 0.000933
proteins I-GENE
with O: 0.009756
with O
thioredoxin I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
Escherichia I-GENE: 0.000730
Escherichia O: 0.000171
Escherichia I-GENE
coli I-GENE: 0.001071
coli O: 0.000255
coli I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
purified O: 0.000209
purified O
using O: 0.000979
using O
reverse I-GENE: 0.000219
reverse O: 0.000067
reverse I-GENE
phase O: 0.000417
phase O
high I-GENE: 0.000341
high O: 0.000924
high O
performance O: 0.000159
performance O
liquid O: 0.000084
liquid O
chromatography O: 0.000107
chromatography O
( I-GENE: 0.006014
( O: 0.014858
( O
RP O: 0.000014
RP O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
HPLC O: 0.000026
HPLC O
) I-GENE: 0.005210
) O: 0.009341
) O
after O: 0.001385
after O
digestion O: 0.000029
digestion O
with O: 0.009756
with O
enterokinase I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
dual O: 0.000046
dual O
specificity O: 0.000214
specificity O
kinases I-GENE: 0.001777
kinases O: 0.000058
kinases I-GENE
mitogen I-GENE: 0.000755
mitogen O: 0.000017
mitogen I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
activated I-GENE: 0.001412
activated O: 0.000356
activated I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
MAPK I-GENE: 0.000706
MAPK I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
MKK I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
7 I-GENE: 0.000390
7 O: 0.000942
7 O
and I-GENE: 0.003263
and O: 0.028529
and O
MKK4 I-GENE
are O: 0.002918
are O
the I-GENE: 0.000268
the O: 0.044902
the O
only O: 0.000794
only O
molecules I-GENE: 0.000268
molecules O: 0.000125
molecules I-GENE
known O: 0.000359
known O
to I-GENE: 0.000195
to O: 0.014977
to O
directly O: 0.000171
directly O
activate O: 0.000165
activate O
the I-GENE: 0.000268
the O: 0.044902
the O
stress I-GENE: 0.000219
stress O: 0.000232
stress O
kinases I-GENE: 0.001777
kinases O: 0.000058
kinases I-GENE
stress I-GENE: 0.000219
stress O: 0.000232
stress O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
activated I-GENE: 0.001412
activated O: 0.000356
activated I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
kinases I-GENE: 0.001777
kinases O: 0.000058
kinases I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
SAPKs I-GENE
)/ O: 0.000101
)/ O
c I-GENE: 0.006111
c O: 0.000101
c I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
Jun I-GENE: 0.001217
Jun I-GENE
N I-GENE: 0.001217
N O: 0.000614
N I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
terminal I-GENE: 0.001169
terminal O: 0.000884
terminal I-GENE
kinases I-GENE: 0.001777
kinases O: 0.000058
kinases I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
JNKs I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
in I-GENE: 0.000536
in O: 0.023304
in O
response I-GENE: 0.000779
response O: 0.000794
response O
to I-GENE: 0.000195
to O: 0.014977
to O
environmental O: 0.000029
environmental O
or I-GENE: 0.000219
or O: 0.003321
or O
mitogenic O: 0.000043
mitogenic O
stimuli O: 0.000078
stimuli O
. I-GENE: 0.004017
. O: 0.044459
. O

This O: 0.000927
This O
unique O: 0.000162
unique O
work O: 0.000099
work O
needs O: 0.000014
needs O
to I-GENE: 0.000195
to O: 0.014977
to O
be O: 0.002370
be O
edited I-GENE
critically I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
afterwards I-GENE
translated O: 0.000067
translated O
into O: 0.000785
into O
Urdu I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
other O: 0.000994
other O
languages I-GENE
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
benefit O: 0.000020
benefit O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
present O: 0.000551
present O
day O: 0.000394
day O
students O: 0.000020
students O
and I-GENE: 0.003263
and O: 0.028529
and O
scholars I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

RANTES I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
regulated I-GENE: 0.000268
regulated O: 0.000368
regulated O
upon O: 0.000156
upon O
activation I-GENE: 0.000365
activation O: 0.001153
activation O
, I-GENE: 0.001923
, O: 0.035091
, O
normally O: 0.000061
normally O
T I-GENE: 0.001558
T O: 0.000548
T I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
cell I-GENE: 0.001144
cell O: 0.001927
cell O
expressed O: 0.000840
expressed O
and I-GENE: 0.003263
and O: 0.028529
and O
presumably O: 0.000023
presumably O
secreted O: 0.000061
secreted O
) I-GENE: 0.005210
) O: 0.009341
) O
is O: 0.006803
is O
a I-GENE: 0.000317
a O: 0.015893
a O
CC O: 0.000026
CC O
chemokine I-GENE
which O: 0.002472
which O
recruits I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
activates O: 0.000078
activates O
monocytes O: 0.000032
monocytes O
, I-GENE: 0.001923
, O: 0.035091
, O
lymphocytes O: 0.000093
lymphocytes O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
eosinophils O: 0.000017
eosinophils O
, I-GENE: 0.001923
, O: 0.035091
, O
all O: 0.000762
all O
cell I-GENE: 0.001144
cell O: 0.001927
cell O
types O: 0.000177
types O
present O: 0.000551
present O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
lung O: 0.000223
lung O
inflammatory O: 0.000101
inflammatory O
infiltrate I-GENE
induced O: 0.001176
induced O
by O: 0.006887
by O
RSV I-GENE
infection O: 0.000319
infection O
. I-GENE: 0.004017
. O: 0.044459
. O

Gabapentin I-GENE
for O: 0.006951
for O
opiod I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
related I-GENE: 0.001266
related O: 0.000597
related I-GENE
myoclonus I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
cancer O: 0.000284
cancer O
patients O: 0.002538
patients O
. I-GENE: 0.004017
. O: 0.044459
. O

Recently O: 0.000043
Recently O
, I-GENE: 0.001923
, O: 0.035091
, O
it O: 0.000733
it O
was O: 0.006960
was O
shown O: 0.000504
shown O
that O: 0.008362
that O
purified O: 0.000209
purified O
RAG1 I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
proteins I-GENE: 0.005673
proteins O: 0.000933
proteins I-GENE
can O: 0.000924
can O
cleave I-GENE
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
hairpins I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
vitro O: 0.000640
vitro O
, I-GENE: 0.001923
, O: 0.035091
, O
but O: 0.001675
but O
the I-GENE: 0.000268
the O: 0.044902
the O
same O: 0.000348
same O
activity O: 0.002295
activity O
was O: 0.006960
was O
also O: 0.001373
also O
described O: 0.000232
described O
for O: 0.006951
for O
a I-GENE: 0.000317
a O: 0.015893
a O
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
complex I-GENE: 0.001315
complex O: 0.000588
complex I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
repair I-GENE: 0.000146
repair O: 0.000110
repair I-GENE
proteins I-GENE: 0.005673
proteins O: 0.000933
proteins I-GENE
Nbs1 I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
Mre11 I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
Rad50 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

APC I-GENE: 0.000170
APC I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
resistance I-GENE: 0.000146
resistance O: 0.000183
resistance O
was O: 0.006960
was O
determined O: 0.000458
determined O
with O: 0.009756
with O
a I-GENE: 0.000317
a O: 0.015893
a O
functional O: 0.000403
functional O
method O: 0.000385
method O
with O: 0.009756
with O
high I-GENE: 0.000341
high O: 0.000924
high O
sensitivity O: 0.000212
sensitivity O
and I-GENE: 0.003263
and O: 0.028529
and O
specificity O: 0.000214
specificity O
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
factor I-GENE: 0.008984
factor O: 0.000510
factor I-GENE
V I-GENE: 0.000463
V O: 0.000151
V I-GENE
Leiden I-GENE
mutation I-GENE: 0.000560
mutation O: 0.000296
mutation I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
picture O: 0.000020
picture O
is O: 0.006803
is O
emerging I-GENE
showing O: 0.000058
showing O
a I-GENE: 0.000317
a O: 0.015893
a O
gradient O: 0.000032
gradient O
of I-GENE: 0.002337
of O: 0.042520
of O
function O: 0.000855
function O
among O: 0.000304
among O
p53 I-GENE: 0.001802
p53 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
p73 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
p63 I-GENE
ranging O: 0.000032
ranging O
from I-GENE: 0.000390
from O: 0.004210
from O
tumor I-GENE: 0.000487
tumor O: 0.000310
tumor I-GENE
suppression O: 0.000090
suppression O
to I-GENE: 0.000195
to O: 0.014977
to O
development O: 0.000388
development O
. I-GENE: 0.004017
. O: 0.044459
. O

High O: 0.000064
High O
plasma I-GENE: 0.000609
plasma O: 0.000484
plasma I-GENE
AVP I-GENE: 0.000146
AVP I-GENE
levels O: 0.001304
levels O
observed O: 0.000635
observed O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
two O: 0.001904
two O
cases O: 0.000458
cases O
suggest O: 0.000585
suggest O
that O: 0.008362
that O
SSRIs I-GENE
stimulate O: 0.000087
stimulate O
AVP I-GENE: 0.000146
AVP I-GENE
secretion O: 0.000165
secretion O
, I-GENE: 0.001923
, O: 0.035091
, O
thereby O: 0.000058
thereby O
causing O: 0.000049
causing O
SIADH I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Mutation O: 0.000035
Mutation O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
octamer O: 0.000041
octamer O
element I-GENE: 0.001680
element O: 0.000577
element I-GENE
also O: 0.001373
also O
significantly O: 0.000733
significantly O
reduced O: 0.000452
reduced O
the I-GENE: 0.000268
the O: 0.044902
the O
ability O: 0.000290
ability O
of I-GENE: 0.002337
of O: 0.042520
of O
HDAC1 I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
confer O: 0.000046
confer O
repression O: 0.000174
repression O
of I-GENE: 0.002337
of O: 0.042520
of O
inducible I-GENE: 0.000170
inducible O: 0.000165
inducible I-GENE
HLA I-GENE: 0.000560
HLA I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
DRA I-GENE
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
activation I-GENE: 0.000365
activation O: 0.001153
activation O
. I-GENE: 0.004017
. O: 0.044459
. O

Requirements I-GENE
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
nuclear I-GENE: 0.001826
nuclear O: 0.000614
nuclear I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
cytoplasmic I-GENE: 0.000268
cytoplasmic O: 0.000188
cytoplasmic I-GENE
translocation O: 0.000084
translocation O
of I-GENE: 0.002337
of O: 0.042520
of O
infected O: 0.000223
infected O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
cell I-GENE: 0.001144
cell O: 0.001927
cell O
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
0 O: 0.002784
0 O
of I-GENE: 0.002337
of O: 0.042520
of O
herpes I-GENE: 0.000146
herpes O: 0.000043
herpes I-GENE
simplex I-GENE: 0.000122
simplex O: 0.000026
simplex I-GENE
virus I-GENE: 0.001437
virus O: 0.000669
virus I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
system O: 0.000524
system O
, I-GENE: 0.001923
, O: 0.035091
, O
designed O: 0.000070
designed O
to I-GENE: 0.000195
to O: 0.014977
to O
exploit I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
relatively O: 0.000099
relatively O
constant O: 0.000093
constant O
small I-GENE: 0.000682
small O: 0.000290
small I-GENE
intestine O: 0.000023
intestine O
transit O: 0.000032
transit O
time O: 0.000542
time O
, I-GENE: 0.001923
, O: 0.035091
, O
consists O: 0.000093
consists O
of I-GENE: 0.002337
of O: 0.042520
of O
a I-GENE: 0.000317
a O: 0.015893
a O
drug O: 0.000267
drug O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
containing I-GENE: 0.000414
containing O: 0.000837
containing O
core I-GENE: 0.000511
core O: 0.000148
core I-GENE
coated I-GENE
with O: 0.009756
with O
a I-GENE: 0.000317
a O: 0.015893
a O
polymeric I-GENE
matrix O: 0.000067
matrix O
formed O: 0.000104
formed O
by O: 0.006887
by O
a I-GENE: 0.000317
a O: 0.015893
a O
channeling I-GENE
agent O: 0.000113
agent O
( I-GENE: 0.006014
( O: 0.014858
( O
NaCl O: 0.000014
NaCl O
, I-GENE: 0.001923
, O: 0.035091
, O
mannitol I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
Emdex I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
an O: 0.003112
an O
inert I-GENE
polymer I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
Eudragit I-GENE
RS100 I-GENE
). O: 0.002228
). O

The O: 0.007383
The O
activity O: 0.002295
activity O
of I-GENE: 0.002337
of O: 0.042520
of O
Rac1 I-GENE: 0.000170
Rac1 I-GENE
leads O: 0.000090
leads O
to I-GENE: 0.000195
to O: 0.014977
to O
STAT3 I-GENE: 0.000170
STAT3 I-GENE
translocation O: 0.000084
translocation O
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
nucleus O: 0.000154
nucleus O
coincident I-GENE
with O: 0.009756
with O
STAT3 I-GENE: 0.000170
STAT3 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
dependent I-GENE: 0.001485
dependent O: 0.000800
dependent I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
expression O: 0.002231
expression O
. I-GENE: 0.004017
. O: 0.044459
. O

Treatment O: 0.000075
Treatment O
of I-GENE: 0.002337
of O: 0.042520
of O
ischemic O: 0.000055
ischemic O
heart O: 0.000235
heart O
disease O: 0.000632
disease O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
elderly O: 0.000041
elderly O

To O: 0.000522
To O
avoid O: 0.000020
avoid O
misinterpretations I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
special O: 0.000035
special O
reference O: 0.000075
reference O
values O: 0.000339
values O
should O: 0.000171
should O
be O: 0.002370
be O
applied O: 0.000061
applied O
for O: 0.006951
for O
preadolescents I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
at O: 0.002976
at O
least O: 0.000255
least O
with O: 0.009756
with O
regard O: 0.000035
regard O
to I-GENE: 0.000195
to O: 0.014977
to O
FVC I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
FEV1 O: 0.000032
FEV1 O
. I-GENE: 0.004017
. O: 0.044459
. O

STUDY I-GENE
OBJECTIVE O: 0.000061
OBJECTIVE O
: I-GENE: 0.000243
: O: 0.002561
: O
This O: 0.000927
This O
study O: 0.001101
study O
assessed O: 0.000119
assessed O
several O: 0.000443
several O
methodological I-GENE
aspects O: 0.000046
aspects O
related I-GENE: 0.001266
related O: 0.000597
related I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
quality O: 0.000046
quality O
of I-GENE: 0.002337
of O: 0.042520
of O
published O: 0.000046
published O
controlled O: 0.000133
controlled O
clinical O: 0.000417
clinical O
trials O: 0.000052
trials O
( I-GENE: 0.006014
( O: 0.014858
( O
CCTs I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
in I-GENE: 0.000536
in O: 0.023304
in O
relation O: 0.000075
relation O
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
participation O: 0.000023
participation O
of I-GENE: 0.002337
of O: 0.042520
of O
an O: 0.003112
an O
epidemiologist I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
biostatistician I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
E I-GENE: 0.001583
E O: 0.000301
E I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
B I-GENE: 0.004066
B O: 0.000640
B I-GENE
). O: 0.002228
). O

To O: 0.000522
To O
the I-GENE: 0.000268
the O: 0.044902
the O
best O: 0.000070
best O
of I-GENE: 0.002337
of O: 0.042520
of O
our O: 0.000252
our O
knowledge O: 0.000041
knowledge O
, I-GENE: 0.001923
, O: 0.035091
, O
SNTCS I-GENE
is O: 0.006803
is O
highly O: 0.000391
highly O
malignant O: 0.000104
malignant O
. I-GENE: 0.004017
. O: 0.044459
. O

Northern O: 0.000127
Northern O
blot O: 0.000145
blot O
analysis O: 0.001194
analysis O
with O: 0.009756
with O
one O: 0.001026
one O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
PARNAs I-GENE
revealed O: 0.000643
revealed O
a I-GENE: 0.000317
a O: 0.015893
a O
highly O: 0.000391
highly O
abundant O: 0.000055
abundant O
signal I-GENE: 0.000536
signal O: 0.000362
signal I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
approximately O: 0.000307
approximately O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
0 O: 0.002784
0 O
kilobases O: 0.000043
kilobases O
( I-GENE: 0.006014
( O: 0.014858
( O
kb I-GENE: 0.000292
kb O: 0.000464
kb O
) I-GENE: 0.005210
) O: 0.009341
) O
present O: 0.000551
present O
in I-GENE: 0.000536
in O: 0.023304
in O
all O: 0.000762
all O
cell I-GENE: 0.001144
cell O: 0.001927
cell O
lines O: 0.000287
lines O
tested O: 0.000275
tested O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
effect O: 0.000866
effect O
of I-GENE: 0.002337
of O: 0.042520
of O
crude O: 0.000029
crude O
oil O: 0.000038
oil O
spillage I-GENE
on O: 0.003416
on O
growth I-GENE: 0.002337
growth O: 0.000510
growth I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
productivity I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
nutrient O: 0.000023
nutrient O
uptake O: 0.000122
uptake O
of I-GENE: 0.002337
of O: 0.042520
of O
maize O: 0.000023
maize O
( I-GENE: 0.006014
( O: 0.014858
( O
Zea I-GENE
mays I-GENE
L I-GENE: 0.000779
L O: 0.000316
L I-GENE
.) O: 0.000070
.) O
was O: 0.006960
was O
assessed O: 0.000119
assessed O
in I-GENE: 0.000536
in O: 0.023304
in O
a I-GENE: 0.000317
a O: 0.015893
a O
pot I-GENE
experiment O: 0.000075
experiment O
using O: 0.000979
using O
an O: 0.003112
an O
Evwreni I-GENE
manifold I-GENE
sample O: 0.000087
sample O
of I-GENE: 0.002337
of O: 0.042520
of O
a I-GENE: 0.000317
a O: 0.015893
a O
petroleum I-GENE
development O: 0.000388
development O
company I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
which O: 0.002472
which O
had O: 0.000890
had O
a I-GENE: 0.000317
a O: 0.015893
a O
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
gravity I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
8778 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

10 I-GENE: 0.000292
10 O: 0.000936
10 O
. I-GENE: 0.004017
. O: 0.044459
. O
0 O: 0.002784
0 O
+/- O: 0.001124
+/- O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
0 O: 0.002784
0 O
pmol I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
24 O: 0.000333
24 O
h O: 0.000368
h O
, I-GENE: 0.001923
, O: 0.035091
, O
P I-GENE: 0.001023
P O: 0.000614
P I-GENE
< O: 0.000455
< O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
01 O: 0.000238
01 O
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
remained O: 0.000130
remained O
elevated O: 0.000226
elevated O
. I-GENE: 0.004017
. O: 0.044459
. O

Pitx2 I-GENE
rescues I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
GABAergic I-GENE
differentiation O: 0.000217
differentiation O
defect O: 0.000075
defect O
and I-GENE: 0.003263
and O: 0.028529
and O
partially O: 0.000122
partially O
rescues I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
axon I-GENE
guidance I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
behavioral O: 0.000032
behavioral O
phenotypes O: 0.000046
phenotypes O
of I-GENE: 0.002337
of O: 0.042520
of O
unc I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
30 O: 0.000423
30 O
mutants I-GENE: 0.001315
mutants O: 0.000258
mutants I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
indicating O: 0.000191
indicating O
a I-GENE: 0.000317
a O: 0.015893
a O
high I-GENE: 0.000341
high O: 0.000924
high O
degree O: 0.000148
degree O
of I-GENE: 0.002337
of O: 0.042520
of O
functional O: 0.000403
functional O
conservation O: 0.000090
conservation O
between O: 0.001394
between O
these O: 0.001478
these O
evolutionarily O: 0.000032
evolutionarily O
related I-GENE: 0.001266
related O: 0.000597
related I-GENE
genes I-GENE: 0.004626
genes O: 0.000918
genes I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Phosphatidylinositol I-GENE
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
potentiates O: 0.000014
potentiates O
, I-GENE: 0.001923
, O: 0.035091
, O
but O: 0.001675
but O
does O: 0.000272
does O
not O: 0.002509
not O
trigger I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
T I-GENE: 0.001558
T O: 0.000548
T I-GENE
cell I-GENE: 0.001144
cell O: 0.001927
cell O
proliferation O: 0.000139
proliferation O
mediated O: 0.000475
mediated O
by O: 0.006887
by O
the I-GENE: 0.000268
the O: 0.044902
the O
IL I-GENE: 0.003019
IL I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
receptor I-GENE: 0.006817
receptor O: 0.000258
receptor I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
addition O: 0.000420
addition O
, I-GENE: 0.001923
, O: 0.035091
, O
stonin I-GENE
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
binds O: 0.000293
binds O
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
C2B I-GENE
domains I-GENE: 0.000852
domains O: 0.000400
domains I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
synaptotagmins I-GENE
I I-GENE: 0.004602
I O: 0.000487
I I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
II I-GENE: 0.003263
II O: 0.000362
II I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Sequence O: 0.000113
Sequence O
comparison O: 0.000214
comparison O
and I-GENE: 0.003263
and O: 0.028529
and O
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
studies O: 0.000678
studies O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
18 I-GENE: 0.000122
18 O: 0.000240
18 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
bp I-GENE: 0.000122
bp O: 0.000617
bp O
MOK2 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
sites I-GENE: 0.001875
sites O: 0.000690
sites I-GENE
present O: 0.000551
present O
in I-GENE: 0.000536
in O: 0.023304
in O
intron I-GENE: 0.000122
intron O: 0.000217
intron O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
bovine I-GENE: 0.000584
bovine O: 0.000099
bovine I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
mouse I-GENE: 0.001680
mouse O: 0.000403
mouse I-GENE
IRBP I-GENE
genes I-GENE: 0.004626
genes O: 0.000918
genes I-GENE
show O: 0.000484
show O
that O: 0.008362
that O
the I-GENE: 0.000268
the O: 0.044902
the O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
'- I-GENE: 0.000414
'- O: 0.000481
'- O
half O: 0.000145
half O
sequence I-GENE: 0.002021
sequence O: 0.001866
sequence I-GENE
is O: 0.006803
is O
the I-GENE: 0.000268
the O: 0.044902
the O
essential O: 0.000351
essential O
core I-GENE: 0.000511
core O: 0.000148
core I-GENE
element I-GENE: 0.001680
element O: 0.000577
element I-GENE
for O: 0.006951
for O
MOK2 I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Measurements O: 0.000017
Measurements O
were O: 0.005244
were O
obtained O: 0.000417
obtained O
: I-GENE: 0.000243
: O: 0.002561
: O
( I-GENE: 0.006014
( O: 0.014858
( O
i I-GENE: 0.000170
i O: 0.000368
i O
) I-GENE: 0.005210
) O: 0.009341
) O
just O: 0.000026
just O
after O: 0.001385
after O
the I-GENE: 0.000268
the O: 0.044902
the O
traumatic I-GENE
exposure O: 0.000174
exposure O
( I-GENE: 0.006014
( O: 0.014858
( O
D0 I-GENE
); O: 0.000136
); O
( I-GENE: 0.006014
( O: 0.014858
( O
ii O: 0.000067
ii O
) I-GENE: 0.005210
) O: 0.009341
) O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
days O: 0.000356
days O
after O: 0.001385
after O
this O: 0.001976
this O
first O: 0.000591
first O
measurement O: 0.000093
measurement O
( I-GENE: 0.006014
( O: 0.014858
( O
D3 O: 0.000049
D3 O
); O: 0.000136
); O
and I-GENE: 0.003263
and O: 0.028529
and O
( I-GENE: 0.006014
( O: 0.014858
( O
iii O: 0.000046
iii O
) I-GENE: 0.005210
) O: 0.009341
) O
30 O: 0.000423
30 O
days O: 0.000356
days O
after O: 0.001385
after O
( I-GENE: 0.006014
( O: 0.014858
( O
D30 I-GENE
). O: 0.002228
). O

Long I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
term O: 0.000185
term O
results O: 0.001162
results O
with O: 0.009756
with O
MACOP I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
B I-GENE: 0.004066
B O: 0.000640
B I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
radiation O: 0.000110
radiation O
therapy O: 0.000351
therapy O
for O: 0.006951
for O
aggressive O: 0.000017
aggressive O
lymphomas O: 0.000026
lymphomas O
] I-GENE: 0.000122
] O: 0.000240
] O
BACKGROUND O: 0.000081
BACKGROUND O
: I-GENE: 0.000243
: O: 0.002561
: O
Long I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
term O: 0.000185
term O
results O: 0.001162
results O
are O: 0.002918
are O
needed O: 0.000055
needed O
to I-GENE: 0.000195
to O: 0.014977
to O
evaluate O: 0.000107
evaluate O
chemotherapy O: 0.000125
chemotherapy O
regimens O: 0.000026
regimens O
and I-GENE: 0.003263
and O: 0.028529
and O
prognostic O: 0.000029
prognostic O
factors I-GENE: 0.001388
factors O: 0.000626
factors I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
non I-GENE: 0.000292
non O: 0.000449
non O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
Hodgkin O: 0.000043
Hodgkin O
' I-GENE: 0.000950
' O: 0.001701
' O
s I-GENE: 0.000243
s O: 0.000724
s O
lymphomas O: 0.000026
lymphomas O
( I-GENE: 0.006014
( O: 0.014858
( O
NHL I-GENE
). O: 0.002228
). O

From O: 0.000070
From O
the I-GENE: 0.000268
the O: 0.044902
the O
above O: 0.000119
above O
results O: 0.001162
results O
, I-GENE: 0.001923
, O: 0.035091
, O
we O: 0.001382
we O
might O: 0.000104
might O
infer I-GENE
that O: 0.008362
that O
the I-GENE: 0.000268
the O: 0.044902
the O
seizure O: 0.000041
seizure O
type I-GENE: 0.003384
type O: 0.000884
type I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
TLE I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
a I-GENE: 0.000317
a O: 0.015893
a O
high I-GENE: 0.000341
high O: 0.000924
high O
frequency O: 0.000171
frequency O
of I-GENE: 0.002337
of O: 0.042520
of O
seizure O: 0.000041
seizure O
are O: 0.002918
are O
two O: 0.001904
two O
major I-GENE: 0.000341
major O: 0.000333
major I-GENE
independent O: 0.000269
independent O
precipitate I-GENE
factors I-GENE: 0.001388
factors O: 0.000626
factors I-GENE
for O: 0.006951
for O
abnormal O: 0.000075
abnormal O
latencies I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
P300 I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
epileptic I-GENE
patients O: 0.002538
patients O
. I-GENE: 0.004017
. O: 0.044459
. O

Rapamycin I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
FRAP I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
mTOR I-GENE
inhibitor I-GENE: 0.000438
inhibitor O: 0.000238
inhibitor I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
blocked O: 0.000099
blocked O
4E I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
BP1 I-GENE
phosphorylation O: 0.000469
phosphorylation O
causing O: 0.000049
causing O
a I-GENE: 0.000317
a O: 0.015893
a O
predominance I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
alpha I-GENE: 0.009009
alpha O: 0.000313
alpha I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
hypophosphorylated I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
band O: 0.000067
band O
. I-GENE: 0.004017
. O: 0.044459
. O

We O: 0.001417
We O
investigate O: 0.000104
investigate O
the I-GENE: 0.000268
the O: 0.044902
the O
reaction O: 0.000235
reaction O
kinetics O: 0.000035
kinetics O
of I-GENE: 0.002337
of O: 0.042520
of O
small I-GENE: 0.000682
small O: 0.000290
small I-GENE
spherical I-GENE
particles O: 0.000052
particles O
with O: 0.009756
with O
inertia I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
obeying I-GENE
coalescence I-GENE
type I-GENE: 0.003384
type O: 0.000884
type I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
reaction O: 0.000235
reaction O
, I-GENE: 0.001923
, O: 0.035091
, O
B I-GENE: 0.004066
B O: 0.000640
B I-GENE
+ I-GENE: 0.001023
+ O: 0.000487
+ I-GENE
B I-GENE: 0.004066
B O: 0.000640
B I-GENE
--> O: 0.000046
--> O
B I-GENE: 0.004066
B O: 0.000640
B I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
being O: 0.000148
being O
advected I-GENE
by O: 0.006887
by O
hydrodynamical I-GENE
flows I-GENE
with O: 0.009756
with O
time O: 0.000542
time O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
periodic O: 0.000017
periodic O
forcing I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Corticosteroid I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
mediated O: 0.000475
mediated O
transcriptional I-GENE: 0.000268
transcriptional O: 0.000672
transcriptional O
inhibition O: 0.000284
inhibition O
was O: 0.006960
was O
greater O: 0.000325
greater O
for O: 0.006951
for O
MR O: 0.000029
MR O
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
GR I-GENE: 0.000170
GR I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
combination O: 0.000246
combination O
than O: 0.001657
than O
for O: 0.006951
for O
MR O: 0.000029
MR O
or I-GENE: 0.000219
or O: 0.003321
or O
GR I-GENE: 0.000170
GR I-GENE
alone O: 0.000185
alone O
. I-GENE: 0.004017
. O: 0.044459
. O

These O: 0.000979
These O
data O: 0.000649
data O
define O: 0.000096
define O
a I-GENE: 0.000317
a O: 0.015893
a O
conserved O: 0.000507
conserved O
pathway O: 0.000385
pathway O
wherein I-GENE
sequential O: 0.000026
sequential O
histone I-GENE: 0.000536
histone I-GENE
modifications O: 0.000020
modifications O
establish O: 0.000041
establish O
a I-GENE: 0.000317
a O: 0.015893
a O
" I-GENE: 0.000170
" O: 0.000449
" O
histone I-GENE: 0.000536
histone I-GENE
code O: 0.000020
code O
" I-GENE: 0.000170
" O: 0.000449
" O
essential O: 0.000351
essential O
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
epigenetic I-GENE
inheritance I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
heterochromatin I-GENE
assembly O: 0.000110
assembly O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
bovine I-GENE: 0.000584
bovine O: 0.000099
bovine I-GENE
PGHS I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
cDNA I-GENE: 0.001802
cDNA O: 0.000640
cDNA I-GENE
was O: 0.006960
was O
cloned O: 0.000319
cloned O
by O: 0.006887
by O
a I-GENE: 0.000317
a O: 0.015893
a O
combination O: 0.000246
combination O
of I-GENE: 0.002337
of O: 0.042520
of O
reverse I-GENE: 0.000219
reverse O: 0.000067
reverse I-GENE
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
polymerase I-GENE: 0.002094
polymerase O: 0.000099
polymerase I-GENE
chain I-GENE: 0.001315
chain O: 0.000177
chain I-GENE
reaction O: 0.000235
reaction O
and I-GENE: 0.003263
and O: 0.028529
and O
cDNA I-GENE: 0.001802
cDNA O: 0.000640
cDNA I-GENE
library O: 0.000206
library O
screening O: 0.000130
screening O
. I-GENE: 0.004017
. O: 0.044459
. O

Telomerase I-GENE
is O: 0.006803
is O
a I-GENE: 0.000317
a O: 0.015893
a O
ribonucleoprotein I-GENE: 0.000195
ribonucleoprotein O: 0.000017
ribonucleoprotein I-GENE
complex I-GENE: 0.001315
complex O: 0.000588
complex I-GENE
that O: 0.008362
that O
synthesizes I-GENE
telomeric O: 0.000029
telomeric O
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
onto O: 0.000026
onto O
chromosomes O: 0.000055
chromosomes O
using O: 0.000979
using O
its O: 0.001020
its O
RNA I-GENE: 0.003555
RNA O: 0.000591
RNA I-GENE
component O: 0.000180
component O
as O: 0.003654
as O
template O: 0.000049
template O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
iterative I-GENE
method O: 0.000385
method O
proposed O: 0.000081
proposed O
by O: 0.006887
by O
Bengtsson I-GENE
[ O: 0.000382
[ O
Appl I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Several O: 0.000067
Several O
distinct O: 0.000252
distinct O
apoptotic O: 0.000029
apoptotic O
stimuli O: 0.000078
stimuli O
induce O: 0.000090
induce O
the I-GENE: 0.000268
the O: 0.044902
the O
expression O: 0.002231
expression O
and I-GENE: 0.003263
and O: 0.028529
and O
caspase I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
dependent I-GENE: 0.001485
dependent O: 0.000800
dependent I-GENE
cleavage O: 0.000139
cleavage O
of I-GENE: 0.002337
of O: 0.042520
of O
hTAF I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
II I-GENE: 0.003263
II O: 0.000362
II I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
80 O: 0.000145
80 O
delta I-GENE: 0.001023
delta O: 0.000127
delta I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
hTAF I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
II I-GENE: 0.003263
II O: 0.000362
II I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
80 O: 0.000145
80 O
delta I-GENE: 0.001023
delta O: 0.000127
delta I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
unlike O: 0.000032
unlike O
hTAF I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
II I-GENE: 0.003263
II O: 0.000362
II I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
80 O: 0.000145
80 O
, I-GENE: 0.001923
, O: 0.035091
, O
forms O: 0.000203
forms O
a I-GENE: 0.000317
a O: 0.015893
a O
TFIID I-GENE: 0.000365
TFIID I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
like I-GENE: 0.002143
like O: 0.000272
like I-GENE
complex I-GENE: 0.001315
complex O: 0.000588
complex I-GENE
lacking O: 0.000116
lacking O
hTAF I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
II I-GENE: 0.003263
II O: 0.000362
II I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
31 O: 0.000145
31 O
. I-GENE: 0.004017
. O: 0.044459
. O

With O: 0.000093
With O
NEU I-GENE
overexpression O: 0.000104
overexpression O
, I-GENE: 0.001923
, O: 0.035091
, O
nodal O: 0.000032
nodal O
control I-GENE: 0.000170
control O: 0.000834
control O
decreased O: 0.000403
decreased O
from I-GENE: 0.000390
from O: 0.004210
from O
72 O: 0.000093
72 O
% O: 0.001741
% O
to I-GENE: 0.000195
to O: 0.014977
to O
34 O: 0.000113
34 O
% O: 0.001741
% O
( I-GENE: 0.006014
( O: 0.014858
( O
p I-GENE: 0.000122
p O: 0.000681
p O
= O: 0.000855
= O
. I-GENE: 0.004017
. O: 0.044459
. O
008 I-GENE
). O: 0.002228
). O

The O: 0.007383
The O
mouse I-GENE: 0.001680
mouse O: 0.000403
mouse I-GENE
platelet I-GENE: 0.000438
platelet O: 0.000075
platelet I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
derived I-GENE: 0.000268
derived O: 0.000290
derived O
growth I-GENE: 0.002337
growth O: 0.000510
growth I-GENE
factor I-GENE: 0.008984
factor O: 0.000510
factor I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
PDGF I-GENE: 0.000536
PDGF I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
beta I-GENE: 0.007816
beta O: 0.000353
beta I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
receptor I-GENE: 0.006817
receptor O: 0.000258
receptor I-GENE
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
contains O: 0.000548
contains O
a I-GENE: 0.000317
a O: 0.015893
a O
CCAAT I-GENE: 0.000317
CCAAT O: 0.000052
CCAAT I-GENE
motif I-GENE: 0.000706
motif O: 0.000316
motif I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
NF I-GENE: 0.002922
NF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
Y I-GENE: 0.000487
Y O: 0.000087
Y I-GENE
plays O: 0.000101
plays O
an O: 0.003112
an O
essential O: 0.000351
essential O
role O: 0.000681
role O
in I-GENE: 0.000536
in O: 0.023304
in O
its O: 0.001020
its O
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Biol O: 0.000032
Biol O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
loop I-GENE: 0.000219
loop O: 0.000142
loop I-GENE
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
heat I-GENE: 0.000292
heat O: 0.000101
heat I-GENE
shock I-GENE: 0.000268
shock O: 0.000104
shock I-GENE
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
factor I-GENE: 0.008984
factor O: 0.000510
factor I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
dictates I-GENE
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
specificity O: 0.000214
specificity O
and I-GENE: 0.003263
and O: 0.028529
and O
responses O: 0.000278
responses O
to I-GENE: 0.000195
to O: 0.014977
to O
heat I-GENE: 0.000292
heat O: 0.000101
heat I-GENE
stress I-GENE: 0.000219
stress O: 0.000232
stress O
. I-GENE: 0.004017
. O: 0.044459
. O

This O: 0.000927
This O
activation I-GENE: 0.000365
activation O: 0.001153
activation O
was O: 0.006960
was O
then O: 0.000154
then O
blocked O: 0.000099
blocked O
by O: 0.006887
by O
CGS I-GENE
12066A I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Among O: 0.000087
Among O
the I-GENE: 0.000268
the O: 0.044902
the O
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
factors I-GENE: 0.001388
factors O: 0.000626
factors I-GENE
known O: 0.000359
known O
to I-GENE: 0.000195
to O: 0.014977
to O
interact O: 0.000127
interact O
with O: 0.009756
with O
Groucho I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
related I-GENE: 0.001266
related O: 0.000597
related I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
only O: 0.000794
only O
RUNX1 I-GENE
was O: 0.006960
was O
appreciably I-GENE
downregulated I-GENE
by O: 0.006887
by O
E2A I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
HLF I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
new O: 0.000464
new O
intron I-GENE: 0.000122
intron O: 0.000217
intron O
of I-GENE: 0.002337
of O: 0.042520
of O
476 I-GENE
base O: 0.000313
base O
pairs O: 0.000145
pairs O
was O: 0.006960
was O
found O: 0.001026
found O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
middle O: 0.000049
middle O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
'- I-GENE: 0.000414
'- O: 0.000481
'- O
untranslated O: 0.000145
untranslated O
leader O: 0.000061
leader O
sequence I-GENE: 0.002021
sequence O: 0.001866
sequence I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
was O: 0.006960
was O
shown O: 0.000504
shown O
to I-GENE: 0.000195
to O: 0.014977
to O
robustly I-GENE
enhance O: 0.000023
enhance O
the I-GENE: 0.000268
the O: 0.044902
the O
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
activity O: 0.002295
activity O
. I-GENE: 0.004017
. O: 0.044459
. O

Our O: 0.000235
Our O
findings O: 0.000258
findings O
further O: 0.000261
further O
our O: 0.000252
our O
understanding O: 0.000061
understanding O
of I-GENE: 0.002337
of O: 0.042520
of O
how O: 0.000046
how O
ZBP I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
89 O: 0.000052
89 O
modulates I-GENE
cell I-GENE: 0.001144
cell O: 0.001927
cell O
proliferation O: 0.000139
proliferation O
and I-GENE: 0.003263
and O: 0.028529
and O
reveals O: 0.000145
reveals O
a I-GENE: 0.000317
a O: 0.015893
a O
novel O: 0.000385
novel O
mechanism O: 0.000304
mechanism O
by O: 0.006887
by O
which O: 0.002472
which O
the I-GENE: 0.000268
the O: 0.044902
the O
p53 I-GENE: 0.001802
p53 I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
is O: 0.006803
is O
stabilized O: 0.000014
stabilized O
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
the I-GENE: 0.000268
the O: 0.044902
the O
free O: 0.000203
free O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
swimming O: 0.000017
swimming O
rotatory I-GENE
test O: 0.000391
test O
mice O: 0.000353
mice O
spend I-GENE
most O: 0.000400
most O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
time O: 0.000542
time O
swimming O: 0.000017
swimming O
close O: 0.000067
close O
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
wall O: 0.000107
wall O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
container I-GENE
attempting I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
escape I-GENE
from I-GENE: 0.000390
from O: 0.004210
from O
an O: 0.003112
an O
aversive I-GENE
test O: 0.000391
test O
situation I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

As O: 0.000162
As O
well O: 0.000626
well O
, I-GENE: 0.001923
, O: 0.035091
, O
mixtures I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
( I-GENE: 0.006014
( O: 0.014858
( O
LA O: 0.000017
LA O
)( I-GENE: 0.000146
)( O: 0.000017
)( I-GENE
12 I-GENE: 0.000292
12 O: 0.000539
12 O
) I-GENE: 0.005210
) O: 0.009341
) O
with O: 0.009756
with O
the I-GENE: 0.000268
the O: 0.044902
the O
longer O: 0.000096
longer O
chain I-GENE: 0.001315
chain O: 0.000177
chain I-GENE
PEs I-GENE
exhibit O: 0.000070
exhibit O
unusual O: 0.000049
unusual O
biomodal I-GENE
enthalpy I-GENE
variations O: 0.000038
variations O
, I-GENE: 0.001923
, O: 0.035091
, O
suggesting O: 0.000400
suggesting O
peptide I-GENE: 0.000584
peptide O: 0.000212
peptide I-GENE
immiscibility I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
thicker I-GENE
gel O: 0.000139
gel O
state O: 0.000206
state O
bilayers I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

At O: 0.000104
At O
the I-GENE: 0.000268
the O: 0.044902
the O
time O: 0.000542
time O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
blind O: 0.000061
blind O
therapeutic O: 0.000104
therapeutic O
doses O: 0.000183
doses O
, I-GENE: 0.001923
, O: 0.035091
, O
Tg I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
off O: 0.000032
off O
values O: 0.000339
values O
ranged O: 0.000046
ranged O
from I-GENE: 0.000390
from O: 0.004210
from O
8 I-GENE: 0.000803
8 O: 0.000939
8 O
to I-GENE: 0.000195
to O: 0.014977
to O
608 I-GENE
microg O: 0.000032
microg O
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
l O: 0.000209
l O
. I-GENE: 0.004017
. O: 0.044459
. O

Nephrotoxicity I-GENE
after O: 0.001385
after O
orthotopic I-GENE
liver I-GENE: 0.000243
liver O: 0.000382
liver O
transplantation O: 0.000084
transplantation O
in I-GENE: 0.000536
in O: 0.023304
in O
cyclosporin O: 0.000035
cyclosporin O
A I-GENE: 0.003530
A O: 0.002246
A I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
FK O: 0.000017
FK O
506 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
treated O: 0.000365
treated O
patients O: 0.002538
patients O
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
contrast O: 0.000336
contrast O
to I-GENE: 0.000195
to O: 0.014977
to O
MPc3 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
data O: 0.000649
data O
indicate O: 0.000438
indicate O
that O: 0.008362
that O
the I-GENE: 0.000268
the O: 0.044902
the O
Pc I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
M33 I-GENE
does O: 0.000272
does O
not O: 0.002509
not O
interact O: 0.000127
interact O
with O: 0.009756
with O
AF9 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Hydrocoele I-GENE
is O: 0.006803
is O
common O: 0.000246
common O
in I-GENE: 0.000536
in O: 0.023304
in O
men O: 0.000136
men O
in I-GENE: 0.000536
in O: 0.023304
in O
Wuchereria I-GENE
bancrofti I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
endemic I-GENE
areas O: 0.000113
areas O
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
treatment O: 0.000921
treatment O
for O: 0.006951
for O
which O: 0.002472
which O
is O: 0.006803
is O
currently O: 0.000046
currently O
surgical O: 0.000075
surgical O
intervention O: 0.000026
intervention O
. I-GENE: 0.004017
. O: 0.044459
. O

Of O: 0.000096
Of O
the I-GENE: 0.000268
the O: 0.044902
the O
patients O: 0.002538
patients O
in I-GENE: 0.000536
in O: 0.023304
in O
each O: 0.000475
each O
regimen O: 0.000084
regimen O
who O: 0.000348
who O
reached O: 0.000061
reached O
study O: 0.001101
study O
end O: 0.000411
end O
points O: 0.000055
points O
, I-GENE: 0.001923
, O: 0.035091
, O
17 O: 0.000281
17 O
of I-GENE: 0.002337
of O: 0.042520
of O
29 O: 0.000122
29 O
( I-GENE: 0.006014
( O: 0.014858
( O
59 O: 0.000055
59 O
%) O: 0.000385
%) O
were O: 0.005244
were O
in I-GENE: 0.000536
in O: 0.023304
in O
regimen O: 0.000084
regimen O
A I-GENE: 0.003530
A O: 0.002246
A I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
11 I-GENE: 0.000365
11 O: 0.000377
11 O
of I-GENE: 0.002337
of O: 0.042520
of O
20 I-GENE: 0.000146
20 O: 0.000484
20 O
( I-GENE: 0.006014
( O: 0.014858
( O
55 O: 0.000096
55 O
%) O: 0.000385
%) O
were O: 0.005244
were O
in I-GENE: 0.000536
in O: 0.023304
in O
regimen O: 0.000084
regimen O
B I-GENE: 0.004066
B O: 0.000640
B I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
28 O: 0.000133
28 O
of I-GENE: 0.002337
of O: 0.042520
of O
43 O: 0.000075
43 O
( I-GENE: 0.006014
( O: 0.014858
( O
65 O: 0.000113
65 O
%) O: 0.000385
%) O
were O: 0.005244
were O
in I-GENE: 0.000536
in O: 0.023304
in O
regimen O: 0.000084
regimen O
C I-GENE: 0.005113
C O: 0.001005
C I-GENE
met I-GENE: 0.000122
met O: 0.000014
met I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
treatment O: 0.000921
treatment O
success O: 0.000020
success O
criterion O: 0.000014
criterion O
. I-GENE: 0.004017
. O: 0.044459
. O

One O: 0.000165
One O
maternal O: 0.000041
maternal O
death O: 0.000136
death O
, I-GENE: 0.001923
, O: 0.035091
, O
reduced O: 0.000452
reduced O
body O: 0.000240
body O
weight O: 0.000226
weight O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
reduced O: 0.000452
reduced O
weight O: 0.000226
weight O
gain O: 0.000075
gain O
were O: 0.005244
were O
noted O: 0.000072
noted O
at O: 0.002976
at O
the I-GENE: 0.000268
the O: 0.044902
the O
high I-GENE: 0.000341
high O: 0.000924
high O
dose O: 0.000469
dose O
; I-GENE: 0.000170
; O: 0.001399
; O
confirmed O: 0.000139
confirmed O
pregnancy O: 0.000127
pregnancy O
rates O: 0.000162
rates O
were O: 0.005244
were O
84 O: 0.000058
84 O
to I-GENE: 0.000195
to O: 0.014977
to O
100 O: 0.000400
100 O
% O: 0.001741
% O
for O: 0.006951
for O
each O: 0.000475
each O
group I-GENE: 0.000414
group O: 0.000869
group O
. I-GENE: 0.004017
. O: 0.044459
. O

Karger I-GENE
AG I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
Basel I-GENE

In O: 0.002266
In O
regards I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
latter O: 0.000072
latter O
activity O: 0.002295
activity O
, I-GENE: 0.001923
, O: 0.035091
, O
it O: 0.000733
it O
has O: 0.001356
has O
been O: 0.001229
been O
shown O: 0.000504
shown O
that O: 0.008362
that O
S3 I-GENE
contains O: 0.000548
contains O
vigorous I-GENE
N I-GENE: 0.001217
N O: 0.000614
N I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
glycosylase I-GENE: 0.000170
glycosylase I-GENE
activity O: 0.002295
activity O
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
removal O: 0.000049
removal O
of I-GENE: 0.002337
of O: 0.042520
of O
8 I-GENE: 0.000803
8 O: 0.000939
8 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
oxoguanine I-GENE
residues I-GENE: 0.000146
residues O: 0.000426
residues O
in I-GENE: 0.000536
in O: 0.023304
in O
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
that O: 0.008362
that O
leaves O: 0.000032
leaves O
baseless I-GENE
sites I-GENE: 0.001875
sites O: 0.000690
sites I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
their O: 0.000736
their O
places I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

We O: 0.001417
We O
describe O: 0.000093
describe O
a I-GENE: 0.000317
a O: 0.015893
a O
total O: 0.000443
total O
of I-GENE: 0.002337
of O: 0.042520
of O
39 O: 0.000087
39 O
DEAH I-GENE
helicases I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
these O: 0.001478
these O
four O: 0.000406
four O
species O: 0.000243
species O
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
prospective O: 0.000052
prospective O
trial O: 0.000087
trial O
was O: 0.006960
was O
undertaken O: 0.000043
undertaken O
to I-GENE: 0.000195
to O: 0.014977
to O
determine O: 0.000255
determine O
( I-GENE: 0.006014
( O: 0.014858
( O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
clinical O: 0.000417
clinical O
characteristics O: 0.000136
characteristics O
of I-GENE: 0.002337
of O: 0.042520
of O
patients O: 0.002538
patients O
with O: 0.009756
with O
chest O: 0.000035
chest O
pain O: 0.000110
pain O
; I-GENE: 0.000170
; O: 0.001399
; O
( I-GENE: 0.006014
( O: 0.014858
( O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
value O: 0.000191
value O
of I-GENE: 0.002337
of O: 0.042520
of O
cardiac I-GENE: 0.000195
cardiac O: 0.000206
cardiac O
markers O: 0.000096
markers O
troponin I-GENE
T I-GENE: 0.001558
T O: 0.000548
T I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
myoglobin I-GENE: 0.000146
myoglobin I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
CK I-GENE: 0.000341
CK I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
MB I-GENE: 0.000243
MB O: 0.000017
MB I-GENE
mass O: 0.000197
mass O
in I-GENE: 0.000536
in O: 0.023304
in O
differentiating O: 0.000014
differentiating O
cardiac I-GENE: 0.000195
cardiac O: 0.000206
cardiac O
and I-GENE: 0.003263
and O: 0.028529
and O
noncardiac I-GENE
chest O: 0.000035
chest O
pain O: 0.000110
pain O
; I-GENE: 0.000170
; O: 0.001399
; O
( I-GENE: 0.006014
( O: 0.014858
( O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
the I-GENE: 0.000268
the O: 0.044902
the O
proportion O: 0.000046
proportion O
of I-GENE: 0.002337
of O: 0.042520
of O
patients O: 0.002538
patients O
with O: 0.009756
with O
ACS I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
whom O: 0.000052
whom O
these O: 0.001478
these O
markers O: 0.000096
markers O
provided O: 0.000096
provided O
helpful O: 0.000014
helpful O
additional O: 0.000156
additional O
information O: 0.000081
information O
on O: 0.003416
on O
admission O: 0.000014
admission O
and I-GENE: 0.003263
and O: 0.028529
and O
afterwards I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Inactivity I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
cytomegalovirus O: 0.000023
cytomegalovirus O
( I-GENE: 0.006014
( O: 0.014858
( O
HCMV O: 0.000014
HCMV O
) I-GENE: 0.005210
) O: 0.009341
) O
major I-GENE: 0.000341
major O: 0.000333
major I-GENE
immediate I-GENE: 0.000317
immediate O: 0.000043
immediate I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
early I-GENE: 0.000706
early O: 0.000374
early I-GENE
regulatory I-GENE: 0.000901
regulatory O: 0.000458
regulatory I-GENE
region I-GENE: 0.001583
region O: 0.001744
region O
( I-GENE: 0.006014
( O: 0.014858
( O
MIERR I-GENE
), O: 0.002269
), O
which O: 0.002472
which O
is O: 0.006803
is O
composed O: 0.000078
composed O
of I-GENE: 0.002337
of O: 0.042520
of O
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
enhancer I-GENE: 0.001461
enhancer O: 0.000226
enhancer I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
unique O: 0.000162
unique O
region I-GENE: 0.001583
region O: 0.001744
region O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
modulator I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
is O: 0.006803
is O
linked O: 0.000235
linked O
to I-GENE: 0.000195
to O: 0.014977
to O
lack O: 0.000093
lack O
of I-GENE: 0.002337
of O: 0.042520
of O
HCMV O: 0.000014
HCMV O
replication I-GENE: 0.000146
replication O: 0.000243
replication O
in I-GENE: 0.000536
in O: 0.023304
in O
latently I-GENE
infected O: 0.000223
infected O
cells O: 0.002663
cells O
and I-GENE: 0.003263
and O: 0.028529
and O
in I-GENE: 0.000536
in O: 0.023304
in O
other O: 0.000994
other O
nonpermissive I-GENE
cell I-GENE: 0.001144
cell O: 0.001927
cell O
types O: 0.000177
types O
, I-GENE: 0.001923
, O: 0.035091
, O
including O: 0.000446
including O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
embryonal I-GENE
NTera2 I-GENE
carcinoma O: 0.000217
carcinoma O
( I-GENE: 0.006014
( O: 0.014858
( O
NT2 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
cells O: 0.002663
cells O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
observed O: 0.000635
observed O
triplexes I-GENE
depend O: 0.000023
depend O
on O: 0.003416
on O
the I-GENE: 0.000268
the O: 0.044902
the O
length I-GENE: 0.000463
length O: 0.000252
length I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
repeat I-GENE: 0.000317
repeat O: 0.000209
repeat I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Statistical I-GENE
Analysis O: 0.000177
Analysis O
included O: 0.000139
included O
ANOVA I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
Pearson I-GENE
Product I-GENE
Moment I-GENE
Correlation I-GENE
Coefficient I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
Principal I-GENE
Components I-GENE
Analysis O: 0.000177
Analysis O
and I-GENE: 0.003263
and O: 0.028529
and O
Discriminant I-GENE
Function I-GENE
Analysis O: 0.000177
Analysis O
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
calculation I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
Cronbach I-GENE
' I-GENE: 0.000950
' O: 0.001701
' O
s I-GENE: 0.000243
s O: 0.000724
s O
alpha I-GENE: 0.009009
alpha O: 0.000313
alpha I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
alpha I-GENE: 0.009009
alpha O: 0.000313
alpha I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
RESULTS O: 0.000180
RESULTS O
: I-GENE: 0.000243
: O: 0.002561
: O
Both O: 0.000168
Both O
Sensitivity I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
specificity O: 0.000214
specificity O
exceed I-GENE
90 O: 0.000180
90 O
. I-GENE: 0.004017
. O: 0.044459
. O
00 O: 0.000017
00 O
at O: 0.002976
at O
23 O: 0.000139
23 O
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
24 O: 0.000333
24 O
, I-GENE: 0.001923
, O: 0.035091
, O
Chronbach I-GENE
' I-GENE: 0.000950
' O: 0.001701
' O
s I-GENE: 0.000243
s O: 0.000724
s O
alpha I-GENE: 0.009009
alpha O: 0.000313
alpha I-GENE
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
total O: 0.000443
total O
scale O: 0.000055
scale O
was O: 0.006960
was O
equal O: 0.000093
equal O
to I-GENE: 0.000195
to O: 0.014977
to O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
95 O: 0.000174
95 O
. I-GENE: 0.004017
. O: 0.044459
. O

BACKGROUND O: 0.000081
BACKGROUND O
: I-GENE: 0.000243
: O: 0.002561
: O
Previous O: 0.000058
Previous O
studies O: 0.000678
studies O
have O: 0.001788
have O
indicated O: 0.000229
indicated O
that O: 0.008362
that O
the I-GENE: 0.000268
the O: 0.044902
the O
60 O: 0.000238
60 O
-, O: 0.000070
-, O
30 O: 0.000423
30 O
-, O: 0.000070
-, O
28 O: 0.000133
28 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
12 I-GENE: 0.000292
12 O: 0.000539
12 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
item I-GENE
versions I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
General I-GENE
Health O: 0.000035
Health O
Questionnaire I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
GHQ I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
are O: 0.002918
are O
liable I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
retest I-GENE
effects O: 0.000652
effects O
, I-GENE: 0.001923
, O: 0.035091
, O
especially O: 0.000090
especially O
when O: 0.000690
when O
administered O: 0.000185
administered O
multiple O: 0.000409
multiple O
times O: 0.000203
times O
with O: 0.009756
with O
short O: 0.000214
short O
intervals O: 0.000035
intervals O
. I-GENE: 0.004017
. O: 0.044459
. O

Cross O: 0.000017
Cross O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
linking O: 0.000061
linking O
FcalphaR I-GENE
on O: 0.003416
on O
wt I-GENE: 0.000122
wt O: 0.000014
wt I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
ITAM I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
IIA I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
ITAM I-GENE
cells O: 0.002663
cells O
triggered O: 0.000017
triggered O
equivalent O: 0.000043
equivalent O
PI I-GENE: 0.000414
PI O: 0.000017
PI I-GENE
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
dependent I-GENE: 0.001485
dependent O: 0.000800
dependent I-GENE
activation I-GENE: 0.000365
activation O: 0.001153
activation O
of I-GENE: 0.002337
of O: 0.042520
of O
PKBalpha I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

An O: 0.000287
An O
F222W I-GENE
: I-GENE: 0.000243
: O: 0.002561
: O
W21F I-GENE
rGST I-GENE
A1 I-GENE: 0.000292
A1 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
double I-GENE: 0.000146
double O: 0.000162
double O
mutant I-GENE: 0.002386
mutant O: 0.000385
mutant I-GENE
provides O: 0.000096
provides O
a I-GENE: 0.000317
a O: 0.015893
a O
direct O: 0.000264
direct O
fluorescence O: 0.000023
fluorescence O
probe O: 0.000116
probe O
of I-GENE: 0.002337
of O: 0.042520
of O
changes O: 0.000466
changes O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
environment O: 0.000041
environment O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
C I-GENE: 0.005113
C O: 0.001005
C I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
terminal I-GENE: 0.001169
terminal O: 0.000884
terminal I-GENE
residue O: 0.000200
residue O
. I-GENE: 0.004017
. O: 0.044459
. O

Binding O: 0.000032
Binding O
of I-GENE: 0.002337
of O: 0.042520
of O
serum I-GENE: 0.002070
serum O: 0.000536
serum I-GENE
response I-GENE: 0.000779
response O: 0.000794
response O
factor I-GENE: 0.008984
factor O: 0.000510
factor I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
CArG I-GENE
box I-GENE: 0.000901
box O: 0.000313
box I-GENE
sequences I-GENE: 0.001290
sequences O: 0.000947
sequences I-GENE
is O: 0.006803
is O
necessary O: 0.000183
necessary O
but O: 0.001675
but O
not O: 0.002509
not O
sufficient O: 0.000180
sufficient O
to I-GENE: 0.000195
to O: 0.014977
to O
restrict I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
expression O: 0.002231
expression O
to I-GENE: 0.000195
to O: 0.014977
to O
arterial O: 0.000174
arterial O
smooth O: 0.000049
smooth O
muscle I-GENE: 0.000292
muscle O: 0.000356
muscle O
cells O: 0.002663
cells O
. I-GENE: 0.004017
. O: 0.044459
. O

They O: 0.000067
They O
consist O: 0.000020
consist O
of I-GENE: 0.002337
of O: 0.042520
of O
at O: 0.002976
at O
least O: 0.000255
least O
two O: 0.001904
two O
separable I-GENE
components O: 0.000177
components O
, I-GENE: 0.001923
, O: 0.035091
, O
one O: 0.001026
one O
heat I-GENE: 0.000292
heat O: 0.000101
heat I-GENE
stable O: 0.000133
stable O
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
other O: 0.000994
other O
heat I-GENE: 0.000292
heat O: 0.000101
heat I-GENE
labile I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

No O: 0.000174
No O
preferential O: 0.000017
preferential O
VH I-GENE: 0.000122
VH I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
VL I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
chains I-GENE: 0.000170
chains O: 0.000029
chains I-GENE
correlated O: 0.000156
correlated O
with O: 0.009756
with O
any O: 0.000264
any O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
12 I-GENE: 0.000292
12 O: 0.000539
12 O
different O: 0.000669
different O
antigen I-GENE: 0.001437
antigen O: 0.000046
antigen I-GENE
reactivities I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
even O: 0.000154
even O
for O: 0.006951
for O
mAbs I-GENE
with O: 0.009756
with O
nearly O: 0.000052
nearly O
identical O: 0.000301
identical O
cross O: 0.000145
cross O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
reactivities I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

These O: 0.000979
These O
results O: 0.001162
results O
were O: 0.005244
were O
compared O: 0.000603
compared O
with O: 0.009756
with O
the I-GENE: 0.000268
the O: 0.044902
the O
estimates O: 0.000038
estimates O
of I-GENE: 0.002337
of O: 0.042520
of O
penetration O: 0.000014
penetration O
from I-GENE: 0.000390
from O: 0.004210
from O
steady O: 0.000087
steady O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
state O: 0.000206
state O
calculations I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
square O: 0.000014
square O
root O: 0.000014
root O
of I-GENE: 0.002337
of O: 0.042520
of O
time O: 0.000542
time O
calculations I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
a I-GENE: 0.000317
a O: 0.015893
a O
biologically O: 0.000014
biologically O
based O: 0.000287
based O
mathematical I-GENE
model O: 0.000327
model O
. I-GENE: 0.004017
. O: 0.044459
. O

Based O: 0.000055
Based O
on O: 0.003416
on O
this O: 0.001976
this O
analysis O: 0.001194
analysis O
, I-GENE: 0.001923
, O: 0.035091
, O
we O: 0.001382
we O
propose O: 0.000064
propose O
that O: 0.008362
that O
the I-GENE: 0.000268
the O: 0.044902
the O
interactions O: 0.000226
interactions O
of I-GENE: 0.002337
of O: 0.042520
of O
Sos I-GENE: 0.000146
Sos I-GENE
with O: 0.009756
with O
the I-GENE: 0.000268
the O: 0.044902
the O
switch O: 0.000026
switch O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
switch O: 0.000026
switch O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
regions I-GENE: 0.000243
regions O: 0.000501
regions O
of I-GENE: 0.002337
of O: 0.042520
of O
Ras I-GENE: 0.001923
Ras I-GENE
have O: 0.001788
have O
distinct O: 0.000252
distinct O
functional O: 0.000403
functional O
consequences O: 0.000032
consequences O
: I-GENE: 0.000243
: O: 0.002561
: O
the I-GENE: 0.000268
the O: 0.044902
the O
interaction I-GENE: 0.000122
interaction O: 0.000478
interaction O
with O: 0.009756
with O
switch O: 0.000026
switch O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
mediates O: 0.000075
mediates O
the I-GENE: 0.000268
the O: 0.044902
the O
anchoring I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
Ras I-GENE: 0.001923
Ras I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
Sos I-GENE: 0.000146
Sos I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
whereas O: 0.000351
whereas O
the I-GENE: 0.000268
the O: 0.044902
the O
interaction I-GENE: 0.000122
interaction O: 0.000478
interaction O
with O: 0.009756
with O
switch O: 0.000026
switch O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
leads O: 0.000090
leads O
to I-GENE: 0.000195
to O: 0.014977
to O
disruption O: 0.000046
disruption O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
nucleotide I-GENE: 0.000317
nucleotide O: 0.000310
nucleotide I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
site I-GENE: 0.003092
site O: 0.001040
site I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
GDP I-GENE: 0.000122
GDP O: 0.000020
GDP I-GENE
dissociation O: 0.000023
dissociation O
. I-GENE: 0.004017
. O: 0.044459
. O

Thus O: 0.000284
Thus O
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
interaction I-GENE: 0.000122
interaction O: 0.000478
interaction O
of I-GENE: 0.002337
of O: 0.042520
of O
Tat I-GENE: 0.000414
Tat I-GENE
with O: 0.009756
with O
the I-GENE: 0.000268
the O: 0.044902
the O
components O: 0.000177
components O
of I-GENE: 0.002337
of O: 0.042520
of O
this O: 0.001976
this O
rel I-GENE: 0.000170
rel I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
AP1 I-GENE: 0.000341
AP1 I-GENE
cooperative O: 0.000023
cooperative O
complex I-GENE: 0.001315
complex O: 0.000588
complex I-GENE
seems O: 0.000064
seems O
to I-GENE: 0.000195
to O: 0.014977
to O
induce O: 0.000090
induce O
quantitative O: 0.000067
quantitative O
and I-GENE: 0.003263
and O: 0.028529
and O
qualitative O: 0.000026
qualitative O
alterations O: 0.000104
alterations O
of I-GENE: 0.002337
of O: 0.042520
of O
this O: 0.001976
this O
complex I-GENE: 0.001315
complex O: 0.000588
complex I-GENE
as O: 0.003654
as O
activation I-GENE: 0.000365
activation O: 0.001153
activation O
progresses I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
resulting O: 0.000151
resulting O
in I-GENE: 0.000536
in O: 0.023304
in O
a I-GENE: 0.000317
a O: 0.015893
a O
decrease O: 0.000264
decrease O
of I-GENE: 0.002337
of O: 0.042520
of O
IL I-GENE: 0.003019
IL I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

SIT I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
SHP2 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
interacting O: 0.000061
interacting O
transmembrane I-GENE: 0.000219
transmembrane O: 0.000104
transmembrane I-GENE
adaptor O: 0.000038
adaptor O
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
is O: 0.006803
is O
a I-GENE: 0.000317
a O: 0.015893
a O
recently O: 0.000139
recently O
identified O: 0.000823
identified O
transmembrane I-GENE: 0.000219
transmembrane O: 0.000104
transmembrane I-GENE
adaptor O: 0.000038
adaptor O
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
which O: 0.002472
which O
is O: 0.006803
is O
expressed O: 0.000840
expressed O
in I-GENE: 0.000536
in O: 0.023304
in O
lymphocytes O: 0.000093
lymphocytes O
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
this O: 0.001976
this O
manuscript I-GENE
we O: 0.001382
we O
demonstrate O: 0.000290
demonstrate O
that O: 0.008362
that O
two O: 0.001904
two O
tandem O: 0.000049
tandem O
Ets I-GENE: 0.000730
Ets I-GENE
sites I-GENE: 0.001875
sites O: 0.000690
sites I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
mouse I-GENE: 0.001680
mouse O: 0.000403
mouse I-GENE
GL I-GENE
alpha I-GENE: 0.009009
alpha O: 0.000313
alpha I-GENE
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
bind O: 0.000296
bind O
the I-GENE: 0.000268
the O: 0.044902
the O
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
factors I-GENE: 0.001388
factors O: 0.000626
factors I-GENE
Elf I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
PU I-GENE: 0.000243
PU I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
that O: 0.008362
that O
the I-GENE: 0.000268
the O: 0.044902
the O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
' I-GENE: 0.000950
' O: 0.001701
' O
site I-GENE: 0.003092
site O: 0.001040
site I-GENE
is O: 0.006803
is O
essential O: 0.000351
essential O
for O: 0.006951
for O
expression O: 0.002231
expression O
of I-GENE: 0.002337
of O: 0.042520
of O
a I-GENE: 0.000317
a O: 0.015893
a O
luciferase I-GENE: 0.000682
luciferase I-GENE
reporter I-GENE: 0.000828
reporter O: 0.000246
reporter I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
driven O: 0.000061
driven O
by O: 0.006887
by O
the I-GENE: 0.000268
the O: 0.044902
the O
GL I-GENE
alpha I-GENE: 0.009009
alpha O: 0.000313
alpha I-GENE
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

ICA I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
reference O: 0.000075
reference O
solution O: 0.000113
solution O
was O: 0.006960
was O
characterised I-GENE
by O: 0.006887
by O
LC I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
time O: 0.000542
time O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
flight I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
TOF O: 0.000014
TOF O
) I-GENE: 0.005210
) O: 0.009341
) O
MS O: 0.000046
MS O
and I-GENE: 0.003263
and O: 0.028529
and O
quantified I-GENE
by O: 0.006887
by O
LC I-GENE
chemiluminescent I-GENE
nitrogen O: 0.000043
nitrogen O
detection O: 0.000127
detection O
( I-GENE: 0.006014
( O: 0.014858
( O
LC I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
CLND I-GENE
). O: 0.002228
). O

These O: 0.000979
These O
disorders O: 0.000104
disorders O
include O: 0.000107
include O
low I-GENE: 0.000146
low O: 0.000440
low O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
back O: 0.000032
back O
pain O: 0.000110
pain O
, I-GENE: 0.001923
, O: 0.035091
, O
saddle I-GENE
anesthesia O: 0.000043
anesthesia O
, I-GENE: 0.001923
, O: 0.035091
, O
bilateral O: 0.000038
bilateral O
sciatica I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
then O: 0.000154
then O
motor O: 0.000087
motor O
weakness I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
lower O: 0.000298
lower O
extremities I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
chronic O: 0.000304
chronic O
paraplegia I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
, I-GENE: 0.001923
, O: 0.035091
, O
bladder O: 0.000052
bladder O
dysfunction O: 0.000041
dysfunction O
. I-GENE: 0.004017
. O: 0.044459
. O

C I-GENE: 0.005113
C O: 0.001005
C I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
elegans I-GENE: 0.000122
elegans O: 0.000052
elegans I-GENE
embryogenesis O: 0.000017
embryogenesis O
begins O: 0.000020
begins O
with O: 0.009756
with O
a I-GENE: 0.000317
a O: 0.015893
a O
stereotyped I-GENE
sequence I-GENE: 0.002021
sequence O: 0.001866
sequence I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
asymmetric O: 0.000014
asymmetric O
cell I-GENE: 0.001144
cell O: 0.001927
cell O
divisions I-GENE
that O: 0.008362
that O
are O: 0.002918
are O
largely O: 0.000043
largely O
responsible O: 0.000142
responsible O
for O: 0.006951
for O
establishing I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
nematode O: 0.000014
nematode O
body O: 0.000240
body O
plan I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Additionally O: 0.000029
Additionally O
, I-GENE: 0.001923
, O: 0.035091
, O
a I-GENE: 0.000317
a O: 0.015893
a O
CaCO3 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
CO2 O: 0.000081
CO2 O
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
N2 O: 0.000032
N2 O
buffered I-GENE
solution O: 0.000113
solution O
was O: 0.006960
was O
necessary O: 0.000183
necessary O
to I-GENE: 0.000195
to O: 0.014977
to O
maintain O: 0.000058
maintain O
a I-GENE: 0.000317
a O: 0.015893
a O
pH O: 0.000116
pH O
of I-GENE: 0.002337
of O: 0.042520
of O
8 I-GENE: 0.000803
8 O: 0.000939
8 O
. I-GENE: 0.004017
. O: 0.044459
. O

Mss4 I-GENE
also O: 0.001373
also O
acts O: 0.000090
acts O
as O: 0.003654
as O
a I-GENE: 0.000317
a O: 0.015893
a O
relatively O: 0.000099
relatively O
inefficient O: 0.000014
inefficient O
guanine I-GENE: 0.000317
guanine O: 0.000032
guanine I-GENE
nucleotide I-GENE: 0.000317
nucleotide O: 0.000310
nucleotide I-GENE
exchange I-GENE: 0.000317
exchange O: 0.000058
exchange I-GENE
factor I-GENE: 0.008984
factor O: 0.000510
factor I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
GEF I-GENE
). O: 0.002228
). O

Effects O: 0.000116
Effects O
of I-GENE: 0.002337
of O: 0.042520
of O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
' I-GENE: 0.000950
' O: 0.001701
' O
terminus I-GENE: 0.000170
terminus O: 0.000278
terminus O
modifications O: 0.000020
modifications O
on O: 0.003416
on O
mRNA I-GENE: 0.003530
mRNA O: 0.000475
mRNA I-GENE
functional O: 0.000403
functional O
decay O: 0.000043
decay O
during O: 0.001095
during O
in I-GENE: 0.000536
in O: 0.023304
in O
vitro O: 0.000640
vitro O
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
synthesis O: 0.000275
synthesis O
. I-GENE: 0.004017
. O: 0.044459
. O

Disciplinary I-GENE
action O: 0.000177
action O
for O: 0.006951
for O
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
violation I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

This O: 0.000927
This O
is O: 0.006803
is O
necessary O: 0.000183
necessary O
if O: 0.000127
if O
psychiatric O: 0.000020
psychiatric O
diagnoses I-GENE
are O: 0.002918
are O
ultimately I-GENE
going I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
be O: 0.002370
be O
refined I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
validated I-GENE
against O: 0.000255
against O
biological O: 0.000125
biological O
criteria O: 0.000075
criteria O
. I-GENE: 0.004017
. O: 0.044459
. O

We O: 0.001417
We O
also O: 0.001373
also O
demonstrate O: 0.000290
demonstrate O
that O: 0.008362
that O
the I-GENE: 0.000268
the O: 0.044902
the O
spo20 I-GENE
(+) I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
product I-GENE: 0.001217
product O: 0.000151
product I-GENE
is O: 0.006803
is O
structurally O: 0.000049
structurally O
homologous I-GENE: 0.000219
homologous O: 0.000267
homologous O
to I-GENE: 0.000195
to O: 0.014977
to O
Saccharomyces I-GENE: 0.000487
Saccharomyces O: 0.000168
Saccharomyces I-GENE
cerevisiae I-GENE: 0.000706
cerevisiae O: 0.000214
cerevisiae I-GENE
Sec14 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
major I-GENE: 0.000341
major O: 0.000333
major I-GENE
phosphatidylinositol I-GENE: 0.000463
phosphatidylinositol I-GENE
transfer I-GENE: 0.000170
transfer O: 0.000099
transfer I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
budding O: 0.000029
budding O
yeast I-GENE: 0.001242
yeast O: 0.000498
yeast I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
addition O: 0.000420
addition O
, I-GENE: 0.001923
, O: 0.035091
, O
another O: 0.000113
another O
derivative O: 0.000043
derivative O
of I-GENE: 0.002337
of O: 0.042520
of O
pCMVJS21 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
pCMVJS21DeltaGP I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
in I-GENE: 0.000536
in O: 0.023304
in O
which O: 0.002472
which O
the I-GENE: 0.000268
the O: 0.044902
the O
gag I-GENE: 0.000268
gag I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
pol I-GENE: 0.000365
pol I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
and I-GENE: 0.003263
and O: 0.028529
and O
orf I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
x O: 0.000200
x O
) I-GENE: 0.005210
) O: 0.009341
) O
coding I-GENE: 0.000243
coding O: 0.000301
coding O
sequences I-GENE: 0.001290
sequences O: 0.000947
sequences I-GENE
were O: 0.005244
were O
deleted O: 0.000087
deleted O
also O: 0.001373
also O
gave O: 0.000052
gave O
transformed O: 0.000174
transformed O
foci I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

It O: 0.000313
It O
is O: 0.006803
is O
shown O: 0.000504
shown O
that O: 0.008362
that O
, I-GENE: 0.001923
, O: 0.035091
, O
for O: 0.006951
for O
any O: 0.000264
any O
periodic O: 0.000017
periodic O
input O: 0.000041
input O
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
map O: 0.000075
map O
representing O: 0.000023
representing O
the I-GENE: 0.000268
the O: 0.044902
the O
relation O: 0.000075
relation O
between O: 0.001394
between O
input O: 0.000041
input O
phases O: 0.000029
phases O
at O: 0.002976
at O
consecutive O: 0.000067
consecutive O
discharge O: 0.000017
discharge O
times O: 0.000203
times O
can O: 0.000924
can O
be O: 0.002370
be O
restricted O: 0.000099
restricted O
to I-GENE: 0.000195
to O: 0.014977
to O
a I-GENE: 0.000317
a O: 0.015893
a O
piecewise I-GENE
continuous O: 0.000075
continuous O
, I-GENE: 0.001923
, O: 0.035091
, O
orientation O: 0.000078
orientation O
preserving I-GENE
circle I-GENE
map O: 0.000075
map O
. I-GENE: 0.004017
. O: 0.044459
. O

Decreased I-GENE
serum I-GENE: 0.002070
serum O: 0.000536
serum I-GENE
ceruloplasmin I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
copper O: 0.000035
copper O
levels O: 0.001304
levels O
in I-GENE: 0.000536
in O: 0.023304
in O
cervical O: 0.000081
cervical O
dystonia I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Northern O: 0.000127
Northern O
blot O: 0.000145
blot O
analysis O: 0.001194
analysis O
of I-GENE: 0.002337
of O: 0.042520
of O
RNAs I-GENE: 0.000122
RNAs O: 0.000072
RNAs I-GENE
from I-GENE: 0.000390
from O: 0.004210
from O
a I-GENE: 0.000317
a O: 0.015893
a O
number O: 0.000362
number O
of I-GENE: 0.002337
of O: 0.042520
of O
mouse I-GENE: 0.001680
mouse O: 0.000403
mouse I-GENE
tissues O: 0.000235
tissues O
reveals O: 0.000145
reveals O
that O: 0.008362
that O
Atp6i I-GENE
is O: 0.006803
is O
expressed O: 0.000840
expressed O
predominantly O: 0.000058
predominantly O
in I-GENE: 0.000536
in O: 0.023304
in O
osteoclasts I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
this O: 0.001976
this O
predominant O: 0.000032
predominant O
expression O: 0.002231
expression O
was O: 0.006960
was O
confirmed O: 0.000139
confirmed O
by O: 0.006887
by O
reverse I-GENE: 0.000219
reverse O: 0.000067
reverse I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
polymerase I-GENE: 0.002094
polymerase O: 0.000099
polymerase I-GENE
chain I-GENE: 0.001315
chain O: 0.000177
chain I-GENE
reaction O: 0.000235
reaction O
( I-GENE: 0.006014
( O: 0.014858
( O
RT I-GENE: 0.000146
RT O: 0.000052
RT I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
PCR O: 0.000148
PCR O
) I-GENE: 0.005210
) O: 0.009341
) O
assay O: 0.000235
assay O
and I-GENE: 0.003263
and O: 0.028529
and O
immunohistochemical O: 0.000014
immunohistochemical O
analysis O: 0.001194
analysis O
. I-GENE: 0.004017
. O: 0.044459
. O

Behavioural I-GENE
tests O: 0.000148
tests O
with O: 0.009756
with O
192 I-GENE
specimen I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
roman I-GENE
garden I-GENE
snail I-GENE
Helix I-GENE
pomatia I-GENE
L I-GENE: 0.000779
L O: 0.000316
L I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
were O: 0.005244
were O
performed O: 0.000351
performed O
in I-GENE: 0.000536
in O: 0.023304
in O
order O: 0.000206
order O
to I-GENE: 0.000195
to O: 0.014977
to O
clarify O: 0.000014
clarify O
whether O: 0.000220
whether O
the I-GENE: 0.000268
the O: 0.044902
the O
thermopreferendum I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
this O: 0.001976
this O
pulmonate I-GENE
is O: 0.006803
is O
influenced O: 0.000038
influenced O
not O: 0.002509
not O
only O: 0.000794
only O
by O: 0.006887
by O
the I-GENE: 0.000268
the O: 0.044902
the O
temperature O: 0.000212
temperature O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
substratum I-GENE
but O: 0.001675
but O
also O: 0.001373
also O
by O: 0.006887
by O
air O: 0.000052
air O
temperature O: 0.000212
temperature O
. I-GENE: 0.004017
. O: 0.044459
. O

As O: 0.000162
As O
well O: 0.000626
well O
, I-GENE: 0.001923
, O: 0.035091
, O
IFN I-GENE: 0.001071
IFN I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
gamma I-GENE: 0.002240
gamma O: 0.000081
gamma I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
induced O: 0.001176
induced O
expression O: 0.002231
expression O
of I-GENE: 0.002337
of O: 0.042520
of O
IRF I-GENE: 0.000755
IRF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
its O: 0.001020
its O
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
IRF I-GENE: 0.000755
IRF I-GENE
element I-GENE: 0.001680
element O: 0.000577
element I-GENE
is O: 0.006803
is O
inhibited O: 0.000220
inhibited O
. I-GENE: 0.004017
. O: 0.044459
. O

Baseline I-GENE
BMD O: 0.000026
BMD O
values O: 0.000339
values O
were O: 0.005244
were O
significantly O: 0.000733
significantly O
lower O: 0.000298
lower O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
oligo I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
amenorrheic I-GENE
group I-GENE: 0.000414
group O: 0.000869
group O
than O: 0.001657
than O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
two O: 0.001904
two O
others O: 0.000041
others O
at O: 0.002976
at O
the I-GENE: 0.000268
the O: 0.044902
the O
level O: 0.000626
level O
of I-GENE: 0.002337
of O: 0.042520
of O
lumbar O: 0.000014
lumbar O
spine O: 0.000026
spine O
( I-GENE: 0.006014
( O: 0.014858
( O
anteroposterior O: 0.000014
anteroposterior O
view O: 0.000052
view O
: I-GENE: 0.000243
: O: 0.002561
: O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
941 I-GENE
+/- O: 0.001124
+/- O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
039 I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
oligo I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
amenorrheic I-GENE
vs O: 0.000159
vs O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
077 I-GENE
+/- O: 0.001124
+/- O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
029 I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
051 I-GENE
+/- O: 0.001124
+/- O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
017 I-GENE
g O: 0.000307
g O
x O: 0.000200
x O
cm O: 0.000070
cm O
(- O: 0.000223
(- O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
), O: 0.002269
), O
P I-GENE: 0.001023
P O: 0.000614
P I-GENE
< O: 0.000455
< O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
005 O: 0.000023
005 O
, I-GENE: 0.001923
, O: 0.035091
, O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
eumenorrheic I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
contraceptive I-GENE
user I-GENE
groups O: 0.000374
groups O
, I-GENE: 0.001923
, O: 0.035091
, O
respectively O: 0.000658
respectively O
) I-GENE: 0.005210
) O: 0.009341
) O
but O: 0.001675
but O
not O: 0.002509
not O
in I-GENE: 0.000536
in O: 0.023304
in O
weight O: 0.000226
weight O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
bearing O: 0.000058
bearing O
bone I-GENE: 0.000219
bone O: 0.000296
bone O
such O: 0.000435
such O
as O: 0.003654
as O
proximal I-GENE: 0.000170
proximal O: 0.000165
proximal I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
midshaft I-GENE
femur O: 0.000020
femur O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
glucose I-GENE: 0.000170
glucose O: 0.000171
glucose O
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
insulin I-GENE: 0.002240
insulin I-GENE
stimulation O: 0.000293
stimulation O
was O: 0.006960
was O
inhibited O: 0.000220
inhibited O
by O: 0.006887
by O
the I-GENE: 0.000268
the O: 0.044902
the O
addition O: 0.000420
addition O
of I-GENE: 0.002337
of O: 0.042520
of O
polyunsaturated I-GENE
fatty I-GENE: 0.000219
fatty O: 0.000072
fatty I-GENE
acids O: 0.000420
acids O
. I-GENE: 0.004017
. O: 0.044459
. O

We O: 0.001417
We O
report O: 0.000304
report O
the I-GENE: 0.000268
the O: 0.044902
the O
results O: 0.001162
results O
of I-GENE: 0.002337
of O: 0.042520
of O
a I-GENE: 0.000317
a O: 0.015893
a O
detailed O: 0.000038
detailed O
policy I-GENE
analysis O: 0.001194
analysis O
comparing O: 0.000046
comparing O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
CJD I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
related I-GENE: 0.001266
related O: 0.000597
related I-GENE
decisions I-GENE
: I-GENE: 0.000243
: O: 0.002561
: O
a I-GENE: 0.000317
a O: 0.015893
a O
1995 O: 0.000026
1995 O
recall I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
blood O: 0.000884
blood O
from I-GENE: 0.000390
from O: 0.004210
from O
a I-GENE: 0.000317
a O: 0.015893
a O
donor O: 0.000043
donor O
with O: 0.009756
with O
classic I-GENE
CJD I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
1999 I-GENE
decision I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
defer I-GENE
donations I-GENE
from I-GENE: 0.000390
from O: 0.004210
from O
individuals O: 0.000087
individuals O
with O: 0.009756
with O
a I-GENE: 0.000317
a O: 0.015893
a O
6 I-GENE: 0.002118
6 O: 0.001153
6 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
month O: 0.000067
month O
travel I-GENE
history O: 0.000104
history O
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
UK I-GENE
between O: 0.001394
between O
1980 O: 0.000020
1980 O
and I-GENE: 0.003263
and O: 0.028529
and O
1996 O: 0.000017
1996 O
due O: 0.000261
due O
to I-GENE: 0.000195
to O: 0.014977
to O
concerns I-GENE
related I-GENE: 0.001266
related O: 0.000597
related I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
variant I-GENE: 0.000268
variant O: 0.000075
variant I-GENE
CJD I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
' I-GENE: 0.000950
' O: 0.001701
' O
flanking I-GENE: 0.000219
flanking O: 0.000272
flanking O
sequence I-GENE: 0.002021
sequence O: 0.001866
sequence I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
3B I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
is O: 0.006803
is O
extremely O: 0.000049
extremely O
A I-GENE: 0.003530
A O: 0.002246
A I-GENE
+ I-GENE: 0.001023
+ O: 0.000487
+ I-GENE
T I-GENE: 0.001558
T O: 0.000548
T I-GENE
rich I-GENE: 0.000195
rich O: 0.000278
rich O
but O: 0.001675
but O
contains O: 0.000548
contains O
five O: 0.000290
five O
G I-GENE: 0.001826
G O: 0.000200
G I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
C I-GENE: 0.005113
C O: 0.001005
C I-GENE
rich I-GENE: 0.000195
rich O: 0.000278
rich O
stretches O: 0.000020
stretches O
, I-GENE: 0.001923
, O: 0.035091
, O
each O: 0.000475
each O
approximately O: 0.000307
approximately O
7bp I-GENE
long I-GENE: 0.000243
long O: 0.000325
long O
, I-GENE: 0.001923
, O: 0.035091
, O
which O: 0.002472
which O
have O: 0.001788
have O
strong O: 0.000156
strong O
sequence I-GENE: 0.002021
sequence O: 0.001866
sequence I-GENE
similarity O: 0.000174
similarity O
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
G I-GENE: 0.001826
G O: 0.000200
G I-GENE
boxes O: 0.000075
boxes O
found O: 0.001026
found O
upstream I-GENE: 0.000414
upstream O: 0.000493
upstream O
of I-GENE: 0.002337
of O: 0.042520
of O
other O: 0.000994
other O
developmentally O: 0.000026
developmentally O
regulated I-GENE: 0.000268
regulated O: 0.000368
regulated O
Dictyostelium O: 0.000017
Dictyostelium O
genes I-GENE: 0.004626
genes O: 0.000918
genes I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

PACAP I-GENE
mRNA I-GENE: 0.003530
mRNA O: 0.000475
mRNA I-GENE
was O: 0.006960
was O
widely O: 0.000052
widely O
expressed O: 0.000840
expressed O
in I-GENE: 0.000536
in O: 0.023304
in O
most O: 0.000400
most O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
tissues O: 0.000235
tissues O
; I-GENE: 0.000170
; O: 0.001399
; O
in I-GENE: 0.000536
in O: 0.023304
in O
transfected O: 0.000185
transfected O
cells O: 0.002663
cells O
, I-GENE: 0.001923
, O: 0.035091
, O
PACAP I-GENE
was O: 0.006960
was O
diffusely I-GENE
expressed O: 0.000840
expressed O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
cytoplasm O: 0.000052
cytoplasm O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
proportion O: 0.000046
proportion O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
biopsies O: 0.000026
biopsies O
found O: 0.001026
found O
to I-GENE: 0.000195
to O: 0.014977
to O
be O: 0.002370
be O
seropositive O: 0.000026
seropositive O
for O: 0.006951
for O
HBs I-GENE: 0.000268
HBs I-GENE
antigen I-GENE: 0.001437
antigen O: 0.000046
antigen I-GENE
was O: 0.006960
was O
27 O: 0.000125
27 O
. I-GENE: 0.004017
. O: 0.044459
. O
9 I-GENE: 0.000268
9 O: 0.000681
9 O
%, O: 0.000296
%, O
and I-GENE: 0.003263
and O: 0.028529
and O
these O: 0.001478
these O
showed O: 0.000863
showed O
either O: 0.000452
either O
MGN I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
MPGN I-GENE
pattern O: 0.000226
pattern O
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
the I-GENE: 0.000268
the O: 0.044902
the O
present O: 0.000551
present O
study O: 0.001101
study O
, I-GENE: 0.001923
, O: 0.035091
, O
we O: 0.001382
we O
have O: 0.001788
have O
determined O: 0.000458
determined O
the I-GENE: 0.000268
the O: 0.044902
the O
ICBP90 I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
structure O: 0.000513
structure O
by O: 0.006887
by O
screening O: 0.000130
screening O
of I-GENE: 0.002337
of O: 0.042520
of O
a I-GENE: 0.000317
a O: 0.015893
a O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
placenta O: 0.000032
placenta O
genomic I-GENE: 0.000122
genomic O: 0.000333
genomic O
library O: 0.000206
library O
and I-GENE: 0.003263
and O: 0.028529
and O
PCR O: 0.000148
PCR O
analysis O: 0.001194
analysis O
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
the I-GENE: 0.000268
the O: 0.044902
the O
stable O: 0.000133
stable O
transfectants O: 0.000017
transfectants O
( I-GENE: 0.006014
( O: 0.014858
( O
BM3 I-GENE
cells O: 0.002663
cells O
) I-GENE: 0.005210
) O: 0.009341
) O
expressing O: 0.000151
expressing O
a I-GENE: 0.000317
a O: 0.015893
a O
mutant I-GENE: 0.002386
mutant O: 0.000385
mutant I-GENE
bacterial I-GENE: 0.000292
bacterial O: 0.000084
bacterial I-GENE
P450 I-GENE: 0.000122
P450 I-GENE
AA O: 0.000014
AA O
epoxygenase I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
F87V I-GENE
BM3 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
which O: 0.002472
which O
was O: 0.006960
was O
genetically O: 0.000023
genetically O
engineered O: 0.000020
engineered O
to I-GENE: 0.000195
to O: 0.014977
to O
metabolize I-GENE
arachidonic I-GENE
acid I-GENE: 0.001315
acid O: 0.000997
acid I-GENE
only O: 0.000794
only O
to I-GENE: 0.000195
to O: 0.014977
to O
14 I-GENE: 0.000243
14 O: 0.000336
14 O
, I-GENE: 0.001923
, O: 0.035091
, O
15 O: 0.000397
15 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
EET I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
AA O: 0.000014
AA O
did O: 0.000536
did O
not O: 0.002509
not O
induce O: 0.000090
induce O
apoptosis O: 0.000145
apoptosis O
and I-GENE: 0.003263
and O: 0.028529
and O
protected O: 0.000035
protected O
against O: 0.000255
against O
agonist O: 0.000101
agonist O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
induced O: 0.001176
induced O
apoptosis O: 0.000145
apoptosis O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
revitalization I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
surgery O: 0.000136
surgery O
for O: 0.006951
for O
Parkinson O: 0.000017
Parkinson O
' I-GENE: 0.000950
' O: 0.001701
' O
s I-GENE: 0.000243
s O: 0.000724
s O
disease O: 0.000632
disease O
( I-GENE: 0.006014
( O: 0.014858
( O
PD I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
has O: 0.001356
has O
fueled I-GENE
discussion O: 0.000026
discussion O
about O: 0.000278
about O
the I-GENE: 0.000268
the O: 0.044902
the O
best O: 0.000070
best O
methodology I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
define O: 0.000096
define O
the I-GENE: 0.000268
the O: 0.044902
the O
target I-GENE: 0.000146
target O: 0.000232
target O
. I-GENE: 0.004017
. O: 0.044459
. O

Foreigners I-GENE
return O: 0.000017
return O
. I-GENE: 0.004017
. O: 0.044459
. O

She I-GENE
drank I-GENE
alcohol O: 0.000061
alcohol O
once O: 0.000049
once O
or I-GENE: 0.000219
or O: 0.003321
or O
twice O: 0.000049
twice O
a I-GENE: 0.000317
a O: 0.015893
a O
week O: 0.000125
week O
and I-GENE: 0.003263
and O: 0.028529
and O
regularly I-GENE
took I-GENE
an O: 0.003112
an O
analgesic O: 0.000020
analgesic O
preparation O: 0.000061
preparation O
, I-GENE: 0.001923
, O: 0.035091
, O
containing I-GENE: 0.000414
containing O: 0.000837
containing O
aspirin O: 0.000023
aspirin O
and I-GENE: 0.003263
and O: 0.028529
and O
acetaminophen I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
for O: 0.006951
for O
alleviation I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
headaches I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
authors O: 0.000064
authors O
did O: 0.000536
did O
not O: 0.002509
not O
detect O: 0.000070
detect O
any O: 0.000264
any O
significant O: 0.000687
significant O
correlations O: 0.000049
correlations O
between O: 0.001394
between O
parameters O: 0.000145
parameters O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
lipids O: 0.000046
lipids O
of I-GENE: 0.002337
of O: 0.042520
of O
bone I-GENE: 0.000219
bone O: 0.000296
bone O
marrow O: 0.000104
marrow O
and I-GENE: 0.003263
and O: 0.028529
and O
leptin I-GENE: 0.000170
leptin I-GENE
levels O: 0.001304
levels O
in I-GENE: 0.000536
in O: 0.023304
in O
serum I-GENE: 0.002070
serum O: 0.000536
serum I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
bone I-GENE: 0.000219
bone O: 0.000296
bone O
marrow O: 0.000104
marrow O
. I-GENE: 0.004017
. O: 0.044459
. O

When O: 0.000183
When O
the I-GENE: 0.000268
the O: 0.044902
the O
blood O: 0.000884
blood O
clot I-GENE
is O: 0.006803
is O
formed O: 0.000104
formed O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
vitreous O: 0.000017
vitreous O
cavity O: 0.000029
cavity O
, I-GENE: 0.001923
, O: 0.035091
, O
intravitreal I-GENE
injection O: 0.000165
injection O
of I-GENE: 0.002337
of O: 0.042520
of O
t I-GENE: 0.000146
t O: 0.000075
t I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
PA I-GENE: 0.000122
PA O: 0.000017
PA I-GENE
can O: 0.000924
can O
convert I-GENE
plasminogen I-GENE: 0.000706
plasminogen I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
plasmin I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
remove I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
clot I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

When O: 0.000183
When O
this O: 0.001976
this O
CCAAT I-GENE: 0.000317
CCAAT O: 0.000052
CCAAT I-GENE
box I-GENE: 0.000901
box O: 0.000313
box I-GENE
was O: 0.006960
was O
inserted O: 0.000043
inserted O
into O: 0.000785
into O
a I-GENE: 0.000317
a O: 0.015893
a O
heterologous O: 0.000087
heterologous O
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
construct I-GENE: 0.000170
construct O: 0.000081
construct I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
OA I-GENE
induction O: 0.000284
induction O
was O: 0.006960
was O
dependent I-GENE: 0.001485
dependent O: 0.000800
dependent I-GENE
on O: 0.003416
on O
an O: 0.003112
an O
intact O: 0.000130
intact O
CCAAT I-GENE: 0.000317
CCAAT O: 0.000052
CCAAT I-GENE
box I-GENE: 0.000901
box O: 0.000313
box I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Encouraged I-GENE
by O: 0.006887
by O
a I-GENE: 0.000317
a O: 0.015893
a O
Dutch I-GENE
study O: 0.001101
study O
using O: 0.000979
using O
etidronate I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
fluoride O: 0.000017
fluoride O
in I-GENE: 0.000536
in O: 0.023304
in O
corticoid I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
induced O: 0.001176
induced O
osteoporosis I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
we O: 0.001382
we O
performed O: 0.000351
performed O
a I-GENE: 0.000317
a O: 0.015893
a O
pilot I-GENE
study O: 0.001101
study O
in I-GENE: 0.000536
in O: 0.023304
in O
33 O: 0.000116
33 O
men O: 0.000136
men O
with O: 0.009756
with O
severe O: 0.000183
severe O
established O: 0.000127
established O
primary O: 0.000281
primary O
osteoporosis I-GENE
giving O: 0.000035
giving O
cyclically I-GENE
etidronate I-GENE
for O: 0.006951
for O
14 I-GENE: 0.000243
14 O: 0.000336
14 O
days O: 0.000356
days O
followed O: 0.000165
followed O
by O: 0.006887
by O
fluoride O: 0.000017
fluoride O
plus O: 0.000127
plus O
calcium O: 0.000252
calcium O
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
vitamin I-GENE: 0.000122
vitamin O: 0.000133
vitamin O
D I-GENE: 0.000901
D O: 0.000232
D I-GENE
for O: 0.006951
for O
76 O: 0.000043
76 O
days O: 0.000356
days O
. I-GENE: 0.004017
. O: 0.044459
. O

Far I-GENE
Western O: 0.000046
Western O
blot O: 0.000145
blot O
analysis O: 0.001194
analysis O
suggested O: 0.000229
suggested O
that O: 0.008362
that O
the I-GENE: 0.000268
the O: 0.044902
the O
tandem O: 0.000049
tandem O
SH2 I-GENE: 0.001388
SH2 I-GENE
domains I-GENE: 0.000852
domains O: 0.000400
domains I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
SHP2 I-GENE
bind O: 0.000296
bind O
to I-GENE: 0.000195
to O: 0.014977
to O
Gab1 I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
a I-GENE: 0.000317
a O: 0.015893
a O
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
orientation O: 0.000078
orientation O
, I-GENE: 0.001923
, O: 0.035091
, O
in I-GENE: 0.000536
in O: 0.023304
in O
which O: 0.002472
which O
the I-GENE: 0.000268
the O: 0.044902
the O
N I-GENE: 0.001217
N O: 0.000614
N I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
SH2 I-GENE: 0.001388
SH2 I-GENE
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
binds O: 0.000293
binds O
to I-GENE: 0.000195
to O: 0.014977
to O
phosphotyrosine O: 0.000014
phosphotyrosine O
( I-GENE: 0.006014
( O: 0.014858
( O
Tyr O: 0.000043
Tyr O
( I-GENE: 0.006014
( O: 0.014858
( O
P I-GENE: 0.001023
P O: 0.000614
P I-GENE
))- I-GENE
627 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
C I-GENE: 0.005113
C O: 0.001005
C I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
SH2 I-GENE: 0.001388
SH2 I-GENE
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
binds O: 0.000293
binds O
to I-GENE: 0.000195
to O: 0.014977
to O
Tyr O: 0.000043
Tyr O
( I-GENE: 0.006014
( O: 0.014858
( O
P I-GENE: 0.001023
P O: 0.000614
P I-GENE
)- I-GENE: 0.000609
)- O: 0.000269
)- I-GENE
659 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Electrophoretic O: 0.000026
Electrophoretic O
mobility I-GENE: 0.000243
mobility O: 0.000148
mobility I-GENE
shift O: 0.000246
shift O
assays O: 0.000365
assays O
and I-GENE: 0.003263
and O: 0.028529
and O
coimmunoprecipitation I-GENE
studies O: 0.000678
studies O
suggest O: 0.000585
suggest O
that O: 0.008362
that O
homo I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
heterodimerization O: 0.000023
heterodimerization O
occurs O: 0.000119
occurs O
between O: 0.001394
between O
cKrox I-GENE
family I-GENE: 0.002922
family O: 0.000313
family I-GENE
members I-GENE: 0.000195
members O: 0.000229
members O
. I-GENE: 0.004017
. O: 0.044459
. O

Expression O: 0.000133
Expression O
of I-GENE: 0.002337
of O: 0.042520
of O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
RACK1 I-GENE
efficiently O: 0.000110
efficiently O
relieves I-GENE
E1A I-GENE: 0.000779
E1A I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
mediated O: 0.000475
mediated O
growth I-GENE: 0.002337
growth O: 0.000510
growth I-GENE
inhibition O: 0.000284
inhibition O
in I-GENE: 0.000536
in O: 0.023304
in O
HF7c I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
protects I-GENE
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
tumor I-GENE: 0.000487
tumor O: 0.000310
tumor I-GENE
cells O: 0.002663
cells O
from I-GENE: 0.000390
from O: 0.004210
from O
E1A I-GENE: 0.000779
E1A I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
induced O: 0.001176
induced O
apoptosis O: 0.000145
apoptosis O
. I-GENE: 0.004017
. O: 0.044459
. O

By O: 0.000113
By O
using O: 0.000979
using O
space O: 0.000049
space O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
discrete O: 0.000026
discrete O
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
continuous O: 0.000075
continuous O
metapopulation I-GENE
dynamic O: 0.000043
dynamic O
models O: 0.000070
models O
and I-GENE: 0.003263
and O: 0.028529
and O
computer O: 0.000032
computer O
simulations I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
we O: 0.001382
we O
show O: 0.000484
show O
that O: 0.008362
that O
there O: 0.000275
there O
can O: 0.000924
can O
be O: 0.002370
be O
two O: 0.001904
two O
principally I-GENE
different O: 0.000669
different O
regimes I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
metapopulation I-GENE
dynamics O: 0.000035
dynamics O
. I-GENE: 0.004017
. O: 0.044459
. O

Arterial I-GENE
blood O: 0.000884
blood O
gas O: 0.000101
gas O
tensions I-GENE
were O: 0.005244
were O
similar O: 0.000574
similar O
across O: 0.000052
across O
all O: 0.000762
all O
ventilation O: 0.000064
ventilation O
modes O: 0.000020
modes O
. I-GENE: 0.004017
. O: 0.044459
. O

Four O: 0.000041
Four O
casein I-GENE: 0.000365
casein I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
I I-GENE: 0.004602
I O: 0.000487
I I-GENE
isoforms I-GENE: 0.000560
isoforms O: 0.000078
isoforms I-GENE
are O: 0.002918
are O
differentially O: 0.000046
differentially O
partitioned I-GENE
between O: 0.001394
between O
nucleus O: 0.000154
nucleus O
and I-GENE: 0.003263
and O: 0.028529
and O
cytoplasm O: 0.000052
cytoplasm O
. I-GENE: 0.004017
. O: 0.044459
. O

CONCLUSION O: 0.000113
CONCLUSION O
: I-GENE: 0.000243
: O: 0.002561
: O
Extrusion I-GENE
cooking I-GENE
is O: 0.006803
is O
effective O: 0.000238
effective O
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
inactivation O: 0.000046
inactivation O
of I-GENE: 0.002337
of O: 0.042520
of O
DON I-GENE
but O: 0.001675
but O
is O: 0.006803
is O
of I-GENE: 0.002337
of O: 0.042520
of O
limited O: 0.000099
limited O
value O: 0.000191
value O
for O: 0.006951
for O
AFB1 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
even O: 0.000154
even O
if O: 0.000127
if O
metabisulphite I-GENE
is O: 0.006803
is O
added O: 0.000035
added O
. I-GENE: 0.004017
. O: 0.044459
. O

Also O: 0.000038
Also O
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
EWS I-GENE: 0.000195
EWS I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
stimulates O: 0.000067
stimulates O
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
mediated O: 0.000475
mediated O
by O: 0.006887
by O
the I-GENE: 0.000268
the O: 0.044902
the O
COOH O: 0.000078
COOH O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
terminal I-GENE: 0.001169
terminal O: 0.000884
terminal I-GENE
transactivation O: 0.000180
transactivation O
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
cofactor I-GENE: 0.000122
cofactor O: 0.000017
cofactor I-GENE
CREB I-GENE: 0.001096
CREB I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
CBP I-GENE: 0.000463
CBP I-GENE
). O: 0.002228
). O

HSF I-GENE: 0.000195
HSF I-GENE
binds O: 0.000293
binds O
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
as O: 0.003654
as O
a I-GENE: 0.000317
a O: 0.015893
a O
trimer I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
additional O: 0.000156
additional O
trimers I-GENE
can O: 0.000924
can O
bind O: 0.000296
bind O
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
co O: 0.000156
co O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
operatively I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Two O: 0.000246
Two O
cases O: 0.000458
cases O
with O: 0.009756
with O
marked O: 0.000127
marked O
chronic O: 0.000304
chronic O
arm O: 0.000070
arm O
lymphoedema I-GENE
reported O: 0.000278
reported O
major I-GENE: 0.000341
major O: 0.000333
major I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
persistent O: 0.000035
persistent O
improvements I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
arm O: 0.000070
arm O
volume O: 0.000203
volume O
for O: 0.006951
for O
at O: 0.002976
at O
least O: 0.000255
least O
12 I-GENE: 0.000292
12 O: 0.000539
12 O
months O: 0.000246
months O
after O: 0.001385
after O
treatment O: 0.000921
treatment O
with O: 0.009756
with O
HBO2 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Growth O: 0.000020
Growth O
hormone I-GENE: 0.001363
hormone O: 0.000107
hormone I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
insulin I-GENE: 0.002240
insulin I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
like I-GENE: 0.002143
like O: 0.000272
like I-GENE
growth I-GENE: 0.002337
growth O: 0.000510
growth I-GENE
factor I-GENE: 0.008984
factor O: 0.000510
factor I-GENE
I I-GENE: 0.004602
I O: 0.000487
I I-GENE
receptors I-GENE: 0.001753
receptors O: 0.000148
receptors I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
temporomandibular I-GENE
joint O: 0.000035
joint O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
rat I-GENE: 0.001607
rat O: 0.000409
rat I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Folate I-GENE
metabolism O: 0.000139
metabolism O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
malaria O: 0.000014
malaria O
parasite O: 0.000014
parasite O
Plasmodium I-GENE
falciparum O: 0.000014
falciparum O
is O: 0.006803
is O
an O: 0.003112
an O
essential O: 0.000351
essential O
activity O: 0.002295
activity O
for O: 0.006951
for O
cell I-GENE: 0.001144
cell O: 0.001927
cell O
growth I-GENE: 0.002337
growth O: 0.000510
growth I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
replication I-GENE: 0.000146
replication O: 0.000243
replication O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
target I-GENE: 0.000146
target O: 0.000232
target O
of I-GENE: 0.002337
of O: 0.042520
of O
an O: 0.003112
an O
important O: 0.000400
important O
class I-GENE: 0.000706
class O: 0.000148
class I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
therapeutic O: 0.000104
therapeutic O
agents O: 0.000180
agents O
in I-GENE: 0.000536
in O: 0.023304
in O
widespread I-GENE
use O: 0.000380
use O
. I-GENE: 0.004017
. O: 0.044459
. O

These O: 0.000979
These O
results O: 0.001162
results O
indicate O: 0.000438
indicate O
that O: 0.008362
that O
BACM I-GENE
has O: 0.001356
has O
antiplaque I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
stronger O: 0.000014
stronger O
antidegradation I-GENE
effects O: 0.000652
effects O
than O: 0.001657
than O
GLCM I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
mutation I-GENE: 0.000560
mutation O: 0.000296
mutation I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
C I-GENE: 0.005113
C O: 0.001005
C I-GENE
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
Rb I-GENE: 0.000317
Rb I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
L901Q I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
has O: 0.001356
has O
been O: 0.001229
been O
identified O: 0.000823
identified O
that O: 0.008362
that O
completely O: 0.000104
completely O
abolishes O: 0.000023
abolishes O
cdk4 I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
D1 I-GENE: 0.000511
D1 I-GENE
phosphorylation O: 0.000469
phosphorylation O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
isolated O: 0.000585
isolated O
C I-GENE: 0.005113
C O: 0.001005
C I-GENE
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Homo I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
oligomerisation I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
nuclear I-GENE: 0.001826
nuclear O: 0.000614
nuclear I-GENE
localisation I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
mouse I-GENE: 0.001680
mouse O: 0.000403
mouse I-GENE
histone I-GENE: 0.000536
histone I-GENE
deacetylase I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Energy I-GENE
expenditure O: 0.000026
expenditure O
was O: 0.006960
was O
obtained O: 0.000417
obtained O
using O: 0.000979
using O
a I-GENE: 0.000317
a O: 0.015893
a O
primed O: 0.000014
primed O
, I-GENE: 0.001923
, O: 0.035091
, O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
hour O: 0.000064
hour O
infusion O: 0.000127
infusion O
of I-GENE: 0.002337
of O: 0.042520
of O
NaH I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
13 O: 0.000348
13 O
) I-GENE: 0.005210
) O: 0.009341
) O
CO O: 0.000020
CO O
( I-GENE: 0.006014
( O: 0.014858
( O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
'), I-GENE
breath I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
13 O: 0.000348
13 O
) I-GENE: 0.005210
) O: 0.009341
) O
CO O: 0.000020
CO O
( I-GENE: 0.006014
( O: 0.014858
( O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
enrichment I-GENE
determination O: 0.000154
determination O
by O: 0.006887
by O
isotope I-GENE
ratio O: 0.000238
ratio O
mass O: 0.000197
mass O
spectroscopy O: 0.000032
spectroscopy O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
application O: 0.000081
application O
of I-GENE: 0.002337
of O: 0.042520
of O
a I-GENE: 0.000317
a O: 0.015893
a O
standard O: 0.000133
standard O
regression O: 0.000058
regression O
equation O: 0.000017
equation O
. I-GENE: 0.004017
. O: 0.044459
. O

Fasting I-GENE
gastrin I-GENE: 0.000195
gastrin I-GENE
levels O: 0.001304
levels O
( I-GENE: 0.006014
( O: 0.014858
( O
normal O: 0.000759
normal O
range O: 0.000229
range O
: I-GENE: 0.000243
: O: 0.002561
: O
25 O: 0.000252
25 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
110 O: 0.000023
110 O
mU I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
L I-GENE: 0.000779
L O: 0.000316
L I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
varied O: 0.000046
varied O
from I-GENE: 0.000390
from O: 0.004210
from O
48 O: 0.000081
48 O
. I-GENE: 0.004017
. O: 0.044459
. O
78 O: 0.000096
78 O
mU I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
L I-GENE: 0.000779
L O: 0.000316
L I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
168 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
20 I-GENE: 0.000146
20 O: 0.000484
20 O
( I-GENE: 0.006014
( O: 0.014858
( O
mean O: 0.000423
mean O
: I-GENE: 0.000243
: O: 0.002561
: O
85 O: 0.000084
85 O
. I-GENE: 0.004017
. O: 0.044459
. O
23 O: 0.000139
23 O
mU I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
L I-GENE: 0.000779
L O: 0.000316
L I-GENE
). O: 0.002228
). O

Identification O: 0.000084
Identification O
of I-GENE: 0.002337
of O: 0.042520
of O
pulmonary O: 0.000162
pulmonary O
vein O: 0.000081
vein O
stenosis O: 0.000035
stenosis O
after O: 0.001385
after O
radiofrequency I-GENE
ablation O: 0.000014
ablation O
for O: 0.006951
for O
atrial O: 0.000049
atrial O
fibrillation O: 0.000017
fibrillation O
using O: 0.000979
using O
MRI O: 0.000029
MRI O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
continuing I-GENE
development O: 0.000388
development O
of I-GENE: 0.002337
of O: 0.042520
of O
ligands O: 0.000029
ligands O
that O: 0.008362
that O
function O: 0.000855
function O
as O: 0.003654
as O
selective O: 0.000145
selective O
estrogens I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
antiestrogens I-GENE
for O: 0.006951
for O
ERalpha I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
ERbeta I-GENE
should O: 0.000171
should O
allow O: 0.000038
allow O
optimized I-GENE
tissue I-GENE: 0.000536
tissue O: 0.000388
tissue I-GENE
selectivity O: 0.000026
selectivity O
of I-GENE: 0.002337
of O: 0.042520
of O
these O: 0.001478
these O
agents O: 0.000180
agents O
for O: 0.006951
for O
menopausal I-GENE
hormone I-GENE: 0.001363
hormone O: 0.000107
hormone I-GENE
replacement O: 0.000084
replacement O
therapy O: 0.000351
therapy O
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
treatment O: 0.000921
treatment O
and I-GENE: 0.003263
and O: 0.028529
and O
prevention O: 0.000049
prevention O
of I-GENE: 0.002337
of O: 0.042520
of O
breast O: 0.000125
breast O
cancer O: 0.000284
cancer O
. I-GENE: 0.004017
. O: 0.044459
. O

Baseline I-GENE
variables O: 0.000058
variables O
associated I-GENE: 0.000755
associated O: 0.000716
associated I-GENE
with O: 0.009756
with O
CD O: 0.000032
CD O
included O: 0.000139
included O
a I-GENE: 0.000317
a O: 0.015893
a O
less O: 0.000724
less O
frequent O: 0.000043
frequent O
use O: 0.000380
use O
of I-GENE: 0.002337
of O: 0.042520
of O
prestroke I-GENE
aspirin O: 0.000023
aspirin O
and I-GENE: 0.003263
and O: 0.028529
and O
a I-GENE: 0.000317
a O: 0.015893
a O
higher O: 0.000469
higher O
incidence O: 0.000127
incidence O
of I-GENE: 0.002337
of O: 0.042520
of O
early I-GENE: 0.000706
early O: 0.000374
early I-GENE
CT O: 0.000090
CT O
changes O: 0.000466
changes O
of I-GENE: 0.002337
of O: 0.042520
of O
edema O: 0.000020
edema O
or I-GENE: 0.000219
or O: 0.003321
or O
mass O: 0.000197
mass O
effect O: 0.000866
effect O
or I-GENE: 0.000219
or O: 0.003321
or O
dense I-GENE
middle O: 0.000049
middle O
cerebral O: 0.000116
cerebral O
artery O: 0.000154
artery O
sign O: 0.000014
sign O
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
peculiar I-GENE
people O: 0.000023
people O
: I-GENE: 0.000243
: O: 0.002561
: O
" I-GENE: 0.000170
" O: 0.000449
" O
the I-GENE: 0.000268
the O: 0.044902
the O
physiological O: 0.000084
physiological O
aspects O: 0.000046
aspects O
of I-GENE: 0.002337
of O: 0.042520
of O
Mormonism I-GENE
1850 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1975 I-GENE
." I-GENE

SH2D1A I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
levels O: 0.001304
levels O
are O: 0.002918
are O
up O: 0.000336
up O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
regulated I-GENE: 0.000268
regulated O: 0.000368
regulated O
by O: 0.006887
by O
CD40 I-GENE: 0.000146
CD40 I-GENE
cross O: 0.000145
cross O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
linking O: 0.000061
linking O
and I-GENE: 0.003263
and O: 0.028529
and O
down O: 0.000084
down O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
regulated I-GENE: 0.000268
regulated O: 0.000368
regulated O
by O: 0.006887
by O
B I-GENE: 0.004066
B O: 0.000640
B I-GENE
cell I-GENE: 0.001144
cell O: 0.001927
cell O
receptor I-GENE: 0.006817
receptor O: 0.000258
receptor I-GENE
ligation O: 0.000058
ligation O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
Genescan I-GENE
program O: 0.000061
program O
predicted O: 0.000238
predicted O
an O: 0.003112
an O
open O: 0.000275
open O
reading I-GENE: 0.000122
reading O: 0.000267
reading O
frame I-GENE: 0.000122
frame O: 0.000220
frame O
of I-GENE: 0.002337
of O: 0.042520
of O
a I-GENE: 0.000317
a O: 0.015893
a O
novel O: 0.000385
novel O
, I-GENE: 0.001923
, O: 0.035091
, O
intron I-GENE: 0.000122
intron O: 0.000217
intron O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
less O: 0.000724
less O
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
adjacent O: 0.000142
adjacent O
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
B236 I-GENE
spot I-GENE
that O: 0.008362
that O
encodes O: 0.000371
encodes O
a I-GENE: 0.000317
a O: 0.015893
a O
putative O: 0.000348
putative O
493 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
amino I-GENE: 0.000560
amino O: 0.001116
amino O
acid I-GENE: 0.001315
acid O: 0.000997
acid I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
containing I-GENE: 0.000414
containing O: 0.000837
containing O
the I-GENE: 0.000268
the O: 0.044902
the O
SNAG I-GENE
repressor I-GENE: 0.000414
repressor O: 0.000099
repressor I-GENE
motif I-GENE: 0.000706
motif O: 0.000316
motif I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
NH2 I-GENE: 0.000122
NH2 O: 0.000075
NH2 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
terminal I-GENE: 0.001169
terminal O: 0.000884
terminal I-GENE
region I-GENE: 0.001583
region O: 0.001744
region O
and I-GENE: 0.003263
and O: 0.028529
and O
five O: 0.000290
five O
C2H2 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
type I-GENE: 0.003384
type O: 0.000884
type I-GENE
zinc I-GENE: 0.000560
zinc O: 0.000125
zinc I-GENE
finger I-GENE: 0.000584
finger O: 0.000090
finger I-GENE
motifs I-GENE: 0.000195
motifs O: 0.000214
motifs O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
COOH O: 0.000078
COOH O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
terminal I-GENE: 0.001169
terminal O: 0.000884
terminal I-GENE
half O: 0.000145
half O
. I-GENE: 0.004017
. O: 0.044459
. O

Under O: 0.000014
Under O
our O: 0.000252
our O
conditions O: 0.000261
conditions O
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
combination O: 0.000246
combination O
O3 I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
UV O: 0.000093
UV O
did O: 0.000536
did O
not O: 0.002509
not O
improve O: 0.000055
improve O
the I-GENE: 0.000268
the O: 0.044902
the O
degradation O: 0.000096
degradation O
rate O: 0.000522
rate O
obtained O: 0.000417
obtained O
by O: 0.006887
by O
ozonation I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
metabolic O: 0.000099
metabolic O
events O: 0.000139
events O
occurring O: 0.000061
occurring O
at O: 0.002976
at O
or I-GENE: 0.000219
or O: 0.003321
or O
near O: 0.000165
near O
that O: 0.008362
that O
structure O: 0.000513
structure O
and I-GENE: 0.003263
and O: 0.028529
and O
involving O: 0.000093
involving O
cyclin I-GENE: 0.001899
cyclin I-GENE
D3 O: 0.000049
D3 O
cause O: 0.000136
cause O
the I-GENE: 0.000268
the O: 0.044902
the O
translocation O: 0.000084
translocation O
of I-GENE: 0.002337
of O: 0.042520
of O
ICP0 I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
cytoplasm O: 0.000052
cytoplasm O
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
the I-GENE: 0.000268
the O: 0.044902
the O
single I-GENE: 0.000195
single O: 0.000582
single O
case O: 0.000220
case O
the I-GENE: 0.000268
the O: 0.044902
the O
restoration I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
a I-GENE: 0.000317
a O: 0.015893
a O
structured O: 0.000017
structured O
daily O: 0.000154
daily O
routine O: 0.000046
routine O
represents O: 0.000096
represents O
the I-GENE: 0.000268
the O: 0.044902
the O
presupposition I-GENE
for O: 0.006951
for O
a I-GENE: 0.000317
a O: 0.015893
a O
cognitive O: 0.000029
cognitive O
therapy O: 0.000351
therapy O
. I-GENE: 0.004017
. O: 0.044459
. O

Immunofluorescence I-GENE
studies O: 0.000678
studies O
in I-GENE: 0.000536
in O: 0.023304
in O
C2C12 O: 0.000014
C2C12 O
myotubes O: 0.000017
myotubes O
show O: 0.000484
show O
that O: 0.008362
that O
Smad2 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
MEF2A I-GENE
co O: 0.000156
co O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
localise I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
nucleus O: 0.000154
nucleus O
of I-GENE: 0.002337
of O: 0.042520
of O
multinuclear I-GENE
myotubes O: 0.000017
myotubes O
during O: 0.001095
during O
differentiation O: 0.000217
differentiation O
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
35 O: 0.000142
35 O
of I-GENE: 0.002337
of O: 0.042520
of O
those O: 0.000461
those O
patients O: 0.002538
patients O
DD I-GENE
was O: 0.006960
was O
measured O: 0.000400
measured O
also O: 0.001373
also O
with O: 0.009756
with O
microlatex I-GENE
tests O: 0.000148
tests O
-- O: 0.000301
-- O
Tinaquant I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
BC I-GENE
d I-GENE: 0.000122
d O: 0.000180
d O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
dimer O: 0.000038
dimer O
. I-GENE: 0.004017
. O: 0.044459
. O

Simulating I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
impact O: 0.000038
impact O
during O: 0.001095
during O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
jumping I-GENE
by O: 0.006887
by O
means O: 0.000110
means O
of I-GENE: 0.002337
of O: 0.042520
of O
a I-GENE: 0.000317
a O: 0.015893
a O
4 I-GENE: 0.002362
4 O: 0.001307
4 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
degrees O: 0.000180
degrees O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
freedom I-GENE
model O: 0.000327
model O
with O: 0.009756
with O
time O: 0.000542
time O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
dependent I-GENE: 0.001485
dependent O: 0.000800
dependent I-GENE
properties O: 0.000197
properties O
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
novel O: 0.000385
novel O
approach O: 0.000104
approach O
was O: 0.006960
was O
developed O: 0.000226
developed O
for O: 0.006951
for O
identifying O: 0.000017
identifying O
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
factor I-GENE: 0.008984
factor O: 0.000510
factor I-GENE
activities O: 0.000261
activities O
associated I-GENE: 0.000755
associated O: 0.000716
associated I-GENE
with O: 0.009756
with O
NGF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
activated I-GENE: 0.001412
activated O: 0.000356
activated I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
but O: 0.001675
but O
not O: 0.002509
not O
EGF I-GENE: 0.000779
EGF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
activated I-GENE: 0.001412
activated O: 0.000356
activated I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
signaling O: 0.000293
signaling O
, I-GENE: 0.001923
, O: 0.035091
, O
using O: 0.000979
using O
random O: 0.000038
random O
oligonucleotide O: 0.000064
oligonucleotide O
clones O: 0.000223
clones O
from I-GENE: 0.000390
from O: 0.004210
from O
a I-GENE: 0.000317
a O: 0.015893
a O
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
recognition I-GENE: 0.000292
recognition O: 0.000145
recognition I-GENE
library O: 0.000206
library O
to I-GENE: 0.000195
to O: 0.014977
to O
isolate O: 0.000055
isolate O
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
proteins I-GENE: 0.005673
proteins O: 0.000933
proteins I-GENE
from I-GENE: 0.000390
from O: 0.004210
from O
PC12 O: 0.000029
PC12 O
nuclear I-GENE: 0.001826
nuclear O: 0.000614
nuclear I-GENE
extracts O: 0.000229
extracts O
. I-GENE: 0.004017
. O: 0.044459
. O

Atheroma I-GENE
appears O: 0.000220
appears O
as O: 0.003654
as O
a I-GENE: 0.000317
a O: 0.015893
a O
very O: 0.000223
very O
low I-GENE: 0.000146
low O: 0.000440
low O
signal I-GENE: 0.000536
signal O: 0.000362
signal I-GENE
intensity O: 0.000084
intensity O
area O: 0.000180
area O
on O: 0.003416
on O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
dimensional O: 0.000058
dimensional O
time O: 0.000542
time O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
flight I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
TOF O: 0.000014
TOF O
) I-GENE: 0.005210
) O: 0.009341
) O
magnetic O: 0.000058
magnetic O
resonance O: 0.000055
resonance O
( I-GENE: 0.006014
( O: 0.014858
( O
MR O: 0.000029
MR O
) I-GENE: 0.005210
) O: 0.009341
) O
images O: 0.000041
images O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
its O: 0.001020
its O
components O: 0.000177
components O
have O: 0.001788
have O
various O: 0.000240
various O
signal I-GENE: 0.000536
signal O: 0.000362
signal I-GENE
intensities I-GENE
on O: 0.003416
on O
spin O: 0.000026
spin O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
echo O: 0.000014
echo O
( I-GENE: 0.006014
( O: 0.014858
( O
SE O: 0.000023
SE O
) I-GENE: 0.005210
) O: 0.009341
) O
images O: 0.000041
images O
. I-GENE: 0.004017
. O: 0.044459
. O

Finally O: 0.000061
Finally O
a I-GENE: 0.000317
a O: 0.015893
a O
10 I-GENE: 0.000292
10 O: 0.000936
10 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
nucleotide I-GENE: 0.000317
nucleotide O: 0.000310
nucleotide I-GENE
region I-GENE: 0.001583
region O: 0.001744
region O
flanking I-GENE: 0.000219
flanking O: 0.000272
flanking O
the I-GENE: 0.000268
the O: 0.044902
the O
exon O: 0.000339
exon O
4 I-GENE: 0.002362
4 O: 0.001307
4 I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
site I-GENE: 0.003092
site O: 0.001040
site I-GENE
is O: 0.006803
is O
homologous I-GENE: 0.000219
homologous O: 0.000267
homologous O
to I-GENE: 0.000195
to O: 0.014977
to O
instability I-GENE
elements I-GENE: 0.000414
elements O: 0.000493
elements O
within O: 0.000823
within O
five O: 0.000290
five O
other O: 0.000994
other O
transcripts I-GENE: 0.000852
transcripts O: 0.000188
transcripts I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
suggesting O: 0.000400
suggesting O
that O: 0.008362
that O
a I-GENE: 0.000317
a O: 0.015893
a O
common O: 0.000246
common O
coding I-GENE: 0.000243
coding O: 0.000301
coding O
region I-GENE: 0.001583
region O: 0.001744
region O
determinant O: 0.000029
determinant O
may O: 0.001078
may O
exist O: 0.000067
exist O
. I-GENE: 0.004017
. O: 0.044459
. O

Chronic O: 0.000032
Chronic O
nutritional O: 0.000020
nutritional O
diseases O: 0.000145
diseases O
of I-GENE: 0.002337
of O: 0.042520
of O
infectious O: 0.000035
infectious O
origin O: 0.000119
origin O
: I-GENE: 0.000243
: O: 0.002561
: O
an O: 0.003112
an O
assessment O: 0.000087
assessment O
of I-GENE: 0.002337
of O: 0.042520
of O
a I-GENE: 0.000317
a O: 0.015893
a O
nascent I-GENE
field O: 0.000139
field O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
cut I-GENE: 0.000122
cut O: 0.000020
cut I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
off O: 0.000032
off O
percentage O: 0.000052
percentage O
positivity I-GENE
value O: 0.000191
value O
was O: 0.006960
was O
established O: 0.000127
established O
using O: 0.000979
using O
500 O: 0.000061
500 O
brucellosis I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
positive O: 0.000411
positive O
and I-GENE: 0.003263
and O: 0.028529
and O
500 O: 0.000061
500 O
brucellosis I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
negative I-GENE: 0.000219
negative O: 0.000403
negative O
serum I-GENE: 0.002070
serum O: 0.000536
serum I-GENE
samples O: 0.000142
samples O
, I-GENE: 0.001923
, O: 0.035091
, O
confirmed O: 0.000139
confirmed O
with O: 0.009756
with O
reference O: 0.000075
reference O
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
sample O: 0.000087
sample O
data O: 0.000649
data O
using O: 0.000979
using O
the I-GENE: 0.000268
the O: 0.044902
the O
indirect O: 0.000032
indirect O
ELISA O: 0.000046
ELISA O
kit I-GENE: 0.000195
kit O: 0.000020
kit I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

PROCEDURE I-GENE
: I-GENE: 0.000243
: O: 0.002561
: O
Cannulas I-GENE
were O: 0.005244
were O
surgically O: 0.000014
surgically O
positioned O: 0.000029
positioned O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
abomasal I-GENE
body O: 0.000240
body O
and I-GENE: 0.003263
and O: 0.028529
and O
pyloric I-GENE
antrum I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
each O: 0.000475
each O
calf O: 0.000023
calf O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
utilities I-GENE
measured O: 0.000400
measured O
in I-GENE: 0.000536
in O: 0.023304
in O
our O: 0.000252
our O
study O: 0.001101
study O
can O: 0.000924
can O
be O: 0.002370
be O
applied O: 0.000061
applied O
directly O: 0.000171
directly O
to I-GENE: 0.000195
to O: 0.014977
to O
quality O: 0.000046
quality O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
life O: 0.000125
life O
determinations O: 0.000026
determinations O
in I-GENE: 0.000536
in O: 0.023304
in O
clinical O: 0.000417
clinical O
trials O: 0.000052
trials O
of I-GENE: 0.002337
of O: 0.042520
of O
adjuvant O: 0.000026
adjuvant O
IFN I-GENE: 0.001071
IFN I-GENE
alpha I-GENE: 0.009009
alpha O: 0.000313
alpha I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
2b I-GENE: 0.000268
2b I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
measure O: 0.000084
measure O
the I-GENE: 0.000268
the O: 0.044902
the O
net I-GENE
benefit O: 0.000020
benefit O
of I-GENE: 0.002337
of O: 0.042520
of O
therapy O: 0.000351
therapy O
. I-GENE: 0.004017
. O: 0.044459
. O

Cells I-GENE
lacking O: 0.000116
lacking O
p116 I-GENE
exhibit O: 0.000070
exhibit O
a I-GENE: 0.000317
a O: 0.015893
a O
striking O: 0.000046
striking O
defect O: 0.000075
defect O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
formation O: 0.000330
formation O
of I-GENE: 0.002337
of O: 0.042520
of O
these O: 0.001478
these O
macropinocytic I-GENE
structures O: 0.000107
structures O
, I-GENE: 0.001923
, O: 0.035091
, O
a I-GENE: 0.000317
a O: 0.015893
a O
concomitant O: 0.000032
concomitant O
reduction O: 0.000206
reduction O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
rate O: 0.000522
rate O
of I-GENE: 0.002337
of O: 0.042520
of O
fluid O: 0.000145
fluid O
phase O: 0.000417
phase O
pinocytosis I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
a I-GENE: 0.000317
a O: 0.015893
a O
significant O: 0.000687
significant O
decrease O: 0.000264
decrease O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
efficiency O: 0.000096
efficiency O
of I-GENE: 0.002337
of O: 0.042520
of O
chemotactic O: 0.000014
chemotactic O
aggregation O: 0.000029
aggregation O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
a I-GENE: 0.000317
a O: 0.015893
a O
decrease O: 0.000264
decrease O
in I-GENE: 0.000536
in O: 0.023304
in O
cellular I-GENE: 0.000243
cellular O: 0.000304
cellular O
F I-GENE: 0.000487
F O: 0.000142
F I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
actin I-GENE: 0.001217
actin I-GENE
content O: 0.000154
content O
. I-GENE: 0.004017
. O: 0.044459
. O

Ectopic I-GENE
expression O: 0.002231
expression O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
dominant I-GENE: 0.000243
dominant O: 0.000110
dominant I-GENE
mutant I-GENE: 0.002386
mutant O: 0.000385
mutant I-GENE
Lg3 I-GENE
allele I-GENE: 0.000292
allele O: 0.000043
allele I-GENE
is O: 0.006803
is O
believed O: 0.000041
believed O
to I-GENE: 0.000195
to O: 0.014977
to O
cause O: 0.000136
cause O
the I-GENE: 0.000268
the O: 0.044902
the O
phenotype O: 0.000159
phenotype O
. I-GENE: 0.004017
. O: 0.044459
. O

Specimen I-GENE
mass O: 0.000197
mass O
reduction O: 0.000206
reduction O
increased O: 0.000817
increased O
with O: 0.009756
with O
irradiance I-GENE
from I-GENE: 0.000390
from O: 0.004210
from O
19 I-GENE: 0.000146
19 O: 0.000226
19 O
to I-GENE: 0.000195
to O: 0.014977
to O
72 O: 0.000093
72 O
% O: 0.001741
% O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
initial O: 0.000154
initial O
mass O: 0.000197
mass O
for O: 0.006951
for O
9 I-GENE: 0.000268
9 O: 0.000681
9 O
-- O: 0.000301
-- O
31 O: 0.000145
31 O
W O: 0.000064
W O
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
cm O: 0.000070
cm O
( I-GENE: 0.006014
( O: 0.014858
( O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
), O: 0.002269
), O
respectively O: 0.000658
respectively O
. I-GENE: 0.004017
. O: 0.044459
. O

Analysis O: 0.000177
Analysis O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
genome O: 0.000217
genome O
sequence I-GENE: 0.002021
sequence O: 0.001866
sequence I-GENE
revealed O: 0.000643
revealed O
26 O: 0.000174
26 O
, I-GENE: 0.001923
, O: 0.035091
, O
588 I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
encoding I-GENE: 0.000414
encoding O: 0.000562
encoding O
transcripts I-GENE: 0.000852
transcripts O: 0.000188
transcripts I-GENE
for O: 0.006951
for O
which O: 0.002472
which O
there O: 0.000275
there O
was O: 0.006960
was O
strong O: 0.000156
strong O
corroborating I-GENE
evidence O: 0.000342
evidence O
and I-GENE: 0.003263
and O: 0.028529
and O
an O: 0.003112
an O
additional O: 0.000156
additional O
approximately O: 0.000307
approximately O
12 I-GENE: 0.000292
12 O: 0.000539
12 O
, I-GENE: 0.001923
, O: 0.035091
, O
000 O: 0.000159
000 O
computationally I-GENE
derived I-GENE: 0.000268
derived O: 0.000290
derived O
genes I-GENE: 0.004626
genes O: 0.000918
genes I-GENE
with O: 0.009756
with O
mouse I-GENE: 0.001680
mouse O: 0.000403
mouse I-GENE
matches O: 0.000014
matches O
or I-GENE: 0.000219
or O: 0.003321
or O
other O: 0.000994
other O
weak O: 0.000072
weak O
supporting O: 0.000020
supporting O
evidence O: 0.000342
evidence O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
other O: 0.000994
other O
inhibitor I-GENE: 0.000438
inhibitor O: 0.000238
inhibitor I-GENE
was O: 0.006960
was O
a I-GENE: 0.000317
a O: 0.015893
a O
single I-GENE: 0.000195
single O: 0.000582
single O
TAR I-GENE
decoy I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
driven O: 0.000061
driven O
by O: 0.006887
by O
the I-GENE: 0.000268
the O: 0.044902
the O
U6 I-GENE: 0.000414
U6 I-GENE
small I-GENE: 0.000682
small O: 0.000290
small I-GENE
nuclear I-GENE: 0.001826
nuclear O: 0.000614
nuclear I-GENE
RNA I-GENE: 0.003555
RNA O: 0.000591
RNA I-GENE
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
U6 I-GENE: 0.000414
U6 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
P I-GENE: 0.001023
P O: 0.000614
P I-GENE
). O: 0.002228
). O

By O: 0.000113
By O
comparison O: 0.000214
comparison O
, I-GENE: 0.001923
, O: 0.035091
, O
in I-GENE: 0.000536
in O: 0.023304
in O
nontumorigenic I-GENE
Ad5 I-GENE
cells O: 0.002663
cells O
, I-GENE: 0.001923
, O: 0.035091
, O
class I-GENE: 0.000706
class O: 0.000148
class I-GENE
I I-GENE: 0.004602
I O: 0.000487
I I-GENE
expression O: 0.002231
expression O
is O: 0.006803
is O
high I-GENE: 0.000341
high O: 0.000924
high O
due O: 0.000261
due O
to I-GENE: 0.000195
to O: 0.014977
to O
negligible I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
COUP I-GENE: 0.000365
COUP I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
TF I-GENE: 0.000219
TF I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
strong O: 0.000156
strong O
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
NF I-GENE: 0.002922
NF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
kappaB I-GENE: 0.001363
kappaB I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Moreover O: 0.000107
Moreover O
, I-GENE: 0.001923
, O: 0.035091
, O
a I-GENE: 0.000317
a O: 0.015893
a O
complex I-GENE: 0.001315
complex O: 0.000588
complex I-GENE
containing I-GENE: 0.000414
containing O: 0.000837
containing O
PTP I-GENE: 0.000170
PTP I-GENE
phi I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
paxillin I-GENE: 0.000219
paxillin I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
a I-GENE: 0.000317
a O: 0.015893
a O
paxillin I-GENE: 0.000219
paxillin I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
associated I-GENE: 0.000755
associated O: 0.000716
associated I-GENE
tyrosine I-GENE: 0.002021
tyrosine O: 0.000261
tyrosine I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
Pyk2 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
can O: 0.000924
can O
be O: 0.002370
be O
immunoprecipitated O: 0.000023
immunoprecipitated O
from I-GENE: 0.000390
from O: 0.004210
from O
macrophage I-GENE: 0.000243
macrophage O: 0.000017
macrophage I-GENE
lysates O: 0.000026
lysates O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
catalytic I-GENE: 0.000122
catalytic O: 0.000145
catalytic O
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
PTP I-GENE: 0.000170
PTP I-GENE
phi I-GENE
selectively O: 0.000084
selectively O
binds O: 0.000293
binds O
paxillin I-GENE: 0.000219
paxillin I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
Pyk2 I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
vitro O: 0.000640
vitro O
. I-GENE: 0.004017
. O: 0.044459
. O

Our O: 0.000235
Our O
previous O: 0.000110
previous O
studies O: 0.000678
studies O
have O: 0.001788
have O
shown O: 0.000504
shown O
that O: 0.008362
that O
SHP I-GENE: 0.000438
SHP I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
a I-GENE: 0.000317
a O: 0.015893
a O
SH2 I-GENE: 0.001388
SH2 I-GENE
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
containing I-GENE: 0.000414
containing O: 0.000837
containing O
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
tyrosine I-GENE: 0.002021
tyrosine O: 0.000261
tyrosine I-GENE
phosphatase I-GENE: 0.001583
phosphatase O: 0.000029
phosphatase I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
is O: 0.006803
is O
expressed O: 0.000840
expressed O
not O: 0.002509
not O
only O: 0.000794
only O
in I-GENE: 0.000536
in O: 0.023304
in O
cells O: 0.002663
cells O
of I-GENE: 0.002337
of O: 0.042520
of O
hematopoietic I-GENE: 0.000146
hematopoietic O: 0.000064
hematopoietic I-GENE
lineages O: 0.000023
lineages O
, I-GENE: 0.001923
, O: 0.035091
, O
but O: 0.001675
but O
also O: 0.001373
also O
in I-GENE: 0.000536
in O: 0.023304
in O
many O: 0.000180
many O
non I-GENE: 0.000292
non O: 0.000449
non O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
hematopoietic I-GENE: 0.000146
hematopoietic O: 0.000064
hematopoietic I-GENE
cells O: 0.002663
cells O
under O: 0.000351
under O
the I-GENE: 0.000268
the O: 0.044902
the O
control I-GENE: 0.000170
control O: 0.000834
control O
of I-GENE: 0.002337
of O: 0.042520
of O
an O: 0.003112
an O
alternative O: 0.000188
alternative O
tissue I-GENE: 0.000536
tissue O: 0.000388
tissue I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
P1 I-GENE: 0.000219
P1 O: 0.000075
P1 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Whereas O: 0.000026
Whereas O
Smad2 I-GENE
was O: 0.006960
was O
rapidly O: 0.000081
rapidly O
phosphorylated O: 0.000200
phosphorylated O
by O: 0.006887
by O
TGF I-GENE: 0.000998
TGF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
beta I-GENE: 0.007816
beta O: 0.000353
beta I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
involved O: 0.000539
involved O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
initial O: 0.000154
initial O
activation I-GENE: 0.000365
activation O: 0.001153
activation O
of I-GENE: 0.002337
of O: 0.042520
of O
Agc I-GENE
expression O: 0.002231
expression O
in I-GENE: 0.000536
in O: 0.023304
in O
confluent I-GENE
cells O: 0.002663
cells O
, I-GENE: 0.001923
, O: 0.035091
, O
Smad2 I-GENE
activation I-GENE: 0.000365
activation O: 0.001153
activation O
was O: 0.006960
was O
not O: 0.002509
not O
required O: 0.000591
required O
for O: 0.006951
for O
maintaining O: 0.000035
maintaining O
the I-GENE: 0.000268
the O: 0.044902
the O
high I-GENE: 0.000341
high O: 0.000924
high O
level O: 0.000626
level O
of I-GENE: 0.002337
of O: 0.042520
of O
Agc I-GENE
expression O: 0.002231
expression O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
astronaut I-GENE
crew I-GENE
operates I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
payload I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
documents I-GENE
its O: 0.001020
its O
operation O: 0.000067
operation O
. I-GENE: 0.004017
. O: 0.044459
. O

This O: 0.000927
This O
molecule I-GENE: 0.000170
molecule O: 0.000075
molecule I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
wH22xeGFP I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
consists O: 0.000093
consists O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
entire O: 0.000099
entire O
humanized I-GENE
anti I-GENE: 0.001704
anti O: 0.000087
anti I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
FcgammaRI I-GENE
mAb I-GENE: 0.000170
mAb I-GENE
H22 I-GENE
with O: 0.009756
with O
eGFP I-GENE
genetically O: 0.000023
genetically O
fused O: 0.000099
fused O
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
C I-GENE: 0.005113
C O: 0.001005
C I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
terminal I-GENE: 0.001169
terminal O: 0.000884
terminal I-GENE
end O: 0.000411
end O
of I-GENE: 0.002337
of O: 0.042520
of O
each O: 0.000475
each O
CH3 I-GENE
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
wH22xeGFP I-GENE
binds O: 0.000293
binds O
within O: 0.000823
within O
the I-GENE: 0.000268
the O: 0.044902
the O
ligand O: 0.000145
ligand O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
region I-GENE: 0.001583
region O: 0.001744
region O
by O: 0.006887
by O
its O: 0.001020
its O
Fc I-GENE: 0.000390
Fc I-GENE
end O: 0.000411
end O
, I-GENE: 0.001923
, O: 0.035091
, O
as O: 0.003654
as O
well O: 0.000626
well O
as O: 0.003654
as O
outside O: 0.000043
outside O
the I-GENE: 0.000268
the O: 0.044902
the O
ligand O: 0.000145
ligand O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
region I-GENE: 0.001583
region O: 0.001744
region O
by O: 0.006887
by O
its O: 0.001020
its O
Fab I-GENE
ends O: 0.000075
ends O
, I-GENE: 0.001923
, O: 0.035091
, O
thereby O: 0.000058
thereby O
cross O: 0.000145
cross O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
linking O: 0.000061
linking O
FcgammaRI I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

On O: 0.000142
On O
the I-GENE: 0.000268
the O: 0.044902
the O
other O: 0.000994
other O
hand O: 0.000061
hand O
, I-GENE: 0.001923
, O: 0.035091
, O
hepatic O: 0.000058
hepatic O
arterial O: 0.000174
arterial O
infusion O: 0.000127
infusion O
therapy O: 0.000351
therapy O
prolongs I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
survival O: 0.000197
survival O
of I-GENE: 0.002337
of O: 0.042520
of O
H3 I-GENE: 0.000146
H3 I-GENE
patients O: 0.002538
patients O
only O: 0.000794
only O
. I-GENE: 0.004017
. O: 0.044459
. O

Hepatitis O: 0.000023
Hepatitis O
B I-GENE: 0.004066
B O: 0.000640
B I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
C I-GENE: 0.005113
C O: 0.001005
C I-GENE
seroprevalence I-GENE
rates O: 0.000162
rates O
among O: 0.000304
among O
high I-GENE: 0.000341
high O: 0.000924
high O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
risk O: 0.000313
risk O
adolescents I-GENE
are O: 0.002918
are O
lower O: 0.000298
lower O
in I-GENE: 0.000536
in O: 0.023304
in O
El I-GENE
Paso I-GENE
than O: 0.001657
than O
in I-GENE: 0.000536
in O: 0.023304
in O
other O: 0.000994
other O
similar O: 0.000574
similar O
US O: 0.000023
US O
populations O: 0.000052
populations O
, I-GENE: 0.001923
, O: 0.035091
, O
presenting O: 0.000038
presenting O
an O: 0.003112
an O
ideal I-GENE
climate I-GENE
for O: 0.006951
for O
prevention O: 0.000049
prevention O
programs O: 0.000023
programs O
. I-GENE: 0.004017
. O: 0.044459
. O

We O: 0.001417
We O
found O: 0.001026
found O
that O: 0.008362
that O
the I-GENE: 0.000268
the O: 0.044902
the O
SOCS I-GENE
box I-GENE: 0.000901
box O: 0.000313
box I-GENE
interacted O: 0.000026
interacted O
with O: 0.009756
with O
Cullin I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
promoted O: 0.000017
promoted O
ubiquitination O: 0.000014
ubiquitination O
of I-GENE: 0.002337
of O: 0.042520
of O
TEL I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
JAK2 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
patient O: 0.000362
patient O
is O: 0.006803
is O
described O: 0.000232
described O
with O: 0.009756
with O
skin O: 0.000133
skin O
lesions O: 0.000200
lesions O
resembling O: 0.000023
resembling O
Kaposi O: 0.000014
Kaposi O
' I-GENE: 0.000950
' O: 0.001701
' O
s I-GENE: 0.000243
s O: 0.000724
s O
sarcoma I-GENE: 0.000122
sarcoma O: 0.000058
sarcoma I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
KS O: 0.000014
KS O
). O: 0.002228
). O

Special I-GENE
issues O: 0.000026
issues O
devoted I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
biosynthesis O: 0.000072
biosynthesis O
of I-GENE: 0.002337
of O: 0.042520
of O
woody I-GENE
plant O: 0.000084
plant O
biopolymers I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
related I-GENE: 0.001266
related O: 0.000597
related I-GENE
substances O: 0.000020
substances O
. I-GENE: 0.004017
. O: 0.044459
. O

These O: 0.000979
These O
data O: 0.000649
data O
suggest O: 0.000585
suggest O
that O: 0.008362
that O
ADAM I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
TS12 I-GENE
may O: 0.001078
may O
play O: 0.000162
play O
roles O: 0.000113
roles O
in I-GENE: 0.000536
in O: 0.023304
in O
pulmonary O: 0.000162
pulmonary O
cells O: 0.002663
cells O
during O: 0.001095
during O
fetal O: 0.000093
fetal O
development O: 0.000388
development O
or I-GENE: 0.000219
or O: 0.003321
or O
in I-GENE: 0.000536
in O: 0.023304
in O
tumor I-GENE: 0.000487
tumor O: 0.000310
tumor I-GENE
processes O: 0.000090
processes O
through O: 0.000403
through O
its O: 0.001020
its O
proteolytic O: 0.000046
proteolytic O
activity O: 0.002295
activity O
or I-GENE: 0.000219
or O: 0.003321
or O
as O: 0.003654
as O
a I-GENE: 0.000317
a O: 0.015893
a O
molecule I-GENE: 0.000170
molecule O: 0.000075
molecule I-GENE
potentially O: 0.000084
potentially O
involved O: 0.000539
involved O
in I-GENE: 0.000536
in O: 0.023304
in O
regulation O: 0.000553
regulation O
of I-GENE: 0.002337
of O: 0.042520
of O
cell I-GENE: 0.001144
cell O: 0.001927
cell O
adhesion I-GENE: 0.000170
adhesion O: 0.000078
adhesion I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Progressive I-GENE
study O: 0.001101
study O
and I-GENE: 0.003263
and O: 0.028529
and O
robustness I-GENE
test O: 0.000391
test O
of I-GENE: 0.002337
of O: 0.042520
of O
QSAR I-GENE
model O: 0.000327
model O
based O: 0.000287
based O
on O: 0.003416
on O
quantum I-GENE
chemical O: 0.000067
chemical O
parameters O: 0.000145
parameters O
for O: 0.006951
for O
predicting O: 0.000020
predicting O
BCF I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
selected O: 0.000139
selected O
polychlorinated I-GENE
organic O: 0.000032
organic O
compounds O: 0.000072
compounds O
( I-GENE: 0.006014
( O: 0.014858
( O
PCOCs I-GENE
). O: 0.002228
). O

Additional I-GENE
deletion I-GENE: 0.000195
deletion O: 0.000238
deletion O
mutations I-GENE: 0.000243
mutations O: 0.000435
mutations O
revealed O: 0.000643
revealed O
a I-GENE: 0.000317
a O: 0.015893
a O
new O: 0.000464
new O
, I-GENE: 0.001923
, O: 0.035091
, O
67 O: 0.000067
67 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
amino I-GENE: 0.000560
amino O: 0.001116
amino O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
acid I-GENE: 0.001315
acid O: 0.000997
acid I-GENE
functional O: 0.000403
functional O
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
within O: 0.000823
within O
the I-GENE: 0.000268
the O: 0.044902
the O
proline O: 0.000099
proline O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
rich I-GENE: 0.000195
rich O: 0.000278
rich O
region I-GENE: 0.001583
region O: 0.001744
region O
of I-GENE: 0.002337
of O: 0.042520
of O
SLP I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
76 O: 0.000043
76 O
, I-GENE: 0.001923
, O: 0.035091
, O
which O: 0.002472
which O
we O: 0.001382
we O
have O: 0.001788
have O
termed O: 0.000087
termed O
the I-GENE: 0.000268
the O: 0.044902
the O
P I-GENE: 0.001023
P O: 0.000614
P I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Patients O: 0.000078
Patients O
with O: 0.009756
with O
type I-GENE: 0.003384
type O: 0.000884
type I-GENE
III I-GENE: 0.001047
III O: 0.000148
III I-GENE
SOD I-GENE: 0.000195
SOD I-GENE
may O: 0.001078
may O
have O: 0.001788
have O
visceral O: 0.000020
visceral O
hyperalgesia I-GENE
; I-GENE: 0.000170
; O: 0.001399
; O
a I-GENE: 0.000317
a O: 0.015893
a O
trial O: 0.000087
trial O
of I-GENE: 0.002337
of O: 0.042520
of O
antidepressants I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
a I-GENE: 0.000317
a O: 0.015893
a O
therapeutic O: 0.000104
therapeutic O
trial O: 0.000087
trial O
with O: 0.009756
with O
botulinum I-GENE: 0.000146
botulinum I-GENE
toxin I-GENE: 0.000511
toxin I-GENE
injection O: 0.000165
injection O
into O: 0.000785
into O
the I-GENE: 0.000268
the O: 0.044902
the O
ampulla I-GENE
should O: 0.000171
should O
be O: 0.002370
be O
considered O: 0.000096
considered O
prior O: 0.000096
prior O
to I-GENE: 0.000195
to O: 0.014977
to O
more O: 0.000687
more O
invasive O: 0.000061
invasive O
endoscopic I-GENE
therapy O: 0.000351
therapy O
. I-GENE: 0.004017
. O: 0.044459
. O

We O: 0.001417
We O
have O: 0.001788
have O
now O: 0.000110
now O
tested O: 0.000275
tested O
all O: 0.000762
all O
known O: 0.000359
known O
mammalian I-GENE: 0.000925
mammalian O: 0.000168
mammalian I-GENE
Groucho I-GENE
family I-GENE: 0.002922
family O: 0.000313
family I-GENE
members I-GENE: 0.000195
members O: 0.000229
members O
for O: 0.006951
for O
their O: 0.000736
their O
ability O: 0.000290
ability O
to I-GENE: 0.000195
to O: 0.014977
to O
interact O: 0.000127
interact O
specifically O: 0.000206
specifically O
with O: 0.009756
with O
individual O: 0.000107
individual O
Tcf I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
Lef I-GENE
family I-GENE: 0.002922
family O: 0.000313
family I-GENE
members I-GENE: 0.000195
members O: 0.000229
members O
. I-GENE: 0.004017
. O: 0.044459
. O

Body I-GENE
weight O: 0.000226
weight O
reduction O: 0.000206
reduction O
increases O: 0.000156
increases O
insulin I-GENE: 0.002240
insulin I-GENE
sensitivity O: 0.000212
sensitivity O
and I-GENE: 0.003263
and O: 0.028529
and O
improves I-GENE
both O: 0.001631
both O
blood O: 0.000884
blood O
glucose I-GENE: 0.000170
glucose O: 0.000171
glucose O
and I-GENE: 0.003263
and O: 0.028529
and O
blood O: 0.000884
blood O
pressure O: 0.000432
pressure O
control I-GENE: 0.000170
control O: 0.000834
control O
. I-GENE: 0.004017
. O: 0.044459
. O

Sequence O: 0.000113
Sequence O
analysis O: 0.001194
analysis O
indicates O: 0.000156
indicates O
that O: 0.008362
that O
RBP21 I-GENE
shares O: 0.000064
shares O
homology I-GENE: 0.000487
homology O: 0.000327
homology I-GENE
with O: 0.009756
with O
other O: 0.000994
other O
retinoblastoma I-GENE: 0.000268
retinoblastoma I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
proteins I-GENE: 0.005673
proteins O: 0.000933
proteins I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
pRb I-GENE: 0.000219
pRb I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
motif I-GENE: 0.000706
motif O: 0.000316
motif I-GENE
LxCxE I-GENE
at O: 0.002976
at O
the I-GENE: 0.000268
the O: 0.044902
the O
C I-GENE: 0.005113
C O: 0.001005
C I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
terminal I-GENE: 0.001169
terminal O: 0.000884
terminal I-GENE
region I-GENE: 0.001583
region O: 0.001744
region O
. I-GENE: 0.004017
. O: 0.044459
. O

Tolerance I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
renal O: 0.000249
renal O
transplantation O: 0.000084
transplantation O
after O: 0.001385
after O
allogeneic I-GENE
bone I-GENE: 0.000219
bone O: 0.000296
bone O
marrow O: 0.000104
marrow O
transplantation O: 0.000084
transplantation O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
6 I-GENE: 0.002118
6 O: 0.001153
6 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
year O: 0.000191
year O
follow O: 0.000090
follow O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
up O: 0.000336
up O
. I-GENE: 0.004017
. O: 0.044459
. O

By O: 0.000113
By O
analyzing O: 0.000014
analyzing O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
'- I-GENE: 0.000414
'- O: 0.000481
'- O
deletion I-GENE: 0.000195
deletion O: 0.000238
deletion O
insulin I-GENE: 0.002240
insulin I-GENE
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
reporter I-GENE: 0.000828
reporter O: 0.000246
reporter I-GENE
constructs I-GENE: 0.000219
constructs O: 0.000148
constructs I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
transient O: 0.000185
transient O
transfections O: 0.000017
transfections O
of I-GENE: 0.002337
of O: 0.042520
of O
clonal I-GENE
INS I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
beta I-GENE: 0.007816
beta O: 0.000353
beta I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
cells O: 0.002663
cells O
, I-GENE: 0.001923
, O: 0.035091
, O
we O: 0.001382
we O
located O: 0.000452
located O
activating I-GENE: 0.000803
activating O: 0.000104
activating I-GENE
Hh I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
responsive I-GENE: 0.000414
responsive O: 0.000185
responsive I-GENE
regions I-GENE: 0.000243
regions O: 0.000501
regions O
within O: 0.000823
within O
the I-GENE: 0.000268
the O: 0.044902
the O
rat I-GENE: 0.001607
rat O: 0.000409
rat I-GENE
insulin I-GENE: 0.002240
insulin I-GENE
I I-GENE: 0.004602
I O: 0.000487
I I-GENE
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
that O: 0.008362
that O
include O: 0.000107
include O
the I-GENE: 0.000268
the O: 0.044902
the O
glucose I-GENE: 0.000170
glucose O: 0.000171
glucose O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
response I-GENE: 0.000779
response O: 0.000794
response O
elements I-GENE: 0.000414
elements O: 0.000493
elements O
Far I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
E2 I-GENE: 0.000852
E2 O: 0.000072
E2 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
Flat I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
A2 I-GENE: 0.000195
A2 I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
A3 I-GENE
). O: 0.002228
). O

However O: 0.000417
However O
, I-GENE: 0.001923
, O: 0.035091
, O
when O: 0.000690
when O
directed O: 0.000148
directed O
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
nucleosome I-GENE
by O: 0.006887
by O
fusion I-GENE: 0.000390
fusion O: 0.000255
fusion I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
core I-GENE: 0.000511
core O: 0.000148
core I-GENE
histone I-GENE: 0.000536
histone I-GENE
H2A I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
H2B I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
non I-GENE: 0.000292
non O: 0.000449
non O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
histone I-GENE: 0.000536
histone I-GENE
tail O: 0.000072
tail O
forms O: 0.000203
forms O
an O: 0.003112
an O
MCB I-GENE
that O: 0.008362
that O
appears O: 0.000220
appears O
identical O: 0.000301
identical O
to I-GENE: 0.000195
to O: 0.014977
to O
that O: 0.008362
that O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
endogenous I-GENE: 0.000292
endogenous O: 0.000127
endogenous I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Data O: 0.000020
Data O
were O: 0.005244
were O
obtained O: 0.000417
obtained O
from I-GENE: 0.000390
from O: 0.004210
from O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
undergraduate I-GENE
student I-GENE
samples O: 0.000142
samples O
, I-GENE: 0.001923
, O: 0.035091
, O
a I-GENE: 0.000317
a O: 0.015893
a O
self O: 0.000078
self O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
report O: 0.000304
report O
group I-GENE: 0.000414
group O: 0.000869
group O
( I-GENE: 0.006014
( O: 0.014858
( O
n O: 0.000264
n O
= O: 0.000855
= O
132 O: 0.000017
132 O
) I-GENE: 0.005210
) O: 0.009341
) O
who O: 0.000348
who O
provided O: 0.000096
provided O
NEO I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
PI I-GENE: 0.000414
PI O: 0.000017
PI I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
R I-GENE: 0.001023
R O: 0.000154
R I-GENE
self O: 0.000078
self O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
ratings I-GENE
on O: 0.003416
on O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
occasions I-GENE
separated O: 0.000078
separated O
by O: 0.006887
by O
a I-GENE: 0.000317
a O: 0.015893
a O
7 I-GENE: 0.000390
7 O: 0.000942
7 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
14 I-GENE: 0.000243
14 O: 0.000336
14 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
day O: 0.000394
day O
interval O: 0.000072
interval O
and I-GENE: 0.003263
and O: 0.028529
and O
an O: 0.003112
an O
informant I-GENE
group I-GENE: 0.000414
group O: 0.000869
group O
( I-GENE: 0.006014
( O: 0.014858
( O
n O: 0.000264
n O
= O: 0.000855
= O
109 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
who O: 0.000348
who O
provided O: 0.000096
provided O
ratings I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
well O: 0.000626
well O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
known O: 0.000359
known O
friends I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
relatives I-GENE
on O: 0.003416
on O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
occasions I-GENE
separated O: 0.000078
separated O
by O: 0.006887
by O
a I-GENE: 0.000317
a O: 0.015893
a O
6 I-GENE: 0.002118
6 O: 0.001153
6 I-GENE
month O: 0.000067
month O
interval O: 0.000072
interval O
. I-GENE: 0.004017
. O: 0.044459
. O

Pulmonary I-GENE
embolectomy I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
lung O: 0.000223
lung O
transplantation O: 0.000084
transplantation O
are O: 0.002918
are O
the I-GENE: 0.000268
the O: 0.044902
the O
main O: 0.000078
main O
indications I-GENE
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
use O: 0.000380
use O
of I-GENE: 0.002337
of O: 0.042520
of O
heart O: 0.000235
heart O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
lung O: 0.000223
lung O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
machine O: 0.000017
machine O
. I-GENE: 0.004017
. O: 0.044459
. O

Comparison O: 0.000116
Comparison O
of I-GENE: 0.002337
of O: 0.042520
of O
German I-GENE
language O: 0.000020
language O
versions I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
QWB I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
SA O: 0.000017
SA O
and I-GENE: 0.003263
and O: 0.028529
and O
SF I-GENE: 0.000341
SF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
36 O: 0.000072
36 O
evaluating O: 0.000023
evaluating O
outcomes O: 0.000017
outcomes O
for O: 0.006951
for O
patients O: 0.002538
patients O
with O: 0.009756
with O
prostate O: 0.000061
prostate O
disease O: 0.000632
disease O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
median O: 0.000075
median O
preoperative O: 0.000020
preoperative O
best O: 0.000070
best O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
corrected O: 0.000017
corrected O
visual O: 0.000116
visual O
acuity I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
08 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
range O: 0.000229
range O
hand O: 0.000061
hand O
motions I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
003 I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
4 I-GENE: 0.002362
4 O: 0.001307
4 I-GENE
), O: 0.002269
), O
improved O: 0.000084
improved O
by O: 0.006887
by O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
lines O: 0.000287
lines O
to I-GENE: 0.000195
to O: 0.014977
to O
a I-GENE: 0.000317
a O: 0.015893
a O
median O: 0.000075
median O
final O: 0.000035
final O
postoperative O: 0.000046
postoperative O
best O: 0.000070
best O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
corrected O: 0.000017
corrected O
visual O: 0.000116
visual O
acuity I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
25 O: 0.000252
25 O
( I-GENE: 0.006014
( O: 0.014858
( O
range O: 0.000229
range O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
025 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
( I-GENE: 0.006014
( O: 0.014858
( O
P I-GENE: 0.001023
P O: 0.000614
P I-GENE
= O: 0.000855
= O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
001 O: 0.000197
001 O
). O: 0.002228
). O

Angina I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
Q O: 0.000041
Q O
) I-GENE: 0.005210
) O: 0.009341
) O
persistence I-GENE
showed O: 0.000863
showed O
marked O: 0.000127
marked O
associations O: 0.000020
associations O
with O: 0.009756
with O
previous O: 0.000110
previous O
myocardial O: 0.000194
myocardial O
infarction O: 0.000099
infarction O
, I-GENE: 0.001923
, O: 0.035091
, O
diagnosed O: 0.000067
diagnosed O
angina O: 0.000032
angina O
, I-GENE: 0.001923
, O: 0.035091
, O
electrocardiogram O: 0.000014
electrocardiogram O
ischemia O: 0.000087
ischemia O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
subsequent O: 0.000093
subsequent O
major I-GENE: 0.000341
major O: 0.000333
major I-GENE
ischemic O: 0.000055
ischemic O
heart O: 0.000235
heart O
disease O: 0.000632
disease O
events O: 0.000139
events O
from I-GENE: 0.000390
from O: 0.004210
from O
Q5 I-GENE
onward I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Site O: 0.000026
Site O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
directed O: 0.000148
directed O
mutagenesis O: 0.000151
mutagenesis O
of I-GENE: 0.002337
of O: 0.042520
of O
CAR I-GENE
revealed O: 0.000643
revealed O
that O: 0.008362
that O
CAR I-GENE
residues I-GENE: 0.000146
residues O: 0.000426
residues O
Leu73 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
Lys121 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
Lys123 I-GENE
are O: 0.002918
are O
critical O: 0.000183
critical O
contact O: 0.000067
contact O
residues I-GENE: 0.000146
residues O: 0.000426
residues O
, I-GENE: 0.001923
, O: 0.035091
, O
with O: 0.009756
with O
Tyr80 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
Tyr83 I-GENE
being O: 0.000148
being O
peripherally I-GENE
involved O: 0.000539
involved O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
interaction I-GENE: 0.000122
interaction O: 0.000478
interaction O
with O: 0.009756
with O
the I-GENE: 0.000268
the O: 0.044902
the O
Ad5 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
Ad9 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
Ad12 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
Ad41L I-GENE
fiber O: 0.000043
fiber O
knobs I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Transforming I-GENE
growth I-GENE: 0.002337
growth O: 0.000510
growth I-GENE
factor I-GENE: 0.008984
factor O: 0.000510
factor I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
beta I-GENE: 0.007816
beta O: 0.000353
beta I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
TGF I-GENE: 0.000998
TGF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
beta I-GENE: 0.007816
beta O: 0.000353
beta I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
induced O: 0.001176
induced O
growth I-GENE: 0.002337
growth O: 0.000510
growth I-GENE
arrest O: 0.000084
arrest O
of I-GENE: 0.002337
of O: 0.042520
of O
cells O: 0.002663
cells O
involves O: 0.000084
involves O
regulation O: 0.000553
regulation O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
activities O: 0.000261
activities O
of I-GENE: 0.002337
of O: 0.042520
of O
both O: 0.001631
both O
D I-GENE: 0.000901
D O: 0.000232
D I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
E I-GENE: 0.001583
E O: 0.000301
E I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
type I-GENE: 0.003384
type O: 0.000884
type I-GENE
cyclin I-GENE: 0.001899
cyclin I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
complexes I-GENE: 0.000487
complexes O: 0.000261
complexes I-GENE
thought O: 0.000041
thought O
to I-GENE: 0.000195
to O: 0.014977
to O
be O: 0.002370
be O
mediated O: 0.000475
mediated O
primarily O: 0.000093
primarily O
by O: 0.006887
by O
the I-GENE: 0.000268
the O: 0.044902
the O
regulation O: 0.000553
regulation O
of I-GENE: 0.002337
of O: 0.042520
of O
p15 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
Ink4b I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
p27 I-GENE: 0.000146
p27 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
Kip1 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
cyclin I-GENE: 0.001899
cyclin I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
inhibitors O: 0.000162
inhibitors O
. I-GENE: 0.004017
. O: 0.044459
. O

These O: 0.000979
These O
data O: 0.000649
data O
indicate O: 0.000438
indicate O
that O: 0.008362
that O
the I-GENE: 0.000268
the O: 0.044902
the O
SmSmad2 I-GENE
responds I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
TGF I-GENE: 0.000998
TGF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
beta I-GENE: 0.007816
beta O: 0.000353
beta I-GENE
signals O: 0.000133
signals O
by O: 0.006887
by O
interaction I-GENE: 0.000122
interaction O: 0.000478
interaction O
with O: 0.009756
with O
receptor I-GENE: 0.006817
receptor O: 0.000258
receptor I-GENE
I I-GENE: 0.004602
I O: 0.000487
I I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
which O: 0.002472
which O
phosphorylates O: 0.000023
phosphorylates O
it O: 0.000733
it O
, I-GENE: 0.001923
, O: 0.035091
, O
whereupon I-GENE
it O: 0.000733
it O
translocates I-GENE
into O: 0.000785
into O
the I-GENE: 0.000268
the O: 0.044902
the O
nucleus O: 0.000154
nucleus O
presumably O: 0.000023
presumably O
to I-GENE: 0.000195
to O: 0.014977
to O
regulate O: 0.000119
regulate O
target I-GENE: 0.000146
target O: 0.000232
target O
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
consequently I-GENE
elicit O: 0.000026
elicit O
a I-GENE: 0.000317
a O: 0.015893
a O
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
TGF I-GENE: 0.000998
TGF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
beta I-GENE: 0.007816
beta O: 0.000353
beta I-GENE
effect O: 0.000866
effect O
. I-GENE: 0.004017
. O: 0.044459
. O

We O: 0.001417
We O
propose O: 0.000064
propose O
that O: 0.008362
that O
TFOs I-GENE
represent O: 0.000041
represent O
a I-GENE: 0.000317
a O: 0.015893
a O
therapeutic O: 0.000104
therapeutic O
potential O: 0.000336
potential O
to I-GENE: 0.000195
to O: 0.014977
to O
specifically O: 0.000206
specifically O
diminish I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
expression O: 0.002231
expression O
of I-GENE: 0.002337
of O: 0.042520
of O
c I-GENE: 0.006111
c O: 0.000101
c I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
sis I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
PDGF I-GENE: 0.000536
PDGF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
B I-GENE: 0.004066
B O: 0.000640
B I-GENE
proto I-GENE: 0.000341
proto I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
oncogene I-GENE: 0.000633
oncogene O: 0.000017
oncogene I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
various O: 0.000240
various O
pathologic O: 0.000026
pathologic O
settings I-GENE
where O: 0.000133
where O
constitutive O: 0.000107
constitutive O
expression O: 0.002231
expression O
of I-GENE: 0.002337
of O: 0.042520
of O
this O: 0.001976
this O
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
has O: 0.001356
has O
been O: 0.001229
been O
observed O: 0.000635
observed O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
increased O: 0.000817
increased O
clearance O: 0.000119
clearance O
observed O: 0.000635
observed O
in I-GENE: 0.000536
in O: 0.023304
in O
young O: 0.000072
young O
infants O: 0.000107
infants O
is O: 0.006803
is O
in I-GENE: 0.000536
in O: 0.023304
in O
contrast O: 0.000336
contrast O
to I-GENE: 0.000195
to O: 0.014977
to O
other O: 0.000994
other O
opioids I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Peripheral I-GENE
metabolism O: 0.000139
metabolism O
of I-GENE: 0.002337
of O: 0.042520
of O
androgens I-GENE
takes I-GENE
place O: 0.000029
place O
in I-GENE: 0.000536
in O: 0.023304
in O
various O: 0.000240
various O
areas O: 0.000113
areas O
within O: 0.000823
within O
the I-GENE: 0.000268
the O: 0.044902
the O
pilosebaceous I-GENE
unit I-GENE: 0.000122
unit O: 0.000116
unit I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
as O: 0.003654
as O
indicated O: 0.000229
indicated O
by O: 0.006887
by O
local O: 0.000101
local O
differences O: 0.000322
differences O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
activities O: 0.000261
activities O
of I-GENE: 0.002337
of O: 0.042520
of O
aromatase I-GENE: 0.000170
aromatase I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
5alpha I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
reductase I-GENE: 0.000584
reductase I-GENE
as O: 0.003654
as O
well O: 0.000626
well O
as O: 0.003654
as O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
presence O: 0.000466
presence O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
androgen O: 0.000026
androgen O
receptors I-GENE: 0.001753
receptors O: 0.000148
receptors I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

This O: 0.000927
This O
unique O: 0.000162
unique O
location O: 0.000075
location O
of I-GENE: 0.002337
of O: 0.042520
of O
cavernous I-GENE
malformation I-GENE
is O: 0.006803
is O
associated I-GENE: 0.000755
associated O: 0.000716
associated I-GENE
with O: 0.009756
with O
a I-GENE: 0.000317
a O: 0.015893
a O
risk O: 0.000313
risk O
of I-GENE: 0.002337
of O: 0.042520
of O
permanent O: 0.000023
permanent O
loss O: 0.000226
loss O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
vision O: 0.000023
vision O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
JHRLSS I-GENE
has O: 0.001356
has O
been O: 0.001229
been O
used O: 0.000808
used O
in I-GENE: 0.000536
in O: 0.023304
in O
prior O: 0.000096
prior O
studies O: 0.000678
studies O
to I-GENE: 0.000195
to O: 0.014977
to O
assess O: 0.000087
assess O
RLS I-GENE
severity O: 0.000038
severity O
, I-GENE: 0.001923
, O: 0.035091
, O
but O: 0.001675
but O
has O: 0.001356
has O
not O: 0.002509
not O
previously O: 0.000481
previously O
been O: 0.001229
been O
validated I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
relation O: 0.000075
relation O
to I-GENE: 0.000195
to O: 0.014977
to O
direct O: 0.000264
direct O
measures O: 0.000052
measures O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
morbidity O: 0.000017
morbidity O
associated I-GENE: 0.000755
associated O: 0.000716
associated I-GENE
with O: 0.009756
with O
RLS I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Consistent O: 0.000061
Consistent O
effects O: 0.000652
effects O
on O: 0.003416
on O
pVHL I-GENE
function O: 0.000855
function O
were O: 0.005244
were O
observed O: 0.000635
observed O
for O: 0.006951
for O
all O: 0.000762
all O
mutations I-GENE: 0.000243
mutations O: 0.000435
mutations O
within O: 0.000823
within O
each O: 0.000475
each O
subclass I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Interestingly O: 0.000090
Interestingly O
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
CYP71D20 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
encoded I-GENE: 0.000317
encoded O: 0.000298
encoded I-GENE
enzyme I-GENE: 0.000706
enzyme O: 0.000307
enzyme I-GENE
activity O: 0.002295
activity O
was O: 0.006960
was O
capable O: 0.000099
capable O
of I-GENE: 0.002337
of O: 0.042520
of O
converting I-GENE: 0.000219
converting I-GENE
both O: 0.001631
both O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
epi I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
aristolochene I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
deoxycapsidiol I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
capsidiol I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
vitro O: 0.000640
vitro O
, I-GENE: 0.001923
, O: 0.035091
, O
consistent O: 0.000133
consistent O
with O: 0.009756
with O
the I-GENE: 0.000268
the O: 0.044902
the O
notion O: 0.000017
notion O
that O: 0.008362
that O
this O: 0.001976
this O
P450 I-GENE: 0.000122
P450 I-GENE
enzyme I-GENE: 0.000706
enzyme O: 0.000307
enzyme I-GENE
catalyzes O: 0.000026
catalyzes O
both O: 0.001631
both O
hydroxylations I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
its O: 0.001020
its O
hydrocarbon I-GENE: 0.000122
hydrocarbon I-GENE
substrate I-GENE: 0.000195
substrate O: 0.000133
substrate I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
new O: 0.000464
new O
species O: 0.000243
species O
of I-GENE: 0.002337
of O: 0.042520
of O
Euspondylus I-GENE
is O: 0.006803
is O
described O: 0.000232
described O
based O: 0.000287
based O
on O: 0.003416
on O
a I-GENE: 0.000317
a O: 0.015893
a O
female O: 0.000148
female O
( I-GENE: 0.006014
( O: 0.014858
( O
taken O: 0.000052
taken O
within O: 0.000823
within O
a I-GENE: 0.000317
a O: 0.015893
a O
bromeliad I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
from I-GENE: 0.000390
from O: 0.004210
from O
Cerro I-GENE
El I-GENE
Humo I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
Sucre I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
northeastern I-GENE
Venezuela I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
most O: 0.000400
most O
important O: 0.000400
important O
finding O: 0.000070
finding O
, I-GENE: 0.001923
, O: 0.035091
, O
however O: 0.000223
however O
, I-GENE: 0.001923
, O: 0.035091
, O
was O: 0.006960
was O
that O: 0.008362
that O
IMT I-GENE
values O: 0.000339
values O
were O: 0.005244
were O
related I-GENE: 0.001266
related O: 0.000597
related I-GENE
with O: 0.009756
with O
24 O: 0.000333
24 O
h O: 0.000368
h O
SBP I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
PP I-GENE
standard O: 0.000133
standard O
deviation O: 0.000017
deviation O
( I-GENE: 0.006014
( O: 0.014858
( O
P I-GENE: 0.001023
P O: 0.000614
P I-GENE
< O: 0.000455
< O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
001 O: 0.000197
001 O
), O: 0.002269
), O
a I-GENE: 0.000317
a O: 0.015893
a O
measure O: 0.000084
measure O
of I-GENE: 0.002337
of O: 0.042520
of O
overall O: 0.000113
overall O
SBP I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
PP I-GENE
variability O: 0.000032
variability O
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
addition O: 0.000420
addition O
, I-GENE: 0.001923
, O: 0.035091
, O
severe O: 0.000183
severe O
vision O: 0.000023
vision O
loss O: 0.000226
loss O
can O: 0.000924
can O
be O: 0.002370
be O
seen O: 0.000162
seen O
with O: 0.009756
with O
interferon I-GENE: 0.001071
interferon I-GENE
alfa I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
2b I-GENE: 0.000268
2b I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
associated I-GENE: 0.000755
associated O: 0.000716
associated I-GENE
retinopathy I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

FLP I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
Cre I-GENE
recombinase I-GENE
function O: 0.000855
function O
in I-GENE: 0.000536
in O: 0.023304
in O
Xenopus I-GENE: 0.000341
Xenopus O: 0.000061
Xenopus I-GENE
embryos O: 0.000099
embryos O
. I-GENE: 0.004017
. O: 0.044459
. O

Keratoconjunctivitis I-GENE
sicca I-GENE
appears O: 0.000220
appears O
to I-GENE: 0.000195
to O: 0.014977
to O
be O: 0.002370
be O
a I-GENE: 0.000317
a O: 0.015893
a O
common O: 0.000246
common O
ocular O: 0.000043
ocular O
complication O: 0.000017
complication O
and I-GENE: 0.003263
and O: 0.028529
and O
all O: 0.000762
all O
children O: 0.000307
children O
with O: 0.009756
with O
JRA I-GENE
should O: 0.000171
should O
be O: 0.002370
be O
screened O: 0.000035
screened O
for O: 0.006951
for O
it O: 0.000733
it O
with O: 0.009756
with O
a I-GENE: 0.000317
a O: 0.015893
a O
comprehensive I-GENE
battery O: 0.000014
battery O
of I-GENE: 0.002337
of O: 0.042520
of O
tests O: 0.000148
tests O
. I-GENE: 0.004017
. O: 0.044459
. O

Moreover O: 0.000107
Moreover O
, I-GENE: 0.001923
, O: 0.035091
, O
PTax I-GENE
expressed O: 0.000840
expressed O
higher O: 0.000469
higher O
background O: 0.000041
background O
activities O: 0.000261
activities O
than O: 0.001657
than O
PTF I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
indicating O: 0.000191
indicating O
that O: 0.008362
that O
the I-GENE: 0.000268
the O: 0.044902
the O
sequence I-GENE: 0.002021
sequence O: 0.001866
sequence I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
synthetic O: 0.000101
synthetic O
regulatory I-GENE: 0.000901
regulatory O: 0.000458
regulatory I-GENE
region I-GENE: 0.001583
region O: 0.001744
region O
can O: 0.000924
can O
influence O: 0.000162
influence O
background O: 0.000041
background O
levels O: 0.001304
levels O
. I-GENE: 0.004017
. O: 0.044459
. O

After O: 0.000168
After O
allowing O: 0.000023
allowing O
time O: 0.000542
time O
for O: 0.006951
for O
absorption O: 0.000093
absorption O
, I-GENE: 0.001923
, O: 0.035091
, O
participants I-GENE
completed O: 0.000038
completed O
a I-GENE: 0.000317
a O: 0.015893
a O
bridge I-GENE
simulator I-GENE
task O: 0.000090
task O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
cleavage O: 0.000139
cleavage O
site I-GENE: 0.003092
site O: 0.001040
site I-GENE
between O: 0.001394
between O
VPg I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
RNA I-GENE: 0.003555
RNA O: 0.000591
RNA I-GENE
dependent I-GENE: 0.001485
dependent O: 0.000800
dependent I-GENE
RNA I-GENE: 0.003555
RNA O: 0.000591
RNA I-GENE
polymerase I-GENE: 0.002094
polymerase O: 0.000099
polymerase I-GENE
was O: 0.006960
was O
predicted O: 0.000238
predicted O
to I-GENE: 0.000195
to O: 0.014977
to O
be O: 0.002370
be O
E445 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
T446 I-GENE
based O: 0.000287
based O
on O: 0.003416
on O
the I-GENE: 0.000268
the O: 0.044902
the O
amino I-GENE: 0.000560
amino O: 0.001116
amino O
acid I-GENE: 0.001315
acid O: 0.000997
acid I-GENE
sequence I-GENE: 0.002021
sequence O: 0.001866
sequence I-GENE
analysis O: 0.001194
analysis O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
polyprotein I-GENE
from I-GENE: 0.000390
from O: 0.004210
from O
different O: 0.000669
different O
sobemoviruses I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Conformational I-GENE
changes O: 0.000466
changes O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
ferric I-GENE
uptake O: 0.000122
uptake O
regulation O: 0.000553
regulation O
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
upon O: 0.000156
upon O
metal O: 0.000038
metal O
activation I-GENE: 0.000365
activation O: 0.001153
activation O
and I-GENE: 0.003263
and O: 0.028529
and O
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
; I-GENE: 0.000170
; O: 0.001399
; O
first O: 0.000591
first O
evidence O: 0.000342
evidence O
of I-GENE: 0.002337
of O: 0.042520
of O
structural I-GENE: 0.000146
structural O: 0.000287
structural O
homologies O: 0.000017
homologies O
with O: 0.009756
with O
the I-GENE: 0.000268
the O: 0.044902
the O
diphtheria I-GENE
toxin I-GENE: 0.000511
toxin I-GENE
repressor I-GENE: 0.000414
repressor O: 0.000099
repressor I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

At O: 0.000104
At O
visit I-GENE
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
isokinetic I-GENE
test O: 0.000391
test O
showed O: 0.000863
showed O
impaired O: 0.000061
impaired O
muscle I-GENE: 0.000292
muscle O: 0.000356
muscle O
function O: 0.000855
function O
recovery O: 0.000130
recovery O
from I-GENE: 0.000390
from O: 0.004210
from O
23 O: 0.000139
23 O
% O: 0.001741
% O
to I-GENE: 0.000195
to O: 0.014977
to O
32 O: 0.000122
32 O
%, O: 0.000296
%, O
while O: 0.000403
while O
the I-GENE: 0.000268
the O: 0.044902
the O
manual I-GENE
test O: 0.000391
test O
showed O: 0.000863
showed O
almost O: 0.000084
almost O
full I-GENE: 0.000414
full O: 0.000180
full I-GENE
recovery O: 0.000130
recovery O
. I-GENE: 0.004017
. O: 0.044459
. O

Constitutive I-GENE
phosphorylation O: 0.000469
phosphorylation O
and I-GENE: 0.003263
and O: 0.028529
and O
nuclear I-GENE: 0.001826
nuclear O: 0.000614
nuclear I-GENE
localization O: 0.000174
localization O
of I-GENE: 0.002337
of O: 0.042520
of O
Smad3 I-GENE
are O: 0.002918
are O
correlated O: 0.000156
correlated O
with O: 0.009756
with O
increased O: 0.000817
increased O
collagen I-GENE: 0.001023
collagen I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
activated I-GENE: 0.001412
activated O: 0.000356
activated I-GENE
hepatic O: 0.000058
hepatic O
stellate I-GENE
cells O: 0.002663
cells O
. I-GENE: 0.004017
. O: 0.044459
. O

Cholesteryl I-GENE
ester O: 0.000049
ester O
transfer I-GENE: 0.000170
transfer O: 0.000099
transfer I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
atherosclerosis O: 0.000020
atherosclerosis O
in I-GENE: 0.000536
in O: 0.023304
in O
Japanese O: 0.000038
Japanese O
subjects O: 0.000394
subjects O
: I-GENE: 0.000243
: O: 0.002561
: O
a I-GENE: 0.000317
a O: 0.015893
a O
study O: 0.001101
study O
based O: 0.000287
based O
on O: 0.003416
on O
coronary O: 0.000174
coronary O
angiography O: 0.000017
angiography O
. I-GENE: 0.004017
. O: 0.044459
. O

And I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
most O: 0.000400
most O
importantly I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
reconstitution I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
a I-GENE: 0.000317
a O: 0.015893
a O
consensus I-GENE: 0.000317
consensus O: 0.000246
consensus I-GENE
CRE O: 0.000116
CRE O
, I-GENE: 0.001923
, O: 0.035091
, O
within O: 0.000823
within O
the I-GENE: 0.000268
the O: 0.044902
the O
21 O: 0.000235
21 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
bp I-GENE: 0.000122
bp O: 0.000617
bp O
enhancers I-GENE: 0.000122
enhancers I-GENE
increases O: 0.000156
increases O
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
CREB I-GENE: 0.001096
CREB I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
ATF I-GENE: 0.000536
ATF I-GENE
proteins I-GENE: 0.005673
proteins O: 0.000933
proteins I-GENE
but O: 0.001675
but O
abrogates I-GENE
basal I-GENE: 0.000122
basal O: 0.000223
basal O
repression O: 0.000174
repression O
of I-GENE: 0.002337
of O: 0.042520
of O
LTR I-GENE: 0.000609
LTR O: 0.000064
LTR I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
directed O: 0.000148
directed O
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
vitro O: 0.000640
vitro O
. I-GENE: 0.004017
. O: 0.044459
. O

Stable O: 0.000017
Stable O
transfection O: 0.000165
transfection O
of I-GENE: 0.002337
of O: 0.042520
of O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
CHOP I-GENE: 0.000146
CHOP I-GENE
cDNA I-GENE: 0.001802
cDNA O: 0.000640
cDNA I-GENE
into O: 0.000785
into O
mammary O: 0.000055
mammary O
carcinoma O: 0.000217
carcinoma O
cells O: 0.002663
cells O
demonstrated O: 0.000409
demonstrated O
that O: 0.008362
that O
CHOP I-GENE: 0.000146
CHOP I-GENE
functioned O: 0.000014
functioned O
not O: 0.002509
not O
as O: 0.003654
as O
a I-GENE: 0.000317
a O: 0.015893
a O
mediator I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
hGH I-GENE: 0.000146
hGH I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
stimulated O: 0.000275
stimulated O
mitogenesis I-GENE
but O: 0.001675
but O
rather O: 0.000087
rather O
enhanced O: 0.000162
enhanced O
the I-GENE: 0.000268
the O: 0.044902
the O
protection O: 0.000096
protection O
from I-GENE: 0.000390
from O: 0.004210
from O
apoptosis O: 0.000145
apoptosis O
afforded I-GENE
by O: 0.006887
by O
hGH I-GENE: 0.000146
hGH I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
a I-GENE: 0.000317
a O: 0.015893
a O
p38 I-GENE: 0.000682
p38 I-GENE
MAPK I-GENE: 0.000706
MAPK I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
dependent I-GENE: 0.001485
dependent O: 0.000800
dependent I-GENE
manner O: 0.000183
manner O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
combination O: 0.000246
combination O
of I-GENE: 0.002337
of O: 0.042520
of O
ifosfamide I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
epirubicin I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
etoposide I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
IEV I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
is O: 0.006803
is O
an O: 0.003112
an O
effective O: 0.000238
effective O
salvage I-GENE
regimen O: 0.000084
regimen O
for O: 0.006951
for O
lymphoproliferative I-GENE
disease O: 0.000632
disease O
. I-GENE: 0.004017
. O: 0.044459
. O

Interestingly O: 0.000090
Interestingly O
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
activity O: 0.002295
activity O
of I-GENE: 0.002337
of O: 0.042520
of O
IkappaB I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
IKK I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
beta I-GENE: 0.007816
beta O: 0.000353
beta I-GENE
), O: 0.002269
), O
which O: 0.002472
which O
plays O: 0.000101
plays O
an O: 0.003112
an O
essential O: 0.000351
essential O
role O: 0.000681
role O
in I-GENE: 0.000536
in O: 0.023304
in O
NF I-GENE: 0.002922
NF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
kappaB I-GENE: 0.001363
kappaB I-GENE
activation I-GENE: 0.000365
activation O: 0.001153
activation O
through O: 0.000403
through O
IkappaB I-GENE
phosphorylation O: 0.000469
phosphorylation O
, I-GENE: 0.001923
, O: 0.035091
, O
was O: 0.006960
was O
largely O: 0.000043
largely O
enhanced O: 0.000162
enhanced O
in I-GENE: 0.000536
in O: 0.023304
in O
paclitaxel I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
treated O: 0.000365
treated O
cells O: 0.002663
cells O
, I-GENE: 0.001923
, O: 0.035091
, O
detected O: 0.000368
detected O
as O: 0.003654
as O
IkappaBalpha I-GENE: 0.000146
IkappaBalpha I-GENE
phosphorylation O: 0.000469
phosphorylation O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
recessive O: 0.000026
recessive O
hos1 I-GENE
mutation I-GENE: 0.000560
mutation O: 0.000296
mutation I-GENE
causes O: 0.000130
causes O
enhanced O: 0.000162
enhanced O
induction O: 0.000284
induction O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
CBF I-GENE: 0.000390
CBF O: 0.000046
CBF I-GENE
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
factors I-GENE: 0.001388
factors O: 0.000626
factors I-GENE
by O: 0.006887
by O
low I-GENE: 0.000146
low O: 0.000440
low O
temperature O: 0.000212
temperature O
as O: 0.003654
as O
well O: 0.000626
well O
as O: 0.003654
as O
of I-GENE: 0.002337
of O: 0.042520
of O
their O: 0.000736
their O
downstream O: 0.000240
downstream O
cold O: 0.000043
cold O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
responsive I-GENE: 0.000414
responsive O: 0.000185
responsive I-GENE
genes I-GENE: 0.004626
genes O: 0.000918
genes I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Apart I-GENE
from I-GENE: 0.000390
from O: 0.004210
from O
antimicrobial O: 0.000023
antimicrobial O
properties O: 0.000197
properties O
, I-GENE: 0.001923
, O: 0.035091
, O
recent O: 0.000084
recent O
data O: 0.000649
data O
indicate O: 0.000438
indicate O
that O: 0.008362
that O
PMN I-GENE
also O: 0.001373
also O
exert O: 0.000035
exert O
anti I-GENE: 0.001704
anti O: 0.000087
anti I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
inflammatory O: 0.000101
inflammatory O
effects O: 0.000652
effects O
by O: 0.006887
by O
stimulation O: 0.000293
stimulation O
and I-GENE: 0.003263
and O: 0.028529
and O
release O: 0.000136
release O
of I-GENE: 0.002337
of O: 0.042520
of O
cytokine O: 0.000081
cytokine O
antagonists O: 0.000049
antagonists O
such O: 0.000435
such O
as O: 0.003654
as O
interleukin I-GENE: 0.000828
interleukin I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
receptor I-GENE: 0.006817
receptor O: 0.000258
receptor I-GENE
antagonist O: 0.000110
antagonist O
( I-GENE: 0.006014
( O: 0.014858
( O
IL I-GENE: 0.003019
IL I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1ra I-GENE
). O: 0.002228
). O

Early O: 0.000017
Early O
indicators O: 0.000041
indicators O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
effect O: 0.000866
effect O
of I-GENE: 0.002337
of O: 0.042520
of O
a I-GENE: 0.000317
a O: 0.015893
a O
breast O: 0.000125
breast O
cancer O: 0.000284
cancer O
screening O: 0.000130
screening O
program O: 0.000061
program O
for O: 0.006951
for O
low I-GENE: 0.000146
low O: 0.000440
low O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
income I-GENE
women O: 0.000281
women O
. I-GENE: 0.004017
. O: 0.044459
. O

An O: 0.000287
An O
association O: 0.000206
association O
was O: 0.006960
was O
demonstrated O: 0.000409
demonstrated O
between O: 0.001394
between O
the I-GENE: 0.000268
the O: 0.044902
the O
expression O: 0.002231
expression O
of I-GENE: 0.002337
of O: 0.042520
of O
aberrantly I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
alternatively O: 0.000038
alternatively O
spliced O: 0.000093
spliced O
mdm2 I-GENE
mRNAs I-GENE: 0.000487
mRNAs O: 0.000116
mRNAs I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
a I-GENE: 0.000317
a O: 0.015893
a O
lack O: 0.000093
lack O
of I-GENE: 0.002337
of O: 0.042520
of O
progesterone I-GENE: 0.000122
progesterone O: 0.000052
progesterone I-GENE
receptor I-GENE: 0.006817
receptor O: 0.000258
receptor I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

BACKGROUND O: 0.000081
BACKGROUND O
: I-GENE: 0.000243
: O: 0.002561
: O
Dermoscopy I-GENE
is O: 0.006803
is O
a I-GENE: 0.000317
a O: 0.015893
a O
noninvasive I-GENE
technique O: 0.000183
technique O
that O: 0.008362
that O
increases O: 0.000156
increases O
the I-GENE: 0.000268
the O: 0.044902
the O
diagnostic O: 0.000107
diagnostic O
accuracy O: 0.000043
accuracy O
of I-GENE: 0.002337
of O: 0.042520
of O
pigmented I-GENE
skin O: 0.000133
skin O
lesions O: 0.000200
lesions O
, I-GENE: 0.001923
, O: 0.035091
, O
particularly O: 0.000067
particularly O
improving I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
diagnosis O: 0.000275
diagnosis O
of I-GENE: 0.002337
of O: 0.042520
of O
patients O: 0.002538
patients O
with O: 0.009756
with O
cutaneous O: 0.000041
cutaneous O
melanoma O: 0.000032
melanoma O
in I-GENE: 0.000536
in O: 0.023304
in O
situ O: 0.000072
situ O
( I-GENE: 0.006014
( O: 0.014858
( O
CMIS I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
early I-GENE: 0.000706
early O: 0.000374
early I-GENE
invasive O: 0.000061
invasive O
melanoma O: 0.000032
melanoma O
. I-GENE: 0.004017
. O: 0.044459
. O

Increased O: 0.000023
Increased O
erythropoietin I-GENE: 0.000365
erythropoietin I-GENE
synthesis O: 0.000275
synthesis O
in I-GENE: 0.000536
in O: 0.023304
in O
patients O: 0.002538
patients O
with O: 0.009756
with O
COLD I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
left O: 0.000264
left O
heart O: 0.000235
heart O
failure O: 0.000171
failure O
is O: 0.006803
is O
related I-GENE: 0.001266
related O: 0.000597
related I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
alterations O: 0.000104
alterations O
in I-GENE: 0.000536
in O: 0.023304
in O
renal O: 0.000249
renal O
haemodynamics I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
( I-GENE: 0.006014
( O: 0.014858
( O
two O: 0.001904
two O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
motif I-GENE: 0.000706
motif O: 0.000316
motif I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
fold O: 0.000229
fold O
contains O: 0.000548
contains O
a I-GENE: 0.000317
a O: 0.015893
a O
pair O: 0.000154
pair O
of I-GENE: 0.002337
of O: 0.042520
of O
calcium O: 0.000252
calcium O
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
sites I-GENE: 0.001875
sites O: 0.000690
sites I-GENE
very O: 0.000223
very O
similar O: 0.000574
similar O
to I-GENE: 0.000195
to O: 0.014977
to O
those O: 0.000461
those O
found O: 0.001026
found O
in I-GENE: 0.000536
in O: 0.023304
in O
a I-GENE: 0.000317
a O: 0.015893
a O
two O: 0.001904
two O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
prokaryotic O: 0.000020
prokaryotic O
betagamma I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
crystallin I-GENE
fold O: 0.000229
fold O
family I-GENE: 0.002922
family O: 0.000313
family I-GENE
member O: 0.000162
member O
, I-GENE: 0.001923
, O: 0.035091
, O
Protein I-GENE: 0.000243
Protein O: 0.000020
Protein I-GENE
S I-GENE: 0.001631
S O: 0.000449
S I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Twenty O: 0.000049
Twenty O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
five O: 0.000290
five O
patients O: 0.002538
patients O
also O: 0.001373
also O
received O: 0.000226
received O
PET O: 0.000029
PET O
examinations O: 0.000049
examinations O
during O: 0.001095
during O
the I-GENE: 0.000268
the O: 0.044902
the O
staging I-GENE
procedures O: 0.000052
procedures O
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
the I-GENE: 0.000268
the O: 0.044902
the O
last O: 0.000090
last O
case O: 0.000220
case O
, I-GENE: 0.001923
, O: 0.035091
, O
both O: 0.001631
both O
hydroxychloroquine I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
carbamazepine I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
fluvoxamine I-GENE
had O: 0.000890
had O
a I-GENE: 0.000317
a O: 0.015893
a O
common O: 0.000246
common O
imputability I-GENE
which O: 0.002472
which O
was O: 0.006960
was O
plausible I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
all O: 0.000762
all O
of I-GENE: 0.002337
of O: 0.042520
of O
these O: 0.001478
these O
cases O: 0.000458
cases O
, I-GENE: 0.001923
, O: 0.035091
, O
expression O: 0.002231
expression O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
implicated O: 0.000099
implicated O
genes I-GENE: 0.004626
genes O: 0.000918
genes I-GENE
was O: 0.006960
was O
absent O: 0.000043
absent O
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
subset O: 0.000043
subset O
of I-GENE: 0.002337
of O: 0.042520
of O
patients O: 0.002538
patients O
( I-GENE: 0.006014
( O: 0.014858
( O
n O: 0.000264
n O
= O: 0.000855
= O
30 O: 0.000423
30 O
) I-GENE: 0.005210
) O: 0.009341
) O
underwent O: 0.000058
underwent O
multichannel I-GENE
pressure O: 0.000432
pressure O
flow O: 0.000362
flow O
studies O: 0.000678
studies O
, I-GENE: 0.001923
, O: 0.035091
, O
which O: 0.002472
which O
demonstrated O: 0.000409
demonstrated O
that O: 0.008362
that O
transrectal I-GENE
HIFU I-GENE
reduces O: 0.000052
reduces O
bladder O: 0.000052
bladder O
outflow O: 0.000023
outflow O
obstruction O: 0.000023
obstruction O
. I-GENE: 0.004017
. O: 0.044459
. O

Biochemical O: 0.000017
Biochemical O
experiments O: 0.000316
experiments O
have O: 0.001788
have O
shown O: 0.000504
shown O
that O: 0.008362
that O
CopG I-GENE
co O: 0.000156
co O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
operatively I-GENE
associates O: 0.000029
associates O
to I-GENE: 0.000195
to O: 0.014977
to O
its O: 0.001020
its O
target I-GENE: 0.000146
target O: 0.000232
target O
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
at O: 0.002976
at O
low I-GENE: 0.000146
low O: 0.000440
low O
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
: I-GENE: 0.000243
: O: 0.002561
: O
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
ratios O: 0.000038
ratios O
, I-GENE: 0.001923
, O: 0.035091
, O
completely O: 0.000104
completely O
protecting I-GENE
four O: 0.000406
four O
helical O: 0.000052
helical O
turns I-GENE
on O: 0.003416
on O
the I-GENE: 0.000268
the O: 0.044902
the O
same O: 0.000348
same O
face O: 0.000035
face O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
double I-GENE: 0.000146
double O: 0.000162
double O
helix I-GENE: 0.000584
helix O: 0.000104
helix I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
both O: 0.001631
both O
directions I-GENE
from I-GENE: 0.000390
from O: 0.004210
from O
the I-GENE: 0.000268
the O: 0.044902
the O
inverted O: 0.000055
inverted O
repeat I-GENE: 0.000317
repeat O: 0.000209
repeat I-GENE
that O: 0.008362
that O
constitutes O: 0.000014
constitutes O
the I-GENE: 0.000268
the O: 0.044902
the O
CopG I-GENE
primary O: 0.000281
primary O
target I-GENE: 0.000146
target O: 0.000232
target O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
mechanism O: 0.000304
mechanism O
of I-GENE: 0.002337
of O: 0.042520
of O
ligand O: 0.000145
ligand O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
activated I-GENE: 0.001412
activated O: 0.000356
activated I-GENE
estrogen I-GENE: 0.000268
estrogen O: 0.000064
estrogen I-GENE
receptor I-GENE: 0.006817
receptor O: 0.000258
receptor I-GENE
alpha I-GENE: 0.009009
alpha O: 0.000313
alpha I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
ERalpha I-GENE
)- I-GENE: 0.000609
)- O: 0.000269
)- I-GENE
dependent I-GENE: 0.001485
dependent O: 0.000800
dependent I-GENE
activation I-GENE: 0.000365
activation O: 0.001153
activation O
of I-GENE: 0.002337
of O: 0.042520
of O
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
expression O: 0.002231
expression O
through O: 0.000403
through O
the I-GENE: 0.000268
the O: 0.044902
the O
SRE O: 0.000041
SRE O
was O: 0.006960
was O
determined O: 0.000458
determined O
by O: 0.006887
by O
mutational O: 0.000032
mutational O
analysis O: 0.001194
analysis O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
analysis O: 0.001194
analysis O
of I-GENE: 0.002337
of O: 0.042520
of O
mitogen I-GENE: 0.000755
mitogen O: 0.000017
mitogen I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
activated I-GENE: 0.001412
activated O: 0.000356
activated I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
MAPK I-GENE: 0.000706
MAPK I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
pathway O: 0.000385
pathway O
activation I-GENE: 0.000365
activation O: 0.001153
activation O
by O: 0.006887
by O
E2 I-GENE: 0.000852
E2 O: 0.000072
E2 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
transforming I-GENE: 0.000122
transforming O: 0.000061
transforming I-GENE
growth I-GENE: 0.002337
growth O: 0.000510
growth I-GENE
factor I-GENE: 0.008984
factor O: 0.000510
factor I-GENE
alpha I-GENE: 0.009009
alpha O: 0.000313
alpha I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
TGF I-GENE: 0.000998
TGF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
alpha I-GENE: 0.009009
alpha O: 0.000313
alpha I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
as O: 0.003654
as O
a I-GENE: 0.000317
a O: 0.015893
a O
positive O: 0.000411
positive O
control I-GENE: 0.000170
control O: 0.000834
control O
. I-GENE: 0.004017
. O: 0.044459
. O

This O: 0.000927
This O
study O: 0.001101
study O
investigated O: 0.000217
investigated O
whether O: 0.000220
whether O
boron I-GENE
would O: 0.000107
would O
enhance O: 0.000023
enhance O
the I-GENE: 0.000268
the O: 0.044902
the O
ability O: 0.000290
ability O
of I-GENE: 0.002337
of O: 0.042520
of O
17beta I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
estradiol O: 0.000078
estradiol O
( I-GENE: 0.006014
( O: 0.014858
( O
E2 I-GENE: 0.000852
E2 O: 0.000072
E2 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
or I-GENE: 0.000219
or O: 0.003321
or O
parathyroid I-GENE: 0.000122
parathyroid I-GENE
hormone I-GENE: 0.001363
hormone O: 0.000107
hormone I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
PTH I-GENE: 0.000243
PTH I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
to I-GENE: 0.000195
to O: 0.014977
to O
improve O: 0.000055
improve O
bone I-GENE: 0.000219
bone O: 0.000296
bone O
quality O: 0.000046
quality O
in I-GENE: 0.000536
in O: 0.023304
in O
ovariectomized I-GENE
OVX I-GENE
rats O: 0.000501
rats O
. I-GENE: 0.004017
. O: 0.044459
. O

2001 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
Gap69C I-GENE
is O: 0.006803
is O
a I-GENE: 0.000317
a O: 0.015893
a O
single I-GENE: 0.000195
single O: 0.000582
single O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
copy O: 0.000104
copy O
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
producing O: 0.000070
producing O
a I-GENE: 0.000317
a O: 0.015893
a O
major I-GENE: 0.000341
major O: 0.000333
major I-GENE
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
kb I-GENE: 0.000292
kb O: 0.000464
kb O
mRNA I-GENE: 0.003530
mRNA O: 0.000475
mRNA I-GENE
throughout O: 0.000101
throughout O
development O: 0.000388
development O
, I-GENE: 0.001923
, O: 0.035091
, O
but O: 0.001675
but O
its O: 0.001020
its O
amount O: 0.000078
amount O
is O: 0.006803
is O
decreased O: 0.000403
decreased O
in I-GENE: 0.000536
in O: 0.023304
in O
larvae O: 0.000029
larvae O
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
the I-GENE: 0.000268
the O: 0.044902
the O
long I-GENE: 0.000243
long O: 0.000325
long O
term O: 0.000185
term O
, I-GENE: 0.001923
, O: 0.035091
, O
questions O: 0.000023
questions O
still O: 0.000101
still O
remain I-GENE
about O: 0.000278
about O
whether O: 0.000220
whether O
pre I-GENE: 0.000219
pre O: 0.000180
pre I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
dialysis O: 0.000046
dialysis O
rHu I-GENE
EPO I-GENE: 0.000268
EPO I-GENE
either O: 0.000452
either O
speeds I-GENE
up O: 0.000336
up O
or I-GENE: 0.000219
or O: 0.003321
or O
delays I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
onset O: 0.000101
onset O
of I-GENE: 0.002337
of O: 0.042520
of O
dialysis O: 0.000046
dialysis O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
validity O: 0.000020
validity O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
FPS I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
R I-GENE: 0.001023
R O: 0.000154
R I-GENE
was O: 0.006960
was O
further O: 0.000261
further O
supported O: 0.000043
supported O
by O: 0.006887
by O
strong O: 0.000156
strong O
positive O: 0.000411
positive O
correlations O: 0.000049
correlations O
with O: 0.009756
with O
the I-GENE: 0.000268
the O: 0.044902
the O
VAS I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
r O: 0.000156
r O
= O: 0.000855
= O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
92 O: 0.000041
92 O
, I-GENE: 0.001923
, O: 0.035091
, O
N I-GENE: 0.001217
N O: 0.000614
N I-GENE
= O: 0.000855
= O
45 O: 0.000136
45 O
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
CAS O: 0.000014
CAS O
( I-GENE: 0.006014
( O: 0.014858
( O
r O: 0.000156
r O
= O: 0.000855
= O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
84 O: 0.000058
84 O
, I-GENE: 0.001923
, O: 0.035091
, O
N I-GENE: 0.001217
N O: 0.000614
N I-GENE
= O: 0.000855
= O
45 O: 0.000136
45 O
) I-GENE: 0.005210
) O: 0.009341
) O
in I-GENE: 0.000536
in O: 0.023304
in O
this O: 0.001976
this O
clinical O: 0.000417
clinical O
sample O: 0.000087
sample O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
BFA I-GENE
System I-GENE
reads I-GENE
a I-GENE: 0.000317
a O: 0.015893
a O
text I-GENE
file I-GENE
with O: 0.009756
with O
flows I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
measured O: 0.000400
measured O
with O: 0.009756
with O
fluorescent O: 0.000038
fluorescent O
microsphere I-GENE
technique O: 0.000183
technique O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
constructs I-GENE: 0.000219
constructs O: 0.000148
constructs I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
lung O: 0.000223
lung O
anatomy I-GENE
with O: 0.009756
with O
volumetric I-GENE
pixels I-GENE
showing O: 0.000058
showing O
the I-GENE: 0.000268
the O: 0.044902
the O
flows I-GENE
with O: 0.009756
with O
a I-GENE: 0.000317
a O: 0.015893
a O
color O: 0.000023
color O
schema I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Therefore O: 0.000107
Therefore O
, I-GENE: 0.001923
, O: 0.035091
, O
to I-GENE: 0.000195
to O: 0.014977
to O
understand O: 0.000043
understand O
how O: 0.000046
how O
ErbB1 I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
ErbB2 I-GENE
signaling O: 0.000293
signaling O
contributes O: 0.000055
contributes O
to I-GENE: 0.000195
to O: 0.014977
to O
this O: 0.001976
this O
process O: 0.000119
process O
, I-GENE: 0.001923
, O: 0.035091
, O
we O: 0.001382
we O
used O: 0.000808
used O
the I-GENE: 0.000268
the O: 0.044902
the O
ErbB I-GENE: 0.000292
ErbB I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
inhibitor I-GENE: 0.000438
inhibitor O: 0.000238
inhibitor I-GENE
AG1478in I-GENE
ErbB2 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
dependent I-GENE: 0.001485
dependent O: 0.000800
dependent I-GENE
BT I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
474 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
SKBR I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
breast O: 0.000125
breast O
cancer O: 0.000284
cancer O
cells O: 0.002663
cells O
. I-GENE: 0.004017
. O: 0.044459
. O

Deletion O: 0.000081
Deletion O
analyses O: 0.000194
analyses O
implicate I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
N I-GENE: 0.001217
N O: 0.000614
N I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
terminal I-GENE: 0.001169
terminal O: 0.000884
terminal I-GENE
110 O: 0.000023
110 O
amino I-GENE: 0.000560
amino O: 0.001116
amino O
acids O: 0.000420
acids O
of I-GENE: 0.002337
of O: 0.042520
of O
Grb14 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
ankyrin I-GENE
repeats I-GENE: 0.000195
repeats O: 0.000136
repeats I-GENE
10 I-GENE: 0.000292
10 O: 0.000936
10 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
19 I-GENE: 0.000146
19 O: 0.000226
19 O
of I-GENE: 0.002337
of O: 0.042520
of O
tankyrase I-GENE
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
mediating O: 0.000061
mediating O
this O: 0.001976
this O
interaction I-GENE: 0.000122
interaction O: 0.000478
interaction O
. I-GENE: 0.004017
. O: 0.044459
. O

Hormonal I-GENE
regulation O: 0.000553
regulation O
of I-GENE: 0.002337
of O: 0.042520
of O
multiple O: 0.000409
multiple O
promoters I-GENE: 0.000609
promoters O: 0.000194
promoters I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
rat I-GENE: 0.001607
rat O: 0.000409
rat I-GENE
mitochondrial I-GENE: 0.000268
mitochondrial O: 0.000107
mitochondrial I-GENE
glycerol I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
phosphate I-GENE: 0.000219
phosphate O: 0.000070
phosphate I-GENE
dehydrogenase I-GENE: 0.000560
dehydrogenase I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
: I-GENE: 0.000243
: O: 0.002561
: O
identification O: 0.000130
identification O
of I-GENE: 0.002337
of O: 0.042520
of O
a I-GENE: 0.000317
a O: 0.015893
a O
complex I-GENE: 0.001315
complex O: 0.000588
complex I-GENE
hormone I-GENE: 0.001363
hormone O: 0.000107
hormone I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
response I-GENE: 0.000779
response O: 0.000794
response O
element I-GENE: 0.001680
element O: 0.000577
element I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
ubiquitous O: 0.000049
ubiquitous O
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
B I-GENE: 0.004066
B O: 0.000640
B I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

SAMPLE I-GENE
POPULATION I-GENE
: I-GENE: 0.000243
: O: 0.002561
: O
MCB I-GENE
from I-GENE: 0.000390
from O: 0.004210
from O
7 I-GENE: 0.000390
7 O: 0.000942
7 O
racing I-GENE
Greyhounds I-GENE
euthanatized I-GENE
for O: 0.006951
for O
reasons I-GENE
unrelated O: 0.000038
unrelated O
to I-GENE: 0.000195
to O: 0.014977
to O
MCB I-GENE
abnormalities O: 0.000099
abnormalities O
. I-GENE: 0.004017
. O: 0.044459
. O

Structural O: 0.000032
Structural O
studies O: 0.000678
studies O
have O: 0.001788
have O
shown O: 0.000504
shown O
that O: 0.008362
that O
class I-GENE: 0.000706
class O: 0.000148
class I-GENE
I I-GENE: 0.004602
I O: 0.000487
I I-GENE
major I-GENE: 0.000341
major O: 0.000333
major I-GENE
histocompatibility I-GENE: 0.000170
histocompatibility I-GENE
complex I-GENE: 0.001315
complex O: 0.000588
complex I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
MHC I-GENE: 0.000487
MHC I-GENE
)- I-GENE: 0.000609
)- O: 0.000269
)- I-GENE
restricted O: 0.000099
restricted O
peptide I-GENE: 0.000584
peptide O: 0.000212
peptide I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
T I-GENE: 0.001558
T O: 0.000548
T I-GENE
cell I-GENE: 0.001144
cell O: 0.001927
cell O
receptor I-GENE: 0.006817
receptor O: 0.000258
receptor I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
TCR I-GENE: 0.000730
TCR I-GENE
)- I-GENE: 0.000609
)- O: 0.000269
)- I-GENE
alpha I-GENE: 0.009009
alpha O: 0.000313
alpha I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
betas I-GENE
make O: 0.000041
make O
multiple O: 0.000409
multiple O
contacts O: 0.000023
contacts O
with O: 0.009756
with O
the I-GENE: 0.000268
the O: 0.044902
the O
alpha1 I-GENE: 0.000243
alpha1 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
alpha2 I-GENE
helices O: 0.000026
helices O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
MHC I-GENE: 0.000487
MHC I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
but O: 0.001675
but O
it O: 0.000733
it O
is O: 0.006803
is O
unclear O: 0.000023
unclear O
which O: 0.002472
which O
or I-GENE: 0.000219
or O: 0.003321
or O
how O: 0.000046
how O
many O: 0.000180
many O
of I-GENE: 0.002337
of O: 0.042520
of O
these O: 0.001478
these O
interactions O: 0.000226
interactions O
contribute O: 0.000087
contribute O
to I-GENE: 0.000195
to O: 0.014977
to O
functional O: 0.000403
functional O
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Fans I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
tunnels I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
open O: 0.000275
open O
windows I-GENE
at O: 0.002976
at O
aboveground I-GENE
locations O: 0.000017
locations O
appeared O: 0.000093
appeared O
to I-GENE: 0.000195
to O: 0.014977
to O
greatly O: 0.000049
greatly O
reduce O: 0.000058
reduce O
the I-GENE: 0.000268
the O: 0.044902
the O
likelihood O: 0.000014
likelihood O
of I-GENE: 0.002337
of O: 0.042520
of O
high I-GENE: 0.000341
high O: 0.000924
high O
PH3 I-GENE
concentrations O: 0.000417
concentrations O
in I-GENE: 0.000536
in O: 0.023304
in O
enclosed I-GENE
areas O: 0.000113
areas O
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
strand O: 0.000110
strand O
exchange I-GENE: 0.000317
exchange O: 0.000058
exchange I-GENE
reactions O: 0.000090
reactions O
using O: 0.000979
using O
oligonucleotides O: 0.000052
oligonucleotides O
, I-GENE: 0.001923
, O: 0.035091
, O
we O: 0.001382
we O
found O: 0.001026
found O
that O: 0.008362
that O
Rec2 I-GENE
exhibited O: 0.000087
exhibited O
a I-GENE: 0.000317
a O: 0.015893
a O
pairing I-GENE
bias I-GENE
that O: 0.008362
that O
is O: 0.006803
is O
opposite O: 0.000041
opposite O
that O: 0.008362
that O
of I-GENE: 0.002337
of O: 0.042520
of O
RecA I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
major I-GENE: 0.000341
major O: 0.000333
major I-GENE
mechanism O: 0.000304
mechanism O
by O: 0.006887
by O
which O: 0.002472
which O
estrogens I-GENE
prevent O: 0.000061
prevent O
osteoporosis I-GENE
seems O: 0.000064
seems O
to I-GENE: 0.000195
to O: 0.014977
to O
be O: 0.002370
be O
repression O: 0.000174
repression O
of I-GENE: 0.002337
of O: 0.042520
of O
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
NF I-GENE: 0.002922
NF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
kappa I-GENE: 0.001972
kappa I-GENE
B I-GENE: 0.004066
B O: 0.000640
B I-GENE
target I-GENE: 0.000146
target O: 0.000232
target O
genes I-GENE: 0.004626
genes O: 0.000918
genes I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
such O: 0.000435
such O
as O: 0.003654
as O
the I-GENE: 0.000268
the O: 0.044902
the O
osteoclast I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
activating I-GENE: 0.000803
activating O: 0.000104
activating I-GENE
cytokines O: 0.000061
cytokines O
interleukin I-GENE: 0.000828
interleukin I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
6 I-GENE: 0.002118
6 O: 0.001153
6 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
interleukin I-GENE: 0.000828
interleukin I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Linear I-GENE
eight O: 0.000148
eight O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
nine O: 0.000090
nine O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
residue O: 0.000200
residue O
D I-GENE: 0.000901
D O: 0.000232
D I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
peptides I-GENE: 0.000195
peptides O: 0.000101
peptides I-GENE
derived I-GENE: 0.000268
derived O: 0.000290
derived O
from I-GENE: 0.000390
from O: 0.004210
from O
the I-GENE: 0.000268
the O: 0.044902
the O
pocket O: 0.000017
pocket O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
cyclic I-GENE: 0.000195
cyclic O: 0.000052
cyclic I-GENE
molecules I-GENE: 0.000268
molecules O: 0.000125
molecules I-GENE
also O: 0.001373
also O
bind O: 0.000296
bind O
specifically O: 0.000206
specifically O
. I-GENE: 0.004017
. O: 0.044459
. O

As O: 0.000162
As O
expected O: 0.000064
expected O
, I-GENE: 0.001923
, O: 0.035091
, O
homologous I-GENE: 0.000219
homologous O: 0.000267
homologous O
loxP I-GENE
sequences I-GENE: 0.001290
sequences O: 0.000947
sequences I-GENE
efficiently O: 0.000110
efficiently O
underwent O: 0.000058
underwent O
Cre I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
mediated O: 0.000475
mediated O
recombination O: 0.000104
recombination O
. I-GENE: 0.004017
. O: 0.044459
. O

Multistage I-GENE
models O: 0.000070
models O
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
A I-GENE: 0.003530
A O: 0.002246
A I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
bomb I-GENE
survivor I-GENE
data O: 0.000649
data O
: I-GENE: 0.000243
: O: 0.002561
: O
implications O: 0.000038
implications O
for O: 0.006951
for O
carcinogenic I-GENE
mechanisms O: 0.000212
mechanisms O
? O: 0.000081
? O

The O: 0.007383
The O
results O: 0.001162
results O
indicate O: 0.000438
indicate O
that O: 0.008362
that O
a I-GENE: 0.000317
a O: 0.015893
a O
more O: 0.000687
more O
differentiated O: 0.000055
differentiated O
diagnosis O: 0.000275
diagnosis O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
molar I-GENE
relationship O: 0.000145
relationship O
will O: 0.000101
will O
allow O: 0.000038
allow O
for O: 0.006951
for O
a I-GENE: 0.000317
a O: 0.015893
a O
more O: 0.000687
more O
causally I-GENE
directed O: 0.000148
directed O
correction O: 0.000038
correction O
of I-GENE: 0.002337
of O: 0.042520
of O
Class O: 0.000041
Class O
II I-GENE: 0.003263
II O: 0.000362
II I-GENE
molar I-GENE
relationship O: 0.000145
relationship O
. I-GENE: 0.004017
. O: 0.044459
. O

It O: 0.000313
It O
is O: 0.006803
is O
surprising I-GENE
that O: 0.008362
that O
dnaE173 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
a I-GENE: 0.000317
a O: 0.015893
a O
potent O: 0.000101
potent O
mutator I-GENE
mutation I-GENE: 0.000560
mutation O: 0.000296
mutation I-GENE
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
for O: 0.006951
for O
sequence I-GENE: 0.002021
sequence O: 0.001866
sequence I-GENE
substitution O: 0.000075
substitution O
as O: 0.003654
as O
well O: 0.000626
well O
as O: 0.003654
as O
single I-GENE: 0.000195
single O: 0.000582
single O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
base O: 0.000313
base O
frameshift O: 0.000023
frameshift O
, I-GENE: 0.001923
, O: 0.035091
, O
did O: 0.000536
did O
not O: 0.002509
not O
enhance O: 0.000023
enhance O
the I-GENE: 0.000268
the O: 0.044902
the O
frequency O: 0.000171
frequency O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
hot O: 0.000029
hot O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
spot I-GENE
frameshift O: 0.000023
frameshift O
mutation I-GENE: 0.000560
mutation O: 0.000296
mutation I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Hypercalcemia I-GENE
associated I-GENE: 0.000755
associated O: 0.000716
associated I-GENE
with O: 0.009756
with O
elevated O: 0.000226
elevated O
serum I-GENE: 0.002070
serum O: 0.000536
serum I-GENE
PTH I-GENE: 0.000243
PTH I-GENE
concentration O: 0.000330
concentration O
indicating O: 0.000191
indicating O
primary O: 0.000281
primary O
hyperparathyroidism I-GENE
was O: 0.006960
was O
found O: 0.001026
found O
in I-GENE: 0.000536
in O: 0.023304
in O
7 I-GENE: 0.000390
7 O: 0.000942
7 O
BC I-GENE
patients O: 0.002538
patients O
( I-GENE: 0.006014
( O: 0.014858
( O
7 I-GENE: 0.000390
7 O: 0.000942
7 O
%) O: 0.000385
%) O
and I-GENE: 0.003263
and O: 0.028529
and O
in I-GENE: 0.000536
in O: 0.023304
in O
none O: 0.000020
none O
of I-GENE: 0.002337
of O: 0.042520
of O
healthy O: 0.000171
healthy O
women O: 0.000281
women O
or I-GENE: 0.000219
or O: 0.003321
or O
patients O: 0.002538
patients O
with O: 0.009756
with O
thyroid I-GENE: 0.000268
thyroid O: 0.000139
thyroid I-GENE
cancer O: 0.000284
cancer O
. I-GENE: 0.004017
. O: 0.044459
. O

[ O: 0.000382
[ O
figure I-GENE
: I-GENE: 0.000243
: O: 0.002561
: O
see I-GENE
text I-GENE
] I-GENE: 0.000122
] O: 0.000240
] O
The O: 0.007383
The O
Stille I-GENE
coupling O: 0.000049
coupling O
reaction O: 0.000235
reaction O
has O: 0.001356
has O
been O: 0.001229
been O
performed O: 0.000351
performed O
in I-GENE: 0.000536
in O: 0.023304
in O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
butyl I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
methylimidazolium I-GENE
tetrafluoroborate I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
BMIM I-GENE
BF4 I-GENE
), O: 0.002269
), O
a I-GENE: 0.000317
a O: 0.015893
a O
room O: 0.000017
room O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
temperature O: 0.000212
temperature O
ionic O: 0.000017
ionic O
liquid O: 0.000084
liquid O
( I-GENE: 0.006014
( O: 0.014858
( O
RTIL I-GENE
). O: 0.002228
). O

Examination O: 0.000029
Examination O
of I-GENE: 0.002337
of O: 0.042520
of O
various O: 0.000240
various O
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
deletion I-GENE: 0.000195
deletion O: 0.000238
deletion O
mutants I-GENE: 0.001315
mutants O: 0.000258
mutants I-GENE
indicated O: 0.000229
indicated O
that O: 0.008362
that O
SF I-GENE: 0.000341
SF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
acts O: 0.000090
acts O
through O: 0.000403
through O
the I-GENE: 0.000268
the O: 0.044902
the O
proximal I-GENE: 0.000170
proximal O: 0.000165
proximal I-GENE
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
region I-GENE: 0.001583
region O: 0.001744
region O
and I-GENE: 0.003263
and O: 0.028529
and O
upstream I-GENE: 0.000414
upstream O: 0.000493
upstream O
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
sequences I-GENE: 0.001290
sequences O: 0.000947
sequences I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

ORF1 O: 0.000023
ORF1 O
( I-GENE: 0.006014
( O: 0.014858
( O
1029 I-GENE
bp I-GENE: 0.000122
bp O: 0.000617
bp O
; I-GENE: 0.000170
; O: 0.001399
; O
EMBL I-GENE
databank I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
Accession I-GENE
No O: 0.000174
No O
. I-GENE: 0.004017
. O: 0.044459
. O

Vector I-GENE
stocks I-GENE
containing I-GENE: 0.000414
containing O: 0.000837
containing O
envelope I-GENE: 0.000243
envelope O: 0.000014
envelope I-GENE
proteins I-GENE: 0.005673
proteins O: 0.000933
proteins I-GENE
from I-GENE: 0.000390
from O: 0.004210
from O
three O: 0.000785
three O
different O: 0.000669
different O
SIVmac I-GENE
clones O: 0.000223
clones O
, I-GENE: 0.001923
, O: 0.035091
, O
namely O: 0.000020
namely O
, I-GENE: 0.001923
, O: 0.035091
, O
SIVmac239 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
T I-GENE: 0.001558
T O: 0.000548
T I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
lymphocyte I-GENE: 0.000170
lymphocyte O: 0.000052
lymphocyte I-GENE
tropic I-GENE
[ O: 0.000382
[ O
T I-GENE: 0.001558
T O: 0.000548
T I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
tropic I-GENE
]), I-GENE
SIVmac316 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
macrophage I-GENE: 0.000243
macrophage O: 0.000017
macrophage I-GENE
tropic I-GENE
[ O: 0.000382
[ O
M I-GENE: 0.000682
M O: 0.000252
M I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
tropic I-GENE
]), I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
SIVmac1A11 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
dualtropic I-GENE
), O: 0.002269
), O
were O: 0.005244
were O
tested O: 0.000275
tested O
. I-GENE: 0.004017
. O: 0.044459
. O

ISS I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
acute O: 0.000359
acute O
physiology O: 0.000020
physiology O
and I-GENE: 0.003263
and O: 0.028529
and O
chronic O: 0.000304
chronic O
health O: 0.000070
health O
evaluation O: 0.000151
evaluation O
( I-GENE: 0.006014
( O: 0.014858
( O
APACHE I-GENE
II I-GENE: 0.003263
II O: 0.000362
II I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
calculated O: 0.000099
calculated O
on O: 0.003416
on O
admission O: 0.000014
admission O
. I-GENE: 0.004017
. O: 0.044459
. O

Ga O: 0.000017
Ga O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
67 O: 0.000067
67 O
and I-GENE: 0.003263
and O: 0.028529
and O
Tl O: 0.000014
Tl O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
201 O: 0.000046
201 O
scintigraphy O: 0.000020
scintigraphy O
in I-GENE: 0.000536
in O: 0.023304
in O
extramedullary I-GENE
plasmacytoma I-GENE
: I-GENE: 0.000243
: O: 0.002561
: O
a I-GENE: 0.000317
a O: 0.015893
a O
case O: 0.000220
case O
report O: 0.000304
report O
. I-GENE: 0.004017
. O: 0.044459
. O

Finally O: 0.000061
Finally O
, I-GENE: 0.001923
, O: 0.035091
, O
there O: 0.000275
there O
are O: 0.002918
are O
a I-GENE: 0.000317
a O: 0.015893
a O
growing O: 0.000029
growing O
number O: 0.000362
number O
of I-GENE: 0.002337
of O: 0.042520
of O
arguments I-GENE
favouring I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
use O: 0.000380
use O
of I-GENE: 0.002337
of O: 0.042520
of O
ACE I-GENE: 0.000243
ACE I-GENE
inhibitors O: 0.000162
inhibitors O
very O: 0.000223
very O
early I-GENE: 0.000706
early O: 0.000374
early I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
patients O: 0.002538
patients O
with O: 0.009756
with O
diabetes O: 0.000075
diabetes O
mellitus O: 0.000032
mellitus O
. I-GENE: 0.004017
. O: 0.044459
. O

This O: 0.000927
This O
paper O: 0.000078
paper O
describes O: 0.000029
describes O
the I-GENE: 0.000268
the O: 0.044902
the O
results O: 0.001162
results O
of I-GENE: 0.002337
of O: 0.042520
of O
an O: 0.003112
an O
initial O: 0.000154
initial O
study O: 0.001101
study O
on O: 0.003416
on O
the I-GENE: 0.000268
the O: 0.044902
the O
application O: 0.000081
application O
of I-GENE: 0.002337
of O: 0.042520
of O
linear O: 0.000052
linear O
solvation I-GENE
energy O: 0.000145
energy O
relationships O: 0.000070
relationships O
( I-GENE: 0.006014
( O: 0.014858
( O
LSERs I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
prediction O: 0.000023
prediction O
of I-GENE: 0.002337
of O: 0.042520
of O
internal O: 0.000142
internal O
standard O: 0.000133
standard O
compounds O: 0.000072
compounds O
in I-GENE: 0.000536
in O: 0.023304
in O
reversed O: 0.000052
reversed O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
phase O: 0.000417
phase O
liquid O: 0.000084
liquid O
chromatographic O: 0.000052
chromatographic O
( I-GENE: 0.006014
( O: 0.014858
( O
RPLC I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
method O: 0.000385
method O
development O: 0.000388
development O
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
38 O: 0.000081
38 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
year O: 0.000191
year O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
old O: 0.000139
old O
woman O: 0.000020
woman O
with O: 0.009756
with O
ulcerative I-GENE
colitis I-GENE
subsequently O: 0.000070
subsequently O
developed O: 0.000226
developed O
sarcoidosis I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Blood O: 0.000038
Blood O
from I-GENE: 0.000390
from O: 0.004210
from O
dams I-GENE
was O: 0.006960
was O
collected O: 0.000052
collected O
prior O: 0.000096
prior O
to I-GENE: 0.000195
to O: 0.014977
to O
inoculation I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
at O: 0.002976
at O
time O: 0.000542
time O
of I-GENE: 0.002337
of O: 0.042520
of O
necropsy I-GENE
for O: 0.006951
for O
measurement O: 0.000093
measurement O
of I-GENE: 0.002337
of O: 0.042520
of O
IgM I-GENE: 0.000487
IgM I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
IgG I-GENE: 0.001120
IgG I-GENE
antibodies I-GENE: 0.001144
antibodies O: 0.000159
antibodies I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
M I-GENE: 0.000682
M O: 0.000252
M I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
pulmonis I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

She I-GENE
has O: 0.001356
has O
since O: 0.000104
since O
developed O: 0.000226
developed O
a I-GENE: 0.000317
a O: 0.015893
a O
positive O: 0.000411
positive O
anti I-GENE: 0.001704
anti O: 0.000087
anti I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
cardiolipin I-GENE
antibody I-GENE: 0.000536
antibody O: 0.000159
antibody I-GENE
but O: 0.001675
but O
does O: 0.000272
does O
not O: 0.002509
not O
meet I-GENE
diagnostic O: 0.000107
diagnostic O
criteria O: 0.000075
criteria O
for O: 0.006951
for O
systemic O: 0.000087
systemic O
lupus O: 0.000026
lupus O
erythematosis I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
CONCLUSION O: 0.000113
CONCLUSION O
: I-GENE: 0.000243
: O: 0.002561
: O
The O: 0.007383
The O
presence O: 0.000466
presence O
of I-GENE: 0.002337
of O: 0.042520
of O
known O: 0.000359
known O
autoimmune I-GENE
disease O: 0.000632
disease O
in I-GENE: 0.000536
in O: 0.023304
in O
a I-GENE: 0.000317
a O: 0.015893
a O
woman O: 0.000020
woman O
with O: 0.009756
with O
POF I-GENE
should O: 0.000171
should O
not O: 0.002509
not O
dissuade I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
clinician I-GENE
from I-GENE: 0.000390
from O: 0.004210
from O
evaluating O: 0.000023
evaluating O
for O: 0.006951
for O
a I-GENE: 0.000317
a O: 0.015893
a O
potential O: 0.000336
potential O
genetic O: 0.000191
genetic O
cause O: 0.000136
cause O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
mutation I-GENE: 0.000560
mutation O: 0.000296
mutation I-GENE
experiments O: 0.000316
experiments O
showed O: 0.000863
showed O
that O: 0.008362
that O
the I-GENE: 0.000268
the O: 0.044902
the O
most O: 0.000400
most O
critical O: 0.000183
critical O
sequence I-GENE: 0.002021
sequence O: 0.001866
sequence I-GENE
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
repression O: 0.000174
repression O
of I-GENE: 0.002337
of O: 0.042520
of O
PTH I-GENE: 0.000243
PTH I-GENE
was O: 0.006960
was O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
'- I-GENE: 0.000414
'- O: 0.000481
'- O
GGGGGAGGGGAG I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
' I-GENE: 0.000950
' O: 0.001701
' O
(+ O: 0.000029
(+ O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
+ I-GENE: 0.001023
+ O: 0.000487
+ I-GENE
12 I-GENE: 0.000292
12 O: 0.000539
12 O
) I-GENE: 0.005210
) O: 0.009341
) O
of I-GENE: 0.002337
of O: 0.042520
of O
PTHSR I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Thus O: 0.000284
Thus O
, I-GENE: 0.001923
, O: 0.035091
, O
while O: 0.000403
while O
the I-GENE: 0.000268
the O: 0.044902
the O
folds I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
all O: 0.000762
all O
Myb I-GENE: 0.000463
Myb I-GENE
domains I-GENE: 0.000852
domains O: 0.000400
domains I-GENE
resemble I-GENE
each O: 0.000475
each O
other O: 0.000994
other O
closely O: 0.000127
closely O
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
function O: 0.000855
function O
of I-GENE: 0.002337
of O: 0.042520
of O
each O: 0.000475
each O
Myb I-GENE: 0.000463
Myb I-GENE
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
depends O: 0.000049
depends O
on O: 0.003416
on O
the I-GENE: 0.000268
the O: 0.044902
the O
amino I-GENE: 0.000560
amino O: 0.001116
amino O
acid I-GENE: 0.001315
acid O: 0.000997
acid I-GENE
residues I-GENE: 0.000146
residues O: 0.000426
residues O
that O: 0.008362
that O
are O: 0.002918
are O
located O: 0.000452
located O
on O: 0.003416
on O
the I-GENE: 0.000268
the O: 0.044902
the O
surface I-GENE: 0.000195
surface O: 0.000209
surface O
of I-GENE: 0.002337
of O: 0.042520
of O
each O: 0.000475
each O
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
cDNA I-GENE: 0.001802
cDNA O: 0.000640
cDNA I-GENE
clone I-GENE: 0.000122
clone O: 0.000240
clone O
encoding I-GENE: 0.000414
encoding O: 0.000562
encoding O
C2H2 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
type I-GENE: 0.003384
type O: 0.000884
type I-GENE
zinc I-GENE: 0.000560
zinc O: 0.000125
zinc I-GENE
finger I-GENE: 0.000584
finger O: 0.000090
finger I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
SCOF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
was O: 0.006960
was O
isolated O: 0.000585
isolated O
from I-GENE: 0.000390
from O: 0.004210
from O
soybean O: 0.000014
soybean O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
purpose O: 0.000038
purpose O
of I-GENE: 0.002337
of O: 0.042520
of O
this O: 0.001976
this O
study O: 0.001101
study O
was O: 0.006960
was O
to I-GENE: 0.000195
to O: 0.014977
to O
evaluate O: 0.000107
evaluate O
simplified I-GENE
methods O: 0.000142
methods O
for O: 0.006951
for O
estimation O: 0.000032
estimation O
of I-GENE: 0.002337
of O: 0.042520
of O
Technetium I-GENE
Tc O: 0.000041
Tc O
99m O: 0.000058
99m O
( I-GENE: 0.006014
( O: 0.014858
( O
99mTc O: 0.000067
99mTc O
)- I-GENE: 0.000609
)- O: 0.000269
)- I-GENE
pentetate I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
orthoiodohippurate I-GENE
I I-GENE: 0.004602
I O: 0.000487
I I-GENE
131 O: 0.000032
131 O
( I-GENE: 0.006014
( O: 0.014858
( O
131I O: 0.000014
131I O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
OIH I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
plasma I-GENE: 0.000609
plasma O: 0.000484
plasma I-GENE
clearance O: 0.000119
clearance O
in I-GENE: 0.000536
in O: 0.023304
in O
dogs O: 0.000130
dogs O
and I-GENE: 0.003263
and O: 0.028529
and O
cats O: 0.000055
cats O
with O: 0.009756
with O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
blood O: 0.000884
blood O
samples O: 0.000142
samples O
. I-GENE: 0.004017
. O: 0.044459
. O

Sevelamer I-GENE
hydrochloride I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
Renagel I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
is O: 0.006803
is O
a I-GENE: 0.000317
a O: 0.015893
a O
nonabsorbed I-GENE
phosphate I-GENE: 0.000219
phosphate O: 0.000070
phosphate I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
polymer I-GENE
marketed I-GENE
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
treatment O: 0.000921
treatment O
of I-GENE: 0.002337
of O: 0.042520
of O
hyperphosphatemia I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
adult O: 0.000162
adult O
patients O: 0.002538
patients O
receiving O: 0.000099
receiving O
hemodialysis O: 0.000029
hemodialysis O
. I-GENE: 0.004017
. O: 0.044459
. O

Using O: 0.000200
Using O
a I-GENE: 0.000317
a O: 0.015893
a O
novel O: 0.000385
novel O
method O: 0.000385
method O
combining I-GENE
chromatin O: 0.000078
chromatin O
immunoprecipitation O: 0.000026
immunoprecipitation O
and I-GENE: 0.003263
and O: 0.028529
and O
genomic I-GENE: 0.000122
genomic O: 0.000333
genomic O
array I-GENE
hybridization O: 0.000119
hybridization O
, I-GENE: 0.001923
, O: 0.035091
, O
we O: 0.001382
we O
have O: 0.001788
have O
identified O: 0.000823
identified O
a I-GENE: 0.000317
a O: 0.015893
a O
460 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
kb I-GENE: 0.000292
kb O: 0.000464
kb O
CENP I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
A I-GENE: 0.003530
A O: 0.002246
A I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
a I-GENE: 0.000317
a O: 0.015893
a O
neocentromere I-GENE
derived I-GENE: 0.000268
derived O: 0.000290
derived O
from I-GENE: 0.000390
from O: 0.004210
from O
the I-GENE: 0.000268
the O: 0.044902
the O
20p12 I-GENE
region I-GENE: 0.001583
region O: 0.001744
region O
of I-GENE: 0.002337
of O: 0.042520
of O
an O: 0.003112
an O
invdup I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
20p I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
marker O: 0.000096
marker O
chromosome O: 0.000307
chromosome O
. I-GENE: 0.004017
. O: 0.044459
. O

Cases I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
lung O: 0.000223
lung O
cancer O: 0.000284
cancer O
with O: 0.009756
with O
intramedullary I-GENE
metastasis O: 0.000041
metastasis O
are O: 0.002918
are O
rare O: 0.000058
rare O
, I-GENE: 0.001923
, O: 0.035091
, O
especially O: 0.000090
especially O
those O: 0.000461
those O
diagnosed O: 0.000067
diagnosed O
before O: 0.000296
before O
death O: 0.000136
death O
. I-GENE: 0.004017
. O: 0.044459
. O

Direct I-GENE
current O: 0.000081
current O
polarography I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
differential O: 0.000084
differential O
pulse O: 0.000041
pulse O
polarographic I-GENE
methods O: 0.000142
methods O
have O: 0.001788
have O
been O: 0.001229
been O
developed O: 0.000226
developed O
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
qualitative O: 0.000026
qualitative O
as O: 0.003654
as O
well O: 0.000626
well O
as O: 0.003654
as O
quantitative O: 0.000067
quantitative O
analysis O: 0.001194
analysis O
of I-GENE: 0.002337
of O: 0.042520
of O
vitamin I-GENE: 0.000122
vitamin O: 0.000133
vitamin O
B1 O: 0.000026
B1 O
, I-GENE: 0.001923
, O: 0.035091
, O
B2 O: 0.000014
B2 O
and I-GENE: 0.003263
and O: 0.028529
and O
B6 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Fluorimetric I-GENE
determination O: 0.000154
determination O
of I-GENE: 0.002337
of O: 0.042520
of O
methylmercury I-GENE
as O: 0.003654
as O
an O: 0.003112
an O
ion O: 0.000070
ion O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
association O: 0.000206
association O
complex I-GENE: 0.001315
complex O: 0.000588
complex I-GENE
with O: 0.009756
with O
rhodamine I-GENE
B I-GENE: 0.004066
B O: 0.000640
B I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
presence O: 0.000466
presence O
of I-GENE: 0.002337
of O: 0.042520
of O
iodide I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
corresponding O: 0.000252
corresponding O
genotype I-GENE
was O: 0.006960
was O
determined O: 0.000458
determined O
with O: 0.009756
with O
a I-GENE: 0.000317
a O: 0.015893
a O
restriction O: 0.000072
restriction O
enzyme I-GENE: 0.000706
enzyme O: 0.000307
enzyme I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
based O: 0.000287
based O
assay O: 0.000235
assay O
. I-GENE: 0.004017
. O: 0.044459
. O

Patients O: 0.000078
Patients O
were O: 0.005244
were O
divided O: 0.000075
divided O
into O: 0.000785
into O
two O: 0.001904
two O
group I-GENE: 0.000414
group O: 0.000869
group O
; I-GENE: 0.000170
; O: 0.001399
; O
Control O: 0.000029
Control O
group I-GENE: 0.000414
group O: 0.000869
group O
A I-GENE: 0.003530
A O: 0.002246
A I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
which O: 0.002472
which O
a I-GENE: 0.000317
a O: 0.015893
a O
hot O: 0.000029
hot O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
water O: 0.000177
water O
circulating O: 0.000043
circulating O
system O: 0.000524
system O
was O: 0.006960
was O
used O: 0.000808
used O
and I-GENE: 0.003263
and O: 0.028529
and O
group I-GENE: 0.000414
group O: 0.000869
group O
B I-GENE: 0.004066
B O: 0.000640
B I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
which O: 0.002472
which O
a I-GENE: 0.000317
a O: 0.015893
a O
transtracheal I-GENE
heating I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
humidification I-GENE
system O: 0.000524
system O
by O: 0.006887
by O
ANAMED I-GENE
HUMITUBE I-GENE
was O: 0.006960
was O
used O: 0.000808
used O
, I-GENE: 0.001923
, O: 0.035091
, O
during O: 0.001095
during O
gastric O: 0.000119
gastric O
cancer O: 0.000284
cancer O
operation O: 0.000067
operation O
. I-GENE: 0.004017
. O: 0.044459
. O

Mental I-GENE
rotation I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
paired I-GENE: 0.000146
paired O: 0.000020
paired I-GENE
figures I-GENE
engendered I-GENE
activation I-GENE: 0.000365
activation O: 0.001153
activation O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
left O: 0.000264
left O
superior O: 0.000035
superior O
parietal I-GENE
lobule I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
right O: 0.000180
right O
frontal O: 0.000032
frontal O
medial O: 0.000043
medial O
gyrus O: 0.000020
gyrus O
. I-GENE: 0.004017
. O: 0.044459
. O

Here O: 0.000214
Here O
we O: 0.001382
we O
demonstrate O: 0.000290
demonstrate O
that O: 0.008362
that O
the I-GENE: 0.000268
the O: 0.044902
the O
Ras I-GENE: 0.001923
Ras I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
activated I-GENE: 0.001412
activated O: 0.000356
activated I-GENE
Raf I-GENE: 0.000755
Raf I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
MEK I-GENE: 0.000584
MEK I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
extracellular I-GENE: 0.000317
extracellular O: 0.000104
extracellular I-GENE
signal I-GENE: 0.000536
signal O: 0.000362
signal I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
regulated I-GENE: 0.000268
regulated O: 0.000368
regulated O
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
ERK I-GENE: 0.000633
ERK I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
signaling O: 0.000293
signaling O
pathway O: 0.000385
pathway O
can O: 0.000924
can O
specifically O: 0.000206
specifically O
control I-GENE: 0.000170
control O: 0.000834
control O
the I-GENE: 0.000268
the O: 0.044902
the O
expression O: 0.002231
expression O
of I-GENE: 0.002337
of O: 0.042520
of O
individual O: 0.000107
individual O
integrin I-GENE: 0.000341
integrin I-GENE
subunits I-GENE: 0.000560
subunits O: 0.000133
subunits I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
a I-GENE: 0.000317
a O: 0.015893
a O
variety O: 0.000127
variety O
of I-GENE: 0.002337
of O: 0.042520
of O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
mouse I-GENE: 0.001680
mouse O: 0.000403
mouse I-GENE
cell I-GENE: 0.001144
cell O: 0.001927
cell O
lines O: 0.000287
lines O
. I-GENE: 0.004017
. O: 0.044459
. O

These O: 0.000979
These O
TxRE I-GENE
contain O: 0.000246
contain O
cyclic I-GENE: 0.000195
cyclic O: 0.000052
cyclic I-GENE
AMP I-GENE: 0.000268
AMP O: 0.000052
AMP I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
responsive I-GENE: 0.000414
responsive O: 0.000185
responsive I-GENE
elements I-GENE: 0.000414
elements O: 0.000493
elements O
( I-GENE: 0.006014
( O: 0.014858
( O
CRE O: 0.000116
CRE O
), O: 0.002269
), O
but O: 0.001675
but O
, I-GENE: 0.001923
, O: 0.035091
, O
remarkably O: 0.000014
remarkably O
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
" I-GENE: 0.000170
" O: 0.000449
" O
TGACGTCA I-GENE
" I-GENE: 0.000170
" O: 0.000449
" O
consensus I-GENE: 0.000317
consensus O: 0.000246
consensus I-GENE
is O: 0.006803
is O
never O: 0.000014
never O
strictly O: 0.000014
strictly O
conserved O: 0.000507
conserved O
in I-GENE: 0.000536
in O: 0.023304
in O
any O: 0.000264
any O
viral I-GENE: 0.000487
viral O: 0.000185
viral I-GENE
strain O: 0.000162
strain O
( I-GENE: 0.006014
( O: 0.014858
( O
e O: 0.000209
e O
. I-GENE: 0.004017
. O: 0.044459
. O
g O: 0.000307
g O
., O: 0.000446
., O
AGACGTCA I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
TGACGGCA I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
TGACCTCA I-GENE
). O: 0.002228
). O

The O: 0.007383
The O
hatcher I-GENE
incubators I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
both O: 0.001631
both O
companies I-GENE
were O: 0.005244
were O
also O: 0.001373
also O
persistently I-GENE
contaminated O: 0.000020
contaminated O
with O: 0.009756
with O
Salmonella I-GENE
livingstone I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
Salmonella I-GENE
thomasville I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
company I-GENE
A I-GENE: 0.003530
A O: 0.002246
A I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
with O: 0.009756
with O
Salmonella I-GENE
senftenberg I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
company I-GENE
B I-GENE: 0.004066
B O: 0.000640
B I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Binding O: 0.000032
Binding O
of I-GENE: 0.002337
of O: 0.042520
of O
cell I-GENE: 0.001144
cell O: 0.001927
cell O
type I-GENE: 0.003384
type O: 0.000884
type I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
nuclear I-GENE: 0.001826
nuclear O: 0.000614
nuclear I-GENE
proteins I-GENE: 0.005673
proteins O: 0.000933
proteins I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
'- I-GENE: 0.000414
'- O: 0.000481
'- O
flanking I-GENE: 0.000219
flanking O: 0.000272
flanking O
region I-GENE: 0.001583
region O: 0.001744
region O
of I-GENE: 0.002337
of O: 0.042520
of O
maize O: 0.000023
maize O
C4 I-GENE
phosphoenolpyruvate I-GENE: 0.000122
phosphoenolpyruvate I-GENE
carboxylase I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
confers O: 0.000026
confers O
its O: 0.001020
its O
differential O: 0.000084
differential O
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
mesophyll I-GENE
cells O: 0.002663
cells O
. I-GENE: 0.004017
. O: 0.044459
. O

Susceptibility I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
ischemia O: 0.000087
ischemia O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
induced O: 0.001176
induced O
arrhythmias O: 0.000035
arrhythmias O
was O: 0.006960
was O
lower O: 0.000298
lower O
in I-GENE: 0.000536
in O: 0.023304
in O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
week O: 0.000125
week O
diabetics I-GENE
: I-GENE: 0.000243
: O: 0.002561
: O
only O: 0.000794
only O
42 O: 0.000110
42 O
% O: 0.001741
% O
of I-GENE: 0.002337
of O: 0.042520
of O
diabetic O: 0.000052
diabetic O
hearts O: 0.000029
hearts O
exhibited O: 0.000087
exhibited O
ventricular O: 0.000194
ventricular O
tachycardia O: 0.000026
tachycardia O
( I-GENE: 0.006014
( O: 0.014858
( O
VT O: 0.000029
VT O
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
16 I-GENE: 0.000243
16 O: 0.000348
16 O
% O: 0.001741
% O
had O: 0.000890
had O
short O: 0.000214
short O
episodes O: 0.000041
episodes O
of I-GENE: 0.002337
of O: 0.042520
of O
ventricular O: 0.000194
ventricular O
fibrillation O: 0.000017
fibrillation O
( I-GENE: 0.006014
( O: 0.014858
( O
VF O: 0.000017
VF O
) I-GENE: 0.005210
) O: 0.009341
) O
as O: 0.003654
as O
compared O: 0.000603
compared O
to I-GENE: 0.000195
to O: 0.014977
to O
VT O: 0.000029
VT O
100 O: 0.000400
100 O
% O: 0.001741
% O
and I-GENE: 0.003263
and O: 0.028529
and O
VF O: 0.000017
VF O
70 I-GENE: 0.000414
70 O: 0.000159
70 I-GENE
% O: 0.001741
% O
( I-GENE: 0.006014
( O: 0.014858
( O
including O: 0.000446
including O
sustained O: 0.000043
sustained O
VF O: 0.000017
VF O
36 O: 0.000072
36 O
%) O: 0.000385
%) O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
non I-GENE: 0.000292
non O: 0.000449
non O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
diabetics I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
P I-GENE: 0.001023
P O: 0.000614
P I-GENE
< O: 0.000455
< O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
05 O: 0.000287
05 O
). O: 0.002228
). O

CONCLUSIONS O: 0.000104
CONCLUSIONS O
: I-GENE: 0.000243
: O: 0.002561
: O
The O: 0.007383
The O
methodology I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
LHR I-GENE: 0.000146
LHR I-GENE
measurement O: 0.000093
measurement O
significantly O: 0.000733
significantly O
influences O: 0.000023
influences O
the I-GENE: 0.000268
the O: 0.044902
the O
clinical O: 0.000417
clinical O
contribution O: 0.000032
contribution O
of I-GENE: 0.002337
of O: 0.042520
of O
Tl O: 0.000014
Tl O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
201 O: 0.000046
201 O
lung O: 0.000223
lung O
uptake O: 0.000122
uptake O
evaluation O: 0.000151
evaluation O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
authors O: 0.000064
authors O
made O: 0.000154
made O
an O: 0.003112
an O
analysis O: 0.001194
analysis O
of I-GENE: 0.002337
of O: 0.042520
of O
social O: 0.000032
social O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
economical I-GENE
conditions O: 0.000261
conditions O
limiting O: 0.000032
limiting O
the I-GENE: 0.000268
the O: 0.044902
the O
possibilities O: 0.000020
possibilities O
of I-GENE: 0.002337
of O: 0.042520
of O
rendering I-GENE
cardiosurgical I-GENE
care O: 0.000107
care O
to I-GENE: 0.000195
to O: 0.014977
to O
children O: 0.000307
children O
. I-GENE: 0.004017
. O: 0.044459
. O

METHODS O: 0.000139
METHODS O
: I-GENE: 0.000243
: O: 0.002561
: O
Experiments O: 0.000026
Experiments O
testing O: 0.000090
testing O
the I-GENE: 0.000268
the O: 0.044902
the O
new O: 0.000464
new O
catheter O: 0.000038
catheter O
and I-GENE: 0.003263
and O: 0.028529
and O
comparing O: 0.000046
comparing O
it O: 0.000733
it O
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
existing O: 0.000026
existing O
catheter O: 0.000038
catheter O
included O: 0.000139
included O
: I-GENE: 0.000243
: O: 0.002561
: O
( I-GENE: 0.006014
( O: 0.014858
( O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
measurement O: 0.000093
measurement O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
laser O: 0.000049
laser O
output O: 0.000055
output O
beam O: 0.000014
beam O
sizes O: 0.000032
sizes O
and I-GENE: 0.003263
and O: 0.028529
and O
divergences I-GENE
; I-GENE: 0.000170
; O: 0.001399
; O
( I-GENE: 0.006014
( O: 0.014858
( O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
evaluation O: 0.000151
evaluation O
of I-GENE: 0.002337
of O: 0.042520
of O
particulate O: 0.000017
particulate O
matter O: 0.000029
matter O
generation O: 0.000061
generation O
during O: 0.001095
during O
ablation O: 0.000014
ablation O
of I-GENE: 0.002337
of O: 0.042520
of O
atherosclerotic I-GENE
tissue I-GENE: 0.000536
tissue O: 0.000388
tissue I-GENE
; I-GENE: 0.000170
; O: 0.001399
; O
( I-GENE: 0.006014
( O: 0.014858
( O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
measurement O: 0.000093
measurement O
of I-GENE: 0.002337
of O: 0.042520
of O
ablation O: 0.000014
ablation O
hole I-GENE
sizes O: 0.000032
sizes O
and I-GENE: 0.003263
and O: 0.028529
and O
tissue I-GENE: 0.000536
tissue O: 0.000388
tissue I-GENE
penetration O: 0.000014
penetration O
rates O: 0.000162
rates O
; I-GENE: 0.000170
; O: 0.001399
; O
( I-GENE: 0.006014
( O: 0.014858
( O
4 I-GENE: 0.002362
4 O: 0.001307
4 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
histopathologic I-GENE
examination O: 0.000096
examination O
of I-GENE: 0.002337
of O: 0.042520
of O
laser O: 0.000049
laser O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
induced O: 0.001176
induced O
in I-GENE: 0.000536
in O: 0.023304
in O
vivo O: 0.000464
vivo O
vessel O: 0.000023
vessel O
wall O: 0.000107
wall O
injury O: 0.000107
injury O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
reproductive O: 0.000041
reproductive O
effects O: 0.000652
effects O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
administration O: 0.000301
administration O
of I-GENE: 0.002337
of O: 0.042520
of O
4 I-GENE: 0.002362
4 O: 0.001307
4 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
chloro I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
methylphenoxyacetic I-GENE
acid I-GENE: 0.001315
acid O: 0.000997
acid I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
MCPA I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
to I-GENE: 0.000195
to O: 0.014977
to O
rats O: 0.000501
rats O
were O: 0.005244
were O
evaluated O: 0.000203
evaluated O
through O: 0.000403
through O
two O: 0.001904
two O
generations I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
from I-GENE: 0.000390
from O: 0.004210
from O
prior O: 0.000096
prior O
to I-GENE: 0.000195
to O: 0.014977
to O
mating O: 0.000026
mating O
, I-GENE: 0.001923
, O: 0.035091
, O
throughout O: 0.000101
throughout O
mating O: 0.000026
mating O
, I-GENE: 0.001923
, O: 0.035091
, O
to I-GENE: 0.000195
to O: 0.014977
to O
gestation O: 0.000046
gestation O
and I-GENE: 0.003263
and O: 0.028529
and O
lactation I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Here O: 0.000214
Here O
we O: 0.001382
we O
suggest O: 0.000585
suggest O
that O: 0.008362
that O
uvrA I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
nucleotide I-GENE: 0.000317
nucleotide O: 0.000310
nucleotide I-GENE
excision O: 0.000038
excision O
repair I-GENE: 0.000146
repair O: 0.000110
repair I-GENE
pathway O: 0.000385
pathway O
are O: 0.002918
are O
involved O: 0.000539
involved O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
repair I-GENE: 0.000146
repair O: 0.000110
repair I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
acid I-GENE: 0.001315
acid O: 0.000997
acid I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
induced O: 0.001176
induced O
DNA I-GENE: 0.002118
DNA O: 0.001791
DNA I-GENE
damage O: 0.000119
damage O
and I-GENE: 0.003263
and O: 0.028529
and O
are O: 0.002918
are O
associated I-GENE: 0.000755
associated O: 0.000716
associated I-GENE
with O: 0.009756
with O
successful O: 0.000049
successful O
adaptation O: 0.000035
adaptation O
of I-GENE: 0.002337
of O: 0.042520
of O
S I-GENE: 0.001631
S O: 0.000449
S I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
mutans I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
low I-GENE: 0.000146
low O: 0.000440
low O
pH O: 0.000116
pH O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
improved O: 0.000084
improved O
CSF I-GENE: 0.001339
CSF O: 0.000029
CSF I-GENE
outflow O: 0.000023
outflow O
conductance O: 0.000014
conductance O
may O: 0.001078
may O
increase O: 0.000513
increase O
the I-GENE: 0.000268
the O: 0.044902
the O
intracranial I-GENE
compliance O: 0.000020
compliance O
and I-GENE: 0.003263
and O: 0.028529
and O
thereby O: 0.000058
thereby O
dampen I-GENE
a I-GENE: 0.000317
a O: 0.015893
a O
pathological O: 0.000041
pathological O
ICP I-GENE
waveform I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

These O: 0.000979
These O
studies O: 0.000678
studies O
demonstrate O: 0.000290
demonstrate O
that O: 0.008362
that O
site I-GENE: 0.003092
site O: 0.001040
site I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
recognition I-GENE: 0.000292
recognition O: 0.000145
recognition I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
bxd I-GENE
PRE I-GENE
by O: 0.006887
by O
d I-GENE: 0.000122
d O: 0.000180
d O
( I-GENE: 0.006014
( O: 0.014858
( O
GA I-GENE
)( I-GENE: 0.000146
)( O: 0.000017
)( I-GENE
n O: 0.000264
n O
) I-GENE: 0.005210
) O: 0.009341
) O
repeat I-GENE: 0.000317
repeat O: 0.000209
repeat I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
activities O: 0.000261
activities O
mediates O: 0.000075
mediates O
PcG I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
dependent I-GENE: 0.001485
dependent O: 0.000800
dependent I-GENE
silencing O: 0.000043
silencing O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
gonadotrope I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
regulated I-GENE: 0.000268
regulated O: 0.000368
regulated O
expression O: 0.002231
expression O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
GnRH I-GENE: 0.000390
GnRH I-GENE
receptor I-GENE: 0.006817
receptor O: 0.000258
receptor I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
GnRH I-GENE: 0.000390
GnRH I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
R I-GENE: 0.001023
R O: 0.000154
R I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
is O: 0.006803
is O
dependent I-GENE: 0.001485
dependent O: 0.000800
dependent I-GENE
on O: 0.003416
on O
multiple O: 0.000409
multiple O
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
factors I-GENE: 0.001388
factors O: 0.000626
factors I-GENE
that O: 0.008362
that O
interact O: 0.000127
interact O
with O: 0.009756
with O
the I-GENE: 0.000268
the O: 0.044902
the O
noncanonical I-GENE
GnRH I-GENE: 0.000390
GnRH I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
R I-GENE: 0.001023
R O: 0.000154
R I-GENE
activating I-GENE: 0.000803
activating O: 0.000104
activating I-GENE
sequence I-GENE: 0.002021
sequence O: 0.001866
sequence I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
GRAS I-GENE
), O: 0.002269
), O
the I-GENE: 0.000268
the O: 0.044902
the O
activator I-GENE: 0.001120
activator O: 0.000093
activator I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
AP I-GENE: 0.002630
AP O: 0.000017
AP I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
element I-GENE: 0.001680
element O: 0.000577
element I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
steroidogenic I-GENE
factor I-GENE: 0.008984
factor O: 0.000510
factor I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
SF I-GENE: 0.000341
SF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
site I-GENE: 0.003092
site O: 0.001040
site I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Before I-GENE
PO3 I-GENE
administration O: 0.000301
administration O
, I-GENE: 0.001923
, O: 0.035091
, O
more O: 0.000687
more O
than O: 0.001657
than O
half O: 0.000145
half O
( I-GENE: 0.006014
( O: 0.014858
( O
57 O: 0.000064
57 O
. I-GENE: 0.004017
. O: 0.044459
. O
4 I-GENE: 0.002362
4 O: 0.001307
4 I-GENE
%) O: 0.000385
%) O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
patients O: 0.002538
patients O
received O: 0.000226
received O
only O: 0.000794
only O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
antituberculous I-GENE
drugs O: 0.000159
drugs O
( I-GENE: 0.006014
( O: 0.014858
( O
ethambutole I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
ethionamide I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
ethambutole I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
oprofloxacin I-GENE
). O: 0.002228
). O

Using O: 0.000200
Using O
the I-GENE: 0.000268
the O: 0.044902
the O
presented O: 0.000156
presented O
categorical I-GENE
structure O: 0.000513
structure O
as O: 0.003654
as O
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
model O: 0.000327
model O
a I-GENE: 0.000317
a O: 0.015893
a O
prototype O: 0.000017
prototype O
DSS I-GENE
for O: 0.006951
for O
dipslide I-GENE
urine O: 0.000081
urine O
cultures O: 0.000075
cultures O
has O: 0.001356
has O
been O: 0.001229
been O
developed O: 0.000226
developed O
. I-GENE: 0.004017
. O: 0.044459
. O

Conclusion I-GENE
: I-GENE: 0.000243
: O: 0.002561
: O
The O: 0.007383
The O
Lp I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
a I-GENE: 0.000317
a O: 0.015893
a O
) I-GENE: 0.005210
) O: 0.009341
) O
levels O: 0.001304
levels O
in I-GENE: 0.000536
in O: 0.023304
in O
these O: 0.001478
these O
children O: 0.000307
children O
were O: 0.005244
were O
the I-GENE: 0.000268
the O: 0.044902
the O
lower O: 0.000298
lower O
ever I-GENE
reported O: 0.000278
reported O
. I-GENE: 0.004017
. O: 0.044459
. O

Foxp1 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
Foxp2 I-GENE
are O: 0.002918
are O
expressed O: 0.000840
expressed O
at O: 0.002976
at O
high I-GENE: 0.000341
high O: 0.000924
high O
levels O: 0.001304
levels O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
lung O: 0.000223
lung O
as O: 0.003654
as O
early I-GENE: 0.000706
early O: 0.000374
early I-GENE
as O: 0.003654
as O
E12 I-GENE: 0.000268
E12 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
mouse I-GENE: 0.001680
mouse O: 0.000403
mouse I-GENE
development O: 0.000388
development O
with O: 0.009756
with O
Foxp2 I-GENE
expression O: 0.002231
expression O
restricted O: 0.000099
restricted O
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
airway O: 0.000049
airway O
epithelium O: 0.000035
epithelium O
. I-GENE: 0.004017
. O: 0.044459
. O

Audiological I-GENE
findings O: 0.000258
findings O
in I-GENE: 0.000536
in O: 0.023304
in O
pregnancy O: 0.000127
pregnancy O
. I-GENE: 0.004017
. O: 0.044459
. O

Children O: 0.000017
Children O
who O: 0.000348
who O
developed O: 0.000226
developed O
lower O: 0.000298
lower O
respiratory O: 0.000116
respiratory O
tract O: 0.000084
tract O
infections O: 0.000096
infections O
or I-GENE: 0.000219
or O: 0.003321
or O
PCP I-GENE
had O: 0.000890
had O
increased O: 0.000817
increased O
rates O: 0.000162
rates O
of I-GENE: 0.002337
of O: 0.042520
of O
decline O: 0.000029
decline O
of I-GENE: 0.002337
of O: 0.042520
of O
CD4 I-GENE: 0.000536
CD4 I-GENE
cell I-GENE: 0.001144
cell O: 0.001927
cell O
counts O: 0.000064
counts O
during O: 0.001095
during O
the I-GENE: 0.000268
the O: 0.044902
the O
first O: 0.000591
first O
6 I-GENE: 0.002118
6 O: 0.001153
6 I-GENE
months O: 0.000246
months O
of I-GENE: 0.002337
of O: 0.042520
of O
life O: 0.000125
life O
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
randomized O: 0.000070
randomized O
mix I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
180 O: 0.000029
180 O
sections O: 0.000023
sections O
( I-GENE: 0.006014
( O: 0.014858
( O
10 I-GENE: 0.000292
10 O: 0.000936
10 O
samples O: 0.000142
samples O
x O: 0.000200
x O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
tissues O: 0.000235
tissues O
x O: 0.000200
x O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
stains I-GENE
x O: 0.000200
x O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
gave O: 0.000052
gave O
90 O: 0.000180
90 O
matched O: 0.000049
matched O
pairs O: 0.000145
pairs O
. I-GENE: 0.004017
. O: 0.044459
. O

Sural I-GENE
nerve I-GENE: 0.000146
nerve O: 0.000072
nerve I-GENE
biopsy O: 0.000052
biopsy O
showed O: 0.000863
showed O
mild O: 0.000081
mild O
thickening I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
perineurium I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
vascular I-GENE: 0.000146
vascular O: 0.000084
vascular I-GENE
alterations O: 0.000104
alterations O
with O: 0.009756
with O
inflammatory O: 0.000101
inflammatory O
cell I-GENE: 0.001144
cell O: 0.001927
cell O
infiltration I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
perineurium I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
remarkable O: 0.000029
remarkable O
loss O: 0.000226
loss O
of I-GENE: 0.002337
of O: 0.042520
of O
large I-GENE: 0.000146
large O: 0.000278
large O
and I-GENE: 0.003263
and O: 0.028529
and O
small I-GENE: 0.000682
small O: 0.000290
small I-GENE
myelinated I-GENE
fibers O: 0.000043
fibers O
. I-GENE: 0.004017
. O: 0.044459
. O

OBJECTIVES O: 0.000017
OBJECTIVES O
: I-GENE: 0.000243
: O: 0.002561
: O
The O: 0.007383
The O
objective O: 0.000035
objective O
of I-GENE: 0.002337
of O: 0.042520
of O
this O: 0.001976
this O
review O: 0.000070
review O
was O: 0.006960
was O
to I-GENE: 0.000195
to O: 0.014977
to O
assess O: 0.000087
assess O
the I-GENE: 0.000268
the O: 0.044902
the O
effects O: 0.000652
effects O
of I-GENE: 0.002337
of O: 0.042520
of O
prophylactic O: 0.000014
prophylactic O
prostaglandin O: 0.000070
prostaglandin O
use O: 0.000380
use O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
third O: 0.000162
third O
stage O: 0.000183
stage O
of I-GENE: 0.002337
of O: 0.042520
of O
labour O: 0.000023
labour O
. I-GENE: 0.004017
. O: 0.044459
. O

Testing I-GENE
was O: 0.006960
was O
associated I-GENE: 0.000755
associated O: 0.000716
associated I-GENE
with O: 0.009756
with O
a I-GENE: 0.000317
a O: 0.015893
a O
history O: 0.000104
history O
of I-GENE: 0.002337
of O: 0.042520
of O
nonsexual I-GENE
risk O: 0.000313
risk O
behavior O: 0.000101
behavior O
, I-GENE: 0.001923
, O: 0.035091
, O
increased O: 0.000817
increased O
knowledge O: 0.000041
knowledge O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
hepatitis I-GENE: 0.000243
hepatitis O: 0.000243
hepatitis I-GENE
C I-GENE: 0.005113
C O: 0.001005
C I-GENE
virus I-GENE: 0.001437
virus O: 0.000669
virus I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
healthcare I-GENE
provider I-GENE
communication I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Cytomegalovirus I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
Chlamydia O: 0.000014
Chlamydia O
pneumoniae O: 0.000017
pneumoniae O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
Helicobacter I-GENE
pylori O: 0.000029
pylori O
IgG I-GENE: 0.001120
IgG I-GENE
antibodies I-GENE: 0.001144
antibodies O: 0.000159
antibodies I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
restenosis I-GENE
after O: 0.001385
after O
stent I-GENE
implantation O: 0.000017
implantation O
: I-GENE: 0.000243
: O: 0.002561
: O
an O: 0.003112
an O
angiographic O: 0.000017
angiographic O
and I-GENE: 0.003263
and O: 0.028529
and O
intravascular O: 0.000017
intravascular O
ultrasound O: 0.000032
ultrasound O
study O: 0.001101
study O
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
month O: 0.000067
month O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
old O: 0.000139
old O
infant O: 0.000023
infant O
with O: 0.009756
with O
persistent O: 0.000035
persistent O
congenital O: 0.000061
congenital O
stridor I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
acute O: 0.000359
acute O
respiratory O: 0.000116
respiratory O
distress O: 0.000020
distress O
is O: 0.006803
is O
presented O: 0.000156
presented O
. I-GENE: 0.004017
. O: 0.044459
. O

OBJECTIVE O: 0.000061
OBJECTIVE O
: I-GENE: 0.000243
: O: 0.002561
: O
To O: 0.000522
To O
determine O: 0.000255
determine O
whether O: 0.000220
whether O
RSTD I-GENE
predicts O: 0.000023
predicts O
coronary O: 0.000174
coronary O
anatomy I-GENE
during O: 0.001095
during O
acute O: 0.000359
acute O
coronary O: 0.000174
coronary O
occlusion O: 0.000055
occlusion O
. I-GENE: 0.004017
. O: 0.044459
. O

Even I-GENE
if O: 0.000127
if O
the I-GENE: 0.000268
the O: 0.044902
the O
electrocardiographic I-GENE
signs O: 0.000058
signs O
are O: 0.002918
are O
subdued I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
underlying O: 0.000043
underlying O
blockade O: 0.000049
blockade O
of I-GENE: 0.002337
of O: 0.042520
of O
I I-GENE: 0.004602
I O: 0.000487
I I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
Kr I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
current O: 0.000081
current O
may O: 0.001078
may O
precipitate I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
occurrence O: 0.000061
occurrence O
of I-GENE: 0.002337
of O: 0.042520
of O
arrhythmia I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Acetoin I-GENE
can O: 0.000924
can O
be O: 0.002370
be O
reused I-GENE
by O: 0.006887
by O
the I-GENE: 0.000268
the O: 0.044902
the O
bacteria O: 0.000087
bacteria O
during O: 0.001095
during O
stationary O: 0.000014
stationary O
phase O: 0.000417
phase O
when O: 0.000690
when O
other O: 0.000994
other O
carbon O: 0.000055
carbon O
sources O: 0.000029
sources O
have O: 0.001788
have O
been O: 0.001229
been O
depleted O: 0.000029
depleted O
. I-GENE: 0.004017
. O: 0.044459
. O

Analysis O: 0.000177
Analysis O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
sequence I-GENE: 0.002021
sequence O: 0.001866
sequence I-GENE
revealed O: 0.000643
revealed O
the I-GENE: 0.000268
the O: 0.044902
the O
presence O: 0.000466
presence O
of I-GENE: 0.002337
of O: 0.042520
of O
a I-GENE: 0.000317
a O: 0.015893
a O
major I-GENE: 0.000341
major O: 0.000333
major I-GENE
transcriptional I-GENE: 0.000268
transcriptional O: 0.000672
transcriptional O
start O: 0.000203
start O
site I-GENE: 0.003092
site O: 0.001040
site I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
a I-GENE: 0.000317
a O: 0.015893
a O
canonical O: 0.000023
canonical O
TATA I-GENE: 0.000390
TATA O: 0.000243
TATA I-GENE
box I-GENE: 0.000901
box O: 0.000313
box I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
putative O: 0.000348
putative O
cis I-GENE: 0.000146
cis O: 0.000200
cis O
regulatory I-GENE: 0.000901
regulatory O: 0.000458
regulatory I-GENE
elements I-GENE: 0.000414
elements O: 0.000493
elements O
for O: 0.006951
for O
pituitary I-GENE: 0.000268
pituitary O: 0.000064
pituitary I-GENE
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
expression O: 0.002231
expression O
as O: 0.003654
as O
well O: 0.000626
well O
as O: 0.003654
as O
an O: 0.003112
an O
E I-GENE: 0.001583
E O: 0.000301
E I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
responsive I-GENE: 0.000414
responsive O: 0.000185
responsive I-GENE
element I-GENE: 0.001680
element O: 0.000577
element I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

IL I-GENE: 0.003019
IL I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1beta I-GENE: 0.000268
1beta I-GENE
was O: 0.006960
was O
significantly O: 0.000733
significantly O
higher O: 0.000469
higher O
in I-GENE: 0.000536
in O: 0.023304
in O
endometrioma I-GENE
than O: 0.001657
than O
in I-GENE: 0.000536
in O: 0.023304
in O
lesions O: 0.000200
lesions O
of I-GENE: 0.002337
of O: 0.042520
of O
other O: 0.000994
other O
localizations I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

An O: 0.000287
An O
economic I-GENE
analysis O: 0.001194
analysis O
using O: 0.000979
using O
West I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
Scotland I-GENE
Coronary O: 0.000017
Coronary O
Prevention O: 0.000014
Prevention O
Study O: 0.000070
Study O
( I-GENE: 0.006014
( O: 0.014858
( O
WOSCOPS I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
findings O: 0.000258
findings O
indicates O: 0.000156
indicates O
that O: 0.008362
that O
statin I-GENE
treatment O: 0.000921
treatment O
would O: 0.000107
would O
have O: 0.001788
have O
prevented O: 0.000064
prevented O
318 I-GENE
events O: 0.000139
events O
per O: 0.000293
per O
10 I-GENE: 0.000292
10 O: 0.000936
10 O
, I-GENE: 0.001923
, O: 0.035091
, O
000 O: 0.000159
000 O
patients O: 0.002538
patients O
in I-GENE: 0.000536
in O: 0.023304
in O
a I-GENE: 0.000317
a O: 0.015893
a O
population O: 0.000136
population O
similar O: 0.000574
similar O
to I-GENE: 0.000195
to O: 0.014977
to O
that O: 0.008362
that O
in I-GENE: 0.000536
in O: 0.023304
in O
WOSCOPS I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
average O: 0.000127
average O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
% O: 0.001741
% O
annual O: 0.000014
annual O
risk O: 0.000313
risk O
of I-GENE: 0.002337
of O: 0.042520
of O
a I-GENE: 0.000317
a O: 0.015893
a O
cardiovascular O: 0.000041
cardiovascular O
event O: 0.000052
event O
) I-GENE: 0.005210
) O: 0.009341
) O
at O: 0.002976
at O
a I-GENE: 0.000317
a O: 0.015893
a O
discounted I-GENE
cost O: 0.000061
cost O
per O: 0.000293
per O
life O: 0.000125
life O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
year O: 0.000191
year O
gained I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
20 I-GENE: 0.000146
20 O: 0.000484
20 O
, I-GENE: 0.001923
, O: 0.035091
, O
375 I-GENE
pounds I-GENE
($ I-GENE
31 O: 0.000145
31 O
, I-GENE: 0.001923
, O: 0.035091
, O
818 I-GENE
). O: 0.002228
). O

Hydrogels I-GENE
for O: 0.006951
for O
tissue I-GENE: 0.000536
tissue O: 0.000388
tissue I-GENE
engineering I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

No O: 0.000174
No O
mutation I-GENE: 0.000560
mutation O: 0.000296
mutation I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
NRL I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
was O: 0.006960
was O
found O: 0.001026
found O
in I-GENE: 0.000536
in O: 0.023304
in O
any O: 0.000264
any O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
two O: 0.001904
two O
families O: 0.000058
families O
. I-GENE: 0.004017
. O: 0.044459
. O

However O: 0.000417
However O
, I-GENE: 0.001923
, O: 0.035091
, O
most O: 0.000400
most O
produced O: 0.000319
produced O
significant O: 0.000687
significant O
alteration O: 0.000020
alteration O
of I-GENE: 0.002337
of O: 0.042520
of O
small I-GENE: 0.000682
small O: 0.000290
small I-GENE
intestinal O: 0.000052
intestinal O
permeability O: 0.000014
permeability O
. I-GENE: 0.004017
. O: 0.044459
. O

Our O: 0.000235
Our O
results O: 0.001162
results O
show O: 0.000484
show O
that O: 0.008362
that O
CVN I-GENE
specifically O: 0.000206
specifically O
recognizes O: 0.000023
recognizes O
with O: 0.009756
with O
nanomolar I-GENE
affinity O: 0.000229
affinity O
Man I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
9 I-GENE: 0.000268
9 O: 0.000681
9 O
) I-GENE: 0.005210
) O: 0.009341
) O
GlcNAc I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
D1D3 I-GENE
isomer I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
Man I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
8 I-GENE: 0.000803
8 O: 0.000939
8 O
) I-GENE: 0.005210
) O: 0.009341
) O
GlcNAc I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
). O: 0.002228
). O

Saccharomyces I-GENE: 0.000487
Saccharomyces O: 0.000168
Saccharomyces I-GENE
cerevisiae I-GENE: 0.000706
cerevisiae O: 0.000214
cerevisiae I-GENE
activates O: 0.000078
activates O
a I-GENE: 0.000317
a O: 0.015893
a O
regulatory I-GENE: 0.000901
regulatory O: 0.000458
regulatory I-GENE
network O: 0.000017
network O
called O: 0.000087
called O
" I-GENE: 0.000170
" O: 0.000449
" O
general O: 0.000113
general O
control I-GENE: 0.000170
control O: 0.000834
control O
" I-GENE: 0.000170
" O: 0.000449
" O
that O: 0.008362
that O
provides O: 0.000096
provides O
the I-GENE: 0.000268
the O: 0.044902
the O
cell I-GENE: 0.001144
cell O: 0.001927
cell O
with O: 0.009756
with O
sufficient O: 0.000180
sufficient O
amounts O: 0.000049
amounts O
of I-GENE: 0.002337
of O: 0.042520
of O
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
precursors O: 0.000035
precursors O
during O: 0.001095
during O
amino I-GENE: 0.000560
amino O: 0.001116
amino O
acid I-GENE: 0.001315
acid O: 0.000997
acid I-GENE
starvation O: 0.000029
starvation O
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
Saccharomyces I-GENE: 0.000487
Saccharomyces O: 0.000168
Saccharomyces I-GENE
cerevisiae I-GENE: 0.000706
cerevisiae O: 0.000214
cerevisiae I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
entry O: 0.000049
entry O
into O: 0.000785
into O
mitosis O: 0.000041
mitosis O
requires O: 0.000136
requires O
activation I-GENE: 0.000365
activation O: 0.001153
activation O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
cyclin I-GENE: 0.001899
cyclin I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
dependent I-GENE: 0.001485
dependent O: 0.000800
dependent I-GENE
kinase I-GENE: 0.010299
kinase O: 0.000264
kinase I-GENE
Cdc28 I-GENE: 0.000146
Cdc28 I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
its O: 0.001020
its O
cyclin I-GENE: 0.001899
cyclin I-GENE
B I-GENE: 0.004066
B O: 0.000640
B I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
Clb I-GENE
)- I-GENE: 0.000609
)- O: 0.000269
)- I-GENE
associated I-GENE: 0.000755
associated O: 0.000716
associated I-GENE
form O: 0.000333
form O
. I-GENE: 0.004017
. O: 0.044459
. O

Data O: 0.000020
Data O
from I-GENE: 0.000390
from O: 0.004210
from O
in I-GENE: 0.000536
in O: 0.023304
in O
vitro O: 0.000640
vitro O
splicing O: 0.000246
splicing O
assays O: 0.000365
assays O
, I-GENE: 0.001923
, O: 0.035091
, O
UV O: 0.000093
UV O
crosslinking I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
RNA I-GENE: 0.003555
RNA O: 0.000591
RNA I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
competition O: 0.000041
competition O
experiments O: 0.000316
experiments O
indicates O: 0.000156
indicates O
a I-GENE: 0.000317
a O: 0.015893
a O
strong O: 0.000156
strong O
correlation O: 0.000177
correlation O
between O: 0.001394
between O
the I-GENE: 0.000268
the O: 0.044902
the O
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
affinities O: 0.000032
affinities O
of I-GENE: 0.002337
of O: 0.042520
of O
PSI I-GENE: 0.000122
PSI I-GENE
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
SELEX I-GENE
sequences I-GENE: 0.001290
sequences O: 0.000947
sequences I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
their O: 0.000736
their O
ability O: 0.000290
ability O
to I-GENE: 0.000195
to O: 0.014977
to O
modulate O: 0.000052
modulate O
splicing O: 0.000246
splicing O
of I-GENE: 0.002337
of O: 0.042520
of O
P I-GENE: 0.001023
P O: 0.000614
P I-GENE
element I-GENE: 0.001680
element O: 0.000577
element I-GENE
IVS3 I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
vitro O: 0.000640
vitro O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
sensitivity O: 0.000212
sensitivity O
of I-GENE: 0.002337
of O: 0.042520
of O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
neuroblastoma O: 0.000014
neuroblastoma O
cells O: 0.002663
cells O
SK I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
N I-GENE: 0.001217
N O: 0.000614
N I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
SH I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
undergo O: 0.000029
undergo O
apoptosis O: 0.000145
apoptosis O
induced O: 0.001176
induced O
by O: 0.006887
by O
thapsigargin I-GENE
was O: 0.006960
was O
examined O: 0.000275
examined O
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
., O: 0.000446
., O
Slatkin I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
D I-GENE: 0.000901
D O: 0.000232
D I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Multiparous I-GENE
women O: 0.000281
women O
presented O: 0.000156
presented O
higher O: 0.000469
higher O
BMI O: 0.000026
BMI O
( I-GENE: 0.006014
( O: 0.014858
( O
P I-GENE: 0.001023
P O: 0.000614
P I-GENE
= O: 0.000855
= O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
01 O: 0.000238
01 O
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
PBF I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
P I-GENE: 0.001023
P O: 0.000614
P I-GENE
= O: 0.000855
= O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
03 O: 0.000052
03 O
) I-GENE: 0.005210
) O: 0.009341
) O
compared O: 0.000603
compared O
with O: 0.009756
with O
primi I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
nulliparous I-GENE
groups O: 0.000374
groups O
. I-GENE: 0.004017
. O: 0.044459
. O

CONCLUSIONS O: 0.000104
CONCLUSIONS O
AND O: 0.000061
AND O
CLINICAL I-GENE
RELEVANCE I-GENE
: I-GENE: 0.000243
: O: 0.002561
: O
Increased O: 0.000023
Increased O
cortical O: 0.000070
cortical O
thickness O: 0.000038
thickness O
and I-GENE: 0.003263
and O: 0.028529
and O
geometric I-GENE
properties O: 0.000197
properties O
of I-GENE: 0.002337
of O: 0.042520
of O
left O: 0.000264
left O
MCB I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
IV I-GENE: 0.000292
IV O: 0.000136
IV I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
V I-GENE: 0.000463
V O: 0.000151
V I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
Greyhounds I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
together O: 0.000194
together O
with O: 0.009756
with O
altered O: 0.000113
altered O
turnover O: 0.000055
turnover O
and I-GENE: 0.003263
and O: 0.028529
and O
orientation O: 0.000078
orientation O
of I-GENE: 0.002337
of O: 0.042520
of O
osteons I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
dorsal O: 0.000055
dorsal O
quadrants I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
left O: 0.000264
left O
MCB I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
are O: 0.002918
are O
site I-GENE: 0.003092
site O: 0.001040
site I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
adaptive O: 0.000014
adaptive O
responses O: 0.000278
responses O
associated I-GENE: 0.000755
associated O: 0.000716
associated I-GENE
with O: 0.009756
with O
asymmetric O: 0.000014
asymmetric O
cyclic I-GENE: 0.000195
cyclic O: 0.000052
cyclic I-GENE
loading O: 0.000017
loading O
as O: 0.003654
as O
a I-GENE: 0.000317
a O: 0.015893
a O
result O: 0.000232
result O
of I-GENE: 0.002337
of O: 0.042520
of O
racing I-GENE
on O: 0.003416
on O
circular O: 0.000014
circular O
tracks I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

To O: 0.000522
To O
examine O: 0.000099
examine O
transcriptional I-GENE: 0.000268
transcriptional O: 0.000672
transcriptional O
regulation O: 0.000553
regulation O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
rat I-GENE: 0.001607
rat O: 0.000409
rat I-GENE
eIF4E I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
kB I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
rat I-GENE: 0.001607
rat O: 0.000409
rat I-GENE
eIF4E I-GENE
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
region I-GENE: 0.001583
region O: 0.001744
region O
was O: 0.006960
was O
cloned O: 0.000319
cloned O
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
contribution O: 0.000032
contribution O
of I-GENE: 0.002337
of O: 0.042520
of O
specific I-GENE: 0.001510
specific O: 0.001165
specific I-GENE
elements I-GENE: 0.000414
elements O: 0.000493
elements O
in I-GENE: 0.000536
in O: 0.023304
in O
regulating O: 0.000084
regulating O
transcription I-GENE: 0.002337
transcription O: 0.001411
transcription I-GENE
was O: 0.006960
was O
determined O: 0.000458
determined O
in I-GENE: 0.000536
in O: 0.023304
in O
primary O: 0.000281
primary O
cultures O: 0.000075
cultures O
of I-GENE: 0.002337
of O: 0.042520
of O
rat I-GENE: 0.001607
rat O: 0.000409
rat I-GENE
cardiocytes I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
in I-GENE: 0.000536
in O: 0.023304
in O
a I-GENE: 0.000317
a O: 0.015893
a O
murine I-GENE: 0.000779
murine O: 0.000148
murine I-GENE
C I-GENE: 0.005113
C O: 0.001005
C I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
C I-GENE: 0.005113
C O: 0.001005
C I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
12 I-GENE: 0.000292
12 O: 0.000539
12 O
) I-GENE: 0.005210
) O: 0.009341
) O
myoblast I-GENE
cell I-GENE: 0.001144
cell O: 0.001927
cell O
line O: 0.000319
line O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
prevalence O: 0.000110
prevalence O
of I-GENE: 0.002337
of O: 0.042520
of O
tobacco I-GENE: 0.000146
tobacco O: 0.000061
tobacco I-GENE
dependence O: 0.000049
dependence O
diagnosed O: 0.000067
diagnosed O
according O: 0.000090
according O
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
ICD I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
10 I-GENE: 0.000292
10 O: 0.000936
10 O
criteria O: 0.000075
criteria O
was O: 0.006960
was O
higher O: 0.000469
higher O
in I-GENE: 0.000536
in O: 0.023304
in O
alcohol O: 0.000061
alcohol O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
dependent I-GENE: 0.001485
dependent O: 0.000800
dependent I-GENE
individuals O: 0.000087
individuals O
( I-GENE: 0.006014
( O: 0.014858
( O
58 O: 0.000052
58 O
. I-GENE: 0.004017
. O: 0.044459
. O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
%) O: 0.000385
%) O
than O: 0.001657
than O
in I-GENE: 0.000536
in O: 0.023304
in O
nondrinkers I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
social O: 0.000032
social O
drinkers I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
12 I-GENE: 0.000292
12 O: 0.000539
12 O
. I-GENE: 0.004017
. O: 0.044459
. O
8 I-GENE: 0.000803
8 O: 0.000939
8 O
%). O: 0.000119
%). O

Management I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
postvitrectomy I-GENE
diabetic O: 0.000052
diabetic O
vitreous O: 0.000017
vitreous O
hemorrhage O: 0.000049
hemorrhage O
with O: 0.009756
with O
tissue I-GENE: 0.000536
tissue O: 0.000388
tissue I-GENE
plasminogen I-GENE: 0.000706
plasminogen I-GENE
activator I-GENE: 0.001120
activator O: 0.000093
activator I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
t I-GENE: 0.000146
t O: 0.000075
t I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
PA I-GENE: 0.000122
PA O: 0.000017
PA I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
volume O: 0.000203
volume O
homeostatic I-GENE
fluid O: 0.000145
fluid O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
fluid O: 0.000145
fluid O
exchanger I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Transactivation I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
oIFNtau I-GENE
enhancer I-GENE: 0.001461
enhancer O: 0.000226
enhancer I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
reporter I-GENE: 0.000828
reporter O: 0.000246
reporter I-GENE
constructs I-GENE: 0.000219
constructs O: 0.000148
constructs I-GENE
was O: 0.006960
was O
primarily O: 0.000093
primarily O
regulated I-GENE: 0.000268
regulated O: 0.000368
regulated O
by O: 0.006887
by O
three O: 0.000785
three O
regions I-GENE: 0.000243
regions O: 0.000501
regions O
containing I-GENE: 0.000414
containing O: 0.000837
containing O
AP I-GENE: 0.002630
AP O: 0.000017
AP I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
site I-GENE: 0.003092
site O: 0.001040
site I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
GATA I-GENE: 0.000682
GATA I-GENE
like I-GENE: 0.002143
like O: 0.000272
like I-GENE
sequence I-GENE: 0.002021
sequence O: 0.001866
sequence I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
site I-GENE: 0.003092
site O: 0.001040
site I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
s I-GENE: 0.000243
s O: 0.000724
s O
) I-GENE: 0.005210
) O: 0.009341
) O
unidentified O: 0.000020
unidentified O
. I-GENE: 0.004017
. O: 0.044459
. O

SELECTION I-GENE
CRITERIA I-GENE
: I-GENE: 0.000243
: O: 0.002561
: O
Randomised I-GENE
controlled O: 0.000133
controlled O
trials O: 0.000052
trials O
of I-GENE: 0.002337
of O: 0.042520
of O
cabergoline I-GENE
versus O: 0.000122
versus O
placebo O: 0.000101
placebo O
in I-GENE: 0.000536
in O: 0.023304
in O
patients O: 0.002538
patients O
with O: 0.009756
with O
a I-GENE: 0.000317
a O: 0.015893
a O
clinical O: 0.000417
clinical O
diagnosis O: 0.000275
diagnosis O
of I-GENE: 0.002337
of O: 0.042520
of O
idiopathic O: 0.000014
idiopathic O
Parkinson O: 0.000017
Parkinson O
' I-GENE: 0.000950
' O: 0.001701
' O
s I-GENE: 0.000243
s O: 0.000724
s O
disease O: 0.000632
disease O
and I-GENE: 0.003263
and O: 0.028529
and O
long I-GENE: 0.000243
long O: 0.000325
long O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
term O: 0.000185
term O
complications O: 0.000081
complications O
of I-GENE: 0.002337
of O: 0.042520
of O
levodopa I-GENE
therapy O: 0.000351
therapy O
. I-GENE: 0.004017
. O: 0.044459
. O

0 O: 0.002784
0 O
%) O: 0.000385
%) O
and I-GENE: 0.003263
and O: 0.028529
and O
IL I-GENE: 0.003019
IL I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
12 I-GENE: 0.000292
12 O: 0.000539
12 O
( I-GENE: 0.006014
( O: 0.014858
( O
42 O: 0.000110
42 O
. I-GENE: 0.004017
. O: 0.044459
. O
6 I-GENE: 0.002118
6 O: 0.001153
6 I-GENE
% O: 0.001741
% O
vs O: 0.000159
vs O
. I-GENE: 0.004017
. O: 0.044459
. O

Copyright O: 0.000032
Copyright O
2000 O: 0.000043
2000 O
John I-GENE
Wiley I-GENE
& O: 0.000046
& O
Sons I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
Ltd I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Here O: 0.000214
Here O
we O: 0.001382
we O
demonstrate O: 0.000290
demonstrate O
that O: 0.008362
that O
native O: 0.000070
native O
MRCK I-GENE
exists O: 0.000023
exists O
in I-GENE: 0.000536
in O: 0.023304
in O
high I-GENE: 0.000341
high O: 0.000924
high O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
molecular O: 0.000298
molecular O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
weight O: 0.000226
weight O
complexes I-GENE: 0.000487
complexes O: 0.000261
complexes I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

METHODS O: 0.000139
METHODS O
: I-GENE: 0.000243
: O: 0.002561
: O
This O: 0.000927
This O
retrospective O: 0.000032
retrospective O
review O: 0.000070
review O
comprised O: 0.000014
comprised O
2711 I-GENE
eyes O: 0.000055
eyes O
that O: 0.008362
that O
had O: 0.000890
had O
LASIK I-GENE
between O: 0.001394
between O
September I-GENE
1996 O: 0.000017
1996 O
and I-GENE: 0.003263
and O: 0.028529
and O
September I-GENE
1999 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Sixty I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
one O: 0.001026
one O
cases O: 0.000458
cases O
of I-GENE: 0.002337
of O: 0.042520
of O
cholera I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
all O: 0.000762
all O
caused O: 0.000220
caused O
by O: 0.006887
by O
V I-GENE: 0.000463
V O: 0.000151
V I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
cholerae O: 0.000014
cholerae O
O1 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
were O: 0.005244
were O
reported O: 0.000278
reported O
. I-GENE: 0.004017
. O: 0.044459
. O

This O: 0.000927
This O
could O: 0.000423
could O
lead O: 0.000090
lead O
to I-GENE: 0.000195
to O: 0.014977
to O
subsequent O: 0.000093
subsequent O
outbreaks I-GENE
if O: 0.000127
if O
Babesia I-GENE
carrier I-GENE: 0.000170
carrier O: 0.000020
carrier I-GENE
animals O: 0.000223
animals O
were O: 0.005244
were O
to I-GENE: 0.000195
to O: 0.014977
to O
be O: 0.002370
be O
introduced O: 0.000084
introduced O
into O: 0.000785
into O
the I-GENE: 0.000268
the O: 0.044902
the O
herd O: 0.000017
herd O
. I-GENE: 0.004017
. O: 0.044459
. O

Instead O: 0.000014
Instead O
, I-GENE: 0.001923
, O: 0.035091
, O
TRPS1 I-GENE
potently I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
specifically O: 0.000206
specifically O
represses O: 0.000049
represses O
transcriptional I-GENE: 0.000268
transcriptional O: 0.000672
transcriptional O
activation I-GENE: 0.000365
activation O: 0.001153
activation O
mediated O: 0.000475
mediated O
by O: 0.006887
by O
other O: 0.000994
other O
GATA I-GENE: 0.000682
GATA I-GENE
factors I-GENE: 0.001388
factors O: 0.000626
factors I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Eliminating I-GENE
any O: 0.000264
any O
subset O: 0.000043
subset O
of I-GENE: 0.002337
of O: 0.042520
of O
ASCUS I-GENE
reduces O: 0.000052
reduces O
the I-GENE: 0.000268
the O: 0.044902
the O
ASCUS I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
SIL I-GENE
ratio O: 0.000238
ratio O
but O: 0.001675
but O
also O: 0.001373
also O
significantly O: 0.000733
significantly O
diminishes I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
sensitivity O: 0.000212
sensitivity O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
Papanicolaou I-GENE
test O: 0.000391
test O
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
order O: 0.000206
order O
to I-GENE: 0.000195
to O: 0.014977
to O
overcome O: 0.000020
overcome O
the I-GENE: 0.000268
the O: 0.044902
the O
false O: 0.000014
false O
positive O: 0.000411
positive O
readings I-GENE
that O: 0.008362
that O
are O: 0.002918
are O
possible O: 0.000267
possible O
in I-GENE: 0.000536
in O: 0.023304
in O
sphincter I-GENE
manometry I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
we O: 0.001382
we O
proposed O: 0.000081
proposed O
to I-GENE: 0.000195
to O: 0.014977
to O
use O: 0.000380
use O
secretin I-GENE
stimulated O: 0.000275
stimulated O
endoscopic I-GENE
ultrasound O: 0.000032
ultrasound O
( I-GENE: 0.006014
( O: 0.014858
( O
SSEUS I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
to I-GENE: 0.000195
to O: 0.014977
to O
measure O: 0.000084
measure O
pancreatic O: 0.000075
pancreatic O
ductal I-GENE
response I-GENE: 0.000779
response O: 0.000794
response O
as O: 0.003654
as O
an O: 0.003112
an O
adjunctive I-GENE
method O: 0.000385
method O
to I-GENE: 0.000195
to O: 0.014977
to O
aid O: 0.000038
aid O
and I-GENE: 0.003263
and O: 0.028529
and O
supplement I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
diagnosis O: 0.000275
diagnosis O
. I-GENE: 0.004017
. O: 0.044459
. O

Endovascular I-GENE
aneurysm I-GENE
repair I-GENE: 0.000146
repair O: 0.000110
repair I-GENE
with O: 0.009756
with O
the I-GENE: 0.000268
the O: 0.044902
the O
AneuRx I-GENE
stent I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
graft O: 0.000043
graft O
is O: 0.006803
is O
safe O: 0.000029
safe O
, I-GENE: 0.001923
, O: 0.035091
, O
but O: 0.001675
but O
is O: 0.006803
is O
it O: 0.000733
it O
effective O: 0.000238
effective O
? O: 0.000081
? O

The O: 0.007383
The O
difference O: 0.000156
difference O
of I-GENE: 0.002337
of O: 0.042520
of O
hardness I-GENE
over O: 0.000240
over O
time O: 0.000542
time O
of I-GENE: 0.002337
of O: 0.042520
of O
composite O: 0.000041
composite O
specimens O: 0.000072
specimens O
was O: 0.006960
was O
measured O: 0.000400
measured O
using O: 0.000979
using O
Knoop I-GENE
hardness I-GENE
measurements O: 0.000156
measurements O
taken O: 0.000052
taken O
at O: 0.002976
at O
the I-GENE: 0.000268
the O: 0.044902
the O
top O: 0.000014
top O
and I-GENE: 0.003263
and O: 0.028529
and O
bottom I-GENE
surfaces I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
resin O: 0.000032
resin O
specimens O: 0.000072
specimens O
made O: 0.000154
made O
in I-GENE: 0.000536
in O: 0.023304
in O
a I-GENE: 0.000317
a O: 0.015893
a O
Teflon I-GENE
mold I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
same O: 0.000348
same O
dimensions O: 0.000029
dimensions O
as O: 0.003654
as O
the I-GENE: 0.000268
the O: 0.044902
the O
cavity O: 0.000029
cavity O
prepared O: 0.000061
prepared O
in I-GENE: 0.000536
in O: 0.023304
in O
dentin O: 0.000017
dentin O
. I-GENE: 0.004017
. O: 0.044459
. O

Implications I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
biomonitoring I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
observed O: 0.000635
observed O
accumulation O: 0.000139
accumulation O
patterns O: 0.000127
patterns O
, I-GENE: 0.001923
, O: 0.035091
, O
especially O: 0.000090
especially O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
different O: 0.000669
different O
tissues O: 0.000235
tissues O
of I-GENE: 0.002337
of O: 0.042520
of O
Posidonia I-GENE
oceanica I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
are O: 0.002918
are O
discussed O: 0.000110
discussed O
. I-GENE: 0.004017
. O: 0.044459
. O

Based O: 0.000055
Based O
on O: 0.003416
on O
mutational O: 0.000032
mutational O
data O: 0.000649
data O
and I-GENE: 0.003263
and O: 0.028529
and O
possible O: 0.000267
possible O
mRNA I-GENE: 0.003530
mRNA O: 0.000475
mRNA I-GENE
structure O: 0.000513
structure O
, I-GENE: 0.001923
, O: 0.035091
, O
we O: 0.001382
we O
hypothesized I-GENE
about O: 0.000278
about O
the I-GENE: 0.000268
the O: 0.044902
the O
effect O: 0.000866
effect O
of I-GENE: 0.002337
of O: 0.042520
of O
mRNA I-GENE: 0.003530
mRNA O: 0.000475
mRNA I-GENE
structure O: 0.000513
structure O
on O: 0.003416
on O
translation I-GENE: 0.000268
translation O: 0.000200
translation I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
two O: 0.001904
two O
major I-GENE: 0.000341
major O: 0.000333
major I-GENE
C I-GENE: 0.005113
C O: 0.001005
C I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
EBPepsilon I-GENE
isoforms I-GENE: 0.000560
isoforms O: 0.000078
isoforms I-GENE
: I-GENE: 0.000243
: O: 0.002561
: O
p32 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
p30 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Retinoids I-GENE
participate O: 0.000052
participate O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
onset O: 0.000101
onset O
of I-GENE: 0.002337
of O: 0.042520
of O
differentiation O: 0.000217
differentiation O
, I-GENE: 0.001923
, O: 0.035091
, O
apoptosis O: 0.000145
apoptosis O
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
inhibition O: 0.000284
inhibition O
of I-GENE: 0.002337
of O: 0.042520
of O
growth I-GENE: 0.002337
growth O: 0.000510
growth I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
a I-GENE: 0.000317
a O: 0.015893
a O
wide O: 0.000064
wide O
variety O: 0.000127
variety O
of I-GENE: 0.002337
of O: 0.042520
of O
normal O: 0.000759
normal O
and I-GENE: 0.003263
and O: 0.028529
and O
cancerous I-GENE
cells O: 0.002663
cells O
. I-GENE: 0.004017
. O: 0.044459
. O

We O: 0.001417
We O
conclude O: 0.000133
conclude O
that O: 0.008362
that O
RPMS I-GENE
acts O: 0.000090
acts O
as O: 0.003654
as O
a I-GENE: 0.000317
a O: 0.015893
a O
negative I-GENE: 0.000219
negative O: 0.000403
negative O
regulator I-GENE: 0.000195
regulator O: 0.000104
regulator I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
EBNA2 I-GENE: 0.000170
EBNA2 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
Notch I-GENE: 0.000195
Notch I-GENE
activity O: 0.002295
activity O
through O: 0.000403
through O
its O: 0.001020
its O
interactions O: 0.000226
interactions O
with O: 0.009756
with O
the I-GENE: 0.000268
the O: 0.044902
the O
CBF1 I-GENE: 0.000195
CBF1 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
associated I-GENE: 0.000755
associated O: 0.000716
associated I-GENE
corepressor I-GENE
complex I-GENE: 0.001315
complex O: 0.000588
complex I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Isolated I-GENE
Systolic I-GENE
Hypertension I-GENE
: I-GENE: 0.000243
: O: 0.002561
: O
An O: 0.000287
An O
Update I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Transfection O: 0.000032
Transfection O
of I-GENE: 0.002337
of O: 0.042520
of O
EGFP I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
tagged O: 0.000052
tagged O
DENTT I-GENE
NLS O: 0.000014
NLS O
deletion I-GENE: 0.000195
deletion O: 0.000238
deletion O
constructs I-GENE: 0.000219
constructs O: 0.000148
constructs I-GENE
lacking O: 0.000116
lacking O
the I-GENE: 0.000268
the O: 0.044902
the O
bipartite O: 0.000017
bipartite O
NLS O: 0.000014
NLS O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
were O: 0.005244
were O
excluded O: 0.000041
excluded O
from I-GENE: 0.000390
from O: 0.004210
from O
the I-GENE: 0.000268
the O: 0.044902
the O
nucleolus I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

VE O: 0.000020
VE O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
DEF I-GENE
animals O: 0.000223
animals O
had O: 0.000890
had O
significantly O: 0.000733
significantly O
higher O: 0.000469
higher O
( I-GENE: 0.006014
( O: 0.014858
( O
p I-GENE: 0.000122
p O: 0.000681
p O
< O: 0.000455
< O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
05 O: 0.000287
05 O
) I-GENE: 0.005210
) O: 0.009341
) O
levels O: 0.001304
levels O
of I-GENE: 0.002337
of O: 0.042520
of O
myocardial O: 0.000194
myocardial O
lipid O: 0.000087
lipid O
peroxidation O: 0.000014
peroxidation O
and I-GENE: 0.003263
and O: 0.028529
and O
lower O: 0.000298
lower O
( I-GENE: 0.006014
( O: 0.014858
( O
p I-GENE: 0.000122
p O: 0.000681
p O
< O: 0.000455
< O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
05 O: 0.000287
05 O
) I-GENE: 0.005210
) O: 0.009341
) O
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
thiols I-GENE
following O: 0.000368
following O
I I-GENE: 0.004602
I O: 0.000487
I I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
R I-GENE: 0.001023
R O: 0.000154
R I-GENE
compared O: 0.000603
compared O
to I-GENE: 0.000195
to O: 0.014977
to O
the I-GENE: 0.000268
the O: 0.044902
the O
CON I-GENE
animals O: 0.000223
animals O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
position O: 0.000180
position O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
analyst I-GENE
as O: 0.003654
as O
expert I-GENE
: I-GENE: 0.000243
: O: 0.002561
: O
yesterday I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
today I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Furthermore O: 0.000238
Furthermore O
, I-GENE: 0.001923
, O: 0.035091
, O
we O: 0.001382
we O
showed O: 0.000863
showed O
that O: 0.008362
that O
ERSF I-GENE
including O: 0.000446
including O
NF I-GENE: 0.002922
NF I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
Y I-GENE: 0.000487
Y O: 0.000087
Y I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
ATF6alpha I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
or I-GENE: 0.000219
or O: 0.003321
or O
beta I-GENE: 0.007816
beta O: 0.000353
beta I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
capable O: 0.000099
capable O
of I-GENE: 0.002337
of O: 0.042520
of O
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
ERSE I-GENE
is O: 0.006803
is O
indeed O: 0.000020
indeed O
formed O: 0.000104
formed O
when O: 0.000690
when O
the I-GENE: 0.000268
the O: 0.044902
the O
cellular I-GENE: 0.000243
cellular O: 0.000304
cellular O
UPR I-GENE
is O: 0.006803
is O
activated I-GENE: 0.001412
activated O: 0.000356
activated I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

We O: 0.001417
We O
performed O: 0.000351
performed O
the I-GENE: 0.000268
the O: 0.044902
the O
present O: 0.000551
present O
study O: 0.001101
study O
to I-GENE: 0.000195
to O: 0.014977
to O
clarify O: 0.000014
clarify O
the I-GENE: 0.000268
the O: 0.044902
the O
relationship O: 0.000145
relationship O
between O: 0.001394
between O
the I-GENE: 0.000268
the O: 0.044902
the O
DOX I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
ability O: 0.000290
ability O
(% I-GENE
DB I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
histologic O: 0.000026
histologic O
response I-GENE: 0.000779
response O: 0.000794
response O
, I-GENE: 0.001923
, O: 0.035091
, O
rate O: 0.000522
rate O
of I-GENE: 0.002337
of O: 0.042520
of O
decrease O: 0.000264
decrease O
in I-GENE: 0.000536
in O: 0.023304
in O
tumor I-GENE: 0.000487
tumor O: 0.000310
tumor I-GENE
volume O: 0.000203
volume O
of I-GENE: 0.002337
of O: 0.042520
of O
malignant O: 0.000104
malignant O
soft O: 0.000020
soft O
tissue I-GENE: 0.000536
tissue O: 0.000388
tissue I-GENE
tumors O: 0.000168
tumors O
after O: 0.001385
after O
preoperative O: 0.000020
preoperative O
chemotherapy O: 0.000125
chemotherapy O
and I-GENE: 0.003263
and O: 0.028529
and O
prognosis O: 0.000038
prognosis O
. I-GENE: 0.004017
. O: 0.044459
. O

We O: 0.001417
We O
have O: 0.001788
have O
also O: 0.001373
also O
isolated O: 0.000585
isolated O
and I-GENE: 0.003263
and O: 0.028529
and O
analyzed O: 0.000151
analyzed O
the I-GENE: 0.000268
the O: 0.044902
the O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
' I-GENE: 0.000950
' O: 0.001701
' O
flanking I-GENE: 0.000219
flanking O: 0.000272
flanking O
region I-GENE: 0.001583
region O: 0.001744
region O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
pea I-GENE
33RNP I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

We O: 0.001417
We O
have O: 0.001788
have O
previously O: 0.000481
previously O
shown O: 0.000504
shown O
that O: 0.008362
that O
the I-GENE: 0.000268
the O: 0.044902
the O
adenoviral I-GENE
12S I-GENE
E1A I-GENE: 0.000779
E1A I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
modulates I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
phosphorylation O: 0.000469
phosphorylation O
status O: 0.000133
status O
of I-GENE: 0.002337
of O: 0.042520
of O
p130 I-GENE: 0.000292
p130 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
p107 I-GENE: 0.000146
p107 I-GENE
without O: 0.000322
without O
apparent O: 0.000113
apparent O
changes O: 0.000466
changes O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
cell I-GENE: 0.001144
cell O: 0.001927
cell O
cycle O: 0.000336
cycle O
dependent I-GENE: 0.001485
dependent O: 0.000800
dependent I-GENE
phosphorylation O: 0.000469
phosphorylation O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
retinoblastoma I-GENE: 0.000268
retinoblastoma I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Baseline I-GENE
MBF I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
females O: 0.000041
females O
was O: 0.006960
was O
significantly O: 0.000733
significantly O
( I-GENE: 0.006014
( O: 0.014858
( O
P I-GENE: 0.001023
P O: 0.000614
P I-GENE
< O: 0.000455
< O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
001 O: 0.000197
001 O
) I-GENE: 0.005210
) O: 0.009341
) O
higher O: 0.000469
higher O
than O: 0.001657
than O
in I-GENE: 0.000536
in O: 0.023304
in O
males O: 0.000081
males O
. I-GENE: 0.004017
. O: 0.044459
. O

Only O: 0.000035
Only O
nine O: 0.000090
nine O
patients O: 0.002538
patients O
were O: 0.005244
were O
offered O: 0.000014
offered O
surgery O: 0.000136
surgery O
( I-GENE: 0.006014
( O: 0.014858
( O
six O: 0.000212
six O
were O: 0.005244
were O
resected I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
three O: 0.000785
three O
were O: 0.005244
were O
found O: 0.001026
found O
inoperable I-GENE
). O: 0.002228
). O

The O: 0.007383
The O
deubiquitinating I-GENE
enzyme I-GENE: 0.000706
enzyme O: 0.000307
enzyme I-GENE
DUB I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
is O: 0.006803
is O
induced O: 0.001176
induced O
in I-GENE: 0.000536
in O: 0.023304
in O
response I-GENE: 0.000779
response O: 0.000794
response O
to I-GENE: 0.000195
to O: 0.014977
to O
IL I-GENE: 0.003019
IL I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
but O: 0.001675
but O
as O: 0.003654
as O
yet O: 0.000081
yet O
its O: 0.001020
its O
function O: 0.000855
function O
has O: 0.001356
has O
not O: 0.002509
not O
been O: 0.001229
been O
determined O: 0.000458
determined O
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
split I-GENE
motor O: 0.000087
motor O
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
a I-GENE: 0.000317
a O: 0.015893
a O
cytoplasmic I-GENE: 0.000268
cytoplasmic O: 0.000188
cytoplasmic I-GENE
dynein I-GENE: 0.000122
dynein I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Immunological I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
biochemical O: 0.000084
biochemical O
characterization O: 0.000206
characterization O
of I-GENE: 0.002337
of O: 0.042520
of O
streptococcal I-GENE
pyrogenic I-GENE
exotoxins I-GENE
I I-GENE: 0.004602
I O: 0.000487
I I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
J O: 0.000183
J O
( I-GENE: 0.006014
( O: 0.014858
( O
SPE I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
I I-GENE: 0.004602
I O: 0.000487
I I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
SPE I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
J O: 0.000183
J O
) I-GENE: 0.005210
) O: 0.009341
) O
from I-GENE: 0.000390
from O: 0.004210
from O
Streptococcus O: 0.000017
Streptococcus O
pyogenes I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Five O: 0.000064
Five O
modalities O: 0.000020
modalities O
of I-GENE: 0.002337
of O: 0.042520
of O
nonpharmacologic I-GENE
approaches O: 0.000023
approaches O
are O: 0.002918
are O
recommended O: 0.000058
recommended O
at O: 0.002976
at O
present O: 0.000551
present O
for O: 0.006951
for O
lifestyle I-GENE
modification O: 0.000058
modification O
and I-GENE: 0.003263
and O: 0.028529
and O
control I-GENE: 0.000170
control O: 0.000834
control O
of I-GENE: 0.002337
of O: 0.042520
of O
arterial O: 0.000174
arterial O
blood O: 0.000884
blood O
pressure O: 0.000432
pressure O
elevation O: 0.000064
elevation O
: I-GENE: 0.000243
: O: 0.002561
: O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
weight O: 0.000226
weight O
reduction O: 0.000206
reduction O
to I-GENE: 0.000195
to O: 0.014977
to O
ideal I-GENE
body O: 0.000240
body O
weight O: 0.000226
weight O
, I-GENE: 0.001923
, O: 0.035091
, O
since O: 0.000104
since O
it O: 0.000733
it O
reduces O: 0.000052
reduces O
risk O: 0.000313
risk O
of I-GENE: 0.002337
of O: 0.042520
of O
hypertension O: 0.000104
hypertension O
as O: 0.003654
as O
well O: 0.000626
well O
as O: 0.003654
as O
overall O: 0.000113
overall O
cardiovascular O: 0.000041
cardiovascular O
morbidity O: 0.000017
morbidity O
and I-GENE: 0.003263
and O: 0.028529
and O
mortality O: 0.000075
mortality O
; I-GENE: 0.000170
; O: 0.001399
; O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
dietary O: 0.000072
dietary O
sodium O: 0.000127
sodium O
restriction O: 0.000072
restriction O
to I-GENE: 0.000195
to O: 0.014977
to O
less O: 0.000724
less O
than O: 0.001657
than O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
g O: 0.000307
g O
a I-GENE: 0.000317
a O: 0.015893
a O
day O: 0.000394
day O
, I-GENE: 0.001923
, O: 0.035091
, O
without O: 0.000322
without O
assurance I-GENE
that O: 0.008362
that O
it O: 0.000733
it O
will O: 0.000101
will O
normalize I-GENE
arterial O: 0.000174
arterial O
pressure O: 0.000432
pressure O
although O: 0.000206
although O
it O: 0.000733
it O
may O: 0.001078
may O
help O: 0.000038
help O
reduce O: 0.000058
reduce O
dosage O: 0.000061
dosage O
and I-GENE: 0.003263
and O: 0.028529
and O
numbers O: 0.000049
numbers O
of I-GENE: 0.002337
of O: 0.042520
of O
prescribed I-GENE
antihypertensive O: 0.000029
antihypertensive O
drugs O: 0.000159
drugs O
; I-GENE: 0.000170
; O: 0.001399
; O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
moderation I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
alcohol O: 0.000061
alcohol O
consumption O: 0.000064
consumption O
to I-GENE: 0.000195
to O: 0.014977
to O
less O: 0.000724
less O
than O: 0.001657
than O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
ounce I-GENE
a I-GENE: 0.000317
a O: 0.015893
a O
day O: 0.000394
day O
; I-GENE: 0.000170
; O: 0.001399
; O
4 I-GENE: 0.002362
4 O: 0.001307
4 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
a I-GENE: 0.000317
a O: 0.015893
a O
regular O: 0.000017
regular O
isotonic I-GENE
exercise O: 0.000148
exercise O
program O: 0.000061
program O
; I-GENE: 0.000170
; O: 0.001399
; O
and I-GENE: 0.003263
and O: 0.028529
and O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
cessation O: 0.000026
cessation O
of I-GENE: 0.002337
of O: 0.042520
of O
tobacco I-GENE: 0.000146
tobacco O: 0.000061
tobacco I-GENE
consumption O: 0.000064
consumption O
. I-GENE: 0.004017
. O: 0.044459
. O

Descriptions I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
this O: 0.001976
this O
locus I-GENE: 0.001193
locus O: 0.000122
locus I-GENE
would O: 0.000107
would O
allow O: 0.000038
allow O
comparison O: 0.000214
comparison O
with O: 0.009756
with O
functionally O: 0.000087
functionally O
relevant O: 0.000046
relevant O
molecular O: 0.000298
molecular O
genetic O: 0.000191
genetic O
features O: 0.000174
features O
of I-GENE: 0.002337
of O: 0.042520
of O
other O: 0.000994
other O
species O: 0.000243
species O
' I-GENE: 0.000950
' O: 0.001701
' O
homologous I-GENE: 0.000219
homologous O: 0.000267
homologous O
loci I-GENE: 0.000317
loci O: 0.000049
loci I-GENE
including O: 0.000446
including O
the I-GENE: 0.000268
the O: 0.044902
the O
single I-GENE: 0.000195
single O: 0.000582
single O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
copy O: 0.000104
copy O
equid I-GENE
LH I-GENE: 0.000341
LH I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
CGbeta I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
the I-GENE: 0.000268
the O: 0.044902
the O
primate O: 0.000017
primate O
LHbeta I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
CGbeta I-GENE
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
cluster I-GENE: 0.000268
cluster O: 0.000078
cluster I-GENE
locus I-GENE: 0.001193
locus O: 0.000122
locus I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

METHODS O: 0.000139
METHODS O
: I-GENE: 0.000243
: O: 0.002561
: O
One O: 0.000165
One O
hundred O: 0.000035
hundred O
fourteen I-GENE
consecutive O: 0.000067
consecutive O
patients O: 0.002538
patients O
( I-GENE: 0.006014
( O: 0.014858
( O
mean O: 0.000423
mean O
age O: 0.000406
age O
61 O: 0.000075
61 O
years O: 0.000409
years O
) I-GENE: 0.005210
) O: 0.009341
) O
with O: 0.009756
with O
focal O: 0.000055
focal O
pancreatic O: 0.000075
pancreatic O
masses O: 0.000026
masses O
, I-GENE: 0.001923
, O: 0.035091
, O
detected O: 0.000368
detected O
on O: 0.003416
on O
CT O: 0.000090
CT O
, I-GENE: 0.001923
, O: 0.035091
, O
underwent O: 0.000058
underwent O
EUS I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
FNA I-GENE
by O: 0.006887
by O
using O: 0.000979
using O
a I-GENE: 0.000317
a O: 0.015893
a O
linear O: 0.000052
linear O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
array I-GENE
echoendoscope I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
22 O: 0.000162
22 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
gauge I-GENE
needles I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
effects O: 0.000652
effects O
of I-GENE: 0.002337
of O: 0.042520
of O
chlordiazepoxide I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
15 O: 0.000397
15 O
. I-GENE: 0.004017
. O: 0.044459
. O
0mg I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
kg O: 0.000585
kg O
), O: 0.002269
), O
a I-GENE: 0.000317
a O: 0.015893
a O
full I-GENE: 0.000414
full O: 0.000180
full I-GENE
benzodiazepine I-GENE
receptor I-GENE: 0.006817
receptor O: 0.000258
receptor I-GENE
agonist O: 0.000101
agonist O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
bretazenil I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
0 O: 0.002784
0 O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
30 O: 0.000423
30 O
. I-GENE: 0.004017
. O: 0.044459
. O
0mg I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
kg O: 0.000585
kg O
), O: 0.002269
), O
a I-GENE: 0.000317
a O: 0.015893
a O
partial O: 0.000148
partial O
benzodiazepine I-GENE
receptor I-GENE: 0.006817
receptor O: 0.000258
receptor I-GENE
agonist O: 0.000101
agonist O
, I-GENE: 0.001923
, O: 0.035091
, O
were O: 0.005244
were O
examined O: 0.000275
examined O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
murine I-GENE: 0.000779
murine O: 0.000148
murine I-GENE
elevated O: 0.000226
elevated O
plus O: 0.000127
plus O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
maze I-GENE
paradigm I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Acute O: 0.000035
Acute O
effects O: 0.000652
effects O
of I-GENE: 0.002337
of O: 0.042520
of O
LI I-GENE
160 O: 0.000017
160 O
( I-GENE: 0.006014
( O: 0.014858
( O
extract O: 0.000072
extract O
of I-GENE: 0.002337
of O: 0.042520
of O
Hypericum I-GENE
perforatum I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
St I-GENE
John I-GENE
' I-GENE: 0.000950
' O: 0.001701
' O
s I-GENE: 0.000243
s O: 0.000724
s O
wort I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
two O: 0.001904
two O
of I-GENE: 0.002337
of O: 0.042520
of O
its O: 0.001020
its O
constituents I-GENE
on O: 0.003416
on O
neuroendocrine I-GENE
responses O: 0.000278
responses O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
rat I-GENE: 0.001607
rat O: 0.000409
rat I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Guidelines I-GENE
for O: 0.006951
for O
performing I-GENE
a I-GENE: 0.000317
a O: 0.015893
a O
routine O: 0.000046
routine O
spiral I-GENE
assay O: 0.000235
assay O
are O: 0.002918
are O
presented O: 0.000156
presented O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
alternative O: 0.000188
alternative O
test O: 0.000391
test O
methods O: 0.000142
methods O
intended I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
overcome O: 0.000020
overcome O
a I-GENE: 0.000317
a O: 0.015893
a O
variety O: 0.000127
variety O
of I-GENE: 0.002337
of O: 0.042520
of O
technical I-GENE
difficulties I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
such O: 0.000435
such O
as O: 0.003654
as O
restricted O: 0.000099
restricted O
sample O: 0.000087
sample O
availability O: 0.000035
availability O
, I-GENE: 0.001923
, O: 0.035091
, O
sample O: 0.000087
sample O
viscosity O: 0.000026
viscosity O
or I-GENE: 0.000219
or O: 0.003321
or O
volatility I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
etc O: 0.000020
etc O
.) O: 0.000070
.) O
are O: 0.002918
are O
recommended O: 0.000058
recommended O
. I-GENE: 0.004017
. O: 0.044459
. O

An O: 0.000287
An O
additional O: 0.000156
additional O
9 I-GENE: 0.000268
9 O: 0.000681
9 O
patients O: 0.002538
patients O
achieved O: 0.000055
achieved O
normal O: 0.000759
normal O
levels O: 0.001304
levels O
with O: 0.009756
with O
adjunctive I-GENE
drug O: 0.000267
drug O
therapy O: 0.000351
therapy O
. I-GENE: 0.004017
. O: 0.044459
. O

Anti I-GENE: 0.000146
Anti I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
nucleolin I-GENE
mAb I-GENE: 0.000170
mAb I-GENE
was O: 0.006960
was O
used O: 0.000808
used O
to I-GENE: 0.000195
to O: 0.014977
to O
confirm O: 0.000046
confirm O
the I-GENE: 0.000268
the O: 0.044902
the O
antigenic O: 0.000017
antigenic O
properties O: 0.000197
properties O
of I-GENE: 0.002337
of O: 0.042520
of O
this O: 0.001976
this O
p95 I-GENE
component O: 0.000180
component O
. I-GENE: 0.004017
. O: 0.044459
. O

Eliminating I-GENE
any O: 0.000264
any O
subset O: 0.000043
subset O
of I-GENE: 0.002337
of O: 0.042520
of O
ASCUS I-GENE
reduces O: 0.000052
reduces O
the I-GENE: 0.000268
the O: 0.044902
the O
ASCUS I-GENE
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
SIL I-GENE
ratio O: 0.000238
ratio O
but O: 0.001675
but O
also O: 0.001373
also O
significantly O: 0.000733
significantly O
diminishes I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
sensitivity O: 0.000212
sensitivity O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
Papanicolaou I-GENE
test O: 0.000391
test O
. I-GENE: 0.004017
. O: 0.044459
. O

Prrp I-GENE
can O: 0.000924
can O
also O: 0.001373
also O
associate O: 0.000043
associate O
with O: 0.009756
with O
the I-GENE: 0.000268
the O: 0.044902
the O
EVH1 I-GENE
domain I-GENE: 0.003482
domain O: 0.001011
domain I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
Mena I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
another O: 0.000113
another O
microfilament I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
associated I-GENE: 0.000755
associated O: 0.000716
associated I-GENE
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Experience I-GENE
with O: 0.009756
with O
xylene O: 0.000014
xylene O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
free O: 0.000203
free O
sections O: 0.000023
sections O
since O: 0.000104
since O
1995 O: 0.000026
1995 O
at O: 0.002976
at O
the I-GENE: 0.000268
the O: 0.044902
the O
Vrinnevi I-GENE
Hospital I-GENE
is O: 0.006803
is O
favorable I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Acquired I-GENE
antithrombin I-GENE: 0.000317
antithrombin I-GENE
deficiency O: 0.000203
deficiency O
in I-GENE: 0.000536
in O: 0.023304
in O
sepsis O: 0.000029
sepsis O
. I-GENE: 0.004017
. O: 0.044459
. O

SIP1 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
Smad I-GENE: 0.000122
Smad I-GENE
interacting O: 0.000061
interacting O
protein I-GENE: 0.019478
protein O: 0.002083
protein I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
deltaEF1 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
delta I-GENE: 0.001023
delta O: 0.000127
delta I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
crystallin I-GENE
enhancer I-GENE: 0.001461
enhancer O: 0.000226
enhancer I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
factor I-GENE: 0.008984
factor O: 0.000510
factor I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
are O: 0.002918
are O
structurally O: 0.000049
structurally O
similar O: 0.000574
similar O
transcriptional I-GENE: 0.000268
transcriptional O: 0.000672
transcriptional O
repressors I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

SERS I-GENE
spectra O: 0.000023
spectra O
were O: 0.005244
were O
obtained O: 0.000417
obtained O
by O: 0.006887
by O
vacuum I-GENE
evaporation I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
casting I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
p I-GENE: 0.000122
p O: 0.000681
p O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
NTP I-GENE
onto O: 0.000026
onto O
silver O: 0.000020
silver O
island O: 0.000023
island O
films O: 0.000017
films O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
also O: 0.001373
also O
from I-GENE: 0.000390
from O: 0.004210
from O
colloidal I-GENE
silver O: 0.000020
silver O
solutions O: 0.000064
solutions O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
moduli I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
elasticity I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
gray O: 0.000014
gray O
and I-GENE: 0.003263
and O: 0.028529
and O
white O: 0.000127
white O
matter O: 0.000029
matter O
were O: 0.005244
were O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
4 I-GENE: 0.002362
4 O: 0.001307
4 I-GENE
+/- O: 0.001124
+/- O
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
4 I-GENE: 0.002362
4 O: 0.001307
4 I-GENE
kPa I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
mean O: 0.000423
mean O
+/- O: 0.001124
+/- O
standard O: 0.000133
standard O
deviation O: 0.000017
deviation O
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
4 I-GENE: 0.002362
4 O: 0.001307
4 I-GENE
+/- O: 0.001124
+/- O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
9 I-GENE: 0.000268
9 O: 0.000681
9 O
kPa I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
axial O: 0.000014
axial O
section O: 0.000014
section O
, I-GENE: 0.001923
, O: 0.035091
, O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
+/- O: 0.001124
+/- O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
kPa I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
+/- O: 0.001124
+/- O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
kPa I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
frontal O: 0.000032
frontal O
section O: 0.000014
section O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
+/- O: 0.001124
+/- O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
9 I-GENE: 0.000268
9 O: 0.000681
9 O
kPa I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
2 I-GENE: 0.009082
2 O: 0.002356
2 I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O
8 I-GENE: 0.000803
8 O: 0.000939
8 O
+/- O: 0.001124
+/- O
0 O: 0.002784
0 O
. I-GENE: 0.004017
. O: 0.044459
. O
4 I-GENE: 0.002362
4 O: 0.001307
4 I-GENE
kPa I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
sagittal I-GENE
section O: 0.000014
section O
, I-GENE: 0.001923
, O: 0.035091
, O
respectively O: 0.000658
respectively O
. I-GENE: 0.004017
. O: 0.044459
. O

[ O: 0.000382
[ O
Clinical O: 0.000078
Clinical O
and I-GENE: 0.003263
and O: 0.028529
and O
epidemiological O: 0.000029
epidemiological O
characteristics O: 0.000136
characteristics O
of I-GENE: 0.002337
of O: 0.042520
of O
squamous O: 0.000026
squamous O
cell I-GENE: 0.001144
cell O: 0.001927
cell O
carcinoma O: 0.000217
carcinoma O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
oral O: 0.000171
oral O
cavity O: 0.000029
cavity O
in I-GENE: 0.000536
in O: 0.023304
in O
women O: 0.000281
women O
] I-GENE: 0.000122
] O: 0.000240
] O
BACKGROUND O: 0.000081
BACKGROUND O
: I-GENE: 0.000243
: O: 0.002561
: O
Squamous I-GENE
cell I-GENE: 0.001144
cell O: 0.001927
cell O
carcinoma O: 0.000217
carcinoma O
( I-GENE: 0.006014
( O: 0.014858
( O
SCC I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
oral O: 0.000171
oral O
cavity O: 0.000029
cavity O
occurs O: 0.000119
occurs O
mainly O: 0.000084
mainly O
in I-GENE: 0.000536
in O: 0.023304
in O
the I-GENE: 0.000268
the O: 0.044902
the O
male O: 0.000162
male O
population O: 0.000136
population O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
core I-GENE: 0.000511
core O: 0.000148
core I-GENE
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
human I-GENE: 0.007109
human O: 0.001136
human I-GENE
thioredoxin I-GENE
reductase I-GENE: 0.000584
reductase I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
: I-GENE: 0.000243
: O: 0.002561
: O
cloning O: 0.000203
cloning O
, I-GENE: 0.001923
, O: 0.035091
, O
transcriptional I-GENE: 0.000268
transcriptional O: 0.000672
transcriptional O
activity O: 0.002295
activity O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
Oct I-GENE: 0.000560
Oct I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
Sp1 I-GENE: 0.002045
Sp1 I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
Sp3 I-GENE: 0.000170
Sp3 I-GENE
binding I-GENE: 0.006696
binding O: 0.001915
binding I-GENE
reveal O: 0.000052
reveal O
a I-GENE: 0.000317
a O: 0.015893
a O
housekeeping O: 0.000017
housekeeping O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
type I-GENE: 0.003384
type O: 0.000884
type I-GENE
promoter I-GENE: 0.007548
promoter O: 0.000994
promoter I-GENE
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
AU I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
rich I-GENE: 0.000195
rich O: 0.000278
rich O
element I-GENE: 0.001680
element O: 0.000577
element I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
regulated I-GENE: 0.000268
regulated O: 0.000368
regulated O
gene I-GENE: 0.021572
gene O: 0.001654
gene I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Phase O: 0.000014
Phase O
II I-GENE: 0.003263
II O: 0.000362
II I-GENE
trial O: 0.000087
trial O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
anti I-GENE: 0.001704
anti O: 0.000087
anti I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
G I-GENE: 0.001826
G O: 0.000200
G I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
D2 I-GENE: 0.000195
D2 I-GENE
) I-GENE: 0.005210
) O: 0.009341
) O
monoclonal I-GENE: 0.000170
monoclonal O: 0.000035
monoclonal I-GENE
antibody I-GENE: 0.000536
antibody O: 0.000159
antibody I-GENE
3F8 I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
granulocyte I-GENE: 0.000268
granulocyte I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
macrophage I-GENE: 0.000243
macrophage O: 0.000017
macrophage I-GENE
colony I-GENE: 0.000438
colony O: 0.000014
colony I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
stimulating I-GENE: 0.000536
stimulating O: 0.000038
stimulating I-GENE
factor I-GENE: 0.008984
factor O: 0.000510
factor I-GENE
for O: 0.006951
for O
neuroblastoma O: 0.000014
neuroblastoma O
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
log O: 0.000029
log O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
linear O: 0.000052
linear O
dose O: 0.000469
dose O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
response I-GENE: 0.000779
response O: 0.000794
response O
was O: 0.006960
was O
obtained O: 0.000417
obtained O
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
average O: 0.000127
average O
increase O: 0.000513
increase O
in I-GENE: 0.000536
in O: 0.023304
in O
FEV1 O: 0.000032
FEV1 O
up O: 0.000336
up O
to I-GENE: 0.000195
to O: 0.014977
to O
6 I-GENE: 0.002118
6 O: 0.001153
6 I-GENE
h O: 0.000368
h O
( I-GENE: 0.006014
( O: 0.014858
( O
AUC0 I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
6 I-GENE: 0.002118
6 O: 0.001153
6 I-GENE
h O: 0.000368
h O
) I-GENE: 0.005210
) O: 0.009341
) O
and I-GENE: 0.003263
and O: 0.028529
and O
peak O: 0.000099
peak O
FEV1 O: 0.000032
FEV1 O
across O: 0.000052
across O
the I-GENE: 0.000268
the O: 0.044902
the O
dose O: 0.000469
dose O
range O: 0.000229
range O
administered O: 0.000185
administered O
by O: 0.006887
by O
Respimat I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

Plasma I-GENE: 0.000219
Plasma O: 0.000058
Plasma I-GENE
DHE I-GENE
concentration O: 0.000330
concentration O
rose O: 0.000038
rose O
promptly I-GENE
above O: 0.000119
above O
5 I-GENE: 0.002678
5 O: 0.002524
5 I-GENE
ng O: 0.000116
ng O
/ I-GENE: 0.005527
/ O: 0.004395
/ I-GENE
ml O: 0.000438
ml O
after O: 0.001385
after O
the I-GENE: 0.000268
the O: 0.044902
the O
application O: 0.000081
application O
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
PSA I-GENE: 0.000195
PSA I-GENE
tape I-GENE
onto O: 0.000026
onto O
the I-GENE: 0.000268
the O: 0.044902
the O
damaged O: 0.000023
damaged O
skin O: 0.000133
skin O
in I-GENE: 0.000536
in O: 0.023304
in O
hairless I-GENE
rat I-GENE: 0.001607
rat O: 0.000409
rat I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

A I-GENE: 0.003530
A O: 0.002246
A I-GENE
complete O: 0.000197
complete O
drug O: 0.000267
drug O
history O: 0.000104
history O
was O: 0.006960
was O
compiled I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
specifying I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
amount O: 0.000078
amount O
and I-GENE: 0.003263
and O: 0.028529
and O
duration O: 0.000078
duration O
of I-GENE: 0.002337
of O: 0.042520
of O
VGB I-GENE
medication O: 0.000035
medication O
. I-GENE: 0.004017
. O: 0.044459
. O

Epithelial I-GENE
cytotoxicity O: 0.000014
cytotoxicity O
of I-GENE: 0.002337
of O: 0.042520
of O
combined O: 0.000122
combined O
antibiotics O: 0.000014
antibiotics O
was O: 0.006960
was O
additive O: 0.000023
additive O
, I-GENE: 0.001923
, O: 0.035091
, O
with O: 0.009756
with O
no O: 0.000687
no O
evidence O: 0.000342
evidence O
of I-GENE: 0.002337
of O: 0.042520
of O
competition O: 0.000041
competition O
or I-GENE: 0.000219
or O: 0.003321
or O
synergism I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

In O: 0.002266
In O
Cd O: 0.000029
Cd O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
spiked I-GENE
OECD I-GENE
soil I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
internal O: 0.000142
internal O
Cd O: 0.000029
Cd O
levels O: 0.001304
levels O
were O: 0.005244
were O
linearly I-GENE
related I-GENE: 0.001266
related O: 0.000597
related I-GENE
to I-GENE: 0.000195
to O: 0.014977
to O
external O: 0.000041
external O
Cd O: 0.000029
Cd O
concentrations O: 0.000417
concentrations O
, I-GENE: 0.001923
, O: 0.035091
, O
whereas O: 0.000351
whereas O
the I-GENE: 0.000268
the O: 0.044902
the O
springtails I-GENE
maintained O: 0.000064
maintained O
fixed O: 0.000032
fixed O
internal O: 0.000142
internal O
levels O: 0.001304
levels O
of I-GENE: 0.002337
of O: 0.042520
of O
Cu O: 0.000017
Cu O
and I-GENE: 0.003263
and O: 0.028529
and O
Zn O: 0.000023
Zn O
regardless O: 0.000026
regardless O
of I-GENE: 0.002337
of O: 0.042520
of O
spiked I-GENE
concentrations O: 0.000417
concentrations O
. I-GENE: 0.004017
. O: 0.044459
. O

Interestingly O: 0.000090
Interestingly O
, I-GENE: 0.001923
, O: 0.035091
, O
the I-GENE: 0.000268
the O: 0.044902
the O
similarities O: 0.000046
similarities O
with O: 0.009756
with O
the I-GENE: 0.000268
the O: 0.044902
the O
endophilin I-GENE
proteins I-GENE: 0.005673
proteins O: 0.000933
proteins I-GENE
cover I-GENE
the I-GENE: 0.000268
the O: 0.044902
the O
entire O: 0.000099
entire O
sequence I-GENE: 0.002021
sequence O: 0.001866
sequence I-GENE
of I-GENE: 0.002337
of O: 0.042520
of O
the I-GENE: 0.000268
the O: 0.044902
the O
SH3GLB I-GENE
family I-GENE: 0.002922
family O: 0.000313
family I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
suggesting O: 0.000400
suggesting O
a I-GENE: 0.000317
a O: 0.015893
a O
common O: 0.000246
common O
fold O: 0.000229
fold O
and I-GENE: 0.003263
and O: 0.028529
and O
presumably O: 0.000023
presumably O
a I-GENE: 0.000317
a O: 0.015893
a O
common O: 0.000246
common O
mode O: 0.000041
mode O
of I-GENE: 0.002337
of O: 0.042520
of O
action O: 0.000177
action O
. I-GENE: 0.004017
. O: 0.044459
. O

Reovirus I-GENE
mRNAs I-GENE: 0.000487
mRNAs O: 0.000116
mRNAs I-GENE
are O: 0.002918
are O
efficiently O: 0.000110
efficiently O
translated O: 0.000067
translated O
within O: 0.000823
within O
host O: 0.000075
host O
cells O: 0.002663
cells O
despite O: 0.000084
despite O
the I-GENE: 0.000268
the O: 0.044902
the O
absence O: 0.000206
absence O
of I-GENE: 0.002337
of O: 0.042520
of O
3 I-GENE: 0.005235
3 O: 0.002251
3 I-GENE
' I-GENE: 0.000950
' O: 0.001701
' O
polyadenylated O: 0.000014
polyadenylated O
tails O: 0.000014
tails O
. I-GENE: 0.004017
. O: 0.044459
. O

Grippers I-GENE
with O: 0.009756
with O
integrated O: 0.000046
integrated O
piezoresistive I-GENE
force O: 0.000026
force O
sensors I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
with O: 0.009756
with O
attached O: 0.000017
attached O
strain O: 0.000162
strain O
gauges I-GENE
have O: 0.001788
have O
been O: 0.001229
been O
reported O: 0.000278
reported O
. I-GENE: 0.004017
. O: 0.044459
. O

Both O: 0.000168
Both O
Z I-GENE: 0.000219
Z O: 0.000035
Z I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
R I-GENE: 0.001023
R O: 0.000154
R I-GENE
expression O: 0.002231
expression O
resulted O: 0.000287
resulted O
in I-GENE: 0.000536
in O: 0.023304
in O
PML I-GENE
dispersion O: 0.000020
dispersion O
in I-GENE: 0.000536
in O: 0.023304
in O
EBV O: 0.000041
EBV O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
positive O: 0.000411
positive O
cells O: 0.002663
cells O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
small I-GENE: 0.000682
small O: 0.000290
small I-GENE
copepod I-GENE
Pseudonychocamptus I-GENE
proximus I-GENE
progressively I-GENE
replaced O: 0.000041
replaced O
the I-GENE: 0.000268
the O: 0.044902
the O
large I-GENE: 0.000146
large O: 0.000278
large O
Tisbe I-GENE
furcata I-GENE
in I-GENE: 0.000536
in O: 0.023304
in O
sand I-GENE
filters I-GENE
during O: 0.001095
during O
the I-GENE: 0.000268
the O: 0.044902
the O
fall O: 0.000043
fall O
of I-GENE: 0.002337
of O: 0.042520
of O
1995 O: 0.000026
1995 O
and I-GENE: 0.003263
and O: 0.028529
and O
was O: 0.006960
was O
responsible O: 0.000142
responsible O
for O: 0.006951
for O
the I-GENE: 0.000268
the O: 0.044902
the O
large I-GENE: 0.000146
large O: 0.000278
large O
increase O: 0.000513
increase O
in I-GENE: 0.000536
in O: 0.023304
in O
meiofaunal I-GENE
biomass I-GENE
observed O: 0.000635
observed O
after O: 0.001385
after O
spring I-GENE
1996 O: 0.000017
1996 O
. I-GENE: 0.004017
. O: 0.044459
. O

Evidence O: 0.000032
Evidence O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
based O: 0.000287
based O
care O: 0.000107
care O
: I-GENE: 0.000243
: O: 0.002561
: O
a I-GENE: 0.000317
a O: 0.015893
a O
new O: 0.000464
new O
formula O: 0.000026
formula O
for O: 0.006951
for O
an O: 0.003112
an O
old O: 0.000139
old O
problem O: 0.000046
problem O
? O: 0.000081
? O

Nrf2 I-GENE
regulates O: 0.000125
regulates O
expression O: 0.002231
expression O
of I-GENE: 0.002337
of O: 0.042520
of O
genes I-GENE: 0.004626
genes O: 0.000918
genes I-GENE
encoding I-GENE: 0.000414
encoding O: 0.000562
encoding O
enzymes O: 0.000127
enzymes O
with O: 0.009756
with O
antioxidant O: 0.000017
antioxidant O
( I-GENE: 0.006014
( O: 0.014858
( O
e O: 0.000209
e O
. I-GENE: 0.004017
. O: 0.044459
. O
g O: 0.000307
g O
. I-GENE: 0.004017
. O: 0.044459
. O
heme O: 0.000023
heme O
oxygenase I-GENE: 0.000122
oxygenase I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
HO I-GENE
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
1 I-GENE: 0.021401
1 O: 0.003355
1 I-GENE
)) O: 0.000023
)) O
or I-GENE: 0.000219
or O: 0.003321
or O
xenobiotic I-GENE
detoxification I-GENE
( I-GENE: 0.006014
( O: 0.014858
( O
e O: 0.000209
e O
. I-GENE: 0.004017
. O: 0.044459
. O
g O: 0.000307
g O
. I-GENE: 0.004017
. O: 0.044459
. O

Workload I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
UAPs I-GENE
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
you I-GENE
. I-GENE: 0.004017
. O: 0.044459
. O

RESULTS O: 0.000180
RESULTS O
: I-GENE: 0.000243
: O: 0.002561
: O
At O: 0.000104
At O
latest I-GENE
examination O: 0.000096
examination O
, I-GENE: 0.001923
, O: 0.035091
, O
mean O: 0.000423
mean O
UPDRS I-GENE
II I-GENE: 0.003263
II O: 0.000362
II I-GENE
and I-GENE: 0.003263
and O: 0.028529
and O
III I-GENE: 0.001047
III O: 0.000148
III I-GENE
scores O: 0.000067
scores O
had O: 0.000890
had O
improved O: 0.000084
improved O
by O: 0.006887
by O
30 O: 0.000423
30 O
% O: 0.001741
% O
( I-GENE: 0.006014
( O: 0.014858
( O
on O: 0.003416
on O
stimulation O: 0.000293
stimulation O
, I-GENE: 0.001923
, O: 0.035091
, O
off O: 0.000032
off O
therapy O: 0.000351
therapy O
) I-GENE: 0.005210
) O: 0.009341
) O
with O: 0.009756
with O
mean O: 0.000423
mean O
50 O: 0.000322
50 O
% O: 0.001741
% O
reduction O: 0.000206
reduction O
in I-GENE: 0.000536
in O: 0.023304
in O
daily O: 0.000154
daily O
off O: 0.000032
off O
time O: 0.000542
time O
. I-GENE: 0.004017
. O: 0.044459
. O

Perfusion I-GENE
technique O: 0.000183
technique O
for O: 0.006951
for O
perfusion O: 0.000075
perfusion O
- I-GENE: 0.107007
- O: 0.025367
- I-GENE
assisted I-GENE
direct O: 0.000264
direct O
coronary O: 0.000174
coronary O
artery O: 0.000154
artery O
bypass O: 0.000049
bypass O
( I-GENE: 0.006014
( O: 0.014858
( O
PADCAB I-GENE
). O: 0.002228
). O

Copyright O: 0.000032
Copyright O
2001 I-GENE
Academic O: 0.000029
Academic O
Press O: 0.000026
Press O
. I-GENE: 0.004017
. O: 0.044459
. O

The O: 0.007383
The O
amount O: 0.000078
amount O
of I-GENE: 0.002337
of O: 0.042520
of O
drained I-GENE
effusion I-GENE
was O: 0.006960
was O
measured O: 0.000400
measured O
, I-GENE: 0.001923
, O: 0.035091
, O
and I-GENE: 0.003263
and O: 0.028529
and O
fluid O: 0.000145
fluid O
was O: 0.006960
was O
sent I-GENE
for O: 0.006951
for O
diagnostic O: 0.000107
diagnostic O
assessment O: 0.000087
assessment O
. I-GENE: 0.004017
. O: 0.044459
. O

